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Nowick and co-workers have reported that ethylene-bridged triureas can be synthesised 
with complete conformational control by judicious use of steric hindrance and hydrogen bonding.1 
The concept of complete but switchable conformational control of these structures has not been 
investigated and is of interest as it gains access to dynamic peptide mimics with switchable 
hydrogen-bond directionality. 
 
Figure 1 – Dynamic hydrogen-bond directionality-switchable oligoureas. 
Previous work in the Clayden group has shown that achiral oligourea-derived foldamers 
can communicate stereochemical information by binding a chiral ligand and inducing a helical 
excess.2 This served as the first example of reversible hydrogen-bond directionality in a synthetic 
foldamer. In our design, the global directionality of an ethylene-bridged oligourea foldamer can 
be controlled by applying an electronic bias at one terminus. When terminated with a hydrogen-
bond acceptor (HBA), the global directionality of the foldamer is defined and controlled owing 
to the hydrogen bond between the HBA and the ureido proton of the adjacent urea, and the 
hydrogen bonding between the ureas in the foldamer. The orientation of the final urea can be 
inferred from variable-temperature 1H NMR and NOE studies of the ureido protons and a benzylic 
methylene spectroscopic reporter.  The opposite directionality can be accessed by using a terminal 
hydrogen-bond donor (HBD) instead of an HBA. The directionality of these foldamers can be 
switched by employing a terminal 2-pyridyl group, which can be switched between an HBD and 
an HBA by protonation/deprotonation. Upon protonation, the first urea reorients in order to 
hydrogen bond to the resultant pyridinium. This reorientation is communicated as binary 
information throughout the rest of the foldamer, resulting in a global directionality switch. 
Preliminary experiments on effecting the switching process with the light-induced 
photodissociation/association of a photoacid have been performed. Investigations into 
directionality-switchable foldamers with binding sites complementary to those of DNA 
nucleobases have been conducted. Different spectroscopic or chemical outputs at the reporting 
terminus have also been explored.   
Ethylene-bridged oligoureas represent a new class of foldamers that can undergo a global 
directionality switch in response to pH change or exposure to light, and could be amenable to 
DNA ligand binding. The concept of switching hydrogen-bond directionality in foldamers is a 
significant simplification of how biological systems store and communicate information and 
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1.1 Informational Communication in Biological Systems 
 
 Hydrogen bonding is one of the most predominant and powerful interactions found in 
nature. It is responsible for myriad natural phenomena on a variety of scales. For example, it gives 
rise to the association of the nucleobases found in deoxyribonucleic acid (DNA) and to the highly 
selective binding of substrates in proteins.3 It also results in the folding of proteins into their 
secondary and tertiary structures, which are vital to their function.4,5 Hydrogen bonds vary greatly 
in strength (1-160 kJ mol-1) but they are, relative to covalent and ionic bonds, weak interactions.6 
This lability confers a rich dynamic nature, which allows them to be switched on and off thermally 
at physiologically relevant temperatures. As a result, they can be exploited to modulate important 
properties, such as reactivity and binding affinity, with an immaculate level of spatial accuracy 
and precision.7 
 A hydrogen bond, as well as being an adhesive interaction, has an inherent directionality 
associated with it that can lend itself to more exotic functions.8 It is this directionality of hydrogen 
bonds that is responsible for the storage, communication and processing of information in 
biological systems.9,10 As a naturally ubiquitous example, codons are trinucleotides that use their 
specific pattern of hydrogen-bonding groups to code for a specific amino acid to be incorporated 
into a growing polypeptide chain by the ribosome.11 In the ‘CCC’ codon, three units of cytidine 
are contiguously bound, which represents a detailed pattern of hydrogen-bond donors and 
acceptors to be templated by messenger RNA (mRNA) (Figure 2). This templating forms a new 
pattern of hydrogen bonds that exactly complements that of the codon. Transfer RNA (tRNA) 
then templates with the mRNA in the same fashion to form an adduct, which fits into the active 
site of aminoacyl tRNA synthetases. The tRNA synthetase then transfers a molecule of the amino 
acid, L-proline to the tRNA. This L-proline is then transferred to the ribosome by the tRNA for it 




Figure 2 – Hydrogen-bond directionality in DNA templating. 
There are four different nucleobases and therefore 43 = 64 different permutations of how 
three nucleobases can be arranged in codons. These 64 codons code for the binding of tRNA to 
21 different aminoacyl synthetases, each with a different amino acid bound to it for protein 
biosynthesis. Some codons are degenerate and therefore result in the incorporation of the same 
amino acid into the polypeptide chain, and some are known as ‘stop’ codons, which terminate 
protein biosynthesis and mark the end of the chain.12 In this natural example, information in the 
form of hydrogen-bond directionality is stored in the codons, communicated through space by 
RNA, and results in the performance of a specific function by the resultant protein. Taking 
inspiration from nature, organic chemists have created many molecular machines that use 
hydrogen bonding to perform function.13 However, there are few examples that exploit their 












1.2 Hydrogen-Bonding Theory 
 
The theoretical consideration and treatment of the hydrogen bond has evolved 
enormously over the past two centuries. Although the study of chlorine decahydrate by Michael 
Faraday in 1823 alluded to such an interaction, it was almost a century later when hydrogen-
bonding interactions became explicable following advances made in X-ray structural analysis and 
contemporary chemical bonding theory.8 The term ‘hydrogen bridge’ was allegedly established 
by Maurice Huggins in his thesis in 1919 and was used to explain the tautomeric behaviour of 
acetoacetic acid. No records of the thesis exist, but the earliest extant citation of his work was by 
his colleagues, Latimer and Rodebush only a year later.14 They described that a hydrogen nucleus 
may be held between two oxygen octets by forces which obey Hooke’s law over great distances 
and that such a hydrogen would be capable of considerable displacement by an electric field. 
These postulates drawn from imagination and simple thermodynamic calculations served as the 
first appropriate recognition of what is today called a hydrogen bond. These early findings could 
account for empirical observations of the exotic properties of water, such as its unusual melting / 
boiling point, deviation from Raoult’s Law, solubility properties, complex formation and 
viscosity.8  
In 1925, the inception of X-ray analytical techniques incurred a significant advancement 
in bonding theory. Over the course of the following 5 years, scientists used these first crystal 
structures to provide evidence for covalent, ionic and metallic bonds, and to lend credence to 
Huggins’ description of a hydrogen bridge. Linus Pauling published a seminal paper in 1931 
describing the quantum mechanical nature of chemical bonds,15 which later culminated in his 
celebrated book ‘The Nature of the Chemical Bond’.16 Here, he described the bonding in               
[H-F-H]+ and attributed the concept of what then became known as the hydrogen bond to Huggins. 
Rapidly, the hydrogen bond became recognised as a crucial element of structural chemistry. It not 
only began to explain previously unaccountable scientific findings such as the exotic properties 
of water, but informed future research which saw the discovery of the α-helix and the β-sheet – 
crucial elements of protein architecture, and culminated in the discovery of the DNA-double helix 






The definition of a hydrogen bond has been subject to extensive refinement since its 
discovery. A modern interpretation, adapted from the theory of relative atom electronegativities 
from Pauling’s ‘The Nature of the Chemical Bond’, is that a hydrogen bond is an attractive 
interaction that forms when a hydrogen-bond donor (HBD), D-H donates a proton to a hydrogen-
bond acceptor (HBA), A (Figure 3).8 For the HBD to be able to donate a hydrogen bond, the 
electronegativity of D must be greater than H such that significant electron density can be 
withdrawn from the D-H σ-bond, leaving the proton partially deshielded. The HBA, A must have 
a lone pair of electrons or π electrons that can interact with the donor bond.  
 
Figure 3 – The formation of a hydrogen bond. 
There are five main components that affect the strength of a hydrogen bond: (a) 
electrostatic attraction, the attractive interaction between the negatively charged electrons in the 
HBA, and the positively charged proton of the HBD; (b) exchange repulsion, the repulsive 
interaction between two fermions which simultaneously occupy the same quantum state in the 
same quantum system, violating the Pauli exclusion principle; (c) polarisation, the attractive 
interaction between a charge cloud on the HBA and the permanent multipoles of the HBD; (d) 
charge transfer, the attractive quantum mechanical interaction arising from the construction of a 
new wavefunction for the hydrogen-bonded complex; and (e) dispersion, the attractive interaction 
arising from the fluctuating dipoles of the HBA and the HBD.8 These five contributions to 
hydrogen-bond strength have different optimum hydrogen-bonding angles (the D-H-A angle, θ) 
and magnitudes depending on the chemical species. Nonempirical calculations performed by 
Duijneveldt have concluded that, in agreement with other independent semiempirical 
investigations, the electrostatic attraction, exchange repulsion, polarisation and charge transfer (a-
d) contributions are all of the same order of magnitude as the total hydrogen-bond energy.17 
Exchange repulsion is insensitive to hydrogen-bonding angle and contributes only to hydrogen-
bond length. This means that the dominant attractive contribution will depend on the specific 





 For example, in hydrogen fluoride, the charge density map about the fluorine atom shows 
a near-spherically symmetrical electronic distribution about the lone pair hemisphere. This means 
that there would be no preferential hydrogen-bond trajectory from an electrostatic standpoint, 
provided it was above 90° to avoid proton-proton interactions. However, the maximum 
polarisation contribution to hydrogen-bond strength is at θ = 180°, as this optimises interaction 
with each of the lone pairs of electrons about the sp3-hybridised fluorine atom. Finally, the optimal 
charge transfer contribution would arise from direct overlap of the highest occupied molecular 
orbital (HOMO) of the hydrogen fluoride (the non-bonding π-orbitals of the fluorine atom, Figure 
4) and the lowest unoccupied molecular orbital (LUMO) of the HBD (the σ* orbital of the D-H 
bond), which would correspond to θ = 102° according to valence shell electron pair repulsion 
theory (VSEPR). In the hydrogen fluoride dimer, the compromise of these factors culminates in 
a calculated minimum-energy angle of 140-160°. Interestingly, as the hydrogen fluoride oligomer 
gets longer, the charge transfer term becomes more dominant, resulting in a lowering of θ.  
 
Figure 4 – Molecular orbital diagram for hydrogen fluoride. 
When formaldehyde acts as an HBA, the HOMO is an n orbital of B2 symmetry, where a 
nodal plane exists in the xz plane (if the xy plane is the molecular plane with the C=O bond in the 
x direction, Figure 5). The polarisation-favoured θ is 180° but transfer of electron density along 
this trajectory is symmetry-forbidden. Therefore, a charge transfer contribution to a hydrogen 
bond with formaldehyde must come from the lower energy A1 σ orbital, where charge transfer is 
allowed. The A1 σ orbital is substantially lower in energy than the B2 n orbital, which means that 
there would only be a small charge transfer contribution to the hydrogen-bonding energy if the 
polarisation-favoured approach was followed. Therefore, in the case of formaldehyde, the 
polarisation-favoured trajectory is compromised in order to maximise charge transfer from the B2 
orbital, resulting in a θ of 116° when water is the HBD.8  
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Additionally, hydrogen bonds that deviate from the carbonyl plane can be bolstered by 
charge transfer occurring from the carbonyl π bond, which is of B1 symmetry. This orbital is lower 
in energy than the B2 orbitals and so the stabilisation from this effect is not as significant as charge 
transfer in the carbonyl plane. 
 
Figure 5 – Optimal geometries for hydrogen-bonding contributions in formaldehyde. 
Dreyfus and Pullman extended this computational analysis and found that θ in the 
formamide dimer is near 120° and that the difference in energy between this conformer and that 
where θ = 180° is 6.3 kJ mol-1, comparable to that of formaldehyde.18 Similarly, the HOMO of 
formamide is an n orbital of B2 symmetry, where the same orbital symmetry effects apply. These 
effects are sensitive to hydrogen-bonding distance – due to their quantum mechanical nature, the 
B2 orbitals will transfer more charge to more proximate HBDs, such that the preference to follow 
the charge-transfer-favoured trajectory of 120° decays with distance and the hydrogen-bonding 
trajectory tends towards the polarisation-favoured direction of 180°. This is commensurate with 
observations from Coulson, Danielson and Michaelides that longer hydrogen bonds are more 
electrostatic in nature, whereas shorter hydrogen bonds have larger charge-transfer contributions 
and are more covalent in nature.18,19 It is proposed that this concept can be extrapolated to 
trisubstituted ureas, in that the optimum θ for hydrogen-bonded urea oligomers is near 120°, and 




Hydrogen bonds provide thermodynamic stabilisation to molecules, meaning that there 
are enthalpic and entropic contributions to their energy. The discussed phenomena have only 
applied to intermolecular hydrogen bonds, where hydrogen-bond strength can be optimised 
without geometric restriction. In an intermolecular hydrogen-bonding pair, dilution will increase 
the entropic cost to hydrogen bonding. The intramolecular analogy is that if a hydrogen bonding-
pair must unite over a certain distance using a tether with many degrees of freedom, there is a 
high entropic cost to pay. As the distance between them increases, the entropic cost becomes 
greater. The enthalpic contribution may also differ from the intermolecular variant as geometric 
restriction may not allow optimal hydrogen bonding to take place. 
Cockroft and co-workers investigated relative intramolecular hydrogen-bonding strength 
between N,N-dimethylamides and phenols by varying the number of rotatable bonds that 
separated them (Figure 6).21 The strength of the intramolecular hydrogen bonds was extrapolated 
by measuring the propensity for external HBAs to interrupt the intramolecular hydrogen bonds.  
 
Figure 6 – Investigation of intramolecular hydrogen bonding by tether extension (the compound 
number denotes the number of rotatable bonds, and the number in brackets denotes the hydrogen-
bonding ring size. Rotatable bonds are emboldened).21 
Compounds 1(6)-9(13) were analysed by 19F NMR with equimolar quantities of external 
HBAs sulfoxide 12 and phosphine oxide 13, and the difference in chemical shift of the aryl 
fluoride signal was monitored as the solutions were diluted. If a weak intramolecular hydrogen 
bond was present, it would be supplanted by an intermolecular hydrogen bond with the external 
HBA. Consequently, the aryl fluoride chemical shift would change with dilution due to the 
increased entropic penalty of intermolecular hydrogen bonding. If a strong intramolecular 
hydrogen bond was present, the aryl fluoride chemical shift would be insensitive to dilution as 
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there would be no contribution from intermolecular hydrogen bonding. For smaller hydrogen-
bonding rings with fewer rotatable bonds, such as compounds 1(6)-5(9), sulfoxide 12 did not 
participate in any detectable intermolecular hydrogen bonding, representing strong intramolecular 
hydrogen bonding between the phenol and the amide (Figure 7a). Upon extending the alkyl 
amide tether to 6(10), intermolecular hydrogen bonding was detected, indicating a sharp decline 
in intramolecular hydrogen-bonding strength. The free energy change upon intermolecular 
binding, ΔGobs was deduced by relation to the binding constant Kobs through the equation ΔGobs = 
−RTlnKobs, where Kobs was obtained by fitting the observed chemical shifts to a 1:1 binding model. 
Extension to 7(11) saw a slight further attenuation of intramolecular hydrogen bonding which 
then stayed approximately constant upon further homologation. This plateau matched the 
observed free energy of hydrogen bonding for the intermolecular variant, phenol 10 with amide 
11. Phosphine oxide 13 is a much stronger HBA than sulfoxide 12 and therefore even with phenols 
2(6) and 3(7), partial intramolecular hydrogen-bond disruption was observed. Extension to 4(8) 
mitigated the competitive intermolecular hydrogen bonding, bringing ΔGobs near to zero. Above 
4 rotatable bonds, phosphine oxide 13 exhibited the same behaviour as sulfoxide 12 (Figure 7a). 
 
Figure 7 – The dependence of (a) experimental binding free energies, ΔGobs and (b) dissected folding 
energies, ΔGintra on the number of rotatable bonds in an alkyl tether.21 
It can be inferred from this that structures with 5 or fewer rotatable bonds form very 
strong intramolecular hydrogen bonds that need remarkably strong HBAs to disrupt them. This 
shows that hydrogen-bonding rings with up to 9 members are among the most stable. However, 
it should be mentioned that the strong intramolecular hydrogen bonding in phenols 1(6) and 2(6) 
may be augmented by conjugation of the phenol with the amide. Additionally, dissected folding 
energies were deduced for compounds with 4 or more rotatable bonds by relating Kobs to the free 
energy change upon intramolecular hydrogen bonding, ΔGintra. There was a steep and negative 
linear correlation between the number of rotatable bonds and ΔGintra (Figure 7b). Inspection of 
this relationship revealed an entropic penalty to hydrogen bonding of 5.7 kJ mol-1 for each 
rotatable bond in this particular system at 20 °C. This hydrogen-bond weakening can also be 
Number of rotatable bonds 
(a) (b) 
Number of rotatable bonds 
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attributed to the transannular strain associated with the formation of the hydrogen-bonding ring. 
Finally, it is worth noting that the system described here only describes modification of the tether 
by extension with an sp3-hybridised methylene group. Different atoms, hybridisations and 
substitutions within the tether are expected to have a large effect on intramolecular hydrogen 
bonding. 
Effective molarity (EM) is a parameter that is commonly applied to intramolecular 
reactions. In the case of intramolecular hydrogen bonding, it is measured as the ratio between the 
intramolecular association constant and the corresponding intermolecular association constant.22 
Hunter and co-workers designed a method to deduce the dependence of the EM of hydrogen bonds 
on geometric and electronic factors. A broad range of zinc porphyrin complexes with pendent 
HBDs and pyridine ligands with pendent HBAs were synthesised.23 The families of zinc 
porphyrin complexes and pyridine ligands were ligated and the contribution to the complexation 
by the resultant hydrogen-bonding interactions was determined by use of a double-mutant cycle 
(Figure 8).  
 
Figure 8 – Double-mutant cycle experiment for the determination of hydrogen-bond EM.
22 
The double-mutant cycle operated by using zinc porphyrin-pyridine complexes that were 
highly structurally analogous to the hydrogen-bonded system, except the HBDs and HBAs were 
sequentially removed. The free energy contributions upon ligand binding could then be deduced 
by using UV-Vis titrations and monitoring the fluorescence of the porphyrin. Comparison of 
ΔGobs of these four complexes could be used to dissect out the contribution of secondary effects 
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of the ligand/complex to binding, leaving only the contribution of the hydrogen bond. This ΔΔG 
could then be used to deduce the association constant for hydrogen bonding, Kassoc, and by 
comparison to the analogous intermolecular complex, the EM of that particular hydrogen bond. 
 Double-mutant cycle experiments for 240 different zinc porphyrin-pyridine complexes 
revealed several correlations. First, different HBAs with similar geometries but different 
polarities were fused to the 3-(3-pyridyl)propionate ligand and contrasted. Comparison of 
complexes with pendent phosphine oxides, amides and esters showed that hydrogen-bond EM 
was insensitive to the polarity of the HBA and therefore the intrinsic strength of the hydrogen 
bond. Similarly, comparison of the complexes in toluene and 1,1,2,2-tetrachloroethane (TCE) 
revealed that hydrogen-bond EM was independent of the polarity of the medium. This means that 
the contribution of the solvent to hydrogen-bond strength is factored out by the double-mutant 
cycle experiment. However, phosphonate diesters and amides are HBAs with similar polarities, 
but different geometries. The two complexes formed of these groups exhibited different 
hydrogen-bond EMs, indicating a sensitivity to subtle changes in hydrogen-bond geometry. 
Finally, a wide range of pyridine linkers were synthesised to give an appropriate range of HBD-
HBA distances, and it was found that hydrogen-bond EM differed greatly depending on the size 
of the linker. In these supramolecular architectures, hydrogen-bond EM can range between 3-240 
mM, and its sensitivity derives only from hydrogen-bond geometry complementarity and length. 
The corollary of this is that, unless a more thermodynamically favourable alternative is available, 
a hydrogen bond will always form independent of hydrogen-bond strength and solvent polarity 
provided that the HBD and HBA are proximate and of the correct geometry to do so. 
 This work was extended by Hunter and co-workers to the hydrogen-bond-accepting 
solvent, cyclohexanone.24 As discussed, EM is an intrinsic property of a complex, and so should 
be insensitive to the polarity of its medium. EMs determined in toluene and TCE were used to 
calculate expected complex stabilities in cyclohexanone. There was strong agreement between 
that of toluene and cyclohexanone, but there were significant discrepancies between TCE and 
cyclohexanone. Ligand coordination and hydrogen bonding were factored out using the double-
mutant cycle experiments, and so these discrepancies were attributed to the stability of the solvent 
shell. It was further clarified that in the case of TCE, EMs of the hydrogen bonds were 
anomalously high due to steric desolvation of the phosphonate diesters upon pyridine 
coordination and hydrogen bonding. This means that hydrogen bonds may become more prone to 




Hydrogen-bonding chains are highly prevalent in supramolecular and biological systems. 
Hydrogen-bond cooperativity – the theory that contiguously bound hydrogen-bonded units 
exhibit a synergistic effect on hydrogen-bond strength, has been widely accepted by the 
supramolecular community.25 The use of this cooperativity to modulate hydrogen-bond strength 
remote from hydrogen-bonding sites is a very useful tool that both nature and supramolecular 
chemists have recognised and exploited to facilitate informational communication26 and control 
macromolecular structure.27,28 Although many properties are affected by hydrogen-bond 
cooperativity, it is very difficult to specifically measure the strength of the effect due to further 
contributions from intermolecular effects, entropy and modified electrostatic and polarisation 
parameters.29 
 To combat this issue, Cockroft and co-workers developed the use of N,N-diaryl 
formamides as molecular balances for the quantification of hydrogen-bond cooperativity.29 One 
of the arenes bore varying numbers of amphoteric phenolic groups for the formation of contiguous 
hydrogen bonds (Figure 9). Due to the rotameric nature of the formamide, the equilibrium 
concentrations of the two rotamers could be quantified by 19F NMR at 20 °C. The equilibrium 
distribution of rotamers was biased towards the s-cis conformation (with respect to the 
hydroxylated arene) due to the formation of a hydrogen bond between the formamide and the 
ortho-phenol. This approach eliminated effects arising from alternative hydrogen-bonding modes, 
intermolecular effects, and steric encumbrance. 
 
Figure 9 – N,N-diarylformamide balances for the quantification of hydrogen-bond cooperativity.29 
 The equilibrium distribution of rotamers was used to determine a value for the 
equilibrium constant, which was then used to determine the difference in free energy of the two 
rotamers, ΔG. ΔG was influenced by the electronic properties of the two arenes, but 
predominantly by the strength of the hydrogen bond that the formamide formed with the phenol. 
This meant that if cooperative hydrogen-bonding effects augmented the hydrogen-bond-donating 
ability of the ortho-phenol, then that effect would be represented by the change in equilibrium 
distribution of formamide rotamers, which could then be converted to ΔG. In the case of ortho-
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phenol, 14, where only one hydrogen bond was present, there was a strong preference for the 
hydrogen-bonded rotamer corresponding to ΔG = −4.2 kJ mol-1 (Figure 10a). Interestingly, when 
a second hydrogen-bonding unit was added in the case of the 3-formamidocatechol, 15, the free 
energy difference approximately doubled to ΔG = −8.1 kJ mol-1, suggesting that the terminal 
phenol became almost twice as good an HBD upon introduction of a second hydrogen bond. This 
effect was persistent even upon addition of 10% (v/v) acetonitrile as a competitive hydrogen-
bond-accepting solvent. This change in hydrogen-bond-donating ability could have been 
attributed to the alteration of substituent effects, and so control experiments were performed by 








Figure 10 – Control experiments for N,N-diarylformamide balances. (a) ΔG values in the presence of 
CD3CN (XH denotes how many intramolecular hydrogen bonds are present). (b) Hammett analyses 
of non-hydrogen-bonded arenes (0X) and singly hydrogen-bonded arenes (1X).29 
Two Hammett plots were constructed by measuring ΔG for N,N-diaryl formamides with 






Figure 10b). The difference in ΔG for 0X and 1X at the certain ∑σ values represented the ΔG of 
hydrogen bonding with substituent effects that would arise from further hydroxylation removed. 
The most pertinent example is the comparison of catechol 15 and hydroquinone 17, which are 
electronically similar as the second hydroxyl group is meta to the formamide in both cases. 
However, these molecules differ because a second hydrogen bond can form in catechol 15 but 
cannot in hydroquinone 17. In this case, it was found that ΔG = −8.0 kJ mol-1 for 15 and ΔG = 
−5.1 kJ mol-1 for 17, corresponding to a difference of −2.9 kJ mol-1 in hydrogen-bonding energy 
arising from hydrogen-bond cooperativity.  
 Upon extension to a third hydroxyl group in 4-formamidopyrogallol 16, a minimal 
decrease in conformer ratio was observed, indicating a lack of cooperative effects with more than 
two hydrogen bonds. Unfortunately, the 2,3,4,5-tetrahydroxyanilide proved too unstable to be 
analysed, and so this example was substituted with B3LYP/6-311G* calculated conformational 
energies. These energies correlated very well with the experimental energy differences 
determined for the other balances. The simulated 2,3,4,5-tetrahydroxyanilide revealed no further 
improvement of hydrogen bonding at the ortho-phenol.  
When phenols 14, 15 and 16 were analysed with equimolar phenol as an intermolecular 
HBD to complement the hydrogen-bonding network, a cooperative effect was observed between 
phenol 14 and phenol, but upon extension to catechol 15 and pyrogallol 16, no further benefit 
occurred. The rationalisation of these data is that addition of one hydrogen bond can substantially 
improve the strength of another by hydrogen-bond cooperativity, but further addition of hydrogen 
bonds has no effect. This phenomenon was accounted for by the fact that only the terminal 
hydrogen-bonding interaction was monitored. It was speculated that the other hydrogen bonds in 
the network thermodynamically benefitted from hydrogen-bond cooperativity upon introduction 
of more hydrogen bonds, but this could not be probed by the N,N-diarylformamide balances. This 
supposition was consistent with previous computations that suggested that polarisation changes 
are most prominent at the end of hydrogen-bonded chains.28  
 In conclusion, hydrogen bonds are interactions that nature has ubiquitously exploited and 
that chemists have recognised the potential of over the past two centuries. The sensitivity of their 
strength and geometry to a huge range of proximal and distal chemical effects render them highly 
valuable interactions for the design of chemical function such as chemical reaction,30 highly 
specific guest binding31 and informational communication.26 Nature has evolved to rely on 
hydrogen bonds for the performance of each of these functions, and synthetic and supramolecular 
chemists are now harnessing their power to replicate and surpass those functions. Finally, 
concepts drawn from the increased understanding of hydrogen bonds have also allowed chemists 
to gain access to novel function that nature could not previously access.2,32 
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1.3 Conformational Change and Informational Communication in Dynamic Foldamers   
 
 The origin of life is a widely researched theme, where the most fundamental contribution 
to it is a subject of great controversy. However, it is widely accepted that the four prerequisites 
for life are compartmentalisation, metabolism, catalysis and informational processing.33 
Informational processing is the ability of a system to respond to a stimulus and communicate that 
response through space to a processing site remote from the informational source. Evolution has 
allowed nature to master this practice and has enabled it to communicate information reliably and 
with exquisite spatial and temporal precision.  
 Nature typically processes information by the induction of conformational change. A 
highly prevalent example of this is G protein-coupled receptors (GPCRs), which are responsible 
for processing physiological information and giving rise to the optical, olfactory and gustatory 
senses and maintenance of mood and the immune system.34 GPCRs are membrane-bound 
receptors that differ by the host molecule(s) they can bind. There are nearly a thousand different 
GPCRs in humans, each endowed with a peptide sequence that allows highly specific binding of 
guest molecules found in their environment.35 A G protein is a heterotrimeric protein that can bind 
either guanosine triphosphate (GTP) or guanosine diphosphate (GDP). When the GPCR is not 
bound to a guest, the G protein is bound to GDP and is closely associated with the GPCR. When 
the guest binds, a conformational change takes place in the GPCR, lowering the G protein’s 
affinity to GDP, releasing it. This GDP is replaced by GTP, which changes the G protein’s 
conformation, causing it to dissociate from the GPCR. The G protein then translates along the 
membrane and is free to interact with other membrane-bound proteins, which can stimulate a 
response. When the guest dissociates, the G protein releases the GTP and reassociates with GDP, 
resulting in turnover. In this biological example, the binding of a specific guest causes a 
conformational change, which is communicated through space from G protein movement and 
facilitates a response (from the stimulation of other membrane-bound proteins). 
 Chemists have taken inspiration from nature’s informational communication mechanisms 
to make artificial molecules that can perform the same functions. These molecules form part of a 
family of synthetic molecules called foldamers. Coined by Gellman in 1996, foldamers are 
defined as polymers that have a strong tendency to adopt a specific compact conformation.36 
Many foldamers have been designed with the goal of making biologically orthogonal 
architectures that can exhibit the same spatially specific orientation of function as their natural 
counterparts. For example, Gellman and co-workers simulated and synthesised β-amino acid 
oligomers derived from trans-2-aminocyclohexanecarboxylic acid (ACHC) and trans-2-
aminocyclopentanecarboxylic acid (ACPC). It was found that these oligomers formed particularly 




Figure 11 – ACHC- and ACPC-derived oligomers (arrows indicate the atoms between which 
hydrogen bonds form). 
 It was shown that the ACHC and ACPC helices were stable in methanol and pyridine 
solutions, and deuteration studies showed that the amido protons were involved in strong 
hydrogen bonds, as their rate of deuteration was slow relative to the exposed N-terminal amido 
protons. This and X-ray crystallographic studies confirmed the helical conformations that 
simulations had predicted. Interestingly, the ACHC and ACPC foldamers show hydrogen-bond 
donation in opposite directions. This shows that the conformation-dependent dipoles and 
hydrogen-bond directionality of the two helices also point in opposite directions. This switch in 
hydrogen-bond directionality is unknown in α-amino acid-based oligopeptides. Foldamers of this 
type and hybrid α/β-amino acid foldamers have been shown to bind to proteins such as Bcl-2 
proteins, which act as apoptosis regulators.38 The overexpression of some of these proteins, such 
as Bcl-xL, can result in cancer, making helical foldamers a very promising area for the 
development of anti-cancer agents.39 They are also known to inhibit other damaging protein-
protein interactions, further bestowing them with medical application. Finally, they can also be 
used for enzyme biomimicry, such as the action of a designed aldolase foldamer.40 
Whilst Gellman’s definition implies the population of a single compact conformation, the 
definition has been extended to families of foldamers that can adopt more than one stable 
conformation. This conformational freedom deviates from the definition. However, if the 
different stable conformations can interconvert in response to a stimulus, they are rendered 
dynamic foldamers. For example, Huc and co-workers have developed aromatic oligoamide 
foldamers, which have been designed to either form β-sheet mimics or wide-diameter helices due 
to π-stacking interactions and the conformational preference of aryl amides.41 These foldamers 
were combined with a metal-sensitive binding site to make a metal-mediated conformational 





    
 
 
Figure 12 – Metal-mediated guest binding in aromatic oligoamide foldamers. 
The 2,6-bis(3-pyridazyl)pyridines adopted an anti-anti relationship between the arenes to 
favour interdipolar interactions. In the presence of a metal cation such as copper or silver, the 
arenes reoriented to coordinate to the metal, adopting a syn-syn conformation. When this 
functional teraryl was connected to two of the helical aromatic oligoamide foldamers, the helices 
were separated from each other in the anti-anti form and did not have a preferred handedness 
relative to each other. Addition of copper or silver cations enforced a syn-syn conformation, which 
rotated the helices into proximity, making a new helix of one continual handedness. Numerous 
helices of this type were made with different diameters, and it was found that the metal-induced 
conformational change allowed acetonitrile and imidazole molecules to be captured by the cavity 
formed. Huc and co-workers have also used their work on β-sheet mimics and helices in aromatic 
oligoamides to synthesise other architectures. These architectures were designed with highly 
defined helical and sheet-like segments with specific geometries constructed with judicious 
employment of interdipolar interactions.43  
Hamilton and co-workers have developed conformational switches that can respond to a 
variety of stimuli.44–46 For example, it was shown that oligomers derived from 2,6-bis(N-
imidazolidin-2-onyl)pyridines act as β-sheet-mimetic foldamers rigidified by interdipolar 
interactions.47 This work was extended by using trifluoroacetic acid (TFA) and 
trifluoromethanesulfonic acid (TfOH) to protonate the pyridines in the oligomer (Figure 13).48 
When protonated, the imidazolidinones reoriented to hydrogen bond to the resultant protonated 
pyridinium cation. This changed the trajectory of the imidazolidinones and introduced curvature 
to the oligomer. In longer oligomers, this curvature and the enantioenrichment of the 












Figure 13 – pH-dependent topology in 2,6-bis(N-imidazolidin-2-onyl)pyridine oligomers. 
 Additionally, subtle changes to the electron-richness of different pyridines in the 
oligomer allowed site-selective protonation, bestowing spatial control of curvature. Finally, the 
basicities of the pyridines decreased with each subsequent protonation, allowing control of 
general curvature by addition of the correct acids in the correct stoichiometries.  
These examples highlight macromolecular conformational change in response to a 
stimulus. This is very useful as it can confer very different function in different states, but 
informational processing does not necessitate this. For example, Hamilton and co-workers have 
also reported the use of diphenylacetylene balances appended with hydrogen-bonding groups that 
shift their conformational equilibrium in response to stimuli, such as the presence of halides 
(Scheme 1).49 
 
Scheme 1 – Hamilton’s anion-dependent conformational switch. 
The molecular balance, 18 exists as a mixture of two conformers in fast exchange on the 
NMR timescale at 25 °C. In these conformers, the benzodioxinone carbonyl hydrogen bonds 
either to the acetamide or to the urea, and the equilibrium constant represents the difference in 
hydrogen-bonding strength between the two groups. In the absence of salt, the conformer 
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distribution lies in favour of the hydrogen-bonded urea because the urea can donate two protons 
to the benzodioxinone. Halides are known to form strong complexes with N,N’-disubstituted 
ureas, and so upon addition of tetrabutylammonium chloride (TBACl), the chloride displaces the 
benzodioxinone. This forces the benzodioxinone to hydrogen bond to the acetamide instead and 
inverts the equilibrium. Similar balances were conceived from appending the diphenylacetylene 
scaffold with 4-(dimethylamino)benzamides, isonicotinamides and ferrocenecarboxamides and 
exploiting their basicities, Lewis acid affinities and redox sensitivities to effect conformational 
switching.44–46 These balances constitute a versatile scaffold that can respond to subtle changes in 
hydrogen-bond-donating ability by changing conformation, and can respond to a wide range of 
stimuli. Whilst these examples have highlighted conformational changes in the response to 
information, they have not involved the relay of that information through a communicable 
scaffold. 
Clayden and co-workers have devised several strategies for intramolecular informational 
communication. For example, xanthene-1,8-dicarboxamides are known to orient their amides 
antiparallel to each other and perpendicular to the plane of the xanthene owing to the 
conformational preference of tertiary benzamides and optimisation of interdipolar interactions.50 
This conformational preference could be intramolecularly communicated between xanthene units, 
meaning that the analogous tris(xanthene-1,8-dicarboxamide) exhibited an all-anti relationship of 
the amides (Scheme 2). 
 
Scheme 2 – 1,23-stereoinduction in tris(xanthene-1,8-dicarboxamide)s. 
 When the tris(xanthene-1,8-dicarboxamide) was terminated with an ephedrine-derived 
chiral oxazolidine, the first amide was induced into a P conformation to minimise steric clashes. 
This conformational preference was communicated over the three xanthene units by alternating 
P,P and M,M xanthene configurations, meaning that an aldehyde incorporated at the opposite 
terminus would be influenced by the chirality of the oxazolidine 23 atoms away. This was 
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validated by treatment of the aldehyde with a Grignard nucleophile, which added to the aldehyde 
with complete diastereoselectivity. This example represents a long-range conformational relay 
where information in the form of chirality can be communicated throughout the scaffold and be 
processed in the form of asymmetric reaction. 
Clayden and co-workers have published extensively in the area of foldamers, 
predominantly on the dynamics and functions of synthetic helices in the context of informational 
communication. For example, oligomers of the achiral quaternary amino acid aminoisobutyric 
acid (Aib) adopt 310-helical conformations.
26 By virtue of its conformation, a helix is a chiral 
object, which has diastereomeric screw-sense preferences when made up of chiral monomers and 
enantiomeric screw-sense preferences when made up of achiral monomers. When comprised of 
Aib monomers, the helix formed is configurationally achiral in solution as the screw sense of the 
helix interconverts rapidly at 20 °C. However, when terminated with a chiral quaternary amino 
acid, the equilibrium is biased towards one diastereomeric screw sense. 
For example, a helical polypeptide was synthesised with two monomers of 
enantiomerically pure L-α-methylvaline at one terminus, with the rest of the helix being made up 
of iterations of four Aib units and a 1-aminocyclohexanecarboxylic acid unit (Figure 14). The two 
initial chiral monomers induced almost complete conformational preference for the structure to 
adopt a P helix, which became more pronounced with decreasing temperature.26 
 
Figure 14 – Screw-sense preference of a 310 helix induced by central chirality. 
On the other end of the helix, stereoselective reactions were performed to determine the 
use of helical fidelity alone in asymmetric reaction (Scheme 3). Asymmetric hydrogenation of a 
Z-styrene in the helix to give the corresponding phenylalanine residue proceeded with excellent 
selectivity in favour of the L-phenylalanine diastereomer. Hydrogen-bonding solvents, such as 
methanol, were deleterious to the selectivity due to a lowering of the screw-sense preference of 
the helix, resulting from competitive hydrogen-bonding interactions with the solvent. Similar 
results were observed by terminating the helix with an acyliminium ion. An electron-rich arene 
was used to attack the acyliminium ion with high diastereoselectivity due to the chiral 
environment the helix imposed. This remote 1,61 asymmetric induction resulted in a 




Scheme 3 – Helices in asymmetric reaction. 
As exemplified by these studies, helices work as excellent communicators of binary 
information by maintaining a screw-sense preference that can be communicated from one 
terminus to the other. This can lend itself to a range of exotic functions and biomimicry, and thus 
methods for inducing screw-sense preference in achiral helices using external stimuli as opposed 
to inherent chirality were investigated.  
 Clayden and co-workers then extended this work by investigating a configurationally 
achiral Aib-derived helix whose screw-sense preference could be influenced by binding a chiral 
ligand. The system chosen used a basic pyridine unit to terminate the helix, and a variety of chiral 
Brønsted acids to interact with it (Figure 15).51  
 




To maximise the influence of the ligand’s chirality on the helix, chiral carboxylic, 
phosphoric and phosphoramidic acids were used so that the conjugate bases could interact with 
the protonated helix. Isotopic labelling of the enantiotopic geminal methyl groups in the 
terminating Aib unit was used to determine terminal screw sense preference. One of the methyl 
groups was 25% enriched with 13C, and the other was 75% enriched with 13C. This meant that the 
terminal methyl groups, that were diastereotopic due to the chiral environment imposed by the 
helix, could be distinguished by relative integration. From this, it was inferred that pyridine 
protonation and binding of the acids could induce a high degree of helical excess with a defined 
screw sense that depended on which enantiomer of the acid was used. This system lent itself to 
the functioning of a complex four-component system whereby competitive acid-base interactions 
gave rise to a conformational switch that depended on what acids were available for binding in 
solution. 
 By itself, pyridine 19 rested as a rapidly racemising mixture of screw-sense preferences. 
Upon addition of enantioenriched carboxylic acid 20, protonation of the pyridine and subsequent 
binding of the carboxylate formed an adduct with a screw-sense preference for an M helix. 
Addition of the opposite enantiomer of phosphoric acid 21 resulted in displacement of carboxylic 
acid 20 and reversed the screw-sense preference to a P helix due to the formation of a new, more 
favoured pyridine 19/phosphoric acid 21 adduct. Next, the opposite enantiomer of phosphoramide 
22 was added, which displaced phosphoric acid 21 and reversed the screw-sense preference of 
the helix back to M again. The path of screw-sense preference switches could then be completely 
reversed by addition of stoichiometric quantities of base. 1.5 equivalents of ammonia were added, 
forming the ammonium salt of the strongest acid, phosphoramide 22. This left the next strongest 
acid, phosphoric acid 21, to bind to the pyridine of the foldamer, so the screw-sense preference 
was reversed to P again. The same effect was observed upon addition of a further 1.5 equivalents 
of ammonia, whereby the ammonia formed the ammonium salt of phosphoric acid 21, leaving 
carboxylic acid 20 to induce its screw-sense preference on the foldamer. Addition of a further 1.5 
equivalents of ammonia resulted in full deprotonation of all the chiral acids, so the helical 
foldamer exhibited no screw-sense preference and thus was configurationally achiral. Finally, 
addition of 4.5 equivalents of HCl resulted in full protonation and liberation of all the chiral acids, 
where phosphoramide 22, as the strongest acid, formed an adduct with the foldamer and induced 
an M helix once again. This represented a complex acid/base switch whereby different 
components of the mixture could form adducts with the foldamer and induce screw-sense 
preference depending on the degree to which free base was present. In this example, information 
was stored in the form of the chirality of the acids and was processed by the pyridyl terminus of 
the helix. Information was then propagated through space in the form of screw-sense preference, 
which was reported by an isotopically labelled spectroscopic reporter.  
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Clayden and co-workers also went on to design and construct a synthetic mimic of a 
GPCR which could also function in the membrane phase. The design comprised of a binding site 
for a cationic metal cofactor, an Aib oligomer for the communication of the chiral information 
through the membrane, and a chiral bis(pyrene) moiety at the opposite terminus (Figure 16).  
 
Figure 16 – Synthetic G protein-coupled receptor. 
 Upon binding of copper(II) and the enantioenriched carboxylate of Boc-L-proline, the 
hydrogen-bonding interactions between the proline and the Aib oligomer induced a screw-sense 
preference for a P helix in the membrane phase. Since the dipyrene spectroscopic reporter at the 
opposite terminus exhibits central chirality, binding of the two different enantiomers of Boc-
proline carboxylate resulted in diastereomeric adducts whose anisochronicity was most 
pronounced at the bis(pyrene). This meant that, depending on which enantiomer of the Boc-
proline was bound, different fluorescent responses could be elicited. This example represented a 
significant simplification of how GPCRs work and acted as a mimic that could perform its 
function in aqueous and biological media.  
To summarise, foldamers have been used to gain access to conformational space that 
nature has not yet discovered, and they have been exploited as such for advances in biomimicry 
and medicine. More recently, dynamic foldamers have been used as sensors, which can respond 
to stimuli by changing macromolecular shape and binding affinity to certain guests. Similarly, 
other families of dynamic foldamers have been developed to communicate information in 
response to stimuli. In these cases, the informational input did not result in topological change, 
but in a subtle conformational change which was effectively communicated throughout the 
scaffold. From this, hydrogen-bonding networks can be influenced by a plethora of external 
stimuli and can be used to communicate binary information in solution and in the membrane phase 
to positions remote from the informational source. These biomimetic constructs have largely used 
diagnostic spectroscopic signals as their output, but they have also been able to perform function 




1.4 Light-Induced Conformational Changes in Foldamers 
 
 The presence or absence of light can also be considered as information, and it is a source 
of high information entropy according to information theory, due to the large range of 
wavelengths it can take.52 Animals have evolved to harness light as a way to gain large amounts 
of information about their surroundings. This is typically done by using a type of GPCR called 
opsins, bound to a polyene chromophore called retinal.53 The absorbance of retinal changes 
depending on the opsin it is bound to, bestowing an absorbance range of 400-700 nm light, and 
therefore a large amount of information that can be processed. Upon absorption of a photon of 
the correct wavelength, an olefin in retinal undergoes a Z to E isomerisation, which results in a 
conformational change of the opsin receptor. This conformational change then results in liberation 
of the G protein, which then interacts with other membrane-bound proteins and elicits a 
response.54 
 Inspired by nature, the vast utility and practicability of light has attracted a large amount 
of scientific research over the past two centuries, culminating in significant discoveries such as 
light-controlled memory devices, self-healing materials and light-triggered drug release.55–57 In 
supramolecular chemistry, it has also been used for the development of unidirectional motors, 
molecular muscles and cargo transporters.58–60 
Light has also found extensive use in dynamic foldamer chemistry. For example, Huc and 
co-workers reported a light-controlled conformational switch in an aromatic oligoamide foldamer 




Scheme 4 – (a) Light-induced [4+4] cycloaddition of bis(diazaanthracene)s. (b) Conformational 




 Due to the conformational restriction imposed by the 1,3-diaminobenzene linker, the 
diazaanthracenes aggregated in a parallel fashion, despite the repulsive interdipolar interactions. 
Before cycloaddition, the oligoamide helices were not well defined – they adopted three 
conformations in slow exchange on the NMR timescale in CDCl3 at temperatures below 25 °C 
(Scheme 4b). Two of these conformers are enantiomeric and comprised of one helix of a particular 
handedness propagating away from the diazaanthracenes, and the other helix of the opposite 
handedness coiling around the first helix. The third conformer is a meso conformer, where the 
helices propagated away from the diazaanthracenes with opposite handedness. Upon quantitative 
photocycloaddition of the diazaanthracenes, the meso form was the only observable conformer. 
This represented a conformational resolution process that, due to the altered trajectory of the 
photoadduct, also resulted in foldamer elongation and cavity enlargement. The retro [4+4] 
reaction could be achieved quantitatively by heating for 48 h, showing that the diazaanthracene 
oligoamide foldamers can be quantitatively interconverted between morphologies. It was alluded 
to that these photoresponsive foldamers could be used for light-induced enantiospecific host-guest 
chemistry.   
The bis(diazaanthracene) example is another of macromolecular conformational change 
in response to a stimulus, but light is also conducive to the modulation of function. For example, 
Hecht and co-workers have published extensively in the field of photoswitchable molecules, 
particularly focusing on the light-induced modulation of dithienylethenes. This motif has been 
used for light-induced modulation of organic semiconductors, photoswitchable polymerisation 
and in the storing of light energy.62–64 More specifically, they have been designed to incorporate 
a hydrogen-bond acceptor-donor-acceptor (ADA) unit in the form of an imide and exploited it for 
its binding affinity to melamines, which have a complementary hydrogen-bonding pattern (DAD) 
(Scheme 5).65 
 




In its ring-opened form, the thiazoles deviate from the maleimide plane in order to negate 
steric encumbrance of the 4-methyl groups. This deviation lowers electron density donation from 
the thiazoles to the imide, lowering its hydrogen-bond-accepting ability and giving rise to a 
melamine binding constant of 142 M-1. Upon photocyclisation, the corresponding thiazolines 
increase their conjugation with the imide, promoting electron density donation and significantly 
strengthening melamine binding to 318 M-1. This example represents the light-induced formation 
of a strong and specific triple hydrogen-bonding unit. This has been recognised as having potential 
utility in ‘smart’ materials, which can respond to light by increasing aggregation and changing its 
mechanical properties. Interestingly, property modulation by photoswitching usually takes the 
form of using a photoisomerisable bond to bring groups into and out of proximity, whereas this 
example uses light to change secondary electronic interactions.  
Another example of light-induced modulation of function has been reported by 
Newhouse, where a bidirectionally quantitative photoswitch derived from hemithioindigo was 
developed (Scheme 6).66  
 
Scheme 6 – Light-induced formation/deletion of a hydrogen bond in hemithioindigos. 
Nine photoswitches were synthesised with the hemithioindigo scaffold, where they could 
each be quantitatively interconverted between their E and Z forms by employing light of the 
appropriate wavelength. Generally, the absorption profile of the Z form was greatly blueshifted 
relative to the E form, owing to the modification of the electronic landscape by the hydrogen 
bond. Additionally, the absorption wavelengths were found to be highly sensitive to the 
substitution on the pyrrole moiety, where the absorption of the E form of the hemithioindigo was 
redshifted to 740 nm with a julolidinyl pyrrole substituent. This example represents a new family 
of photoswitches with highly tunable absorptions. Interestingly, in the Z form, the pyrrole is free 
to act as an HBD, which could be used to perform function. Upon photoisomerisation, the pyrrole 
would form a hydrogen bond with the hemithioindigo, precluding the function. Whilst there are 
many examples of photoswitches that can be used to modulate function, there have been few 
reports on the use of photoswitchable moieties for the communication of information. 
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 Clayden and co-workers have reported a switch of screw-sense preference in a helical 
foldamer in the form of a fumaramide/maleamide photoswitch (Figure 17).67 This was made by 
appending one side of a fumaramide (E) with a helix made up of Aib units. On the other side of 
the fumaramide, a chiral L-α-methylvaline unit was covalently bound. In the E geometry, the L-
α-methylvaline was sufficiently separated from the Aib oligomer such that no transmission of 
stereochemical information over the fumaramide was observed, and thus there was no strong bias 
of screw-sense preference of the Aib oligomer. However, upon irradiation of the fumaramide, the 
olefin photoisomerised to form the corresponding maleamide (Z), bringing the L-α-methylvaline 
much closer to the Aib oligomer.  
 
Figure 17 – Induction of screw-sense preference by photoisomerisation of a fumaramide. 
In the Z orientation, the L-α-methylvaline was sufficiently proximate to the Aib oligomer 
to allow the chirality of the terminus to influence the screw-sense preference of the helix. By 
forming a reactive oxazolone on the opposite end of the helix, diastereoselective chain extension 
could be performed. In the fumaramide (E), where the L-α-methylvaline was too distant from the 
Aib oligomer to transmit stereochemical information, chain extension by the methyl ester of L-
valine resulted in a 50:50 mixture of diastereomers. However, when photoisomerised to the 
maleamide (Z), where the L-α-methylvaline was brought close enough to the Aib oligomer to 
induce screw-sense preference, a diastereoselective reaction was observed, whose selectivity was 
augmented with decreasing temperature. Therefore, the use of a fumaramide/maleamide 
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photoswitch for induction of screw-sense preference of an otherwise configurationally achiral 
helical foldamer and its use in a diastereoselective reaction was demonstrated.  
Helical foldamers derived from Aib have also shown to be sufficiently lipophilic to 
dissolve in the membrane phase. A similar Aib oligomer with a photoswitch derived from a 
diazobenzene moiety and a geminal di-(fluoromethyl) spectroscopic reporter has proven useful in 
transmitting stereochemical information by turning on and off the occupation of an L-valine unit 
in hydrogen bonding.68 When the diazobenzene was in its Z orientation, the nitrogen of the diazo 
group hydrogen bonded weakly to the amido proton of the L-valine unit. This weak hydrogen 
bonding of the azobenzene allowed the L-valine to hydrogen bond strongly with the next Aib unit 
and propagate the stereochemical information along the length of the helix, as determined by solid 
state 19F NMR in a phospholipid bilayer. Upon photoisomerisation of the diazobenzene to the E 
form, the phenyl groups deviated from coplanarity in order to accommodate for their steric 
encumbrance. This promoted the basicity of the diazo nitrogen, strengthening the hydrogen bond 
between it and the amide proton of the L-valine. As a result of this, the hydrogen bond between 
the L-valine and the next Aib unit was weakened, and therefore the influence of the chiral unit on 
the screw-sense preference of the otherwise achiral helical foldamer was greatly reduced. This 
effect was demonstrated in the membrane phase at lengths of up to 2 nm. As such, the 
diazobenzene moiety acted as an on/off switch for the transmission of stereochemical information 
by use of an Aib oligomer, whose helical fidelity was retained on the nanometre scale in the 
membrane phase. This system acted as a synthetic mimic of the photoswitchable vision protein, 
rhodopsin.  
The highlighted examples represent advances in light-mediated conformational change. 
The host of photoswitchable moieties that chemists have developed have been harnessed by the 
supramolecular community to make on/off switches for different functions. These include 
biomimetic functions such as a macromolecular conformational change reminiscent of GPCRs, 
and the modulation of hydrogen bonding. Other examples have been highlighted where 
information has also been communicated through different media and then performed function, 








1.5 Reversible Hydrogen-Bond Directionality in Synthetic Helices 
 
 An α-helix can adopt two different screw senses. Due to the chirality in natural α-amino 
acids, α-helices in nature ubiquitously form P helices.37 Hydrogen-bonded helices also exhibit 
hydrogen-bond directionality, where the dipole of the helix orients from the N-terminus to the C-
terminus (all the hydrogen bonds donate towards the N-terminus). Theoretically, these helices can 
adopt two conformations with opposite directionalities. Without exception, natural helices orient 
to universally adopt one directionality.36 
 Nature has failed to notice the function that can be conferred by reversible hydrogen-
bond directionality.37 The selection of the macromolecular dipole moment of a biological 
molecule and terminal hydrogen-bonding functionality could be used to orient other biological 
molecules in a desired fashion. These properties can be accessed by amino acid-derived foldamers 
whilst maintaining universal helical screw sense as alluded to by Gellman (Figure 11).36 However, 
the use of a dynamic molecule that can switch between directionalities in response to a stimulus 
is an underexploited field in informational communication, and has not yet been observed in 
nature. Directionality-reversible dynamic foldamers represent a novel field in supramolecular 
chemistry, which can be used to gain access to informational communication mechanisms that 
nature has not harnessed.  
 The Guichard group have worked extensively on synthetic helices derived from ureas. 
These oligourea foldamers have been successfully employed for enantioselective catalysis, anion 
binding and as bactericides.69–71 Oligoureas derived from meso cyclohexane-1,2-diamine that 
form 2.512/14 helical conformations have been synthesised whereby two ureido protons hydrogen 
bond with the carbonyl of the urea two units preceding it (Figure 18).2 This pattern propagated 
through the entire length of the helix and resulted in two pendent ureido protons at one terminus 
of the urea, and a ureido carbonyl at the other – defining the N- and C-termini. It is noteworthy 







Figure 18 – Hydrogen-bond directionality-reversal in helical oligoureas. 
 By an iterative elongation method using orthogonally protected and enantioenriched 
cyclohexane-1,2-diamine derivatives, hexamer 23 was synthesised, giving a configurationally 
meso helix. Even in hydroxylic solvent, the two enantiotopic tert-butyl signals in the 1H NMR 
spectrum gave rise to two different signals, indicating that the helix was in slow exchange between 
its two screw-sense preferences on the NMR timescale. Variable-temperature NMR (VTNMR) 
and Eyring analysis indicated that, depending on the solvent, the barrier to screw-sense inversion 
was around ΔG
‡
298 K = 70.0 kJ mol
-1. Due to the enantiotopicity of the two termini in the meso 
helix, a chiral ligand exclusively induced one handedness of the helix. Additionally, its hydrogen-
bonding nature allowed it to bind to one terminus selectively, enforcing one directionality which 
was communicated through the length of the helix. In this system, the carboxylate of Boc-D-
proline was formed by deprotonation of the corresponding acid using tetrabutylammonium 
hydroxide. The carboxylate and carbamate of the Boc-D-proline carboxylate acted as HBAs by 
each hydrogen bonding to a pair of ureido protons in the first two residues of the helix, forming 
a 1:1 adduct. This set the binding site at the N-terminus. While the central chirality in the ligand 
induced a screw-sense preference for a P helix in the oligourea, the Boc-D-proline carboxylate 
induced directionality in the oligourea by selectively binding at the N-terminus over the C-
terminus. This example served as the first example of reversible hydrogen-bond directionality in 










 This work was extended to the development of a molecular spring torsion balance by 
desymmetrisation of the helical oligourea (Figure 19).32 Thioureas are much stronger HBDs and 
weaker HBAs than their analogous ureas due to the higher diffusivity of the orbitals on sulfur.72 
Therefore, when one of the enantiotopic ureas was replaced with a homologous thiourea, the helix 
equilibrium shifted to ensure the thiourea acted as an HBD, placing the thiourea at the C-terminus 
and enforcing a P helix. 
Figure 19 – Helical oligoureas as a molecular spring torsion balance.32 
Carbamates can only act as single HBDs as there is only one nitrogen to have a pendent 
amido proton. Therefore, when a thiourea terminated the helix on one end, and a carbamate on 
the other, a P helix was formed exclusively. When a homologous urea was used, the preference 
was not as strong as ureas are weaker HBDs and stronger HBAs than thioureas. When termini of 
similar hydrogen-bond-donating/accepting ability were used, as is the case with tert-butyl and 
benzyl ureas, the helix approached being configurationally racemic. When the stronger/double 
HBDs were used on the opposite terminus, a directionality switch took place, swapping the N- 
and C-termini accompanied by a helical inversion. This scaffold acted as a molecular torsion 
balance which can compare the hydrogen-bond-donating/accepting abilities of terminating groups 
to see which biased the helical screw sense and therefore the directionality more strongly. These 




1.6 Hydrogen-Bond Directionality Control in Ethylene-Bridged Oligoureas 
 
 Nowick and co-workers have investigated the conformational behaviour of oligoureas 
bridged with different lengths of aliphatic linkers and used them as molecular scaffolds for β-
sheet mimicry. Using an iterative elongation method, Nowick synthesised di- and triureas derived 
from 1,3-diaminopropane and N-(3-aminopropyl)-1,3-diaminopropane (Figure 20).73 
 
Figure 20 – Nowick oligoureas derived from 1,3-diaminopropane and N-(3-aminopropyl)-1,3-
diaminopropane. 
 The oligoureas were synthesised with a variety of urea substituents and termini, using 
both bulky aromatic groups and smaller aliphatic groups, and their behaviour was studied using 
1H NMR and FTIR spectroscopy. When a phenyl group was used at one terminus, the adjacent 
urea was forced into a conformation whereby the aryl group and the carbonyl were trans to each 
other due to the electrostatic repulsion between the phenyl group and the ureido carbonyl.74,75 This 
conformation induced the directionality of the first urea, which resulted in a pendent carbonyl 
being adjacent to the second urea. Due to this, the second urea hydrogen bonded to the first urea 
through its ureido proton, and thus the second urea had the same directionality as the first. This 
effect propagated through the oligourea, meaning that the phenyl group biased the global 
directionality in the ureas and exerted conformational control on the structure. The FTIR studies 
revealed an 85:15 ratio of conformers in CHCl3, each with uniform directionality. In this example, 
the phenyl group set the phenyl urea at the N-terminus, and the dipole was communicated as 
binary information in the form of hydrogen-bond directionality from one terminus to the other.  
Nowick conducted further studies on this hydrogen-bonding phenomenon by varying the 
length of the aliphatic linker between ureas. By comparison to analogous monoureas where no 
intramolecular hydrogen bonding could take place, the intramolecular hydrogen-bonding strength 
between the ureas with different aliphatic linkers could be quantified. Upon changing the linker 
from a 1,3-propane bridge to an ethylene bridge, a marked increase in hydrogen bonding was 
observed as shown by FTIR and 1H NMR studies.76 None of the directional conformer where the 
phenyl urea was at the C-terminus was observed, and this was further supported by molecular 
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mechanics calculations. Hence, 9-membered hydrogen-bonding rings (5 rotatable bonds) exhibit 
greater stability than that of 10-membered hydrogen-bonding rings (6 rotatable bonds) in these 
structures. This increased stability was attributed to the mitigated entropic contribution to 
hydrogen bonding, which was in agreement with analogous observations by Gellman in 
diamides.5 This means that ethylene-bridged oligoureas prove to be better candidates for 
communicating directional information than 1,3-propane-bridged oligoureas due to their 
increased hydrogen-bonding fidelity.  
Next, extensive conformational studies were conducted by 1H NMR and molecular 
mechanics simulations (Figures 21-22). Initially, calculations were performed on diurea 24 using 
an AMBER* force field, which did not explicitly address the angular dependence of hydrogen 
bonding.77 With these calculations, the four lowest energy conformers were identified, all of 
which were within 10 kJ mol-1 of the calculated ground state conformation. 
 
Figure 21 – Simulated conformations of 24. 
 The simulations revealed a gauche conformer, two anti conformers and a conformer with 
no hydrogen bond. The two anti conformers differed only by rotation of the N–Ph bond and so 
were treated as the same. Model inspection revealed that the hydrogen-bonded gauche and anti 
conformers had N–C–C–N torsion angles of 50° and 160°, respectively. The orientations of the 
ureas in the lower-energy gauche conformer were unusual as the hydrogen-bonded ureido proton 
seemed to hydrogen bond to the π cloud of the adjacent ureido carbonyl. In contrast, the hydrogen-
bonded ureido proton in the anti conformation hydrogen bonded directly towards one of the sp2 
lone pairs of electrons on the ureido carbonyl. 
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Figure 22 – Hydrogen bonding in gauche and anti conformers in ethylene-bridged diureas. 
 Taylor and co-workers have used the angles, θH and ϕH to quantify geometric 
relationships in carbonyls.78 θH represents the deviation from the z-axis in the xz plane and ϕH 
represents the deviation from the x-axis in the xy plane (Figure 22). For example, a hydrogen bond 
donating directly to one of the carbonyl oxygen’s sp2 lone pairs would take θH = 90° and ϕH = 
30°. In the simulated gauche conformer, θH = 16° and ϕH = 30°. This indicates that the ureido 
proton donates almost directly to the π bond, whereas the anti conformer, with θH = 82° and ϕH = 
39°, orients the ureido proton almost coplanar with the carbonyl and points directly towards an 
oxygen lone pair. When in the gauche conformation, the ureido carbonyl hydrogen bonds by 
donating electron density from its B1-symmetrical π bond, and when in the anti conformation, it 
donates electron density from the higher-energy B2-symmetrical oxygen lone pairs. As discussed 
(Section 1.2), hydrogen bonds formed from π bonds are weaker than those formed from lone pairs 
of electrons, as the lone pairs are higher in energy. The gauche conformation exhibits a hydrogen 
bond to the carbonyl π bond because the ureas are too close to allow efficient hydrogen bonding 
through the oxygen lone pairs. In contrast, the anti conformer involves a hydrogen bond through 
one of the oxygen lone pairs as the ureas are sufficiently separated. The force field used for the 
computational studies did not account for the angular dependence of hydrogen bonding, which 
rendered the simulations unreliable for the determination of the favourable hydrogen-bonded 
conformation. However, it did determine the specific hydrogen-bonding geometries of the gauche 




 X-ray crystallographic analysis of 25 and related diureas showed a hydrogen-bonded anti 
relationship, which was in very strong agreement with the anti conformer that had been simulated. 
Additionally, the 1H NMR signals of the methylenes connecting the ureas were analysed and 
found to exist as an AA’BB’ system, with vicinal couplings of 5 and 10 Hz. The gauche and anti 
conformers were simulated, and the coupling constants were predicted to be 5 and 6 Hz for the 
gauche conformer, and 4 and 11 Hz for the anti conformer. This result indicated that 25 exists 
predominantly as two enantiomeric anti conformers that are in fast exchange on the NMR 
timescale, and that solid-state structures of the diureas are representative of that in solution. To 
further validate the notion that the diureas adopt an anti conformation, a diurea derived from 
trans-cyclohexane-1,2-diamine, 26 was synthesised and studied as an analogue with an imposed 
gauche conformation (Figure 23). 
 
Figure 23 – Diureas for conformational analysis of the ethylene bridge. 
 1H NMR analysis indicated that cyclohexyl diurea 26 existed as a 9:1 mixture of slowly 
interconverting conformers. Both ureas lay equatorial in both conformers and FTIR analysis 
revealed that the minor conformer was not hydrogen bonded. However, the relative wavenumbers 
and chemical shifts of the hydrogen-bonded ureido proton in the major conformer indicated that 
the hydrogen bonding was weaker in cyclohexyl diurea 26 than in acyclic diurea 25. Finally, 
molecular mechanics simulations of 26 predicted an energy minimum which was superimposable 
on the gauche conformer simulated for 24. This lent further credence to the notion that gauche 
relationships between the conformationally mobile diureas are not the true energy minimum 
corresponding to an optimised hydrogen bond. Next, the analogous triurea 27 was synthesised 






Figure 24 – (a) Anti relationships in ethylene-bridged triurea, 27. (b) X-ray crystal structure of 27.  
Each of the ureas lay approximately coplanar, with anti relationships between each of the 
ureas. The N–Ph vectors were at an angle of 50°, displaying significant curvature in the 
diethylenetriamine scaffold. Analysis of the 1H NMR resonances of the methylenes between the 
ureas show consistent 5 and 10 Hz vicinal couplings, indicative of all-anti relationships in CDCl3 
solution. Interestingly, when more than two ureas are present, the enantiomeric anti 
conformations become diastereomeric in relation to each other. It was envisaged that an 
anti+/anti+/anti+ conformer would predominate to avoid repulsive syn-pentane interactions.77 
However, the alternating anti−/anti+/anti− conformation predominated with anti−/anti+/anti+ 
minorly present, which was attributed to the appropriate alignment of the ureas for hydrogen 
















 By synthesising isocyanates from oligopeptides, the iterative synthesis of the scaffold 
allowed the installation of different oligopeptides onto the different ureas, whilst maintaining the 
rigid hydrogen-bonded conformation that the phenyl group imposed. Predictably, the order of 
these structures was well defined in chlorinated solvents, but was disrupted when studied in more 
polar solvents due to competitive hydrogen-bonding interactions.80 The ureas were separated by 
5 Å, which made them ideal scaffolds for the artificial introduction of β-turns and rendered them 
extremely effective in β-sheet mimicry.76 β-turns are naturally constructed by incorporation of the 
amino acid, proline. This proline is incorporated into natural oligopeptides derived from α-amino 
acids, which have defined and irreversible hydrogen-bond directionality. The ethylene-bridged 
triurea scaffold studied by Nowick also has defined directionality due to the directional control 
imposed by the phenyl group. If the ureas were free to rotate, switching their N- and C-termini, 
the scaffold could be bestowed with directional reversibility. This directional reversibility could 
be controlled and give rise to a new family of dynamic foldamers with switchable hydrogen-bond 
directionality. The development of this property has been untouched by nature, where it has huge 
potential for the development of orthogonal communication mechanisms that could be conducive 
to biological systems. Control over this also confers selection of overall dipole moment and 
terminal foldamer functionality, which could be used to replace natural phenomena and even 















2.0 Project Aims 
 
 Studies performed by Clayden and co-workers have demonstrated that information in the 
form of chirality can be communicated through a configurationally achiral helix upon 
introduction of a chiral influence.10,26,51,67 The aim of this project was to develop a novel class of 
foldamers that could communicate information in the form of hydrogen-bond directionality or 
polarity. Ethylene-bridged triureas terminated with phenyl groups have been shown to exhibit 
complete uniformity of hydrogen-bond directionality, where it has been used as a rigid scaffold 
for artificial parallel β-sheets.77,79 The work in this project seeked to remove this conformational 
restriction and investigate if both directionalities could be accessed by the scaffold (Figure 25). 
The thermodynamic and kinetic factors affecting the prevalence of both directionalities were to 
be explored by variable-temperature NMR (VTNMR) experiments. With this information, 
directional control was to be implemented using covalently linked hydrogen-bonding groups, and 
the ability of the scaffold to communicate this directionality was to be determined. 
 
Figure 25 – Directionality control using hydrogen-bonding groups. 
  After directional reversal and control was established in these foldamers, these concepts 
were to be combined and manifested in directional switching (Figure 26). The directionalities 
were planned to be interconverted in response to a stimulus, and that switch to be propagated 
through the scaffold as binary information in the form of hydrogen-bond directionality and 






Figure 26 – Directionality switching using hydrogen-bonding groups that interconvert in response 
to a stimulus. 
 Investigation of hydrogen-bond directionality switching was envisaged by using acid and 
base, converting a basic site from an HBA in its neutral form to an HBD in its conjugate acid 
form. This process was then to be switched back using base. With the concept of hydrogen-bond 
directionality switchability having been successfully demonstrated, additional switching stimuli 
such as light and the presence of hydrogen-bonding additives like sulfoxides and anions was to 
be investigated. Initially, VTNMR would be used to ascertain the different directionalities and 
the degree to which they were present. After this method was used to study the scaffold, other 
responses would be used in local directionality detection remote from the informational source at 
millimolar concentrations, such as fluorescence change. Finally, this research aimed to develop 
ethylene-bridged oligoureas into robust conformational relays that can process information and 
communicate it through a barrier or into a compartment, where the information could be used to 




3.0 Hydrogen-Bond Directionality in Ethylene-Bridged Oligoureas 
 
3.1 Development of Conformationally Mobile Oligoureas 
 
 X-ray crystallographic, solution-state FTIR and 1H NMR studies conducted by Nowick 
showed that ethylene-bridged triurea, 27 adopts a single conformation whereby the N,N’-diphenyl 
urea ureido proton is not hydrogen bonded, but the two other ureido protons are contiguously 
hydrogen bonded (Figure 27).79 This conformational bias arises due to the strong preference for 
the N-phenyl group of the trisubstituted nitrogen atom to be oriented trans to the ureido carbonyl 
in order to avoid electrostatic repulsion of the groups.74,75 This directionality is propagated to the 
next two ureas by formation of inter-urea hydrogen bonds, defining the diphenyl urea terminus as 
the N-terminus. 
 
Figure 27 – Nowick’s conformationally controlled ethylene-bridged triurea, 27. 
 Initial efforts on derivatising the oligoureas were focused on varying the ureido arenes to 
ensure they could be modified to confer desirable properties without damaging the fidelity of the 
intramolecular communication. The first change made was the conversion of the phenyl ureas to 
4-methoxyphenyl ureas to show that alkoxy groups were conducive to the hydrogen-bonding 
network and could be used to aid characterisation of longer oligoureas. Triurea, 32 was 




Scheme 7 – Synthesis of triurea 32. 
 N-Phenylethylenediamine underwent palladium-catalysed hydrogenative reductive 
alkylation with N-Boc-2-aminoacetaldehyde to afford carbamate 28 in good yield. Two 4-
methoxyphenyl ureas were then installed on 28 using 4-methoxyphenyl isocyanate to give diurea 
29 in moderate yield. The Boc group was then cleaved using TFA to give the corresponding 
primary amine, 30, which then underwent a Michael addition to acrylonitrile, which proceeded in 
excellent yield. Carboxamidation of the corresponding secondary amine 31 gave the target triurea, 
32, in good yield. 
 If more than one conformation was appreciably populated upon derivatisation of 
Nowick’s triurea 27, then it would be difficult to identify them by Nowick’s method of solution-
state FTIR as this would only reveal the number of hydrogen-bonding and non-hydrogen-bonding 
environments. Instead, variable-temperature 1H NMR (VTNMR) was used, where a sample of 
triurea 32 was prepared in CD2Cl2 and its 
1H NMR spectrum recorded at 25 °C. Spectra were then 





Figure 28 – VTNMR of 32 (CDCl3, 500 MHz, 15 mM). 
 In triurea 32, signals were observed at 6.11 (diaryl urea ureido proton), 8.16 (peripheral 
ureido proton) and 8.70 ppm (central ureido proton) at 25 °C. Upon cooling of the sample, the 
signal at 6.11 ppm remained at approximately the same chemical shift. The other two signals at 
8.16 and 8.70 ppm, however, shifted markedly downfield. The other alkyl and aromatic signals 
remained approximately constant. These observations can be explained by the N,N’-diaryl urea 
adopting a conformation whereby the carbonyl and the phenyl group are oriented trans to each 
other, forcing the ureido proton away from the adjacent urea. In this orientation, this ureido proton 
would not be hydrogen bonded and would therefore correspond to a relatively upfield signal (6.11 
ppm at 25 °C). The other two ureido protons signals are much more downfield because they are 
in hydrogen bonds with their adjacent ureas. As the sample is cooled, the entropic cost of 
intramolecular hydrogen bonding is mitigated and so the hydrogen bonds became stronger, hence 
the downfield shifting with decreasing temperature. Finally, if the directionalities were in slow 
exchange on the NMR timescale at one of the recorded temperatures, signal decoalescence would 









decoalescence has occurred, showing either that slow exchange can only be reached at lower 
temperatures, or triurea 32 exists as one populated conformation, where the diaryl urea is at the 
N-terminus. In the latter case, this would indicate that conformation control is still established by 
the phenyl group and that 4-alkoxylphenyl ureas are conducive to the hydrogen-bonding network.  
Next, it was desirable to design a more dynamic foldamer to show that both 
directionalities could be accessed by the same molecule and to more conclusively assign the 
dynamics observed in 32. The proposed triurea, 37, was analogous to Nowick’s triurea, 27, but 
the terminating phenyl group was replaced by an ethyl group in the hope that the ethyl group 
would not subject the oligourea to any directional bias. Triurea 37 was synthesised in an 
analogous manner to diaryl urea 32 to provide ethyl urea 37 in 36% total yield over five steps 
(Scheme 8).   
 
Scheme 8 – Synthesis of triurea 37. 
Triurea 37 was then studied by VTNMR. To increase the likelihood that the triurea would 
reach slow exchange on the NMR timescale, spectra were recorded at temperatures from 20 °C 
to −80 °C in increments of 10 °C (Figure 29). CD2Cl2 was the solvent of choice because it does 





Figure 29 – VTNMR of 37 (CD2Cl2, 300 MHz, 18 mM). 
 Triurea 37 showed one broad signal at 6.53 ppm (cyanoethyl urea ureido proton) and two 
closely overlapping signals at 9.20 ppm (the two other ureido protons) at 20 °C. Upon cooling, 
the signals at 6.53 and 9.20 ppm sharpened and shifted downfield with decreasing temperature. 
The two signals at 9.20 ppm were not distinguishable at any temperature and they maintained an 
integration of two protons throughout the experiment. The remaining aromatic signals stayed 
approximately constant with decreasing temperature, whereas the alkyl signals broadened at −50 
°C. Like triurea 32, these data indicated either that slow exchange had not been reached, or 37 
exists as one populated conformation. The downfield shifting of each of the ureido protons 
indicated that each ureido proton was involved in a hydrogen bond, one of which was significantly 
weaker than the other two. The two ureido protons in stronger hydrogen bonds were in the same 
hydrogen-bonding environment as they both have the same chemical shift-dependence on 
temperature. The broadening of signals in the alkyl region below −50 °C could be attributed to 
the slowing down of the interconversion between diastereotopic ± gauche and ± anti conformers 
of the ethylene bridges on the NMR timescale at these temperatures.77  
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These observations could be accounted for by orientation of the cyanoethyl urea so that 
its ureido proton protruded towards the nitrile. This would then form a complementary hydrogen-
bonding pair where the ureido proton acts as an HBD, and the nitrile as an HBA, allowing the 
foldamer to homodimerise (Figure 30a). This would set the directionality of the cyanoethyl urea, 
which would be communicated to the other two ureas, making the cyanoethyl urea at the N-
terminus. The C2h-symmetry of the proposed dimer was consistent with exactly three different 
hydrogen-bonding environments, where two of the hydrogen-bonding environments are nearly 
identical. This would be consistent with reports by Nowick and co-workers that N-
bis(cyanoethyl)-N’-phenyl ureas form homodimers of the this type.82 To further validate the 
hypothesis that foldamer homodimerisation was occurring, a concentration-dependence study was 
performed whereby a solution of the foldamer was diluted and the 1H NMR spectrum was 












Figure 30 – (a) Proposed homodimer of 37. (b) Concentration-dependence study of 37 (CD2Cl2, 500 
MHz). 
 Monitoring the signal corresponding to the ureido proton of the cyanoethyl urea, where 
intermolecular hydrogen bonding was suspected to be taking place, revealed a clear chemical shift 
dependence on concentration. Even though only one directionality was observable in 37, it is 
noteworthy that the populated directionality places the cyanoethyl urea at the N-terminus. In the 
parent foldamer 32, (Figure 28) the cyanoethyl urea was at the C-terminus. This indicated that 
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replacement of the directionality-controlling phenyl group with an alkyl group allowed 
conformational freedom such that it could be controlled by other factors, such as 
homodimerisation. 
 As the propionitrile terminus in 37 was giving rise to global directionality control, a new 
target compound was sought where the propionitrile was replaced with another group which 
would not subject the oligourea to directionality control. The target triurea, 41, where a benzyl 
urea was used instead of a cyanoethyl urea, was synthesised in two steps from 39 (Scheme 9), 
which was synthesised analogously to 30 (Scheme 7) using N-ethylethylenediamine as the starting 
material. 
 
Scheme 9 – Synthesis of triurea 41. 
 Amine 39 underwent reductive alkylation with benzaldehyde by a one-pot 
condensation/reduction using sodium borohydride to give secondary amine 40 in moderate yield. 
Amine 40 then underwent carboxamidation using 4-methoxyphenyl isocyanate to give the target 





Figure 31 – VTNMR of 41 (CD2Cl2, 500 MHz, 15 mM). 
In triurea 41, signals were observed at 4.60 (benzylic methylene) and 8.92 ppm (central 
urea ureido proton) at 25 °C. Upon cooling, the signal at 4.60 ppm broadened and decoalesced 
into two distinct singlets at −15 °C. These decoalesced signals sharpened at −25 °C, where they 
were present in a ratio of 60:40. The signal at 8.92 ppm (1 H) shifted downfield with decreasing 
temperature to reach a value of 9.19 ppm at −25 °C. At 5 °C, a new signal appeared at 6.76 ppm 
(1 H), which sharpened and shifted downfield upon further decreasing the temperature. Similarly, 
new signals emerged at 8.90 (0.40 H) and 9.23 ppm (0.60 H, overlapping) at −15 °C, which 
behaved the same. These data showed that there were two conformations in fast exchange on the 
NMR timescale at 20 °C, which enter the slow-exchange region between −5 °C and −15 °C. These 
two conformations are the two different directionalities, populated in a 40:60 ratio at −25 °C. 
Each of the directionalities have two hydrogen-bonded ureido protons, and a non-hydrogen-
bonded ureido proton. The signals at 6.76 and 9.19 ppm at −25 °C correspond to the non-
hydrogen-bonded and central hydrogen-bonded ureido protons, respectively of both conformers. 
The signals at 8.90 (0.40 H) and 9.23 ppm (0.60 H) at −25 °C correspond to the peripheral 
hydrogen-bonded ureido protons in the minor and major conformers, respectively. It is proposed 
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that the major conformer is where the benzyl urea is at the N-terminus as the benzyl group can 
form an attractive N-H-π interaction with the proximate urea.83  
This result confirmed the supposition that triureas 32 and 37 exist as one conformation 
due to the control imposed by their termini. It also indicated that foldamers terminated with alkyl 
groups confer conformational mobility in oligoureas such that both directionalities can be 
accessed by the same foldamer. The directionalities in the oligoureas are in fast exchange on the 
NMR timescale, and enter the slow-exchange region between −5 °C and −15 °C when using a 
500 MHz spectrometer. It is notable that the peripheral ureido protons gave rise to very broad 
signals at 20 °C, indicating that directionality reversal is either much slower or much faster at the 
ends of the foldamer. 
 Now that it had been established that alkyl-terminated foldamers conferred 
conformational mobility in the oligoureas, the kinetics of the interconversion between the 
directionalities were investigated. A series of analogous compounds with different numbers of 
ureas was then synthesised (Scheme 10) and their dynamics analysed by VTNMR to determine 
the effect of the number of urea units on hydrogen-bonding dynamics. 
 
Scheme 10 – Synthesis of 42-46. 
Monourea 42 and diurea 43 were synthesised by reacting the appropriate benzylated 
amines with 4-methoxyphenyl isocyanate. Triurea 45 and tetraurea 46 were synthesised by 
twofold reductive alkylation of the corresponding oligoethylenediamine with benzaldehyde 
followed by reaction with isocyanate. The synthesis of 45 proceeded in moderate yield over two 
steps. The crude product of the dibenzylated tetramine was reacted with isocyanate to afford 
tetraurea 46. 46 was successfully isolated, albeit in poor yield due to the increased competitive 
formation of imidazolidines from the 1,2-diamines and benzaldehyde.  Ureas 42, 43, 45 and 46 





Figure 32 – VTNMR of 42 (CD2Cl2, 300 MHz, 29 mM). 
 Monourea 42 showed signals at 4.56 (benzylic methylenes) and 6.20 ppm (ureido proton) 
at 20 °C. The signal at 4.56 ppm was unaffected by decreasing temperature until −50 °C, where 
it broadened and eventually decoalesced into two singlets in a 50:50 ratio at −70 °C, which 
sharpened further at −80 °C. The signal at 6.20 ppm sharpened with decreasing temperature and 
moved steadily downfield. The design was been contrived so the two directionalities are identical 
to each other and are related by C2 symmetry about the axis going through the Bn2N–CO bond. 
These data were consistent with one populated conformation where rotation of the Bn2N–CO 
bond is fast on the NMR timescale and becomes slow between −60 °C and −70 °C. The signals 
corresponding to the benzylic methylenes decoalesced because at slow exchange, one of the 
benzylic methylenes is proximate to a ureido proton, and the other is proximate to a ureido 
carbonyl, making them chemically inequivalent. Additionally, the downfield shift of the ureido 
proton with decreasing temperature is attributed to intermolecular hydrogen bonding. The 
assignment of the decoalesced benzylic methylene signals is arbitrary – it is unknown which 
methylene is proximate to the ureido carbonyl/proton. 
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Figure 33 – VTNMR of 43 (CD2Cl2, 300 MHz, 19 mM). 
 Diurea 43 displayed a signal at 4.48 ppm (benzylic methylenes) at 20 °C. Upon cooling, 
this signal broadened and decoalesced at −50 °C. The decoalesced signals appeared to recombine 
at −70 °C. Signals appeared at 6.47 (1 H) and 9.06 ppm (1 H) at −30 °C, which sharpened and 
shifted downfield with decreasing temperature. These data were also consistent with one 
populated conformer of uniform directionality where the two benzylic methylenes are chemically 
inequivalent at slow exchange. At slow exchange, one ureido proton is in hydrogen bonding (9.06 
ppm at −40 °C) and the other is not (6.47 ppm at −40 °C). Triurea 45 and tetraurea 46 were also 
analysed by VTNMR (Figures A2, A4), and they were found to behave analogously to diurea 43, 
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There are numerous ways to examine the dynamics of interconverting mixtures of 
conformers in solution.84 Such methods are useful for quantifying barriers to rotation in 
atropisomers, elucidating the mechanism of interconversion of conformers in dynamic structures, 
and quantifying the rates and activation barriers at/through which they happen. VTNMR is a 
powerful tool for examining dynamics in solution. It can be used to identify different conformers 
present in solution and quantify to what degree they are present at different temperatures. Using 
NMR simulation software, the rates of interconversion between the conformers, along with their 
enthalpy/entropy of activation and other useful parameters, can be determined.  
 In a dynamic system where two interconverting nuclei A and B are enantiotopic and 
necessarily isoenergetic, their rate of interconversion can be determined by use of the Eyring-








k = Rate constant (s-1) 
kB = Boltzmann constant = 1.38 x 10
-23 J K-1 
T = Temperature (K) 
h = Planck’s constant = 6.63 x 10-34 J s 
ΔG‡ = Activation energy (J mol-1) 
R = Molar gas constant = 8.31 J K-1 mol-1 
Equation 1 – The Eyring-Polanyi equation. 
 By use of the Gibbs free energy equation (Equation 2), the Gibbs free energy can be 
separated into its enthalpic and entropic contributions. 
 
𝛥𝐺‡ =  𝛥𝐻‡ − 𝑇𝛥𝑆‡ 
ΔH‡ = Enthalpy of activation (J mol-1) ΔS‡ = Entropy of activation (J K-1 mol-1) 
Equation 2 – The Gibbs free energy equation. 
 Substituting the Gibbs free energy equation into the Eyring-Polanyi equation, and 

















Equation 3 – The linear form of the Eyring-Polanyi equation. 
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 From this, plotting ln(k/T) against (1/T) produces a straight line whose gradient is equal 
to (−ΔH‡/R) and intercept is equal to (ln(kB/h) + ΔS
‡/R). In a dynamic system where two 
interconverting nuclei A and B are diastereotopic and therefore of different energy, the rate 
constants for the forward reaction and backward reaction will be different. If K and the rate are 
known, then the rate can be dissected into the different rate constants of the forward and backward 
reactions. If rate constants can be determined for different temperatures, then the ΔH‡, ΔS‡, and 
therefore ΔG‡ can be determined for the dynamic process in question at any temperature. These 
data can be used to determine the values of other useful parameters in dynamic processes such as 
half-life and rate constants at unmeasured temperatures. 
The signals corresponding to the benzylic methylenes of oligoureas 42 (monourea), 43 
(diurea), 45 (triurea) and 46 (tetraurea) were modelled using SpinWorks 4 NMR processing and 
simulation software and the rate constants at different temperatures extracted. The rate constants 
were then plotted as a function of temperature to give an Eyring plot (see Appendix, section 8.2) 
whose gradient and intercept were used to deduce the free energy barrier of directionality reversal, 
ΔG‡. Eyring analyses were then performed on ureas 42, 43, 45 and 46 to reveal ΔG
‡
298 K (CD2Cl2) 
to be 48.9, 59.4, 59.0 and 60.9 kJ mol-1, respectively. This shows that, upon introduction of an 
intramolecular hydrogen bond (42 to 43), ΔG‡ dramatically increases as directionality reversal is 
now associated with the breakage and reformation of a hydrogen bond. Upon addition of a third 
urea and a second hydrogen bond (45), there is no change in ΔG‡. Finally, upon introduction of a 
fourth urea and a third hydrogen bond (46), there is an insignificant increase in ΔG‡. These results 
appear to contradict hydrogen-bond cooperativity from a kinetic standpoint.29 If hydrogen-bond 
cooperativity was operating in these foldamers, it is expected that ΔG‡ would be greater in triurea 
45 than in diurea 43, as the cooperative effects would strengthen the intramolecular hydrogen 
bonds and confer additional kinetic stability. However, it is possible that the kinetic stability of 
the intramolecular hydrogen bonds is independent of hydrogen-bond cooperativity. The breakage 
and reformation of the hydrogen bonds could be occurring at the same rate, but the hydrogen 
bonds are more thermodynamically stable. Future work in this area will focus on addressing the 
possibility of hydrogen-bond cooperativity in these structures from a thermodynamic perspective. 
Interestingly, ΔS‡ was found to be universally negative, meaning that oligourea 
directionality reversal goes by an associative mechanism. ΔG
‡
298 K (CD2Cl2) of tetraurea 46 
corresponded to a rate of directionality reversal of 130 s-1 at 298 K, showing that if an ethylene-
bridged oligourea foldamer had controlled directionality, a perturbation of that directionality 
control would be communicated through the foldamer on the order of milliseconds. Eyring 
analysis was also performed on triurea 41 (Figure 31), where ΔG
‡
298 K (CD2Cl2) was found to be 
58.1 kJ mol-1 for the minor to major conformer transition, and 59.2 kJ mol-1 for the major to minor 
conformer transition. Finally, due to the lack of discrepancy between the barriers of triureas 41 
63 
 
and 45, bis(ethyl) diurea, 47 was synthesised so its kinetic behaviour could be compared to that 
of the analogous bis(benzyl) diurea, 43. Diurea 47 was synthesised by reaction of N,N’-
diethylethylenediamine with 4-methoxyphenyl isocyanate, which proceeded in excellent yield. 
47 was then studied by VTNMR (Figure 34). 
 
 
Figure 34 – VTNMR of 47 (CD2Cl2, 300 MHz, 24 mM). 
Diurea 47 displayed a signal at 1.18 ppm (terminal methyl groups) at 20 °C. Upon 
cooling, the signal at 1.18 ppm lost its multiplicity and broadened until it decoalesced at −40 °C 
into two broad triplets. At −30 °C, signals appeared at 6.49 (1 H) and 8.86 ppm (1 H), which 
sharpened and shifted downfield upon further decreasing the temperature. These data showed that 
bis(ethyl) diurea 47 behaves analogously to bis(benzyl) diurea 43, further validating the 
hypothesis that ethyl groups and benzyl groups can be used to terminate the oligoureas and permit 
conformational mobility. Eyring analysis of 47 revealed ΔG
‡
298 K (CD2Cl2) to be 51.5 kJ mol
-1, a 
value substantially lower than that of 43, indicating that the barrier to and therefore the rate of 
directionality reversal is sensitive to the alkyl groups that terminate the foldamer.  
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 Initial investigations into alternative terminations of ethylene-bridged oligoureas have 
shown that conformational mobility is conferred to the foldamer if they are terminated with alkyl 
groups. Access to these conformationally mobile oligoureas has allowed Eyring analyses, which 
have been used to determine ΔG‡ in foldamers with a variety of lengths. Use of different termini 
had a significant effect on ΔG‡, which will be considered when making foldamers with directional 
control. It was shown that intramolecular hydrogen bonding introduces kinetic stability to the 
foldamer, slowing down directionality reversal. This kinetic stability did not augment upon 
introduction of more hydrogen bonds to the network, suggesting a lack of hydrogen-bond 
cooperativity in these structures. The consistency of ΔG‡ across oligoureas 43, 45 and 46 indicates 
that further extension of the oligourea should not affect hydrogen-bonding dynamics, which could 




3.2 Solvent Effects on Hydrogen-Bond Directionality  
 
 If these oligoureas were to be used in a biological setting, the communication of 
information would have to be feasible in the presence of biologically relevant molecules such as 
phospholipids, sugars, purine and pyrimidine-based nucleotides and most importantly, water. 
With oligoureas 42, 43, 45 and 46 in hand, it was desirable to further examine the effect of 
hydrogen-bonding additives on the fidelity of the hydrogen-bonding network. Firstly, monourea 
42, diurea 43 and triurea 45 were studied by VTNMR in CD2Cl2 with 40% v/v of CD3OH as a 
competitive hydrogen-bonding solvent (Figures 35-36, Figure A3). The CD2Cl2/CD3OH mixture 
was used to maintain solubility, and d4-methanol was not used as proton-deuteron exchange 
would prohibit analysis of the ureido protons.  
 
 
Figure 35 – VTNMR of 42 (40% v/v CD3OH in CD2Cl2, 300 MHz, 29 mM). 
 In monourea 42, signals were observed at 4.52 (benzylic methylenes) and 6.95 ppm 
(ureido proton) at 20 °C. Upon cooling, the signal at 4.52 ppm broadened until eventually 
decoalescing at −70 °C. The signal at 6.95 ppm shifted downfield with decreasing temperature. 
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At −40 °C, the peak at 7.58 ppm (ureido proton) decoalesced into two singlets in a 40:60 ratio 
which shifted downfield at the same rate upon further cooling. These results indicated that the 
ureido proton is in two different hydrogen-bonded chemical environments when in slow 
exchange. In the presence of CD3OH, 42 either hydrogen bonds with itself or with CD3OH, giving 
rise to the two different intermolecularly hydrogen-bonded environments. In comparison to that 
observed in neat CD2Cl2 (Figure 32), a decoalescence event was observed at the same temperature 
but the anisochronicity was much less pronounced in the presence of CD3OH. The ureido proton 
signal was also much more downfield in the presence of CD3OH due to intermolecular hydrogen 
bonding with the solvent.   
 
 
Figure 36 – VTNMR of 43 (40% v/v CD3OH in CD2Cl2, 300 MHz, 19 mM). 
 In diurea 43, signals were observed at 4.43 (benzylic methylenes) and 8.21 ppm (ureido 
protons) at 10 °C (the benzylic methylene signal was obscured by the alcohol peak at 20 °C). 
Upon cooling, the signal at 4.43 ppm broadened with decreasing temperature and decoalesced at 
−40 °C into two singlets in a 50:50 ratio, which sharpened upon further cooling. The signal at 
8.21 ppm shifted downfield and broadened with decreasing temperature, until it decoalesced into 
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two broad singlets (1 H each) at −30 °C. These singlets sharpened and shifted further downfield 
with further cooling. If the CD3OH interrupted the intramolecular hydrogen bonding, the resultant 
intermolecular hydrogen bond with CD3OH would give rise to conformations where both ureas 
are chemically identical at slow exchange. However, decoalescence of the benzylic methylenes 
was still observed, indicating directional uniformity. The CD3OH did not interrupt the 
intramolecular hydrogen bonding, it simply complemented it by hydrogen bonding to both ends; 
one through the hydroxyl oxygen and the other through the hydroxyl proton. This was further 
validated by the chemical shifts of the ureido protons at low temperature. At −60 °C, there is a 
signal at 9.29 ppm corresponding to an intramolecularly hydrogen-bonded ureido proton, which 
is very similar to 43 in CD2Cl2 (9.18 ppm). The other ureido proton shows a signal at 8.56 ppm, 
which is very different to that observed in CD2Cl2 (6.66 ppm) due to the formation of a hydrogen 
bond with CD3OH (Figure 33). The anisochronicity of the benzylic methylenes in the presence of 
CD3OH is much more pronounced than that in neat CD2Cl2 (ΔΔδ298 K = 0.05 ppm). This is because 
at slow exchange, both benzylic methylenes are proximate to hydrogen-bonding CD3OH, and the 
difference between these two environments is much more pronounced. Triurea 45 was also 
analysed by VTNMR (Figure A3), and was found to behave analogously to diurea 43, but with 
two hydrogen-bonding ureido protons. 
As methanol hydrogen bonds to the ends of these oligoureas, it was desirable to determine 
to what extent the central ureas interact with the solvent. To this end, triurea 45 was dissolved in 
CD2Cl2 and its 
1H NMR spectrum was recorded. Three equivalents of d4-methanol were then 
added to the sample and its 1H NMR spectrum recorded after specified times in order to see the 













Figure 37 – 1H NMR array upon addition of d4-methanol to 45. 
 Unfortunately, the peripheral ureido protons could not be observed at 20 °C, so their rate 
of deuteration could not be determined. Upon addition of d4-methanol, the central ureido proton 
signal (8.92 ppm) attenuated to 60% of its original integration. This attenuation continued until it 
stopped after 10 minutes. This result shows that the central ureas in these oligourea foldamers are 
protected from solvent to the extent that proton-deuteron exchange does not occur 
instantaneously. However, it is unknown whether deuteration of the central urea occurs directly 
from exchange with the d4-methanol or by intramolecular exchange with adjacent ureas.  
42, 43, 45 and 46 were analysed by VTNMR with 10% v/v of d6-DMSO as a competitive 
HBA (Figures 38-39, Figures A4, A6). The CD2Cl2/d6-DMSO mixture was used instead of d6-
DMSO alone because d6-DMSO freezes above the slow-exchange region of the oligoureas when 
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Figure 38 – VTNMR of 42 (10% v/v d6-DMSO in CD2Cl2, 300 MHz, 29 mM). 
 In monourea 42, signals were observed at 4.46 (benzylic methylenes) and 7.63 ppm 
(ureido proton) at 20 °C. The signal at 4.46 ppm broadened with decreasing temperature and 
eventually decoalesced at −80 °C. The signal at 7.63 ppm shifted downfield and sharpened upon 
cooling. These results showed that 42 exists as one conformation, and rotation about the Bn2N–
CO bond is slow on the NMR timescale below −80 °C. Additionally, d6-DMSO hydrogen bonds 
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Figure 39 – VTNMR of 43 (10% v/v d6-DMSO in CD2Cl2, 300 MHz, 19 mM). 
 In diurea 43, signals were observed at 4.38 (benzylic methylenes) and 8.47 ppm (ureido 
protons) at 20 °C. The signal at 4.38 ppm broadened and decoalesced at −30 °C into two singlets 
in a 50:50 ratio, which sharpened further upon cooling. The signal at 8.47 ppm shifted downfield 
and broadened with decreasing temperature, until it decoalesced into two singlets (1 H each) at 
−20 °C, which then sharpen and shift further downfield with decreasing temperature. These data 
concluded that that d6-DMSO also does not interrupt the intramolecular hydrogen bonding in 43, 
it instead complements it by hydrogen bonding to the exposed terminal ureido proton. This is 
further validated by the chemical shifts of the ureido protons at low temperature. At −60 °C, there 
is a signal at 9.21 ppm corresponding to a ureido proton intramolecularly hydrogen bonded to the 
other urea. The other ureido proton shows a signal at 8.59 ppm, which is much more downfield 
than that observed in CD2Cl2 (6.66 ppm at −60 °C) as it is hydrogen bonding with d6-DMSO. 
Triurea 45 and tetraurea 46 were also analysed by VTNMR (see Appendix, Figures A4, A6), and 
they were found to behave analogously to diurea 43, but with increasing numbers of hydrogen-
bonding ureido protons. 
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 These results were then subject to Eyring analyses to reveal ΔG
‡
298 K values with varying 
numbers of ureas and in the presence of different hydrogen bonding cosolvents (Table 1). 
Table 1 – ΔG
‡
298 K values (kJ mol
-1) for ureas 42, 43, 45 and 46 in the presence of hydrogen bonding 
cosolvents (the number in brackets denotes the number of intramolecular hydrogen bonds). 
 ΔG
‡
298 K (kJ mol
-1
) 
Cosolvent None 40% v/v CD3OH 10% v/v d6-DMSO 
Monourea 42 (0) 48.9 59.9 54.5 
Diurea 43 (1) 59.4 55.3 52.3 
Triurea 45 (2) 59.0 58.6 54.9 
Tetraurea 46 (3) 60.9 - 53.7 
 
The Eyring analyses of 42, 43, 45 and 46 are explicable by considering intermolecular 
hydrogen bonding with cosolvent. Monourea 42 showed a significant increase in ΔG‡ upon 
introduction of CD3OH as directionality reversal is now being associated with breakage of two 
hydrogen bonds to CD3OH or concurrent movement of CD3OH with C–N bond rotation, resulting 
in inhibited directionality reversal. The ΔS
‡
  term is still negative for 42, 43 and 45, suggesting the 
latter is the rate-determining step because the release of two molecules of CD3OH is presumed to 
result in a positive ΔS
‡
  term. CD3OH forms two hydrogen bonds as it can act as an HBD through 
the hydroxyl proton and as an HBA through the oxygen lone pairs and hydrogen bond with the 
ureido carbonyl and proton, respectively. The ΔG
‡
  for 43 decreases a small amount and is 
approximately the same in 45 when CD3OH is present. This is also consistent with slowed C–N 
bond rotation in tertiary amides in polar media.86 In the presence of d6-DMSO, ΔG
‡
   changes for 
42, 43, 45 and 46 to approximately 54 kJ mol-1. This is lower than that observed with CD3OH 
because two urea-CD3OH hydrogen bonds are weaker than one urea-d6-DMSO hydrogen bond. 
Much like the case of CD3OH, this is consistent with directionality reversal being associated with 
breakage and reformation of a hydrogen bond with DMSO. It is notable that ΔS‡ is still negative 
in the presence of d6-DMSO, suggesting that directionality reversal is associated with concurrent 
movement of d6-DMSO with C–N bond rotation. 
 VTNMR and subsequent Eyring analyses have concluded that the intramolecular 
hydrogen bonding in the oligoureas is robust in the presence of hydrogen-bonding cosolvents 
CD3OH and d6-DMSO. In some cases, the kinetic parameters are significantly altered, but 
thermodynamically, the oligoureas are most stable when forming an intramolecular hydrogen-
bonding network, which may or may not be complemented by HBDs and HBAs present in the 
bulk. This result indicates that this class of foldamers may be conducive to informational 
communication in the presence of other competitive hydrogen-bonding molecules that would be 
present in a biological setting.  
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 With these encouraging results surrounding the robustness of the hydrogen-bonding 
network in these oligourea foldamers, it was interesting to find out how strong hydrogen-bonding 
competitors need to be in order to provide a better thermodynamic alternative to intramolecular 
hydrogen bonding. The VTNMR experiment of 45 was repeated with 50% v/v d6-DMSO in 
CD2Cl2 (Figure 40). Spectra were not recorded below −60 °C as the solution began to freeze 
between −50 °C and −60 °C. 
 
 
Figure 40 – VTNMR of 45 (50% v/v d6-DMSO in CD2Cl2, 300 MHz, 14 mM). 
 Triurea 45 with 50% v/v d6-DMSO in CD2Cl2 behaved in a highly analogous fashion to 
when it was in 10% v/v d6-DMSO in CD2Cl2, showing that d6-DMSO is not a strong enough HBA 
to disrupt the intramolecular hydrogen bonding in 45. It may be that disruption of the hydrogen-
bonding network could be achieved with stronger HBAs, such as phosphine oxides. 
Schreiner’s thiourea is a very strong double HBD which forms very stable complexes 
with carbonyl compounds (Figure 41).87 It was suspected that this may have sufficient hydrogen-
bond-donating power to disrupt the hydrogen-bonding network. 2.5 equivalents of Schreiner’s 
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thiourea were added to 45 in CD2Cl2. More Schreiner’s thiourea would have been used to help 
destroy the hydrogen-bonding network, but its solubility in CD2Cl2 was limiting. The same 
stoichiometry was maintained throughout the VTNMR experiment (Figure 41), but particulate 
precipitation resulted in a loss of resolution at lower temperatures. 
 
 
Figure 41 – VTNMR of 45 with 2.5 equivalents of Schreiner’s thiourea (CD2Cl2, 300 MHz, 14 mM). 
 Triurea 45 showed signals at 4.57 (benzylic methylenes), 8.90 (Schreiner’s thiourea 
thioureido protons) and 8.96 ppm (central ureido proton) at 20 °C. The signal at 4.57 ppm 
broadened with decreasing temperature but did not appear to decoalesce, and the signals at 8.90 
and 8.96 ppm shifted downfield. At 0 °C, new signals appeared at 6.30 and 9.31 ppm (obscured 
by Schreiner’s thiourea thioureido protons), which sharpened and shifted downfield with 
decreasing temperature. These results can be explained by the population of only one conformer 
with uniform directionality where, at slow exchange, there is one non-hydrogen-bonded ureido 
proton (6.38 ppm at −60 °C) and two intramolecularly hydrogen-bonded ureido protons (9.27 and 
9.72 ppm at −60 °C). Schreiner’s thiourea complements the directionality by hydrogen bonding 
to the terminal ureido carbonyl, hence the downfield shift of the thioureido protons with 
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decreasing temperature. It is proposed that a decoalescence of the benzylic methylene signal is 
not observed due to a loss of spectral resolution associated with particulate precipitation of 
Schreiner’s thiourea. 
 Experiments with 50% v/v d6-DMSO and Schreiner’s thiourea showed that strong 
hydrogen-bonding additives, even when present to a high degree, are not powerful enough to 
impart any preferential thermodynamic alternative to these foldamers. This further supports the 
notion that these oligoureas could lend themselves to informational communication in biological 
settings without disruption from biological molecules. Unfortunately, these foldamers are not 
soluble in mixtures of DCM/methanol that would solubilise other biologically relevant potent 
hydrogen-bonding molecules. Further work in this area will involve derivatisation of the 
foldamers to confer water/methanol solubility, such that water/methanol mixtures can be used to 




















3.3 Electronic Control of Hydrogen-Bond Directionality 
 
 At this point, a host of conformationally mobile oligourea foldamers had been synthesised 
and used to demonstrate hydrogen-bonding fidelity within the ethylene-bridged oligourea 
scaffold. Next, research was focused on making oligourea foldamers terminated with groups that 
can control directionality electronically. The initial target selected was thiourea, 49 (Scheme 11) 
in the hope that it would control directionality in the opposite fashion to the phenyl groups 
established by Nowick (act as the C-terminus). Thioureas are much stronger HBDs and weaker 
HBAs than their homologous ureas due to the higher diffusivity of the orbitals on sulfur, so it was 
expected that they could impose directional control by hydrogen bonding through their thioureido 
protons.87,88 The 4-nitrophenyl substitution on the thiourea was used to further augment the 
thiourea’s hydrogen-bond-donating ability.  
 
Scheme 11 – Synthesis of 49. 
 Amine 39 underwent reductive alkylation with acetaldehyde, and the corresponding 
secondary amine was reacted with 4-nitrophenyl isothiocyanate to give the target thiourea 49 in 








Figure 42 – VTNMR of 49 (CDCl3, 500 MHz, 16 mM). 
 Thiourea 49 showed signals at 6.32 (peripheral ureido proton), 9.09 (central ureido 
proton) and 10.26 ppm (thioureido proton) at 25 °C. Each of these signals were broad at 25 °C, 
but all sharpened and shifted downfield upon cooling. There was no observable decoalescence of 
the alkyl or aromatic signals throughout the experiment. These data indicate that 49 exists as one 
conformation, where the thioureido proton (10.26 ppm at 25 °C) is in hydrogen bonding. The 
central ureido proton (9.09 ppm at 25 °C) is also in hydrogen bonding with another urea, but the 
peripheral ureido proton (6.32 ppm at 25 °C) is not hydrogen bonded. This shows that the thiourea 
establishes complete conformational control over the diurea by forcing the adjacent urea to 
hydrogen bond to it through its carbonyl. This directionality is communicated to the second urea, 
and so the ureido proton in the peripheral urea cannot form an intramolecular hydrogen bond, 
defining the thiourea terminus as the C-terminus. 
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 These studies have shown that electron-deficient thioureas can impart total directional 
control in ethylene-bridged diureas. Next, the synthesis of longer oligoureas with terminal 
hydrogen-bonding groups was sought to show that directional control still operates with more 
ureas in the foldamer. Additionally, another hydrogen-bonding group that would act as an HBA 
(act as the N-terminus) was also desired. Imides do not contain acidic protons, and so it was 
expected that they could impose directional control by acting as an HBA through their imido 
carbonyls. Due to the slow, poorly yielding and wasteful nature of an iterative process, the 
synthesis of the new targets, thiourea 50 and phthalimide 51 (Figure 43) was to be achieved in a 
more modular process deriving from the corresponding oligoethylenediamine. Previous 
experiments had shown that the benzylic methylene would be remote from other signals in the 1H 
NMR spectrum, meaning that it could be used as an effective spectroscopic reporter for conformer 
distribution. In thiourea 50, phenyl groups are used at both ends in order to remove any steric 
effects that could be associated with directionality control. 
 
Figure 43 – Elongated directionality-controlled targets, 50 and 51. 
The first attempted method was adapted from Leigh and co-workers by making a 
directionality-controlling fragment attached to an aldehyde, which could be coupled to the N-
benzyl-substituted oligoethylenediamine by reductive amination (Scheme 12).89 After coupling 
of these fragments, protecting group removal and subsequent installation of the ureas would give 




Scheme 12 – Synthesis of aldehyde fragments, 54 and 59. 
 N-(2-hydroxyethyl)ethylenediamine was protected selectively at the secondary amine by 
trifluoroacetylation of the primary amine, Boc-protection of the secondary amine and then 
hydrolysis of the corresponding trifluoroacetamide.89 The synthetic scheme was then bifurcated 
to make the two different aldehyde fragments, 54 and 59. Amine 52 was reacted with phthalic 
anhydride to give the corresponding amic acid, which was then activated to cyclisation using 
excess CDI (1,1’-carbonyldiimidazole) to give the corresponding phthalimide. This effected the 
desired cyclisation, but unfortunately, the alcohol also reacted with the CDI to give an imidazolyl 
carbamate. Attempts to hydrolyse the carbamate using aqueous sodium hydroxide resulted in 
hydrolysis of both the carbamate and the phthalimide. Instead, the cyclisation of the amic acid 
was triggered thermally by heating in toluene, giving phthalimide 53 in excellent yield. Oxidation 
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of the alcohol to the aldehyde using Dess-Martin periodinane (DMP) proceeded in good yield to 
give the target aldehyde fragment 54. Next, reductive amination using N-benzylethylenediamine 
and sodium cyanoborohydride was attempted. This reducing agent was chosen to avoid potential 
overreduction of the phthalimide to the corresponding isoindolinone. However, decomposition 
was observed under these reductive amination conditions. The same was also observed when the 
imine was preformed in methanol and also when no reducing agent was present. Due to the known 
stability of the aldehyde, it was presumed that the imine was the unstable component that was 
decomposing before it could be reduced. It was speculated that the 1,2-diamine relationship in the 
nucleophile was causing the decomposition as the imine could react further intramolecularly to 
form an imidazolidinone. N-Boc-N-benzylethylenediamine was synthesised in an analogous way 
to amine 52 from N-benzylethylenediamine (Scheme 12) and used for imine formation, but 
unfortunately, decomposition of aldehyde 54 was still observed. Due to the instability of 54 to 
reductive amination conditions, an alternative method was sought. 
 The synthesis of thiourea fragment, 59 was then attempted. Reductive alkylation of 52 
with benzaldehyde followed by reaction with 4-nitrophenyl isothiocyanate afforded 58 in 
excellent yield over two steps. Next, oxidation of the alcohol to the aldehyde using DMP yielded 
numerous products, none of which corresponded to the desired aldehyde. Other attempts to 
oxidise the alcohol included Swern oxidation, reaction with MnO2 and with pyridinium 
chlorochromate (PCC), all with similar results. From this, the thiourea was deemed too reactive 
to be conducive to a fragment-based synthesis of the longer directionality-controlled oligoureas. 
It was speculated that the thiourea was reacting with the oxidising agents at the sulfur atom, 
resulting in decomposition. The fragment-based synthesis of the longer directionality-controlled 
oligoureas was consequently abandoned, and it was deduced that these controlling groups had to 
be installed near the end of the synthesis. 
 A new stratagem was devised for the synthesis of the longer directionality-controlled 
oligoureas based on a method from Leigh and co-workers.89 The method involved the protection 
of the secondary amines of an oligoethylenediamine, followed by desymmetrising reductive 
alkylation and further functional group manipulation to afford the desired directionality-




Scheme 13 – Synthesis of intermediates, 63 and 64. 
 Triethylenetetramine was protected at the secondary amines with Boc groups analogously 
to amine 52 (Scheme 12). Desymmetrising reductive alkylation was then attempted with diamine 
60 and benzaldehyde but unfortunately, only the dibenzylated product could be isolated. As Leigh 
and co-workers have previously performed desymmetrising reductive alkylations using 1-
naphthaldehyde, the desymmetrisation was attempted using 1-naphthaldehyde instead of 
benzaldehyde. This reaction proceeded in poor yield to give naphth-1-ylmethylamine 61, but upon 
scale-up and dropwise addition of the aldehyde to a concentrated solution of the diamine, the yield 
was improved to 50%. As this method for desymmetrisation proved successful, the naphth-1-
ylmethyl group was used to terminate the longer directionality-controlled triureas. 
Next, trifluoroacetamide formation, Boc installation and trifluoroacetamide hydrolysis 
installed a final Boc group on the remaining secondary amine. This proceeded in excellent yield 
over the three steps to give the primary amine, 62. 62 was then heated to reflux in toluene with 
succinic anhydride to form the imide. This saw no conversion of starting material and the same 
result was observed when 62 was heated with an excess of triethylamine and succinic anhydride. 
Similarly, when heated in ethanol with an excess of 1-naphthaldehyde and 1 mol% of acetic acid, 
no imine formation was observed. From this, it was concluded that upon formation of the third 
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Boc group on the tetramine, the Boc groups distorted the conformation of the 
oligoethylenediamine such that the reactivity of the primary amine was greatly inhibited. Due to 
this, the steps of the synthesis were rearranged so that the ureas were installed before formation 
of the directionality controller (Scheme 14). 
 
Scheme 14 – Synthesis of directionality-controlled oligoureas, 68 and 69. 
 In this method, the desymmetrised amine, 61 was deprotected using TFA to liberate the 
mono-naphth-1-ylmethylated tetramine. Unfortunately, during purification, this tetramine 
partitioned into the aqueous phase despite attempting different polar organic phases, including 
when the aqueous phase was strongly alkaline. The aqueous phase was concentrated and the 
residue triturated with ethyl acetate, but this did not furnish the desired tetramine. Hence, the 
synthetic steps were rearranged again to promote organic solubility. Primary amine 61 was 
trifluoroacetylated at the primary amine, and the Boc groups cleaved using TFA. Three ureas 
were then installed to give the desired triurea 65, albeit in poor yield over the three steps. The 
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trifluoroacetamide was then hydrolysed using aqueous hydroxide to create the primary amine 66, 
which was then used to install the two different directionality-controlling groups. 
 Primary amine 66 underwent reductive alkylation with 1-naphthaldehyde to give the 
corresponding naphth-1-ylmethylamine 67, which was then reacted with 4-nitrophenyl 
isothiocyanate to form the target thiourea, 68. Separately, 66 was reacted with succinic anhydride 
and acetyl chloride, giving the target succinimide, 69 in good yield. Thiourea 68 and succinimide 
69 were then studied using VTNMR (Figures 44-45). 
 
 
Figure 44 – VTNMR of 68 (CD2Cl2, 300 MHz, 19 mM). 
 In thiourea 68, signals were observed at 5.05 (urea benzylic methylene), 5.65 (thiourea 
benzylic methylene), 6.38 (peripheral ureido proton), 9.01 (two central ureido protons) and 10.55 
ppm (thioureido proton) at 20 °C. Upon cooling, the signal at 5.05 ppm remained approximately 
constant until broadening at −60 °C. The signal at 5.65 ppm broadened and decoalesced into two 
equal singlets (1 H each) at −60 °C. The signals at 6.38, 9.01 and 10.55 ppm sharpened and shifted 
downfield with decreasing temperature. A lack of decoalescence of the reporting terminal 
benzylic methylene and thio(ureido) protons shows that 68 exists as one conformation. This 
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conformation is the directionality where the thiourea is at the C-terminus, as the chemical shifts 
indicate that the thioureido proton and two ureido protons are in hydrogen bonding (10.55 and 
9.01 ppm, respectively at 20 °C), and one ureido proton is not (6.38 ppm at 20 °C). It is worth 
noting that the thioureido benzylic methylene decoalesces into two equal singlets (1 H each) at 
very low temperature, which is attributed to diastereotopicity arising from the chiral anti 
conformations in the adjacent ethylene bridge.  
A nuclear Overhauser effect (NOE) 1H NMR experiment was then performed on thiourea 
68. NOE experiments are used as a method to determine how close two nuclei are in space, which 
makes it an excellent tool for the determination of conformation in solution.90 An NOE 
experiment is performed by irradiating a specific nucleus according to the energy difference 
between its spin up and spin down state (chemical shift). That specific nucleus can then relax its 
spin state and reemit a photon of the same energy that irradiated it. However, proximate nuclei 
can also concurrently relax their spin states due to the interdipolar interactions of the nuclear 
spins, releasing a photon of different energy. This process is known as cross-relaxation. These 
released photons correspond to the energy difference of spin states of the proximate nucleus, 
meaning that an NOE correlation will be observed at their chemical shift. This cross-relaxation is 
highly sensitive to internuclear distance, and the decay of this effect correlates with r6, where r is 
the internuclear distance. NOE analysis of 68 revealed a correlation between the terminal non-
hydrogen-bonding ureido proton with the benzylic methylene (see Appendix, Figures A27-28), 
















Figure 45 – VTNMR of 69 (CD2Cl2, 300 MHz, 12 mM). 
 In succinimide 69, signals were observed at 2.70 (succinimidyl methylenes), 5.11 
(benzylic methylene) and 8.84 ppm (one ureido proton) at 20 °C. Upon cooling, the signal at 2.70 
ppm broadened and decoalesced at −10 °C into two singlets, which then sharpened upon further 
decreasing the temperature (2.87 H and 1.13 H at −60 °C). The signal at 5.11 ppm also broadened 
and decoalesced into two closely overlapping singlets at −40 °C. The signal at 8.84 ppm moved 
downfield with decreasing temperature before decoalescing into three signals at −20 °C, which 
then shifted further downfield. Additionally, a new signal appeared at 6.39 ppm (0.28 H) at −10 
°C, which sharpened and moved downfield upon further decreasing the temperature. These data 
are consistent with the presence of two conformations populated in a 28:72 ratio at −60 °C, which 
are the two different directionalities. This is indicated by the two different environments of the 
succinimide at slow exchange – one where it is hydrogen bonding to the adjacent urea, and one 
where it is not. Finally, the two different conformations give rise to six different environments for 
ureido protons. Five of these ureido protons hydrogen bond either to other ureas or to the 
succinimide, but the sixth ureido proton is not hydrogen bonded, giving rise to a signal at 6.39 
ppm at −10 °C. This signal also integrates for 0.28 H at −60 °C, and the other ureido proton 
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integrations account for the remaining 2.72 H, indicating that the conformer where the 
succinimide is at the C-terminus is the minor conformer. 
 Unfortunately, the VTNMR experiment on succinimide 69 revealed that succinimides are 
not powerful enough HBAs to impose total directionality control on ethylene-bridged triureas. 
This was attributed to the fact that 69 was terminated with a naphth-1-ylmethyl group, which can 
form an attractive N-H-π interaction, promoting the conformation where the succinimide was at 
the C-terminus.83 
 To combat the issues associated with the succinimide, a stronger HBA was sought. The 
proposed target was tetrasubstituted urea, 71 (Scheme 15), which is analogous to the other ureas 
in the foldamer except it has been methylated at nitrogen, removing its ability to donate hydrogen 
bonds and rendering it exclusively an HBA. Additionally, this meant that 71 could also be 
terminated with naphth-1-ylmethyl groups at both ends, so any directionality control could be 
attributed to the tetrasubstituted urea as opposed to the naphth-1-ylmethyl group at the reporting 
end of the foldamer.  
 
Scheme 15 – Synthesis of 71. 
 Chloroformylation of N-methyl-4-methoxyaniline gave carbamoyl chloride, 70 in 
quantitative yield. 70 was then reacted with secondary amine, 67 to give the new directionality-







Figure 46 – VTNMR of 71 (CD2Cl2, 300 MHz, 13 mM). 
Tetraurea 71 showed signals at 4.50 (tetrasubstituted urea benzylic methylene), 5.07 
(trisubstituted urea benzylic methylene), 8.72, 8.79 (very broad) and 9.08 ppm (three ureido 
protons) at 20 °C. Upon cooling, the signals at 4.50 and 5.07 ppm remained approximately 
constant until broadening at −40 °C. The signals at 8.72, 8.79 and 9.08 ppm all shifted downfield 
and sharpened with decreasing temperature until they broadened at −40 °C. These results show 
that 71 exists as one conformer, which is the directionality where the tetrasubstituted urea is at 
the N-terminus. The chemical shifts of the ureido protons show that they are all in hydrogen 
bonding, and there is no observable signal for non-hydrogen-bonded ureido protons at around 
6.40 ppm. In direct contrast to thiourea 68, NOE analysis showed that the reporting benzylic 
methylene are not proximate to any ureido protons (see Appendix, Figure A29), further supporting 
the notion that the tetrasubstituted urea is at the N-terminus. Finally, it is notable that the 4-
methoxyphenyl group in the tetrasubstituted urea is oriented s-trans.75 
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To conclude, electron-deficient thioureas and tetrasubstituted ureas can be used to attain 
complete directional control in ethylene-bridged triureas in opposite fashions. The non-iterative 
synthesis of triureas with different terminal functionalities has been developed, allowing the 
appendage of different functions to the termini of the foldamer in a convergent manner. Finally, 
terminating benzylic ureas have been shown to be effective reporters of local hydrogen-bond 
directionality, where NOEs can be observed with adjacent ureido protons in one directionality, 




3.4 The Development of the Synthesis of Longer Oligoureas  
 
 It has been established that ethylene-bridged triureas with different directionality-
controlling termini can be synthesised from triethylenetetramine. It was next desirable to 
determine if any decay in informational communication manifests in longer oligoureas. It was 
proposed that the corresponding pentaurea could be synthesised by an analogous method using 
the largest commercially available oligoethylenediamine, pentaethylenehexamine (Scheme 16).  
 
Scheme 16 – Synthesis of 75. 
 Pentaethylenehexamine underwent a twofold trifluoroacetylation and fourfold Boc-
protection in one pot in good yield. The corresponding bis(trifluoroacetamide) was then 
hydrolysed to give diamine 72 in excellent yield over the three steps. 72 then underwent reductive 
alkylation with 1-naphthaldehyde to give naphth-1-ylmethylamine 73 in moderate yield. The four 
Boc groups were then cleaved using TFA to give the corresponding pentamine, which proceeded 
in only reasonable yield due to the loss of some product to the aqueous phase during purification. 
Finally, pentamine 74 was to undergo a fivefold carboxamidation using excess isocyanate, but 
unfortunately a complex mixture of products was observed corresponding to different 
permutations of missing ureas from the product.  
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Upon resubmission of the crude product to the reaction conditions with more isocyanate 
and heating, no further conversion was observed. From this, it was deduced that the installation 
of several ureas at once can prove difficult depending on the order in which the ureas are formed. 
It was envisaged that installation of the central ureas as early in the synthesis as possible would 
be conducive to a much more practical and convergent synthesis of longer oligourea foldamers.  
 To this end, pentaethylenehexamine was submitted to the same trifluoroacetylation 
procedure, but instead of adding Boc2O, 4-methoxyphenyl isocyanate was added in the hope that 
the corresponding protected tetraurea would be formed (Scheme 17).  
 
Scheme 17 – Synthesis of 78. 
Gratifyingly, the desired product precipitated out of solution after stirring for 16-48 h, 
giving the desired protected tetraurea 76 in poor yield. This poor yield was tolerated due to the 
large amount of functionalisation the reaction involved and because the reaction was conducive 
to scale-up. More of the desired product was identified in the filtrate and could be isolated by 
recrystallisation from DCM:MeOH mixtures. A majority of the converted mass corresponded to 
products with different permutations of missing ureas but fortunately, these by-products could be 
easily removed by filtration. Tetraurea 76 could then be solubilised in the subsequent hydrolysis 
reaction mixture and after 3-5 h, the corresponding diamine precipitated out of the mixture and 
could be easily filtered to attain the desired diamine 77 in excellent yield. 77 was found to be 
insoluble in MeOH, so the subsequent reductive alkylation was performed after solubilising in a 
heated DCM:MeOH mixture. After the proposed monoimine formation, a precipitate was 
observed. Filtration and subsequent analysis revealed that the bis(imine) had formed and 
precipitated with remaining 77. The reaction mixture was treated with sodium borohydride in the 
hope that reduction of any monoimine present would yield the desired product. Unfortunately, 
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the subsequent purification revealed that only the bis(naphth-1-ylmethyl)amine, and the starting 
material 77 could be isolated. In the reaction mixture, monoimine formed upon reaction of 77 
with 1-naphthaldehyde, but undesirably reacted again to form the bis(imine). The bis(imine) was 
then insoluble in the reaction mixture and precipitated. This precipitation then greatly inhibited 
the reverse reaction to the monoimine, such that all of the 1-naphthaldehyde was consumed in 
forming the bis(imine). Reduction then converted the two imines irreversibly to the undesired 
bis(naphth-1-ylmethyl)amine. As there was a substoichiometric amount of 1-naphthaldehyde 
used for disubstitution, 77 was also left in the reaction mixture. Due to the concomitant 
precipitation of 77, it was supposed that DCM:MeOH solutions of 77 are metastable, and 
precipitate given sufficient time. Subsequent reaction attempts corroborated this hypothesis. 
Due to the solubility issues associated with the desymmetrisation of 77, the oligourea 
intermediate was changed to the corresponding triurea to be derived from tetraethylenepentamine 
(Scheme 18). To supplement this shortened oligourea with additional amines, the reductive 




Scheme 18 – Synthesis of 85. 
 Tetraethylenepentamine was protected at the primary amines with ethyl trifluoroacetate 
and reacted at the secondary amines with 4-methoxyphenyl isocyanate to give the corresponding 
triurea, 79 in poor yield. Much like tetraurea 76, triurea 79 precipitated out of the reaction mixture 
and was collected by filtration. Similarly, the trifluoroacetamides were then hydrolysed to give 
diamine 80, which also precipitated in excellent yield. Separately, 2-(benzylamino)ethanol was 
Boc-protected and the alcohol oxidised by Swern oxidation to furnish the desired aldehyde 
fragment 82 in excellent yield over the two steps. 80 then underwent reductive alkylation with 
82, which saw no solubility issues and provided 83 in moderate yield, along with the undesired 
dialkylated product. Primary amine 83 was then protected at the primary amine as a 
trifluoroacetamide, and the Boc group removed with TFA to give the corresponding protected 
diamine 84 in good yield. Subsequent dicarboxamidation then furnished the corresponding 
pentaurea 85, albeit in poor yield.  
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Next, the trifluoroacetamide protecting group was hydrolysed (Scheme 19), and the 
corresponding amine underwent reductive alkylation with 82 to give amine 87 in moderate yield. 
A sixth urea was formed, and the Boc group cleaved using TFA to give amine 89 in excellent 
yield over the two steps. Amine 89 was then reacted with 4-nitrophenyl isothiocyanate and 
carbamoyl chloride 70 to furnish the desired longer directionality-controlled oligoureas, thiourea 
90 and tetrasubstituted urea 91. 
 
Scheme 19 – Synthesis of 90 and 91. 





Figure 47 – VTNMR of 90 (CD2Cl2, 300 MHz, 30 mM). 
 Thiourea 90 showed signals at 4.54 (ureido benzylic methylene), 5.25 (thioureido 
benzylic methylene), 6.25 (peripheral ureido proton), from 9.02-9.23 (central ureido protons, 5 
H) and 10.43 ppm (thioureido proton) at 20 °C. Upon cooling, the signal at 4.54 ppm remained 
approximately constant until broadening at −60 °C. The signal at 5.25 ppm (obscured by the 
residual CDHCl2 peak) broadened and decoalesced into two singlets (1 H each) at −50 °C. The 
signals at 6.25, from 9.02-9.23 and at 10.43 ppm all sharpened and shifted downfield with 
decreasing temperature. The lack of the decoalescence of the reporting benzylic methylene 
indicated that 90 exists as one populated conformer, which is the directionality where the thiourea 
is at the C-terminus. The chemical shifts of the (thio)ureido protons indicate that one ureido proton 
is not hydrogen bonded, but the other five and the thioureido proton are. This hypothesis was 
further validated by NOE experiments, which showed the reporting benzylic methylene is 
proximate to the non-hydrogen-bonding ureido proton (see Appendix, Figure A30). Finally, it is 
worth noting that like thiourea 68, the thioureido benzylic methylene decoalesces at very low 
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temperature as it enters the slow-exchange region of the chiral conformations of the adjacent 
ethylene bridge. 
 
Figure 48 – VTNMR of 91 (CD2Cl2, 300 MHz, 24 mM). 
 In heptaurea 91, signals were displayed at 4.04 (tetrasubstituted urea benzylic methylene), 
4.56 (trisubstituted urea benzylic methylene) and from 9.00-9.15 ppm (ureido protons, 5 H) at 20 
°C. Upon cooling, the signal at 4.04 ppm stayed approximately constant until it broadened at −60 
°C. The signal at 4.56 ppm behaved similarly but broadened at −40 °C. The signals from 9.00-
9.15 ppm (5 H) resolved, sharpened and shifted downfield with decreasing temperature. Finally, 
a broad signal appeared at 9.12 ppm at 0 °C, which also sharpened and shifted downfield with 
decreasing temperature. The lack of decoalescence of the reporting benzylic methylene indicated 
that one conformation is populated, which is the directionality where the tetrasubstituted urea is 
at the N-terminus. At 20 °C, it is shown that five ureido protons are in hydrogen bonding, but the 
peripheral ureido proton signal is too broad to be observed. Crucially, there is no signal around 
6.25 ppm corresponding to any non-hydrogen-bonding ureido protons. However, at 0 °C, the final 
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ureido proton appears at 9.12 ppm and joins the other hydrogen-bonding ureido protons. This 
proposition was further validated by the lack of NOE correlations between the reporting benzylic 
methylene and any ureido protons (see Appendix, Figure A31).  
 These experiments have shown that electron-deficient thioureas and tetrasubstituted ureas 
can be utilised to impose directional control on adjacent ureas, and that bias can be communicated 
through six ureas with no sign of signal decay. The developed synthetic strategy also represents 
a facile method for the synthesis of heptameric structures, where the orthogonal protecting group 
strategy endows simple modification of foldamers at their termini. After coupling, the protected 
aldehyde fragments can be functionalised separately, allowing the diversification of foldamer 
targets at a late stage. Crucially, informational transfer can occur with no apparent loss of 
hydrogen-bonding fidelity over distances of up to six ureas, rendering the oligourea scaffold a 
very promising candidate for nanometre-scale transmission of binary information in the form of 



















3.5 Hydrogen-Bond Directionality Switching 
 
 Now that families of foldamers had been synthesised with the ability to enforce one 
directionality in ethylene-bridged oligourea foldamers, it was desirable to see whether one 
foldamer could be made to switch between both directionalities in response to a stimulus. The 
initial target was 2-pyridyl-terminated foldamer 97 with the proposal that, under neutral 
conditions, the pyridine would act as an HBA, enforcing the directionality where the pyridine is 
at the N-terminus (Scheme 20). Upon treatment with acid, the resultant pyridinium would act as 
an HBD, and enforce the opposite directionality, where the pyridinium would be at the C-
terminus.  
 
Scheme 20 – Initial target for an acid-mediated directionality switch, 97. 
 Ethylenediamine underwent nucleophilic aromatic substitution (SNAr) with 2-
fluoropyridine to give N-(2-pyridyl)ethylenediamine in excellent yield. This was then used as the 
starting material to synthesise pyridyl urea 97 in an analogous manner to triurea 41 (Scheme 7 














Figure 49 – VTNMR of 97 (CD2Cl2, 300 MHz, 14 mM). 
Pyridyl urea 97 showed signals at 3.96 (pyridyl urea α-methylene) 4.61 (benzylic 
methylene), 8.97 (central ureido proton) and 12.36 ppm (pyridyl urea ureido proton) at 20 °C. 
Upon cooling, the signal at 3.96 ppm broadened, losing its multiplicity, until decoalescing into 
two singlets (1 H each) at −60 °C. Similarly, the signal at 4.61 ppm stayed approximately constant 
until it broadened at −50 °C and decoalesced at into two singlets (1 H each) at −70 °C. The signals 
at 8.97 and 12.36 ppm sharpened and shifted downfield with decreasing temperature. At 0 °C, a 
signal appeared at 8.86 ppm (1 H), which sharpened and shifted downfield upon further cooling. 
The lack of the decoalescence of the benzylic methylene signal until very low temperature 
indicated the population of one conformation. This conformation is the directionality where the 
pyridine is at the N-terminus. This is further validated by the chemical shifts of the ureido protons, 
where two of them are hydrogen bonding with other ureas (9.25 and 9.29 ppm at −60 °C) and the 
third is in a very strong hydrogen bond with the pyridine (12.77 ppm at −60 °C). Similar to 68 
and 91, the decoalescence of the pyridyl urea α-methylene and the benzylic methylene into two 
equal signals is attributed to diastereotopicity arising from the chiral conformations in the ethylene 
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bridges. Additionally, NOE analysis revealed no correlation between the benzylic methylene and 
any ureido protons (see Appendix, Figure A32). 
 Now that it had been proven that the pyridyl urea of 97 controls directionality in the 
desired fashion, directionality switching with acid was attempted. Five equivalents of acetic acid 
were added to the sample, which unfortunately saw no change in the signals of 97. As the 
protonation site is a 2-pyridyl urea, with the pyridyl nitrogen engaged in a strong 6-membered 
hydrogen-bonding ring, it was supposed that acetic acid was not a strong enough acid in DCM to 




Figure 50 – Titration of TFA into 97 (4.50-13.00 ppm region, CD2Cl2, 500 MHz, 14 mM). 
 Before addition, signals were observed for pyridyl urea 97 at 7.84 (pyridyl para methine), 
8.38 (pyridyl ortho methine), 8.97 (central ureido proton) and 12.36 ppm (pyridyl urea ureido 
proton). Upon addition of TFA, the signal at 7.84 ppm shifted downfield and broadened with a 
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concomitant upfield shift and broadening of the signal at 8.38 ppm. These two signals then 
sharpened again above 3.8 equivalents of TFA. The signal at 8.97 ppm shifted downfield with 
TFA addition, and then moved upfield again after 2.2 equivalents. The signal at 12.36 ppm 
broadened and shifted upfield, before sharpening again after the addition of 3.4 equivalents of 
TFA. A broad signal (2.6 H) was observed at 4.75 ppm, which shifted downfield with increasing 
TFA and grew in relative integration before arriving at 7.71 ppm at 4.0 equivalents. Finally, at 
4.2 equivalents, a new signal appeared at 6.54 ppm (1 H), which then sharpened with further 
addition. The relative shifting of the ortho and para pyridyl methines is characteristic of 
protonation taking place at pyridine. If a directionality switch took place, the central ureido proton 
would not be expected to change markedly in its chemical shift as it is shifting between two 9-
membered hydrogen-bonding rings with ureas. Hence this signal did not displace significantly 
from its starting position. The reason for the downfield and then upfield shifting is unknown. The 
pyridyl urea ureido proton shifted significantly upfield (Δδ = 1.86 ppm) with TFA, indicating that 
it moved out of a very strong 6-membered hydrogen bond with a pyridine into a relatively weaker 
9-membered hydrogen-bonding ring with a urea. The signal that appeared at 4.75 ppm at 0.6 
equivalents of TFA corresponds to the TFA, which was in fast exchange with the present water 
and the pyridinium. This equilibrium shifted towards the pyridinium trifluoroacetate with 
increasing TFA before arriving at 7.71 ppm when the pyridine was completely protonated. The 
appearance of a signal at 6.54 ppm signified the presence of a non-hydrogen bonded ureido 
proton. Finally, superstoichiometric quantities of TFA were required to promote pyridine 
protonation, presumably due to the comparable acidities of the pyridinium and TFA in DCM. 
These data indicated that protonation of the pyridine had taken place and that it resulted in a global 
directionality switch, making the pyridinium at the C-terminus. To further corroborate this 














Figure 51 – VTNMR of 97.TFA (CD2Cl2, 300 MHz, 14 mM). 
 Pyridinium trifluoroacetate 97.TFA displayed signals at 4.64 (benzylic methylene), 6.54 
(peripheral ureido proton), 8.59 (central ureido proton) and 10.48 ppm (pyridyl urea ureido 
proton) at 20 °C. Upon cooling, the signal at 4.64 ppm remained approximately constant until 
broadening at −80 °C. The signals at 6.54 and 8.59 ppm sharpened and shifted downfield with 
decreasing temperature, whereas the signal at 10.48 ppm shifted upfield. The lack of 
decoalescence of the benzylic methylene signal indicated one populated conformer, which is the 
directionality-switched structure, where the pyridinium is at the C-terminus. This was also alluded 
to by the chemical shifts of the ureido protons, where there are two hydrogen-bonded ureido 
protons (8.65 and 10.12 ppm at −60 °C) and one non-hydrogen-bonded ureido proton (6.53 ppm 
at −60 °C). The upfield shifting of the pyridyl urea ureido proton signal is peculiar, and its 
reasoning is unknown. Finally, the conformation of 97.TFA was confirmed by the observed NOE 
correlations between the reporting benzylic methylene and the non-hydrogen-bonded ureido 
proton, where no such correlation existed before the switch (see Appendix, Figure A33). To 
further validate the proposition that TFA was not acidic enough in DCM to effect a stoichiometric 
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switch, 97 was protonated with 1.5 equivalents of a stronger acid, p-toluenesulfonic acid 
monohydrate (TsOH.H2O), which resulted in the same degree of protonation as 4.6 equivalents 
of TFA (see Appendix, Figure A1). 
It was shown that treatment of pyridyl urea 97 with TFA resulted in a global directionality 
switch. To be sure that this switch could be attributed to protonation of the pyridine and 
subsequent urea reorientation and not from coordination of the trifluoroacetate anion or 
protonation at other atoms in the molecule, a control experiment was designed. Phenyl-terminated 
triurea 99 was used as an analogue of pyridyl urea 97 without its basic functionality. 
Conveniently, the phenyl group would control directionality analogously to the pyridine in 97 but 
cannot be protonated and therefore would not switch directionality upon treatment with TFA. 99 
was synthesised analogously to triurea 97 using amine 30 as the starting amine (Scheme 21).  
 
Scheme 21 – Synthesis of 99. 
To appropriately simulate the TFA-mediated switch conditions with 99, pyridinium 
cations and trifluoroacetate anions had to be present. To attain this, triurea 99 was combined with 








Figure 52 – Titration of TFA into 99.pyridine (CD2Cl2, 500 MHz, 14 mM). 
 The triurea 99/pyridine mixture showed signals at 6.26 (phenyl urea ureido proton), 7.50 
(pyridine meta protons), 7.69 (pyridine para proton), 8.58 (pyridine ortho protons), 8.73 
(peripheral ureido proton) and 8.88 ppm (central ureido proton) with no TFA present. Upon TFA 
addition, the signal at 6.26 ppm remained approximately constant until it shifted downfield at 2.6 
equivalents. The signals at 7.50, 7.69 and 8.58 ppm all shifted significantly downfield after 
addition of 0.2 equivalents of TFA and continued to do so upon further addition. The signal at 
8.73 ppm broadened upon addition and could not be observed at 0.6 equivalents. Finally, the 
signal at 8.88 ppm stayed approximately constant with increasing TFA, until it moved quickly 
upfield at 2.2 equivalents. The immediate and significant alteration of the pyridine signals 
indicated that it had protonated. The pyridine signal shifting continued (indicating equilibrium 
shifting to pyridinium trifluoroacetate) upon further addition of TFA until it became 
approximately constant after 1.8 equivalents. At this point, it is worth noting that pyridine signal 
shifting is greater for pyridine than for 97 due to the much greater basicity of pyridine. The signals 
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corresponding to 99 were unaffected by TFA until 2.2 equivalents, at which time they did not 
shift according to a directionality switch. These results indicated that 99 is unaffected by the 
presence of pyridinium cations and trifluoroacetate anions in solution, further proving that the 
directionality switch observed in 97 can be fully attributed to protonation of the pyridine instead 
of any ionic effects. However, it is worth noting that excess TFA could potentially affect the 
foldamer, presumably by partial protonation of the ureas. 
 Gratifyingly, washing of the sample with aqueous NaHCO3 quantitatively recovered 97 
and restored all original signals of the neutral form. These experiments have shown that 2-pyridyl 
ureas can be used to terminate ethylene-bridged triureas, which confers the property of hydrogen-
bond directionality-switchability. The alternate directionalities can be selected by use of acid and 
base and can be quantitatively switched between the two. In both forms, the directionality 
enforced by the pyridine/pyridinium is communicated throughout the foldamer. This serves as the 
first ethylene-bridged oligourea foldamer that can communicate binary information in the form 
of hydrogen-bond directionality in the response to a stimulus – the presence or absence of acid. 
 Now that pyridyl ureas had been used for directionality switching, it was desirable to 
append pyridyl ureas to longer oligoureas by using the methodology applied to the synthesis of 
90 and 91. To achieve this, the development of an electrophilic source of N-(2-pyridyl)ethylamine 
was required, preferably in the aldehyde oxidation state to allow the established coupling by 
reductive amination. The first proposed electrophile was 102, where the 2-aminopyridine was 
protected with a Boc group, as it was suspected that the unprotected aminoacetaldehyde would 
decompose by polymerisation (Scheme 22). 
 
Scheme 22 – Synthesis of 102. 
 2-Fluoropyridine underwent SNAr by heating in neat ethanolamine to provide 100 in good 
yield. The amine was then protected with a Boc group to give carbamate, 101 in good yield. 101 
was then oxidised by Swern oxidation, which led to decomposition, presumably by 
polymerisation. It was hoped that the aldehyde was metastable and was simply sensitive to the 
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oxidation conditions, so other attempts to oxidation involved the use of DMP, PCC and MnO2, 
each with the same result. Due to this, the synthesis of aldehyde 102 by alcohol oxidation was 
abandoned. Due to the stability of Boc-protected aminoacetaldehyde 82, it was presumed that the 
instability of 102 could be attributed to the proximate N-pyridyl carbamate. To circumvent this 
issue, the pyridine was distanced by introduction of an additional Boc-protected amine (Scheme 
23).  
 
Scheme 23 – Synthesis of 108. 
 2-Fluoropyridine underwent SNAr with amine 52 to give pyridyl amine 103 in reasonable 
yield. The remaining amine of 103 was then protected with a Boc group using Boc2O to give 
bis(carbamate) 104 in good yield. 104 was then subjected to Swern oxidation conditions, which 
furnished the desired aldehyde in good yield. Now that an electrophilic source of N-(2-
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pyridyl)ethylamine had been accessed, it was trialled in a model reductive amination to save the 
unnecessary consumption of amine 86. Model monourea 107 was synthesised by 
trifluoroacetylation and urea formation on N-benzylethylenediamine, affording 106 
quantitatively. 106 then underwent hydrolysis to give 107 in good yield. 107 and 105 were then 
subject to a trial reductive amination. The trial reaction resulted in total conversion of 105 back 
to 104 by aldehyde reduction, indicating that imine formation did not take place. This was 
corroborated by monitoring the 1H NMR of aliquots of the reaction as it progressed. It was 
suspected that the two Boc groups were providing such steric encumbrance that they were forced 
into a conformation which inhibited nucleophilic addition to the aldehyde. Attempts to 
circumvent this issue were imine formation by heating in methanol, and heating in toluene with 
an attached Dean-Stark apparatus, but neither saw any conversion of the aldehyde to the desired 
imine. Due to this, 105 was deemed too unreactive to be used as a reductive alkylation partner as 
a result of steric encumbrance. 
 To mitigate the steric hindrance in bis(carbamate) 105, an analogous compound was made 
with the ureas already installed instead of the Boc groups (Scheme 24). Decomposition of diurea 
111 was foreseen by cyclisation of the central urea onto the aldehyde. However, it was hoped that 
the directional control that the pyridine provides would bestow kinetic stability on the aldehyde, 
as the ureido nitrogen would be locked in a hydrogen bond with the adjacent urea.  
 
Scheme 24 – Synthesis of 111. 
Diurea 110 was synthesised by SNAr of N-(2-hydroxyethyl)ethylenediamine with 2-
fluoropyridine, which proceeded in good yield. Dicarboxamidation using 4-methoxyphenyl 
isocyanate then afforded diurea 110 in moderate yield. Unfortunately, oxidation of this substrate 
resulted in decomposition upon treatment with DMP, PCC, MnO2 and under Swern oxidation 
conditions, so this route was abandoned as a reductive amination candidate. 
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It was hoped that the need to isolate an electrophilic source of N-(2-pyridyl)ethylamine 
could be circumvented by using an electrophilic source of pyridine and using SNAr or Buchwald-
Hartwig chemistry. Hence, reaction of amine 107 with 2-fluoropyridine was attempted, but this 
unfortunately resulted in thermal deureation. Buchwald-Hartwig amination of 2-bromopyridine 
and 107 was also attempted, but this also decomposed 107.  
 At this point, alcohols 100, 101, 104 and 110 did not provide viable aldehydes for 
reductive alkylation. Instead, each was converted into its corresponding alkyl chloride and 
tosylate to see if these compounds could be used for monoalkylation of amine 106 instead. 
Unfortunately, treatment of 100, 101, 104 and 110 with tosyl chloride and TEA resulted in 
decomposition, possibly by elimination and polymerisation. Treatment of 101, 104 and 110 with 
thionyl chloride and TEA saw the same result. Interestingly, reaction of alcohol 100 with thionyl 
chloride alone provided the corresponding alkyl chloride 112 in reasonable yield (Scheme 25). 
However, reaction with amine 107 saw no conversion of 107, but decomposed the alkyl chloride 
by what was presumed to be polymerisation. 
 
Scheme 25 – Synthesis of 113. 
 Alcohol oxidation and the formation of alkyl tosylates and alkyl chlorides had failed to 
furnish an electrophilic source of N-(2-pyridyl)ethylamine. Next, acquisition of pyridyl aldehydes 




Scheme 26 – Synthesis of 118. 
 2-Aminopyridine underwent a nucleophilic substitution (SN2) reaction with allyl bromide 
to yield allylamine 114, which was then Boc-protected to give the corresponding carbamate 115 
in reasonable yield over the two steps. 115 was then subjected to Lemieux-Johnson oxidation 
conditions, which furnished the desired aldehyde quantitatively. Aldehyde 102 was then used for 
a successful reductive alkylation with amine 86 to give the coupled product 116 in moderate yield. 
The Boc group was removed with TFA and then the corresponding diamine, 117, was reacted 
with 4-methoxyphenyl isocyanate in DCM at room temperature. A urea was successfully installed 
on the dialkylamine, but the 2-aminopyridine was inert to the reaction conditions. The reaction 
was further encouraged by heating with an excess of 4-methoxyphenyl isocyanate in 1,2-




Figure 53 – 1H NMR of the product of reaction of 117 with 4-methoxyphenyl isocyanate (CD2Cl2, 500 
MHz). 
 The signals at 4.04 (2-pyridyl urea α-methylene), 7.03 (pyridyl meta methine), 7.73 
(pyridyl para methine) and 8.33 ppm (pyridyl ortho methine) were all consistent with 
carboxamidation having taken place at the 2-aminopyridine. Signals between 9.02 and 9.23 ppm 
(ureido protons, 5 H) were consistent with 5 ureido protons in hydrogen bonding. However, two 
broad signals were observed at 12.14 (0.46 H) and 12.59 ppm (0.43 H), where it was expected 
that only one 2-pyridyl urea ureido proton signal would be observed. Additionally, the signals at 
3.78 (methoxy groups) and 6.81 ppm (4-methoxyphenyl ortho methines) integrated much more 
highly than was expected, and a signal was observed at 6.30 ppm (0.28 H). It was deduced that 
some of the isocyanate had decomposed into a N,N’-disubstituted urea from the presence of water 
(Scheme 27).91 
 




 The presence of this decomposition product accounted for additional signals in the 4-
methoxyphenyl regions and the ureido protons at 6.30 ppm. However, the additional signal in the 
2-pyridyl urea ureido proton region was not accounted for. Mass spectrometric analysis revealed 
that the desired mass ion for heptaurea 118 was observed, so it was suspected that the isocyanate 
decomposition product was tightly binding to 118 and giving rise to two environments for the 
pyridyl urea ureido proton. This was further corroborated by COSY and HMBC NMR techniques, 
which showed that the additional signals did not correlate with that of 118. The decomposition 
product is a N,N’-disubstituted urea, and so its removal was attempted by washing it into an 
aqueous phase with acid, base, LiCl and urea, to no avail. Trituration using DCM/Et2O, 
acetone/Et2O and DMSO/Et2O gave similar results. Due to this, it was proposed that heptaurea 
118 could be synthesised effectively from amine 117 if the isocyanate decomposition product was 
not able to form. This could be ensured if the final urea was formed from an isocyanate surrogate, 
such as an aryl or N-hydroxysuccinimidyl carbamate, or a N’-imidazolyl urea.92  
Alternatively, the difficulties associated with installing the final urea at such a late stage 
could be avoided if the 2-pyridyl urea was incorporated into the aldehyde fragment, 102. This 
was preliminarily investigated by the synthesis of aldehyde 120, which was achieved in an 
analogous manner to aldehyde 102 (Scheme 28), with the hope that the directional control 
imposed by the pyridine would confer kinetic stability to the aldehyde.  
 
Scheme 28 – Decomposition of 120. 
Unfortunately, upon formation, the urea cyclised onto the aldehyde to give the 
corresponding 5-membered heterocycle. It is unknown whether the corresponding 4-
hydroxyimidazolidin-2-one or 4-hydroxy-2-iminooxazolidinone formed, but the product was 
inert to any subsequent reductive amination conditions attempted. To use this strategy to make a 
viable reductive amination partner, the aldehyde would have to be removed from the pyridyl urea 
by another amine, as is proposed in pyridyl urea 121 (Scheme 28). It is hoped that due to the 
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removal of the aldehyde from the pyridyl urea, cyclisation will not occur and the aldehyde will 
be stable enough for reductive amination. Having a pyridyl urea as opposed to the pyridyl tert-
butyl carbamate in 104 will also mitigate the steric bulk about the aldehyde, allowing reductive 
amination to proceed. 
 All of the proposed switches discussed so far have involved the protonation of a basic 
site to provide an HBD. In theory, the opposite can also be exploited – an acidic site that acts as 
an HBD could be deprotonated to form an anion, which would then act as an HBA. To test this 
concept, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was titrated into a sample of thiourea 68, 
which had already been established to control directionality by acting as an HBD (Figure 54). It 
was proposed that the thiourea was the most acidic function in 68, meaning that a base would 
deprotonate it first, giving the corresponding anion, which would then switch the directionality. 
 
 
Figure 54 – Titration of DBU into 68 (4.50-11.00 ppm region, CD2Cl2, 500 MHz, 19 mM). 
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 In thiourea 68, signals were observed at 6.42 (peripheral ureido proton), 9.00 (central 
ureido protons, 2 H) and 10.58 ppm (thioureido proton). Upon addition of 0.2 equivalents of DBU, 
the signal at 6.42 ppm attenuated, broadened and shifted downfield. The signals at 9.00 ppm 
stayed approximately constant throughout the experiment. The signal at 10.58 ppm attenuated 
immediately upon addition of DBU and continued to attenuate until it was no longer observable 
at 0.8 equivalents. A new signal appeared at 9.04 ppm at 2.2 equivalents and shifted downfield 
thereafter. These results are consistent with deprotonation of the thiourea, where the equilibrium 
had shifted to total deprotonation by 1.0 equivalents of DBU. The central ureido protons would 
be switching between two 9-membered hydrogen-bonding rings, so it is not expected that they 
would change appreciably in chemical shift. It is notable that one central ureido proton would 
switch out of hydrogen bonding with another urea and into hydrogen bonding with a thioureido 
anion. It is suspected that the hydrogen-bond-accepting nature of this would be comparable to an 
amidine, as the negative charge would presumably be localised on the sulfur atom.72 The 
peripheral ureido proton, shifted downfield with increasing DBU, until joining the other ureido 
protons at 1.8 equivalents, indicating that it had entered hydrogen bonding. DBU did not further 
deprotonate 68 as all of the other ureido protons were accounted for, even at superstoichiometric 
quantities of DBU. These data indicated that thiourea 68 underwent a base-induced directionality 
switch, which was further validated by the absence of any NOE correlation between the ureido 
benzylic methylene and any ureido protons. The same experiment was performed using thiourea 




Figure 55 – Addition of DBU to 90 (4.50-11.00 ppm region, CD2Cl2, 500 MHz, 30 mM). 
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 Thiourea 90 showed signals at 6.31 (peripheral ureido proton), 9.03-9.30 (central ureido 
protons, 5 H) and 10.47 ppm (thioureido proton). Upon addition of DBU, the signal at 6.31 ppm 
attenuated and the signals at 9.03-9.30 ppm broadened to make an apparent singlet (6 H). The 
signal at 10.47 ppm completely attenuated with addition of DBU. These data show that the 
directional switch occurred due to the disappearance of the thioureido proton signal and the 
shifting of the peripheral ureido proton signal to the urea-urea hydrogen-bonding region. This was 
further validated by the absence of an NOE between the ureido benzylic methylene and any ureido 
protons, where one originally existed.  
 These experiments have shown that thioureas can also be used for directionality switching 
by exploiting their relative acidity. Deprotonation of the thiourea using an organic base liberates 
an anion which acts as an HBA and switches the directionality of the entire foldamer. This is 
particularly significant in the case of thiourea 90, as the directionality switch is communicated 
through six ureas. Gratifyingly, the signals of the neutral form are restored upon washing with 
hydrochloric acid, meaning that the directionality reversal can be switched between the forms 
selectively without the expense of hydrogen-bonding fidelity with each iteration. 
 In each of the switches discussed, the exact numbers of hydrogen bonds between the two 
forms are the same. Tetrasubstituted urea 71 exhibits three hydrogen bonds between each of the 
ureas. It was suspected that if the foldamer was provided a better alternative hydrogen-bond-
accepting additive to the tetrasubstituted urea, then 71 would also undergo a global directionality 
switch. The HBA could coordinate in two places – at the N-terminus, where there would be no 
directionality switch as the tetrasubstituted urea would be simply replaced by the HBA, and the 
C-terminus, where there would be a directionality switch. To investigate this, 71 was studied by 















Figure 56 – VTNMR of 71 (10% v/v d6-DMSO in CD2Cl2, 300 MHz, 13 mM). 
 Tetrasubstituted urea 71 displayed signals at 4.46 (tetrasubstituted urea benzylic 
methylene), 4.97 (trisubstituted urea benzylic methylene) and at 8.66-8.77 ppm (ureido protons, 
3 H) at 20 °C. Upon cooling, the signals at 4.46 and 4.97 ppm broadened and each decoalesced 
into two singlets (0.64 and 1.36 H) at −30 °C. The signals broadened further with decreasing 
temperature. The signals at 8.66-8.77 ppm broadened and shifted downfield with decreasing 
temperature, before decoalescing at −30 °C, where a signal appeared at 8.51 ppm (0.32 H). The 
decoalesced signals broadened further with further cooling. These data revealed that, in the 
presence of d6-DMSO, 71 exists as a mixture of two conformations in a ratio of 32:68 at −30 °C. 
These conformations are the two directionalities – one where the tetrasubstituted urea is at the N-
terminus, and the other where d6-DMSO hydrogen bonds to the opposite end of the foldamer, 
making the tetrasubstituted urea at the C-terminus. The signal at 8.51 ppm (0.32 H) at −30 °C 
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corresponds to a terminal ureido proton hydrogen bonding to d6-DMSO. This attributed the minor 
conformer to the directionality where the tetrasubstituted urea is at the C-terminus. It is suspected 
that the d6-DMSO facilitates a directionality switch by hydrogen bonding to the opposite end of 
the foldamer to the tetrasubstituted urea. This is because coordination next to the tetrasubstituted 
urea would transmit hydrogen-bonding information in the same way, such that a carbonyl would 
still be proximate to the reporting benzylic methylene. This would cause a negligible change in 
chemical environment and a lack of an observable decoalescence.  
 In summary, ethylene-bridged oligourea foldamers can undergo global hydrogen-bond 
directionality switching using acid and base when terminated with the appropriate basic and acidic 
functionality. Foldamers with directional control imposed by tetrasubstituted ureas can also 
undergo a partial additive-induced switch, and it is proposed that they could be switched more 
completely if a strong hydrogen-bond-accepting additive, such as a phosphine oxide, was 
employed. Foldamers can be switched between their directional forms by the appropriate addition 
of acid/base and subsequent washing with base/acid with no erosion of hydrogen-bonding fidelity. 
The switch can also be communicated over nanometre distances as demonstrated by 90, where a 
base-induced switch culminated in directional reorientation over six ureas. The robustness of the 
hydrogen-bonding network over these distances and its amenability to directional switching 
bestow great applicability upon these foldamers, as they are now able to take hydrogen-bonding 















3.6 Towards a Light-Induced Hydrogen-Bond Directionality Switch 
 
 It has been shown that ethylene-bridged oligourea foldamers can communicate hydrogen-
bonding information over nanometre distances and with high fidelity. The directionality switches 
described previously necessitate the use of strong acids and bases. These stimuli are not 
compatible with biological environments, where there are stronger bases and acids than pyridyl 
ureas and thioureas such as lysine and aspartic acid residues.93 Additionally, the stimulus may 
interact with the biomolecules in a negative way, such as disrupting the pH balance in a cell, 
which would result in its death. 
 A prevalent way to evade the issues associated with the use of chemical stimuli is light. 
Light is non-invasive – it does not require the insertion of a chemical into a system as it can travel 
through barriers. Also, a wide range of wavelengths are available for the selective irradiation of 
a certain bond or species, which lends itself to biological orthogonality with high spatial and 
temporal precision. Over the past decades, chemists have developed a plethora of photoswitchable 
moieties, which cover an excellent range of conformational space and irradiation wavelengths 
and have been exploited as such. Since the 1970s, a prominent category of photoswitchable 
molecules known as photoacids has been emerging. Photoacids are molecules that, upon 
irradiation, isomerise into a form that is more acidic (Figure 57). They have been used to facilitate 
many acid-catalysed processes reversibly by exposure to light of the appropriate wavelength.94 
 
Figure 57 – Commonly employed photoacids. 
 Photoacids fall into two classes – photoacid generators and reversible photoacids. 
Photoacid generators are molecules that adopt their excited state, and irreversibly convert to a 
highly acidic species, such as the photochemical decomposition of triphenylsulfonium triflate into 
triflic acid. Reversible photoacids adopt an acidic photoexcited state but can revert back to the 
less acidic ground state. The reversibility property is highly desirable in photoacids as it allows 
the modulation of pH by altering the intensity of light, which can lend itself to the halting or 
reversal of a pH-sensitive process. 
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 One of the most prevalent photoacid classes are the merocyanines (Scheme 29). Multiple 
research groups have derivatised the merocyanines to shift the pH ranges they can access, their 
absorbance wavelengths, kinetic parameters and organic solubility for specific applications.95–97  
 
Scheme 29 – Isomerisation of merocyanine-derived photoacids. 
 Liao and co-workers have extensively studied merocyanine systems and the factors that 
affect their photophysics. Photoacid, 124 is stable in its zwitterionic indolium sulfonate (ME-H) 
form, and the proton is localised on the phenoxide.98 Upon irradiation with visible light, the olefin 
photoisomerised to the Z form, where the phenol spirocyclised to give corresponding spiropyran 
(SP-H) form. The phenol then transfers its proton to the indoline to give an indolinium, which 
was much more acidic than the parent phenol. Electron-withdrawing groups on the phenol have 
often been used to enhance the acidity of the E-ME-H and Z-ME-H forms, but this also inhibits 
the spirocyclisation step relative to thermal isomerisation of Z-ME-H back to E-ME-H. 
Conversely, electron-donating groups have been used to speed up the spirocyclisation, but this 
also decreases the acidity of E-ME-H, Z-ME-H and SP-H. These modifications also affect the 
absorption wavelength of E-ME-H and the quantum yield of the transformation. 
 The kinetics of the reverse reaction have been studied in water, ethanol and DMSO.98 The 
kinetic data fit well to a second order rate equation in each case, indicating that protonation was 
involved in the rate-determining step. This also meant that the reverse reaction was highly 
sensitive to concentration. These experiments determined rate constants of 73, 1.6, and 0.03 M-1 
s-1 in water, ethanol and DMSO, respectively. These data were correlated with the solvents ability 
to donate hydrogen bonds, where the reverse reaction proceeded more quickly in solvents with a 
greater hydrogen-bond-donating capacity. This is because the developing negative charge on the 
phenoxide can be stabilised by HBDs during the reverse reaction.94 
 As an initial method for light-induced directionality switching, 124 was synthesised 
(Scheme 30) and combined with pyridyl urea 97 in the hope that the generated indolium sulfonate 
acid would be of sufficient acidity to protonate the foldamer in DCM. It was assumed that, 
because of DCM’s inability to donate hydrogen bonds, reversion of the photostationary state to 
E-ME-H after irradiation had stopped would occur slowly enough to allow analysis by 1H NMR 




Scheme 30 – Synthesis of 124.* 
 Phenylhydrazine hydrochloride underwent a Fischer indole reaction with methyl 
isopropyl ketone to give the corresponding indolenine, 122, which was then reacted with 1,3-
propane sultone to give the zwitterion, 123 in moderate yield over two steps. 123 then underwent 
an aldol condensation with salicylaldehyde to give 124, in good yield. 97 was then combined with 
an equivalent of 124, irradiated at 485 nm for one hour in CD2Cl2 and studied by 
1H NMR (Figure 
58). Unfortunately, 124 was found to be insoluble in CD2Cl2, but it was assumed that the SP-H 
form would be soluble, and the pyridinium sulfonate salt that would form from protonation of the 







                                                   





Figure 58 – Irradiation of 97.124 (500 MHz, CD2Cl2, 10 mM). 
 Signals were observed at 8.84 (central ureido proton) and 12.24 ppm (pyridyl urea ureido 
proton) before irradiation. Upon irradiation, the signal at 8.84 ppm broadened and moved 
downfield, whereas the signal at 12.24 ppm broadened and shifted significantly upfield. 
Additionally, several new alkyl and aromatic signals appeared, the most pertinent of which were 
the signals at 1.12 (one of the diastereotopic methyl groups in the SP form, 2.17 H) and 2.68 ppm 
(sulfonate α methylene, 1.35 H). These results show that after irradiation, approximately 0.67 
equivalents (based on the sulfonate α methylene) of merocyanine 124 were present in solution. 
This resulted in partial protonation of the foldamer as indicated by the shifting of the ureido proton 
signals. However, it did not correspond to a full directionality switch as was seen with 5.0 
equivalents of TFA or 1.5 equivalents of TsOH.H2O. Due to the substoichiometric generation of 
the indolinium, an additional four equivalents of 124 were added to the sample and the experiment 
was repeated. This gave no further improvement on the switch and broadened the signals in the 
sample due to the amount of solid in the suspension. Mixing the sample with CD3OH did not 
improve the solubility, but d6-DMSO fully dissolved the 97/124 mixture. However, irradiation of 
this sample gave no change in the foldamer signals at all. It was hoped that a more hydrophobic 
analogue of 124 would solubilise the photoacid in CD2Cl2, where the acid-induced directionality 
switch was known to proceed. Merocyanine 127 was synthesised analogously to 124 using (4-n-
hexylphenyl)hydrazine hydrochloride and 3-butyl-heptan-2-one in 12% total yield (Scheme 30). 
Gratifyingly, 127 was found to be fully soluble in CD2Cl2. However, it is notable that the alkyl 
substitution will raise the pKa of the SP-H form, making it less favourable for the foldamer to 
deprotonate it. The behaviour of 127 upon irradiation at 485 nm was examined by 1H NMR 










Figure 59 – Irradiation of 127 (CDCl3, 500 MHz, 10 mM). 
 Merocyanine 127 displayed signals at 4.88 (indolium α methylene), 6.85 (phenol para 
methine), 8.22-8.30 (olefin protons) and 11.32 ppm (phenolic proton) before irradiation (in the E-
ME-H form). After irradiation, all of the aforementioned signals attenuated and additional signals 
appeared at 4.39 (indolium α methylene, 1.0 H), 6.19 (olefin proton, 0.5 H), 7.04 (olefin proton, 
0.5 H), 8.04 (phenol meta methine, 0.5 H) and 10.82 ppm (phenolic proton, 0.5 H). Over the 
course of one hour, each of the new peaks attenuate with concurrent restoration of the original 
peaks. These data show that, after irradiation, a new chemical species arose which was in a 50:50 
ratio with the original E-ME-H form. The new olefinic signals corresponding to this species were 
consistent with a Z olefin, indicating that photoisomerisation had taken place. However, a 
phenolic resonance (10.82 ppm) was still present, and diastereotopicity was not revealed in the 
geminal methylenes (1.29 ppm), which would occur if spirocyclisation had taken place. These 
results indicated that, at the photostationary state, the E-ME-H and Z-ME-H forms were present 











indolinium acid did not generate and therefore, combination of five equivalents of 127 with 97 
and subsequent irradiation resulted in no change in the signals of 97.  
It was suspected that, as the geminal dimethyl group had been changed to a geminal di-
n-butyl group, the steric bulk about the indolyl iminium was too great for the phenol to attack in 
the Z-ME-H form. To combat this issue, merocyanine 130 was synthesised as an analogous 
molecule to 127 (Scheme 30), with the n-hexyl group to promote organic solubility, but with 
geminal methyl groups to allow spirocyclisation to occur. 130 was synthesised in 30% total yield 
and then analysed by 1H NMR upon irradiation (Figure 60). Unfortunately, 130 was contaminated 
with its zwitterionic precursor, 129, but it was suspected that this would be insensitive to light as 
it does not contain a photosensitive olefin. 
 
 
Figure 60 – Irradiation of 130 (CDCl3, 500 MHz, 10 mM). 
 Before irradiation, merocyanine 130 showed signals at 4.86 (indolium α methylene), 7.89 
(olefin proton), 8.34 (olefin proton) and 10.96 ppm (phenolic proton). After irradiation, the signal 
at 4.86 ppm stayed approximately the same, but signals at 7.89 and 8.34 ppm attenuated by 91%. 
Also, the signal at 10.96 ppm completely attenuated and a new signal appeared at 6.19 ppm. These 
data show that at the photostationary state, 91% of the E-ME-H form was consumed. All of the 
E-ME-H form converted to the SP-H form, since no phenolic resonance remained after irradiation 
and a new signal appeared at 6.19 ppm, which could correspond to the indolinium. Unfortunately, 
the olefin shifts in the Z-ME-H or the SP-H form were not observed and diastereotopicity in the 
geminal methyl groups was not evident in the 1H NMR spectrum. Additionally, thermal relaxation 
did not quantitatively restore all of the signals of the E-ME-H form. Instead, a small amount of 







Pyridyl urea 97 was then combined with five equivalents of merocyanine 130 and 
irradiated for one hour at 485 nm. Unfortunately, this gave rise to no change in the signals of 97. 
As 124 can undergo facile spirocyclisation, the lack of interaction with 97 was not attributed to 
inhibited spirocyclisation. Instead, it was suspected that due to the alkyl substitution on the indole, 
the increased basicity of the indoline disfavoured deprotonation of the corresponding indolinium 
by pyridyl urea 97. This could be counteracted by furnishing the pyridine of 97 with electron-
donating groups, increasing its basicity and making it more favourable to be protonated by 
merocyanines 124 or 130. 
 Zwitterionic merocyanine-derived photoacids were unable to give rise to effective 
directional switching in pyridyl urea-terminated oligoureas, so the photoacid scaffold was altered. 
Photoacids without a sulfonate tether, such as spiropyran 132 have also been successfully 
employed in acid-mediated processes (Scheme 31).99,100 
 
Scheme 31 – Isomerisation of merocyanine salt-derived photoacids. 
 Browne and co-workers have shown that spiropyran 132 is stable under neutral 
conditions, but upon exposure to a sufficiently strong acid, it undergoes ring opening and 
isomerisation to form 132 in its thermodynamically stable E-ME-H form.97 Upon 
photoisomerisation, the Z-ME-H form was metastable and several pKa units lower than the 
corresponding E-ME-H form (as deduced in MeCN). The phenol was not nucleophilic enough to 
attack the indolyl imine, but if the conjugate base A- was sufficiently basic, the phenol could be 
deprotonated and facilitate an irreversible spirocyclisation to form the indoline, SP. The 
spiropyran could then only be reopened by exposure to ultraviolet (UV) light. Further studies 
have investigated this pH-gating phenomenon using NaH2PO4, where its pKaH was sufficiently 
low so as to not deprotonate the E-ME-H form, but high enough to deprotonate the Z-ME-H 
form.97 It is hoped that the pKaH of pyridyl urea 97 is intermediate to the pKas of the E-ME-H and 
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Z-ME-H forms of 132 to allow efficient pH-gated directionality switching. With this, 132 was 
synthesised by the procedure reported by Browne and co-workers (Scheme 32).97 
 
Scheme 32 – Synthesis of 132. 
 Spiropyran 132 was synthesised by methylation of 2,3,3-trimethyl-3H-indole to give 131, 
which then underwent a pseudo-aldol condensation with salicylaldehyde to afford 132 in good 
yield over two steps. 132 was then to be reacted with TFA to generate its E-ME-H form (Scheme 
33), where the trifluoroacetate anion is not basic enough to deprotonate either the E-ME-H or Z-
ME-H forms of 132, and so would be dormant in the photoswitching procedure. Pyridyl urea 97, 
however, would act as the base in the procedure – upon photoisomerisation of 132 to the more 
acidic Z-ME-H form, 97 would deprotonate 132, irreversibly facilitating spirocyclisation to the 
SP form. 97 would then retain the proton originally belonging to the phenol, resulting in the 
directionality switch.  
 
Scheme 33 – Proposed photoacid-induced directionality switching in 97. 
As established, the trifluoroacetate anion was not basic enough to deprotonate the 
conjugate acid of pyridyl urea 97, and it was also hoped that the same applied to the indolinyl 
moiety in the SP form of 132. This would give rise to a pH-gated switch, where the SP form of 
129 could only be reopened upon irradiation with UV light. This would convert 132 between the 
SP and Z-ME forms. The Z-ME form would not be basic enough to deprotonate the pyridinium 
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trifluoroacetate of 97, but thermal isomerisation yields the E-ME form, which would be. The E-
ME form of 132 would then deprotonate the pyridinium trifluoroacetate of 97, returning the E-
ME-H form and switching the directionality of 97 back again. 
As a preliminary investigation into this, merocyanine 132 was combined with one 
equivalent of TFA. It took around 24 h for the SP-H form to convert to the Z-ME-H form and 
subsequently to the E-ME-H form. Samples of 132.TFA were then irradiated for 1 h at 485 nm 
with and without an equivalent of pyridine (Figure 61). 
 
 
Figure 61 – Irradiation of 132 with 1 eq. of pyridine and/or TFA (CD2Cl2, 500 MHz, 10 mM). 
 Before irradiation, signals were observed at 1.82 (geminal methyls, E-ME-H form), 4.04 
(N-methyl, E-ME-H form) and 8.54 ppm (olefin proton, E-ME-H form). Upon irradiation at 485 
nm for one hour, these signals attenuated and new signals appeared at 1.59 (geminal methyls, Z-
ME-H form, 1.74 H), 3.25 (N-methyl, Z-ME-H form, 3.49 H) and 6.35 ppm (olefin proton, Z-
ME-H form, 0.61 H). The olefin coupling constants were consistent with the proposed geometries. 
The signals corresponding to Z-ME-H 132 attenuated to restore the original spectrum over 16 h. 
The signal ratios did not change upon further irradiation, indicating that the photostationary state 
132.TFA.Py 
After irradiation 
132.TFA      
After irradiation 




had been reached. These data showed that in the presence of one equivalent of TFA, the 
photostationary state shows a 42:58 ratio of E:Z forms of 132. It is notable that when base is 
introduced, the equilibrium will dynamically resolve to the Z-ME-H form as any Z-ME-H will be 
deprotonated and converted irreversibly to the SP form.  
To ensure that the Z-ME-H form could be deprotonated by pyridine bases in DCM, 
132.TFA was combined with an equivalent of pyridine and irradiated at 485 nm for one hour 
(Figure 61). Upon addition of pyridine, the signals at 1.82 (geminal methyls, E-ME-H form, 0.31 
H), 4.04 (N-methyl, E-ME-H form) and 8.54 ppm (olefin proton, E-ME-H form) attenuated to 
10% of their original size. The signals at 3.25 (N-methyl, Z-ME-H form), 4.04 (N-methyl, E-ME-
H form) and 6.35 ppm (olefin proton, Z-ME-H form) also greatly attenuated. New signals 
appeared at 1.18 and 1.31 (diastereotopic geminal methyls, SP form, 3 H each), 2.74 (N-methyl, 
SP form) and 5.72 ppm (olefin proton, SP form). Notably, a signal at 8.16 ppm (pyridine para 
proton) also appeared. These results indicated that the pyridine deprotonated all of the 132 Z-ME-
H to give Z-ME, which spirocyclised to give SP. This removed Z-ME-H from the E-ME-H/Z-
ME-H equilibrium, and so E-ME-H attenuated to convert to more Z-ME-H and SP, leaving behind 
only 10% of the original E-ME-H. It was assumed that E-ME-H was present instead of the 
deprotonated E-ME as the signals corresponding to E-ME-H did not change. Additionally, the 
pyridine signals were markedly downfield shifted in comparison to its neutral form, indicating 
that protonation had taken place. Finally, the sample was left for 24 h, with no change in signals 
occurring, indicating that the spiropyran was stable in the presence of pyridinium trifluoroacetate. 
With this, ten equivalents of 132.TFA were combined with an equivalent of 97. The mixture was 
irradiated with 485 nm light for one hour and studied by 1H NMR (Figure 62). 
 
 







Prior to irradiation, a signal was observed at 1.80 ppm (geminal methyls, E-ME-H form). 
After irradiation, this signal attenuated with concomitant appearance of a signal at 1.25 ppm 
(geminal methyls, Z-ME-H form). All of the signals corresponding to 97 remained the same.  
These experiments showed that upon irradiation, 132 E-ME-H photoisomerised to Z-ME-
H, but the foldamer was not basic enough to deprotonate either form. Pyridyl urea 97 remained 
unaffected, and the Z-ME-H form thermally reverted back to the E-ME-H form over 16 h. From 
this, it was inferred that acidification of 132.TFA was required to shift the pKa range down to the 
pKaH of 97. To this end, 133 was synthesised as an analogous photoacid with a para-nitro group 
on the salicylaldehyde fragment. 133 was synthesised from 131 using 4-nitrosalicylaldehyde 
(Scheme 32). 133 was then ring-opened with TFA to give the E-ME-H form. Five equivalents of 
this were added to 97 and the resulting mixture was studied by 1H NMR (Figure 63).  
 
 
Figure 63 – 97.5(133.TFA) (CD2Cl2, 500 MHz, 10 mM). 
 Merocyanine 130 showed signals at 1.30 (geminal methyls, E-ME-H form) and 2.83 ppm 
(N-methyl, E-ME-H form). The central ureido proton of pyridyl urea 97 was observed at 9.12 
ppm. Unfortunately, the signals of 97 indicated that the E-ME-H form of 133 was sufficiently 
acidic to protonate 97. This meant that acidifying 132 with a para nitro group lowered the pKas 
too much, to the point that both forms protonate 97, rendering the photoswitching process 
redundant. In order to overcome this issue, another photoacid needs to be synthesised with an 
electron-withdrawing substituent on the salicylaldehyde fragment of intermediate electron-
withdrawing ability such that the pKaH of 97 lies between that of the E-ME-H and Z-ME-H forms. 
Alternatively, it was shown that in DCM, the pKaH of pyridine lied in this region and allowed 
efficient pH-gating. Therefore, an alternative acid-sensitive directional switch could be made with 
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electron-donating groups on the pyridine. This would increase the basicity of the foldamer, and 
could raise the pKaH to the appropriate region for pH-gating with 132. This may also allow 
deprotonation of 130 upon irradiation, and allow directionality switching using weaker acids, 
which would make the switch more tolerable and feasible under physiological conditions. 
The attempted light-induced directionality switches described still necessitate the use of 
acids, which may give rise to undesirable side-processes in biological settings. The photoacid also 
does not need to associate with the foldamer, and so the acid generated can protonate other basic 
moieties instead. A more functional alternative would be to have the photoswitchable moiety as 
a part of the foldamer, meaning that photoisomerisation could affect the foldamer directly from 
intramolecular interactions. The proposed method of doing this is to have an HBD and HBA as 
different substituents on a photosensitive bond (Scheme 34). 
 
Scheme 34 – Schematic for light-induced conformational switching of oligourea foldamers. 
 Ideally, the E and Z forms of the photosensitive bond would have orthogonal light 
absorption, allowing the two forms to interconvert upon exposure to different wavelengths of 
light. In one form, an HBA would be proximate to the adjacent urea and the HBD on the other 
side of the olefin would not. The HBA would form a hydrogen bond with the adjacent ureido 
proton, and the directionality would be controlled as such. Photoisomerisation would switch the 
HBA out of hydrogen bonding and bring the HBD close to the adjacent urea. The directionality 
of the adjacent urea would then switch in order to form a new hydrogen bond with the HBD 
through the ureido carbonyl, and the new directionality would be communicated through the 
foldamer. Previous work by Clayden and co-workers has explored numerous candidates to satisfy 
this phenomenon, and it has been shown that fumaramides (E) can photoisomerise to form the 
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corresponding maleamides (Z) and hydrogen bond with adjacent ureas (Figure 64). The advantage 
of this scaffold is that HBDs and HBAs are already present in the form of amides. 
 
Figure 64 – Directionality control using fumaramides (E) and maleamides (Z). 
 Unfortunately, it was discovered that in both the E and Z forms of the diamide, the amido 
carbonyl acted as an HBA, imposing directional control on the proximate urea such that the 
diamide was at the N-terminus.* In order to attain a light-mediated directionality switch, one of 
the forms must act as an HBD instead. In the case of the fumaramide, the amido carbonyl acts as 
an HBA. This interaction can be changed by acidifying the amido proton or decreasing the 
hydrogen-bond-accepting ability of the amido carbonyl (Figure 65).  
 
Figure 65 – Interconversion of the 7-membered hydrogen-bonding rings in maleamides. 
 The maleamide, however, can act as either an HBA or an HBD to the proximate urea by 
interconversion between two different 7-membered hydrogen-bonding rings. When the 
maleamide was terminated with a benzyl group, the leftmost hydrogen-bonding ring 
predominated (Figure 65), resulting in the maleamide acting as an HBA. It is proposed that if this 
terminal amide was acidified by an electron-withdrawing substituent, the rightmost 7-membered 
hydrogen-bonding ring would be more thermodynamically favoured. This would leave an amido 
proton proximate to the urea, setting the opposite directionality to the fumaramide. It was hoped 
that the hydrogen-bonding properties of the fumaramide would be unaffected by this 
modification. The initial target was phenyl-substituted maleamide, 135 (Scheme 35). 
                                                   




Scheme 35 – Synthesis of 135. 
 Maleamide 135 was synthesised by acylation of aniline using maleic anhydride followed 
by coupling of the corresponding amic acid with amine 107 using peptide coupling reagents, 
providing 135 in good yield over two steps. To ascertain the directionality that the N-phenyl 
maleamide imposed, 135 was then studied by VTNMR (Figure 66). 
 
 
Figure 66 – VTNMR of 135 (CD2Cl2, 300 MHz, 21 mM). 
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 Maleamide 135 showed signals at 4.53 (benzylic methylene), 6.05 and 6.14 (olefin 
protons), 7.69 (ureido proton), 8.71 (alkyl amido proton) and 11.31 ppm (phenyl amido proton) 
at 20 °C. Upon cooling, the signals at 4.53, 6.05 and 6.14 ppm stayed approximately constant 
until they broadened at −60 °C. The signals at 7.69, 8.71 and 11.31 ppm shifted downfield and 
broadened with decreasing temperature and then sharpened again at −50 °C. The lack of 
decoalescence of the benzylic methylene indicated that one conformation is populated. It is hoped 
that the maleamide is at the C-terminus, as is the case in thioureas 68 and 90. By chemical shift 
inspection, it is difficult to assign the directionality of the adjacent urea. However, the ureido 
proton chemical shift is likely to be very different to that of 68 and 90, as the urea is in a 7- or 9-
membered hydrogen-bonding ring with an amide. NOE analyses were performed (see Appendix, 
Figures A34-35), and it was shown that the benzylic methylene was proximate to the ureido 
proton, but the other two methylenes in the ethylene bridge were not. This indicated that the urea 
directionality was set such that the maleamide was at the C-terminus, as desired. 
 Future work on this light-induced directionality switch will be to extend maleamide 135 
by one urea, to ensure that the first urea can communicate its directionality to the second. By 
analogy with thiourea 90 and tetrasubstituted urea 91, if the first and second urea can 
communicate, then the hydrogen-bonding information can be communicated throughout the rest 
of a larger foldamer. The analogous fumaramide will have to be synthesised to ensure that 
opposite directionality is retained upon phenyl substitution. Finally, the forms will be 
interconverted between each other by use of UV light. Additionally, it is noteworthy that 
maleamides can be chemically isomerised to fumaramides using amine catalysts, meaning that 
135 could also undergo a mild chemical-induced directionality reversal.101 However, the 
maleamide would have to be restored photochemically. Finally, fumaramides and maleamides 
photoisomerise under exposure to UV light. It would be useful if olefin modification redshifted 
the absorption wavelength of the photoswitch to allow photoisomerisation using light that is more 
conducive to biological systems.  
 To conclude, significant progress has been made towards attaining a light-induced 
directionality switch in ethylene-bridged oligourea foldamers, both in inter- and intramolecular 
fashions. The development of this kind of foldamer provides access to molecules that can 
communicate hydrogen-bonding information in response to a non-invasive stimulus with 
excellent spatial and temporal control. These foldamers could also be developed further to be 




3.7 A Fluorescent Reporter for Local Hydrogen-Bond Directionality 
 
 Up to this point, local directionality in ethylene-bridged oligourea foldamers has been 
inferred from chemical shift and the presence or absence of an NOE correlation using an 
appropriate spectroscopic reporter. This has been used effectively to ascertain the kinetic and 
thermodynamic behaviour of the oligoureas, but as the oligoureas get larger, the relative size of 
the relevant signals gets smaller, making them more difficult to analyse. Additionally, larger 
molecules tumble more slowly in solution, which makes NOE analyses more problematic.90 
Finally, the 1H NMR reporters have been used at concentrations above 10 mM, as obfuscation by 
spectroscopic noise renders them unreliable at higher dilution. This drawback is particularly 
pertinent in biological settings, where analysis must be carried out at sub-millimolar 
concentrations. 
 Fluorescence has been very well established as a method for the microscopic analysis of 
compounds. It occurs by photoexcitation of a fluorophore to a high energy state, which then 
undergoes a non-radiative relaxation process to adopt to a lower-energy state.102 The fluorophore 
then emits a photon whose wavelength is redshifted relative to the absorption wavelength. This is 
very useful in biomedical applications, as fluorophores can typically be irradiated with 
biologically orthogonal light. The redshift of their emission also means that their presence can be 
detected precisely in biological systems. Hence it is very common for fluorophores to be ligated 
to biological molecules and later irradiated to monitor their position by fluorescence. 
 Due to the increased sensitivity and effectiveness of fluorophores in biomedical 
scenarios, a fluorescent reporter for local hydrogen-bond directionality in ethylene-bridged 
oligourea foldamers was highly desirable. The first design incorporating a fluorescent moiety was 
pyridyl urea 137 (Scheme 36), where the foldamer was terminated with a fluorescent pyrene 
group.  
 
Scheme 36 – Local directionality-detection by pyrene fluorescence. 
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 It was proposed that in the directionality where pyridine is at the N-terminus, the pyrene 
would not be involved in any intramolecular interactions and therefore give rise to a certain 
fluorescence. However, upon directional switching, a pendent ureido proton would form an N-H-
π interaction with the pyrene, giving rise to a fluorescence change. Pyrene 137 was synthesised 
in an analogous manner to pyridyl urea 97, but reductive alkylation was performed using 1-
pyrenecarboxaldehyde in a DCM/MeOH mixture (Scheme 37).  
 
Scheme 37 – Synthesis of 137. 
Five equivalents of TFA were then added to 137 and the resulting mixture was analysed 
by 1H NMR. Unfortunately, it was evident that the acid had resulted in decomposition of the 
pyrene, yielding numerous products corresponding to the different permutations of pyrene 
oxidation. 
 An alternative fluorescent reporter proposed was bis(pyrene) 139 (Scheme 38), where in 
the directionality where the pyridine is at the N-terminus, the pyrene moieties would not associate 
with each other intramolecularly. Upon directional switching, the pyrenes would be brought 




Scheme 38 – Local directionality-detection by bis(pyrene) fluorescence. 
 Bis(pyrene) 139 was synthesised from 136 and 1-(isocyanatomethyl)pyrene, which was 
made from 1-pyrenylmethylammonium chloride and triphosgene (Scheme 39).  
 
Scheme 39 – Synthesis of 139.  
Bis(pyrene) 139 was successfully isolated, but unfortunately, oxidation of the pyrenes 
took place upon treatment with TFA. Due to the instability of the pyrenes in the presence of TFA, 
an alternative fluorescent scaffold was sought. 
O’Reilly and co-workers reported the use of a dithiomaleimide (DTM) functional group 
as a highly emissive and sensitive fluorescent reporter for supramolecular architecture, such as 
the detection of self-assembled micelles.103 The DTM is a maleimide, and so it was suspected that 
the imido carbonyls could be used as a weak HBA that, if presented with an HBD, would 
hydrogen bond and result in a fluorescence change. Similar to the succinimide in 69, as 
maleimides are relatively weak HBAs, it was hoped they would not be able to strongly impose 
any directional preference. The pyridyl urea would still maintain complete conformational control 




Scheme 40 – Local directionality-detection by DTM fluorescence. 
 Pyridyl urea 145 was synthesised by the development of an electrophilic source of the 
DTM in the aldehyde oxidation state (Scheme 41). This electrophilic source of the DTM was to 
be coupled to a N-(2-pyridyl)ethylenediamine by reductive amination. 
 
Scheme 41 – Synthesis of 145. 
 Maleic anhydride underwent a twofold dibromination/elimination cascade to give 
dibromomaleic anhydride 140 in good yield. The anhydride was then used to acylate allylamine 
and underwent a ring-closing condensation in acetic acid to give the corresponding allyl 
maleimide in excellent yield.103 141 then underwent twofold bromide substitution using n-
butanethiol to provide 138, and subsequent Lemieux-Johnson oxidation of 142 furnished 
aldehyde 143 in moderate yield over two steps. With an electrophilic source of the DTM acquired, 
92 underwent a reductive alkylation with 143 and NaB(OAc)3H to prevent potential overreduction 
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of the imide, giving amine 144. The crude product was then reacted with 4-methoxyphenyl 
isocyanate to give the desired diurea 145 in poor yield over two steps. To ensure that 145 behaved 
analogously to pyridyl urea 97 and did not decompose under acidic conditions, TFA was titrated 
into 145 (Figure 67). 
 
 
Figure 67 – Titration of TFA into 145 (6.50-13.00 ppm region, CD2Cl2, 500 MHz, 14 mM). 
 In its neutral form, pyridyl urea 145 displayed signals at 7.09 (pyridine meta methine), 
7.26 (pyridine meta methine), 7.85 (pyridine para methine), 8.39 (pyridine ortho methine), 8.56 
(rightmost ureido proton) and 12.44 ppm (pyridyl urea ureido proton). Upon addition of TFA, the 
signals at 7.09, 7.26 and 7.85 ppm all shifted downfield, broadened (losing their multiplicity) at 
2.2 equivalents and sharpened at 10.0 equivalents. Conversely, the signal at 8.39 ppm shifted 
upfield with increasing TFA and maintained its multiplicity throughout. The signal at 8.56 ppm 
shifted downfield up to 0.6 equivalents of TFA, and then shifted downfield again, before 
broadening and becoming too broad to observe at 1.8 equivalents. Finally, the signal at 12.44 ppm 
shifted upfield as TFA was added. This signal also broadened but sharpened again at 5.0 
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equivalents. Fortunately, no signals corresponding to decomposition arose during the experiment. 
In its neutral form, the chemical shifts of the ureido protons agreed closely with that of 97, 
indicating uniform directionality in the desired fashion. These data were consistent with 
protonation of the pyridine due to the relative shifting of their signals.  
Much like the case of pyridyl urea 97, the central ureido proton moved downfield and 
then upfield with increasing TFA. The pyridyl urea ureido proton shifted significantly upfield 
with increasing TFA, indicating directional switching taking place. These results were 
commensurate with that observed with triurea 97, where superstoichiometric TFA was required 
to effect the directionality switch. This is explicable by the lack of basicity of the pyridyl ureas in 
triurea 97 and DTM 145 in DCM. A stoichiometric switch could be attained by using a more basic 
foldamer, a stronger acid such as TsOH.H2O, or by using a solvent system where the pKa of TFA 
is much lower than the pKaH of pyridyl urea 145. 
 At this point, analysis by 1H NMR indicated that the DTM was stable in the presence of 
acid, and that protonation of pyridyl urea 145 resulted in a directionality switch. The ability of the 
DTM to detect this change was then investigated. A 1 mM solution of 145 was prepared in DCM, 
and its emission profile upon irradiation with 405 nm light was recorded (Figure 68). 
 
 
Figure 68 – Emission profile of 145 after addition of TFA/TEA (irradiation at 405 nm, ~1 mM). 





















 5 eq. TFA
 5 eq. TFA, 25 eq. TEA
 50 eq. TFA, 25 eq. TEA
 50 eq. TFA, 100 eq. TEA
136 
 
 In its neutral form, DTM 145 emitted with a nominal wavelength of 522 nm. After 
addition of 5.0 equivalents of TFA, this wavelength redshifted to 539 nm, accompanied by a 
hyperchromic shift. Addition of TEA returned the nominal wavelength to 522 nm and attenuated 
the signal. Excess addition of TFA relative to the TEA shifted the nominal wavelength to 539 nm 
and augmented the signal. Finally, addition of excess TEA relative to the TFA restored the 
nominal wavelength of 522 nm, associated with a large hyperchromic shift. It was presumed that 
the hyper- and hypochromic shifts were associated with sensitisation of the salts and differing 
quantum yields between the neutral and protonated species.103 These results showed that upon 
protonation of the foldamer, the DTM formed a hydrogen bond with the proximate urea, resulting 
in a redshift of the emission wavelength. Deletion of this hydrogen bond upon treatment with base 
restored the original spectrum. This process was switched forwards and backwards twice, 
indicating robustness of the DTM in local directionality detection, and that directionality can be 
switched backwards and forwards in acid-sensitive oligoureas in the same pot without any 
detectable erosion of fidelity.  
 It was next desirable to ensure that the fluorescence change accompanying the 
directionality switch came from the formation of a hydrogen bond between the DTM and the 
adjacent urea. To this end, a 1 mM solution of DTM intermediate 142 was treated with TFA and 
the emission profile upon irradiation with 405 nm light was recorded (Figure 69).  
 
Figure 69 – Emission profile of 142 after addition of TFA (irradiation at 405 nm, ~1 mM). 
 In DTM 142, the nominal wavelength observed upon irradiation with 405 nm light was 
at 522 nm. Interestingly, this was the same nominal wavelength as the neutral form of DTM 145, 
where the DTM was not hydrogen bonded. Addition of TFA gave rise to no change in nominal 
wavelength of the DTM. Next, it was desirable to see if the presence of pyridinium cations and 
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trifluoroacetate anions, as would be present in 145, gave rise to any fluorescence change in DTMs. 
A 1 mM solution of 142 was combined with an equivalent of pyridine and the emission profile 
upon irradiation with 405 nm light was recorded (Figure 70). 
 
Figure 70 – Emission profile of 142/pyridine after addition of TFA (irradiation at 405 nm, ~1 mM). 
 Again, no change in nominal wavelength was observed in the 142/pyridine mixture upon 
addition of TFA, nor when the TFA was neutralised with TFA. These experiments showed that 
the change in fluorescence of DTM 145 can be fully attributed to the formation of an 
intramolecular hydrogen bond between the DTM and its adjacent urea. The pyridine was cycled 
between protonated and neutral states twice, and each time the state was communicated through 
the oligourea scaffold effectively and the information was relayed to the DTM reporter. 
To summarise, fluorimetry experiments have revealed that DTMs can be used as efficient 
reporters for local hydrogen-bond directionality in ethylene-bridged oligoureas without imparting 
any directionality bias. The DTM can be attached to the foldamer by coupling of an amine 
function with an electrophilic source of DTM, 142 under mild reductive alkylation conditions. 
The reporter is robust, and very sensitive to intramolecular effects as opposed to any 
intramolecular hydrogen bonding from HBDs such as TFA and triethylammonium 
trifluoroacetate at millimolar concentrations. It is notable that this phenomenon may be general, 
in that DTMs may be able to detect the presence of intramolecular HBDs in other systems as well. 
This development represents a significant advancement in the study of ethylene-bridged oligourea 
foldamers, as the hydrogen-bonding information can be relayed in a foldamer and be effectively 
reported at millimolar concentrations. 
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3.8 Hydrogen-Bond Directionality Switching by Anion Binding 
 
 Another desirable stimulus for informational communication is the binding of specific 
chemical species. Nature has recognised the utility of such an event and has evolved to utilise the 
spatially specific binding of certain ligands to communicate information and/or perform function. 
For example, porphyrins are highly prolific in biological systems due to their ability to bind 
transition metal cations. In the metalloprotein, haemoglobin, the exotic redox properties of iron 
porphyrins are harnessed to bind oxygen and carbon dioxide reversibly and transport them around 
the body.104 When carbon dioxide is in high concentration, oxygenated haemoglobin undergoes a 
conformational change that lowers oxygen binding affinity, resulting in the release of oxygen 
from the haemoglobin. Conversely, in areas of high oxygen concentration, such as in the alveoli, 
the conformation of the haemoglobin shifts to increase oxygen binding affinity. Additionally, this 
initial oxygen binding results in further conformational change and renders oxygen binding 
cooperative. The haemoglobin can also be appended with specific amino acid residues meaning 
that they will capture and release carbon dioxide and oxygen at highly specific sites.  
 Previous work by Clayden and co-workers has shown that N-3,5-
bis(trifluoromethyl)phenyl-N’-alkyl ureas are very strong HBDs, which can hydrogen bond 
favourably to alkyl ureas intramolecularly. Alkyl ureas are weaker HBDs than their analogous 
aryl ureas due to a lack of electron-density delocalisation into the arene. However, if the N-3,5-
bis(trifluoromethyl)phenyl urea can form a stronger intermolecular hydrogen bond, then its 
directionality may switch and force the adjacent alkyl urea to act as an HBD (Scheme 42).* This 
effect did not translate to aryl ureas, as their hydrogen-bond-donating/accepting abilities were 
comparable to the N-3,5-bis(trifluoromethyl)phenyl urea such that directionality was not 
completely controlled by the N-3,5-bis(trifluoromethyl)phenyl urea. 
 
Scheme 42 – Directionality switching using anions. 
 As a continuation of the study of anion binding to ethylene-bridged oligourea, the aim of 
this work was to extend the concept to foldamers where the anion binding event would 
communicate through the foldamer and be read out by the previously designed DTM fluorescent 
                                                   
* Work performed by Dr David Tilly. 
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reporter. This was done to ensure that the DTM could read out hydrogen-bonding information in 
response to remote stimuli other than the presence of acid. Initially, it was desirable to ascertain 
if alkyl ureas were conducive to communication through the ethylene-bridged oligourea scaffold, 
and if they also exhibited uniform directionality. Triurea, 146 was made by reaction of 44 with n-
butyl isocyanate (Scheme 43).  
 
Scheme 43 – Synthesis of 146. 
Triurea 146 was then studied by VTNMR (Figure 71). 
 
 
Figure 71 – VTNMR of 146 (CD2Cl2, 300 MHz, 17 mM). 
 Triurea 146 displayed signals at 4.39 (benzylic methylenes) and 6.63 ppm (central ureido 
proton) at 20 °C. Upon cooling, the signal at 4.39 ppm broadened and decoalesced into two 
singlets (2 H each) at −30 °C. The signal at 6.63 ppm shifted downfield with decreasing 
temperature. At −30 °C, additional signals appeared at 4.49 (1 H) and 6.92 ppm (1 H, broad and 
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overlapping) and shifted downfield upon further decreasing the temperature. These data indicated 
that 146 exists as one conformation of uniform directionality, where the directionalities 
interconvert between each other slowly on the NMR timescale below −30 °C. This is supported 
by the chemical shifts, where one ureido proton is not hydrogen bonded (4.49 ppm at −30 °C) and 
two of them are (6.88 and 6.92 ppm at −30 °C). It can be inferred from this that alkyl ureas are 
fully conducive to intramolecular hydrogen bonding in ethylene bridged oligoureas in apolar 
solvents. Eyring analysis of 146 revealed a ΔG
‡
298 K (CD2Cl2) of 57.9 kJ mol
-1, a value 
commensurate with that of the analogous tris(aryl urea), 45. Alkyl ureas are weaker HBDs but 
stronger HBAs than their corresponding aryl ureas, so this result shows that these effects 
approximately cancel each other from a kinetic perspective. 
Aryl ureas may also be present in the proposed anion-sensitive directional switch, so it 
was also desirable to investigate the effects on the thermodynamics of mixed alkyl/aryls ureas. 
To this end, triurea 151 was synthesised (Scheme 44).  
 
Scheme 44 – Synthesis of 151. 
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 Diethylenetriamine underwent twofold trifluoroacetylation at the primary amines, and the 
secondary amine was reacted with 4-methoxyphenyl isocyanate to give the corresponding 
monourea, 147 in excellent yield. The trifluoroacetamides were hydrolysed and the diamine 148 
was isolated in poor yield. Loss of product may have occurred due to water solubility of the 
product during purification. Twofold reductive alkylation using benzaldehyde gave diamine 149 
in poor yield. Installation of one urea proceeded in good yield, and a final alkyl urea was formed 
using n-butyl isocyanate, affording the target triurea 151 in moderate yield. 151 was then analysed 
by VTNMR (Figure 72). 
 
 
Figure 72 – VTNMR of 151 (CD2Cl2, 300 MHz, 15 mM). 
 Triurea 151 displayed signals at 4.37 (alkyl urea benzylic methylene), 4.53 (aryl urea 
benzylic methylene), 8.65 (peripheral aryl urea ureido proton) and 9.11 ppm (central ureido 
proton) at 20 °C. Upon cooling, the signal at 4.37 ppm stayed approximately constant until it 
broadened at −20 °C and decoalesced into two singlets (0.30 H and 1.70 H) at −30 °C. The signal 
at 4.53 ppm broadened until it could not be observed at −80 °C. The signals at 8.65 (very broad) 
and 9.11 ppm sharpened and shifted downfield with decreasing temperature. At −10 °C, signals 
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appeared at 4.59 (0.85 H) and 4.77 ppm (0.15 H), which sharpened and shifted downfield upon 
further decreasing the temperature. Another signal appeared at 9.10 ppm (0.15 H) at −30 °C, 
which shifts downfield with further cooling. These data indicated that 151 exists as two 
conformations populated in a 85:15 ratio at −60 °C. These conformations are the two 
directionalities, and the major conformer is the directionality where the n-butyl urea is at the N-
terminus. This is evidenced by the observable decoalescence of the alkyl urea benzylic methylene 
into two signals in a 85:15 ratio. At −60 °C, the two conformers are in slow exchange on the NMR 
timescale, and so three ureido protons can be observed for each. For the major conformer, there 
is a non-hydrogen bonded alkyl ureido proton (4.78 ppm, 0.85 H), and two aryl ureido protons 
that are (9.30 and 9.43 ppm, 0.85 H each). For the minor conformer, there is an alkyl ureido proton 
in hydrogen bonding (5.55 ppm, 0.15 H) and an aryl ureido proton in hydrogen bonding (9.21 
ppm, 0.15 H). There should also be a non-hydrogen-bonded peripheral aryl ureido proton around 
6.50 ppm but this was not observed, presumably as a result of exchange processes with trace water 
in the sample.  
 It was shown by triurea 151 that alkyl ureas can significantly perturb the equilibrium 
distribution of directionalities in otherwise aryl-substituted oligoureas. Due to the difference in 
hydrogen-bonding properties of these two types of urea, it was proposed that external HBAs could 
also significantly change the conformer distribution. To investigate this, triurea 151 was studied 

















Figure 73 – VTNMR of 151 (10% v/v d6-DMSO in CD2Cl2, 300 MHz, 15 mM). 
 In triurea 151, signals were shown at 4.33 (alkyl urea benzylic methylene), 4.44 (aryl urea 
benzylic methylene), 6.05 (alkyl urea ureido proton), 8.62 (peripheral aryl urea ureido proton) 
and 9.09 ppm (central ureido proton) at 20 °C. Upon cooling, the signal at 4.33 ppm broadened 
throughout the experiment. The same was observed for the signal at 4.44 ppm but it also moved 
upfield. The signals at 6.05, 8.62 and 9.09 ppm shifted downfield with decreasing temperature. 
Additional signals appeared at 5.38 (0.30 H), 8.38 (0.30 H) and 9.07 ppm (0.30 H) at −10 °C, 
which sharpened and shifted downfield upon further cooling. These observations can be explained 
by the population of two conformers in a 70:30 ratio. This was not elucidated by an observable 
decoalescence of the benzylic methylene signals but could be inferred from the chemical shifts 
and relative integrations of the ureido protons. The two conformers corresponded to the two 
directionalities and in each case, d6-DMSO hydrogen bonded to the exposed ureido proton. At 
slow exchange, each of the two conformers contain three ureido protons. In one directionality, 
the n-butyl urea acts as an intramolecular HBA, forcing the other two aryl ureido protons into 
intramolecular hydrogen bonding and leaving its own ureido proton to hydrogen bond to d6-
DMSO. This is shown by the signals at 5.52 (alkyl urea ureido proton, 0.30 H), 8.58 (peripheral 
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aryl urea ureido proton, 0.30 H) and 9.20 ppm (central ureido proton, 0.30 H) at −60 °C. This also 
identifies this directionality as the minor conformer. In the other directionality (the major 
conformer), where the n-butyl urea acts as an intramolecular HBD, one of the aryl ureas is in an 
intramolecular hydrogen bond and the other an intermolecular hydrogen bond with d6-DMSO. 
This shows signals at 6.58 (alkyl urea ureido proton, 0.70 H), 9.18 (peripheral aryl urea ureido 
proton) and 9.49 ppm (central ureido proton) at −60 °C. This is a particularly pertinent result as 
it shows that triurea 151 can change, and even invert its ratio of directionalities upon introduction 
of a hydrogen-bond-accepting additive. Crucially, it has also been shown that all-alkyl and 
alkyl/aryl mixed oligoureas still exhibit uniform directionality, although the differing hydrogen-
bonding properties of alkyl and aryl ureas can play a crucial role in hydrogen-bond strength. 
 Now that it had been shown that the oligourea scaffold was conducive to mixtures of 
alkyl and aryl ureas, a target fluorescent anion-sensitive foldamer 154 was pursued. DTM 154 
was synthesised by reductive alkylation and urea formation on amine 152, which proceeded in 
reasonable yield over the two steps (Scheme 45, n = 1, R = nBu). 
 
Scheme 45 – Synthesis of 154 and 157. 
A 1 mM solution of DTM 154 was then analysed by fluorimetry and various anionic 
ligands were added (Figure 74). A tetrabutylammonium cation was used in each case to promote 
solubility in DCM. Solubility was further bolstered by a diphenylphosphate anion in the case of 





Figure 74 – Emission profiles of 154 after addition of anionic ligands (a) TBACl (b) TBAAc (c) TBA 
diphenylphosphate (irradiation at 405 nm, ~1 mM). 
 Before ligand addition, DTM 154 exhibited fluorescence at 529 nm. In each case, one 
equivalent of the tetrabutylammonium salt resulted in a blueshifting of the nominal wavelength 
to 522 nm. Further addition of tetrabutylammonium salt resulted in an attenuation of the signal 
but remained otherwise constant. These results indicated that in each case, the DTM starts in a 
hydrogen-bonded state, hence its deviation from the non-hydrogen-bonded state emission, 522 
nm. The blueshift relative to the non-hydrogen-bonded state is much less than that of DTM 145 
(Δλ = 17 nm vs 7 nm), which is attributed to the fact that the alkyl urea is hydrogen bonding to 
the DTM. This is a weaker HBD, and so the DTM will form a weaker hydrogen bond with it and 
be less affected. After addition of one equivalent of tetrabutylammonium salt, the emission 
profiles centred about 522 nm, indicating that the DTM was no longer hydrogen bonding and that 
a successful directionality switch had taken place. To ensure switching orthogonality in the 
different fluorescent switches, DTMs 142 and 145 were exposed to the various 
tetrabutylammonium salts, resulting in no nominal wavelength shift (see Appendix, section 8.4).  
 Next, an analogous DTM 157 was synthesised in which the directionality switch was to 
be transmitted over four ureas. 157 was made in the same manner as amine 154 using amine 155 
and n-butyl isocyanate (Scheme 45, n = 3, R = nHex). TBAAc was then titrated into a 1 mM 
sample of DTM 157 and analysed by fluorimetry (Figure 75). 
 




















 0.0 eq. TBACl
 1.0 eq. TBACl
 3.0 eq. TBACl




















 0.0 eq. TBAAc
 1.0 eq. TBAAc
 3.0 eq. TBAAc




















 0.0 eq. TBA phosphate
 1.0 eq. TBA phosphate
 3.0 eq. TBA phosphate





Figure 75 – Titration of TBAAc into 157 (irradiation at 405 nm, ~1 mM). 
 Before ligand addition, DTM 157 showed a nominal wavelength of 529 nm. Titration of 
TBAAc into 157 blueshifted the profile accompanied by a hyperchromic shift to arrive at a 
nominal wavelength of 522 nm at 1.00 equivalents of TBAAc. This experiment also showed that 
the DTM in 157 was also hydrogen bonding to its proximate urea, but it was switched out of 
hydrogen bonding upon addition of TBAAc. This was consistent with a directionality switch 
taking place at the N,N’-disubstituted urea binding site, which was communicated through four 
ureas and reported by the DTM.  
To further demonstrate switching orthogonality and the efficacy of the DTM in reporting 
it, DTMs 142, 145 and 157 were each treated with TFA and TBAAc and the change in their 
fluorescence was recorded (Table 2). The extent of DTM hydrogen bonding was qualitatively 
determined by calculating the ratio of the emission at 529 (hydrogen-bonded) to 522 nm (non-
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Table 2 – Switching orthogonality in ethylene-bridged oligoureas as reported by a DTM. 





   
 
 The DTM in 142 did not form hydrogen bonds, which did not change upon addition of 
TFA or TBAAc. Pyridyl urea 145 responded to TFA by switching the DTM into hydrogen 
bonding but did not respond to TBAAc. Conversely, N,N’-disubstituted urea 157 was insensitive 
to TFA but switched the DTM out of hydrogen bonding upon addition of TBAAc. 
 Foldamers terminated with a N-3,5-bis(trifluoromethyl)phenyl-N’-alkyl urea can control 
directionality in ethylene-bridged oligourea foldamers, which can be reported by a fluorescent 
DTM at the opposite end of the foldamer. Three different anions (chloride, acetate and 
diphenylphosphate) were shown to coordinate to the N-3,5-bis(trifluoromethyl)phenyl-N’-alkyl 
urea and switch the directionality, which can be detected by a change in fluorescence at millimolar 
concentrations. This further confirms the robustness of the DTM reporter in detecting local 
directionality changes and indicates that the strength of the hydrogen bond can be qualitatively 
inferred from the relative redshift of the DTM emission in the hydrogen-bonded state. The 
detection of anions such as chloride, acetate and phosphate and subsequent communication over 
four ureas lends further weight to the versatility of the scaffold. The results discussed here suggest 
that biological molecules bearing a negative charge can be used to communicate information 
through the oligourea foldamer and result in a directionality change. This method could be 
developed further to make the anion-binding site more anion-specific to achieve foldamers 
sensitive to different biomolecules. 













































































































3.9 Inducing a Fault in the Hydrogen-Bonding Network 
 
Thus far, all the compounds studied have the whole length of oligourea in exclusively 
one hydrogen-bond directionality, even if the two modes are in exchange, and so there has been 
no observed disruption to the hydrogen-bonding network. Intermolecular hydrogen-bonding 
additives such as d6-DMSO and Schreiner’s thiourea imparted no observable disruption. When 
the reporting end of the foldamer is appended with biomimetic functions, it is likely they will 
contain hydrogen-bonding groups themselves, which could damage hydrogen-bonding fidelity in 
the scaffold and wither the efficacy of the function it was designed to perform. Hence, it was 
desirable to know what electronic properties would be necessary to disrupt the 9-membered 
hydrogen-bonding rings in an intramolecular fashion. 
 The beginning of this investigation involved synthesising and studying diureas which 
had directionality-controlling groups on both ends, each vying for control of directionality. If 
uniform directionality prevailed, this would leave one of the controlling groups unsatisfied. 
Therefore, the only way to satisfy both directionality-controlling groups would be to induce a 
fault in the hydrogen-bonding network. The initial substrate chosen was a diurea with terminal 
succinimides. The disuccinimidyl diurea, 160 (Scheme 46) could either fault in the centre, where 
the ureas would not hydrogen bond with each other, or next to one of the succinimide groups, 
where one succinimide would not hydrogen bond. This structure was contrived such that fault 
induction in the centre would cause the diurea to fault symmetrically, but if it occurred next to 
one of the succinimides, it would do so unsymmetrically. These forms would be identifiable by 





Scheme 46 – Synthesis of 160. 
 Disuccinimide 160 was synthesised from triethylenetetramine by trifluoroacetamide 
protection and urea formation to give bis(trifluoroacetamide) 158 in moderate yield. The 
trifluoroacetamides were hydrolysed, and the corresponding amines were reacted with succinic 
anhydride followed by acetyl chloride to give disuccinimide 160 in reasonable yield over two 
















Figure 76 – VTNMR of 160 (CD2Cl2, 300 MHz, 16 mM). 
 Disuccinimide 160 displayed signals at 2.66 (succinimidyl methylenes) and 8.13 ppm 
(ureido protons) at 20 °C. Upon cooling, the signal at 2.66 ppm broadened and decoalesced into 
two equal singlets at −40 °C, where one of the singlets sharpened upon further decreasing the 
temperature and the other broadened. The signal at 8.13 ppm broadened with decreasing 
temperature and decoalesced into two equal singlets at −30 °C, which shifted downfield with 
further cooling. These results indicated the presence of one populated conformer, where no fault 
in hydrogen bonding between the ureas had been induced. This was concluded by the 
decoalescence, as at slow exchange, one of the succinimides is in hydrogen bonding and the other 
one is not. At slow exchange, two ureido proton resonances are observed, one corresponding to a 
ureido proton hydrogen bonding to a succinimide (8.06 ppm at −60 °C) and a ureido proton 
hydrogen bonding to the other urea (8.97 ppm at −60 °C). It can be concluded from this that 
succinimides are not strong enough HBAs to disturb the inter-urea hydrogen bonding to any 
observable degree. This is consistent with the observation in pyridyl urea 145 that the DTM does 
not strongly oppose the conformational preference induced by the pyridine.  
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 To impart a fault in inter-urea hydrogen bonds, compounds with increased hydrogen-
bond-accepting power were proposed. In tetraurea 161 (Figure 77), the succinimides were 
replaced with tetrasubstituted ureas, which are expected to be of similar hydrogen-bond-accepting 
power to the trisubstituted ureas. Bis(pyridine) 162 has the tetrasubstituted ureas of 161 replaced 
with 2-pyridyl groups, which is expected to be of greater hydrogen-bond-accepting power than 
the trisubstituted ureas.  
 
Figure 77 – Fault-inducing substrates, 161 and 162. 
 An initial investigation into the synthesis of 161 and 162 involved the derivatisation of 




Scheme 47 – Attempted syntheses of fault-inducing substrates. 
 Dibenzylation of diamine 159 proceeded in moderate yield to give diamine, 163, which 
was then reacted with N-methyl-N-phenylcarbamoyl chloride. This afforded none of the desired 
substrate, 161. Instead, the monosubstituted triurea 164 was isolated in 53% yield. It was 
speculated that upon formation of the first urea, the resultant tetrasubstituted urea and the 
remaining secondary amine competed for directional control. The secondary amine is a stronger 
HBA than the tetrasubstituted urea, so the amine formed a strong hydrogen bond with the adjacent 
urea, inhibiting its nucleophilicity and stopping the reaction. Repeating the reaction in refluxing 
DCE saw no further conversion of the triurea. Similar effects were observed when attempting 
twofold SNAr on 163 with 2-fluoropyridine, where monosubstitution proceeded in 40% yield, 
giving 165 with no conversion to the desired disubstituted product. To combat this issue, the ureas 
were attached after the directionality-controlling groups had been formed, such that the amines 




Scheme 48 – Synthesis of 161. 
Diamine 60 was dibenzylated by reductive alkylation with benzaldehyde to give 166, 
which proceeded in good yield. The tetrasubstituted ureas were then attached by reaction with N-
methyl-N-phenylcarbamoyl chloride, which gave the desired disubstituted product, 167 in good 
yield. Subsequent removal of the Boc groups with TFA and carboxamidation of the resultant 
amines gave the target tetraurea 161 in good yield over two steps. 161 was then studied by 










Figure 78 – VTNMR of 161 (CD2Cl2, 300 MHz, 11 mM). 
 Tetraurea 161 displayed signals at 4.15 (benzylic methylenes) and 8.87 ppm (ureido 
protons) at 20 °C. Upon cooling, the signal at 4.15 ppm broadened and decoalesced into three 
singlets in the ratio 37:37:26 at −20 °C. These singlets sharpened with decreasing temperature 
until they broadened again at −70 °C. The signal at 8.87 ppm broadened and shifted downfield 
with decreasing temperature until it decoalesced into three singlets in the ratio 37:26:37 at −20 
°C. These singlets then sharpened and shifted downfield upon further cooling. These experiments 
showed that 161 exists as two conformations populated in a 74:26 ratio. The major conformer has 
two chemical environments for benzylic methylenes as shown by the singlets of equal integration, 
and the minor has only one chemical environment. The same applies to the ureido protons. This 
indicated that the major conformer is that where the tetrasubstituted ureas do not cause a fault in 
hydrogen bonding in the centre. However, the minor conformer is the one in which a fault has 
been induced in the centre as shown by its solitary benzylic methylene and ureido proton signal. 
These results indicated that some degree of fault induction can take place if the terminal HBAs 
are of comparable hydrogen-bond-accepting power to the trisubstituted ureas.  
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Focus then returned to synthesising the fault-inducing substrate, bis(pyridine) 162. 
Twofold SNAr was attempted with diamine 166 (Scheme 48) and 2-fluoropyridine by heating to 
reflux in toluene and N,N-diisopropylethylamine (DIPEA) but unfortunately, no reaction 
occurred, which was attributed to the steric encumbrance about the amines. The same result 
occurred when Buchwald-Hartwig coupling with 2-bromopyridine was attempted. Due to the 
difficulty associated with the installation of the pyridines, an alternate route was sought. 
 
Scheme 49 – Synthesis of 162. 
 To avoid the steric encumbrance issues concerning the SNAr and Buchwald-Hartwig 
coupling in the synthesis of bis(pyridine) 162, the pyridine moiety was installed first. Previously 
synthesised amine 100 underwent benzylation at the secondary amine, which proceeded in good 
yield to give 169. Oxidation using DMP was then carried out which gave aldehyde 170 in 
moderate yield. Ethylenediamine then underwent twofold reductive alkylation with two 
equivalents of aldehyde 170, which occurred in poor yield as the major product was the single 
reductive alkylation product. This is explicable by formation of an imidazolidine by cyclisation 
of the second amine onto the imine formed after the first amine had undergone condensation with 
170. This would inhibit second condensation reaction, promoting single reduction to the 
monosubstituted product. Despite this, the crude mixture was reacted with 4-methoxyphenyl 








Figure 79 – VTNMR of 162 (CD2Cl2, 300 MHz, 12 mM). 
 In bis(pyridine) 162, signals were displayed at 4.66 (benzylic methylenes) and 9.20 ppm 
(ureido protons) at 20 °C. Upon cooling, the signal at 4.66 ppm broadened and decoalesced into 
three singlets of ratio 20:20:60 at −30 °C. These singlets then sharpened upon further decreasing 
the temperature and broadened again at −70 °C. The signal at 9.20 ppm broadened and shifted 
downfield with decreasing temperature until it decoalesced into three singlets of ratio 20:60:20 at 
−30 °C. This showed that 162 exists as two conformations that are in slow exchange below −30 
°C in a 40:60 ratio. The major conformer is that where the pyridines have induced a fault in the 
inter-urea hydrogen bonding, and the minor conformer is that where they have not. This shows 
that upon introducing a more powerful HBA to the termini of the diurea, more of the fault-induced 
conformer is populated.  
As a 2-aminopyridine was not a powerful enough HBA to induce a complete fault in 
inter-urea hydrogen bonding, more stable hydrogen-bonding rings had to be used to effect the 
desired fault. It was speculated that due to the greater strength of all-sp2 6-membered versus 9-
membered hydrogen-bonding rings, a pyridine in a 6-membered hydrogen-bonding ring with a 
urea could form a sufficiently strong hydrogen bond so as to induce a complete fault in the 
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hydrogen-bonding network.21 Bis(pyridine) 173 was synthesised as a new hydrogen-bond-
disrupting substrate (Scheme 50).  
 
Scheme 50 – Synthesis of 173. 
Diurea 173 was synthesised by twofold SNAr with ethylenediamine with 2-
fluoropyridine, giving bis(pyridine) 172, followed by twofold carboxamidation using 4-
methoxyphenyl isocyanate, giving the desired diurea 173 in good yield. Diurea 173 was then 
studied by VTNMR (Figure 80). 
 
 
Figure 80 – VTNMR of 173 (CD2Cl2, 300 MHz, 18 mM). 
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 Bis(pyridine) 173 showed signals at 4.23 (methylenes) and 12.57 ppm (ureido protons) 
at 20 °C. Upon cooling, the signal at 4.23 ppm stayed approximately constant until it broadened 
at −20 °C and decoalesced into two equal singlets at −70 °C. The signal at 12.57 ppm shifted 
downfield with decreasing temperature before broadening at −40 °C and sharpening at −70 °C. 
The remainder of the signals stayed the same throughout the experiment. It was deduced from 
these data that 173 exists as one conformation, where there is a complete fault in inter-urea 
hydrogen bonding due to the single chemical environment of the pyridines and ureido protons. 
Interestingly, the methylenes decoalesced into two equal signals corresponding to two protons 
each. It was inferred from this that at very low temperatures, 173 adopts a C2-symmetric and 
therefore chiral conformation that racemises on the NMR timescale above −40 °C.  
As this conformation is C2-symmetric, the carbon atoms of the methylenes should be 
chemically identical at slow exchange. This hypothesis was validated by comparison of the low-
temperature (−60 °C) 13C NMR spectra of diureas 43 and 173 (Figure 81). 
 
 
Figure 81 – 13C NMR spectra of 43 and 173 at −60 °C (40.0-56.0 ppm region, CD2Cl2, 300 MHz). 
At −60 °C, diurea 173 exhibited one signal corresponding to its methylenes, whereas 
diurea 43, an analogous diurea without a fault in hydrogen bonding, exhibited two. This 
experiment corroborated the supposition that 173 exists as one chiral conformation, where a 
complete fault has been induced in the inter-urea hydrogen bonding. This result is also 
commensurate with studies on pyridyl ureas 97 and 145, which have shown that pyridines in 6-







 Now that complete faults had been induced in diureas, it was desirable to extend the 
oligourea to deduce whether multiple faults are possible and if a fault preferentially lies between 
certain residues in an oligourea foldamer. With this, triurea 174 was synthesised by twofold SNAr 
of diethylenetriamine with 2-fluoropyridine and subsequent threefold carboxamidation using 4-
methoxyphenyl isocyanate.  
 
Scheme 51 – Synthesis of 174. 
Triurea 174 was then studied by VTNMR (Figure 82). 
 
 
Figure 82 – VTNMR of 174 (CD2Cl2, 300 MHz, 14 mM). 
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 Triurea 174 showed signals at 4.13 (pyridyl urea α methylenes), 8.88 (central ureido 
proton) and 12.61 ppm (pyridyl urea ureido protons) at 20 °C. Upon cooling, the signal at 4.13 
ppm broadened and decoalesced into two equal multiplets at −60 °C. The signal at 8.88 ppm 
shifted downfield with decreasing temperature, before broadening at −60 °C. The signal at 12.61 
ppm shifted downfield and broadened with decreasing temperature and decoalesced into two 
equal singlets at −40 °C. These data showed that 174 exists as one populated conformer, where a 
hydrogen-bonding fault has occurred between one of the pyridyl ureas and the central urea. The 
directionalities of the central urea are in slow exchange below −40 °C. This is evidenced by the 
decoalescence of the pyridyl urea α methylenes and pyridyl urea ureido protons in equal ratio, 
whilst the central ureido proton stayed the same throughout. This experiment showed that 
pyridines control the directionality of the ureas adjacent to them, effectively making the whole of 
the pyridyl ureas new HBAs, which hydrogen bond to the central urea. The directionality of the 
central urea interconverts by changing the pyridyl urea that it hydrogen bonds to. 
 To summarise, the hydrogen-bonding network in ethylene-bridged oligoureas is robust to 
intramolecular electronic effects. The ability of a group to induce a fault in directionality 
correlates with its hydrogen-bond-accepting ability relative to the central ureas. Succinimides, 
being weaker HBAs than ureas, fail to induce a fault in the network. Tetrasubstituted ureas and 
pyridines in 9-membered hydrogen-bonding rings, being of similar hydrogen-bond-accepting 
capacity to trisubstituted ureas, can induce a partial fault in directionality. If pyridines are 
involved in more stable hydrogen-bonding rings, complete fault induction can take place. This 
evidence suggests that only the formation of a very strong hydrogen-bonding alternative is 
sufficient to induce a fault in directionality. This promises that with judicious care over the 
hydrogen-bonding rings and functions at the ends of these foldamers, hydrogen-bonding fidelity 
can be maintained throughout the structure, conferring robust informational communication and 






There are four well-established types of chirality, each of which is prominent either in 
nature and/or in synthetic chemistry – central, axial, helical and planar chirality (Figure 83).105,106 
Other forms of chirality exist but will not be discussed here.107 Central chirality is ubiquitous in 
natural systems and control of it is vital in all cases where orientation in three-dimensional space 
is involved, such as in the selective binding of substrates in the active sites of enzymes and in the 
correct folding of DNA. Other forms of chirality are a result of non-covalent interactions. For 
example, axial chirality is very important in the function of ligands for asymmetric catalysis in 
organometallic chemistry. Axial chirality arises when the rotation of a specific single bond is 
inhibited by steric interactions. In the chiral ligand BINAP, the biaryl bond cannot rotate due to 
steric interactions between the naphthyl groups, meaning that two different enantiomers of the 
phosphine can be isolated.  
 
Figure 83 – Types of chirality. 
Conversely, helical chirality arises either because the barrier to screw-sense inversion of 
a helix is too great due to steric encumbrance, or because intramolecular hydrogen bonding is too 
strong for rapid racemisation.26 Planar chirality typically arises from restricted movement of 
groups from one side of a planar moiety to the other. As previously discussed, hydrogen-bonding 
networks can be used to perform a plethora of useful functions in both natural and synthetic 
contexts. A pertinent natural example is the cyclic arrangement of guanine tetrads in G-
quadruplexes. Telomeric DNA, which is rich in guanine, allow for guanines to aggregate by 
Hoogsteen base-pairing and alkali metal cation binding. This confers stability to single-stranded 
chromosomes and prevents them from being incorrectly processed and damaging the cell.108 The 
directionality of the G-quadruplex is dictated by the central and therefore helical chirality in the 






The ubiquity of central chirality in biological systems means that there are no known natural 
examples where chirality is derived solely from the strength of a cyclic hydrogen-bonding array. 
However, numerous synthetic examples have been reported, a simple example of which is the 
campestarenes (Figure 84).  
 
Figure 84 – Campestarenes and their tautomeric behaviour. 
Campestarenes are highly symmetrical Schiff-base macrocycles with interesting 
tautomeric behaviour. They are formed from the polycondensation of 2-amino-6-formylphenols 
to form the corresponding macrocyclic polyimine.109 This polymerisation occurs spontaneously, 
therefore precursors are required to synthesise these structures with selectivity. As shown by 
MacLachlan and co-workers, in the case of 2-nitro-6-formylphenols, reduction of a nitro group to 
acquire the amine resulted in exclusive formation of the C5h campestarene (Figure 84).
109 The 
campestarene could exist in two different tautomeric forms, a keto-enamine form and an enol-
imine form. In different solvents, the energy difference between the two tautomeric forms differs 
greatly, allowing solvent-dependent modulation of the equilibrium. Crucially, 1H NMR, 
computational and X-ray crystallographic evidence suggested that the phenolic protons are in 
identical chemical environments and in very strong hydrogen bonding. To satisfy this criterion, 
in the enol-imine form, all of the hydroxyl groups have to be aligned in either a clockwise or 
anticlockwise fashion. This means that if these structures were not degenerate from the horizontal 
plane of symmetry, they would be enantiomers of each other by virtue of their cyclic hydrogen-
bonding array alone. 
Aida and co-workers used a cyclic hydrogen-bonding network to slow the bowl-to-bowl 
inversion of corannulenes as a means of accessing the corannulene family’s unique properties and 
functions (Figure 85). The group functionalised the corannulene with both enantiopure and achiral 




Figure 85 – Amide-appended thioalkyl-substituted C5-symmetrical corannulenes. 
Serendipitously, the hydrogen-bonding network gave rise to some unexpected chiroptical 
properties. When achiral side chains were used on the corannulene, all of the amides hydrogen 
bonded in an intramolecular fashion to form a cyclic hydrogen-bonding array. Due to the helical 
chirality of the corannulene, which arose from its bowl shape and substitution pattern, the two 
hydrogen-bond directionalities were diastereomeric, and therefore one was favoured over the 
other. As desired, the strength of the cyclic hydrogen-bonding array slowed down the bowl-to-
bowl inversion of the corannulene significantly. The corannulene was then examined in 
enantiomerically pure (R)-limonene as a chiral solvent. Due to the chiral environment the (R)-
limonene imposed on the molecule, a clear Cotton effect was observed in the absorbance range 
of the corannulene motif. The presence of the chiral solvent induced global directionality of the 
amides in the cyclic hydrogen-bonding array, which was communicated to the corannulene. The 
same effect was observed upon introduction of chiral residues on the corannulene. Analogues 
were synthesised with (R) and (S)-2,6-dimethyloctane residues. Studies of these in an achiral 
solvent, methylcyclohexane resulted in opposite Cotton effects. This indicated that the chiral 
residues induced preferential directionality in the cyclic hydrogen-bonding array. This effect was 
further exemplified by addition of ethanol to the mixture. The ethanol disrupted the cyclic 
hydrogen-bonding array by competitive hydrogen-bonding interactions, which increased the rate 
of bowl-to-bowl inversion, and thus no Cotton effect was observed. This supported the notion 
that the cyclic hydrogen-bonding array was responsible for the corannulene’s chiroptical 
properties. Whilst these examples showed that cyclic hydrogen-bonding arrays can give rise to 
interesting properties and useful functions, they did not exploit the function that the directionality 




4.1 Cyclochirality in Cyclic Ethylene-Bridged Oligoureas 
 
Macrocyclic oligoethylenediamines and their derivatives have found widespread use in 
coordination and medicinal chemistry. Much like the crown ethers, they can be used to 
accommodate a variety of metal cations and can sometimes exhibit selectivity between them 
depending on their cavity size.111 Due to their enhanced basicity in comparison to crown ethers, 
they and their ammonium salts also make for useful cation and anion hosts, respectively.112 Their 
rich coordination chemistry makes them interesting targets for biomimetic esterases, β-
cyclodextrin hosts and other supramolecular devices.113–115 Due to the rich dynamic behaviour 
discovered in oligoureas derived from acyclic oligoethylenediamines, it was interesting to see if 
the properties translated to their cyclic analogues, where a cyclic hydrogen-bonding array could 
form.   
As an initial investigation into this, 1,4,7-triazacyclononane (TACN) was reacted with 4-
methoxyphenyl isocyanate to give the corresponding triurea 175 in reasonable yield. 175 was then 
studied by 1H NMR (Figure 86). 
 
 
Figure 86 – 1H NMR of 175 (CDCl3, 500 MHz). 
At 25 °C, triurea 175 showed signals at 3.06 (alkyl methines, 6 H), 3.95 (alkyl methines, 
3 H), 4.40 (alkyl methines, 3 H) and 7.84 ppm (ureido protons, 3 H). This spectrum showed that 
diastereotopicity has been revealed in the ethylene bridges, consistent with C3-symmetry, as four 
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broad signals can be observed (two of them overlapping, 3.06 ppm) in the alkyl region. These 
signals were attributed to four different methine environments in the ethylene bridges, and three 
identical ethylene bridges. There is one signal corresponding to the ureido protons (7.84 ppm), 
further validating the C3-symmetry, and suggesting that the ureido protons are each in hydrogen 
bonding. It is proposed that the diastereotopicity arises because each of the ureas orient 
themselves into a bowl shape in order to hydrogen bond in a cyclic manner. 175 was then 









Figure 87 – Depiction and X-ray crystal structure of 175. 
 The X-ray crystal structure of triurea 175 corroborates the supposition that the ureas 
hydrogen bond with each other by forming a bowl-like structure. This contradicted simulations 
carried out by Charbonnier which suggested TACN-derived triureas orient one ureido carbonyl 
into the cavity so the other two ureido protons can hydrogen bond to it.113 A similar conformation 
is adopted in CDCl3 solution, rationalising the observed diastereotopicity by 
1H NMR. This 
conformation is chiral due to the cyclic hydrogen-bonding array alone, representing an interesting 
opportunity for enantiospecific host-guest chemistry or enantioselective catalysis. In order to have 
any applicability in these areas, the cyclic hydrogen-bonding network must racemise at a rate 
slower than the timescale of chiral separation, and of the desired chiral function. To ascertain this, 
175 was studied by VTNMR (Figure 88). d8-Toluene was selected as the solvent due to its 




Figure 88 – VTNMR of 175 (d8-toluene, 500 MHz, 17 mM).  
 At 25 °C, triurea 175 showed signals at 1.90 (alkyl methines, 3 H), 2.09 (alkyl methines, 
3 H, obscured by C6D5CD2H), 3.39 (alkyl methines, 3 H, obscured by methoxy groups), 4.12 
(alkyl methines, 3 H) and 8.10 ppm (ureido protons). Upon heating, the signals at 1.90, 2.09, 3.39 
and 4.12 ppm all broadened until they could not be observed at 70 °C. These signals then 
coalesced into one singlet (12 H) at 80 °C, which sharpened with increasing temperature. The 
signal at 8.10 ppm shifted upfield with increasing temperature. These data showed that the 
enantiotopic conformers were in slow exchange on the NMR timescale at 25 °C. This 
racemisation rate increased with temperature until it was in fast exchange at temperatures above 
80 °C. The ureido protons signal also moved upfield with temperature as hydrogen bonding gets 
weaker at higher temperature.  
Triurea 175 was then subjected to Eyring analysis (under the assumption that each of the 
alkyl methines exchange with each other at the same rate), unveiling ΔG
‡
298 K (d8-toluene) = 65.3 
kJ mol-1 and t1/2 = 17 ms. Unfortunately, this racemisation rate is too fast to allow chiral separation 
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in toluene, so other solvents were screened. The same approximate coalescence temperatures were 
reached in CDCl3 and d6-benzene, but it was suspected that the hydrogen-bonding network could 
be strengthened in polar or hydrogen-bonding solvents. To investigate this, CD3OH was titrated 
into a solution of 175 in CDCl3 (Figure 89). 
 
Figure 89 – Titration of CD3OH into 175 (2.00-5.00 ppm region, CDCl3, 500 MHz). 
 The signals at 3.06 (alkyl methines, 6 H), 3.95 (alkyl methines, 3 H) and 4.40 ppm (alkyl 
methines, 3 H) all broadened upon addition of CD3OH, indicating that, in the presence of CD3OH, 
triurea 175 was brought closer to the fast exchange region. This showed that addition of hydrogen-
bonding solvents damaged the cyclic hydrogen-bonding network, lowering ΔG‡ . This was further 
corroborated as solutions of 175 in d6-DMSO and 50% v/v CDCl3/d4-methanol displayed only 
one signal corresponding to alkyl methines at 25 °C, showing that it was already in fast exchange. 
Subsequent efforts focused on derivatisation of the arenes of 175 in attempts to raise ΔG‡   (Scheme 
52).   
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Scheme 52 – Derivatisation of 175. 
 TACN was reacted with a variety of aryl isocyanates to liberate the corresponding triureas 
in variable yields. 4-Pyridyl isocyanate is unstable and so triurea 177 was made from 4-pyridyl 
phenyl carbamate, 176 in good yield. Unfortunately, 177 (4-pyridyl), 178 (4-
trifluoromethylphenyl) and 179 (4-cyanophenyl) were all insoluble in the desired non-hydrogen-
bonding solvents, but dissolved in d6-DMSO where the ureas did not adopt a cyclochiral 
conformation at 25 °C. However, 180 (4-chlorophenyl) and 181 (4-ethyl benzoate) were soluble 
in CDCl3 and d8-toluene, which allowed them to be studied by VTNMR and Eyring analysis (see 
Appendix, section 8.2). These analyses corresponded to ΔG
‡




298 K (d8-toluene) = 62.7 kJ mol
-1 for 181, indicating that alternate substitution on the 
arenes did not give rise to a significant change to ΔG‡  . Additionally, previous work by Clayden 
and co-workers has shown that alkyl triureas have much lower ΔG‡   values (49.5 kJ mol-1 for ethyl 
ureas), and are very sensitive to degree of substitution.* In order to deduce what could be done to 
raise ΔG‡  , the rate-determining step to racemisation had to be determined, so the correct 
parameters could be altered for racemisation inhibition (Scheme 53).   
 
Scheme 53 – Postulated mechanisms of racemisation of TACN-derived triureas. 
 Two mechanisms that result in racemisation are possible – (a) bowl inversion, where each 
of the ureas move onto the other side of the TACN with a concomitant bowl inversion of the 
TACN, and (b) directionality reversal, where each of the ureas undergoes a 180° C–N bond 
rotation, analogously to the acyclic oligoureas. These mechanisms bifurcate with the alkyl 
methines they exchange with. If directionality reversal was the rate-determining racemisation 
                                                   
* Work performed by BSc student Elliot Seward.  
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mechanism, then the alkyl methines would exchange with vicinal methines; if it were bowl 
inversion, then the alkyl methines would exchange with geminal methines. 
 Initially, the mechanistic elucidation was attempted by using variable-mixing time NOE 
experiments. The ureido protons were irradiated, and the time that passed before the spectrum 
was recorded was altered. If a proton is irradiated, it can exhibit an NOE correlation if another 
proton is proximate to it. However, if that proximate proton is exchanging with another in a 
dynamic process, then an NOE can be observed after it has exchanged, even if it is no longer 
proximate to the irradiated proton. The extent of this phenomenon depends on how long the NOE 
signal is built relative to the speed of the dynamic process. If the dynamic process is slow, the 
NOE correlation is shown between the irradiated proton and the proximate proton before the 
proximate proton can exchange and so one correlation is observed. If the dynamic process is fast, 
the proton is irradiated, and the proximate proton equilibrates before the spectrum is recorded, so 
NOEs are observed with each proton in exchange, even if they are not proximate to the irradiated 
proton. This experiment could potentially prove whether the bowl inversion mechanism operates. 
The half-life of triurea 175 at 25 °C is 28 ms, theoretically meaning that if the ureido protons are 
irradiated, they will only exhibit an NOE with the methines on top of the bowl if the spectrum 
was taken immediately. If the spectrum was recorded after 28 ms, then half of the methines on 
top of the bowl would have equilibrated, generating a 3:1 ratio of signals corresponding to 
methines on top and bottom of the bowl (if bowl inversion is the rate-determining mechanism). 
Unfortunately, the spectrum cannot be taken at this time as insufficient time has passed to allow 
spin relaxation to take place to generate a signal. NOEs were recorded after 50 ms (≈ two half-
lives) of mixing time but unfortunately, equal NOEs were observed with all alkyl methines. The 
same was observed when the NOEs were recorded at 0 °C. This result meant that racemisation 
occurs too quickly for mechanistic elucidation by NOE studies, so another method will have to 
be used.  
 Next, it was envisaged that mechanically locking the ureas together would prohibit both 
mechanisms and increase ΔG‡ . This was attempted by linking the ureas through an alkyl linker 




Scheme 54 – Synthesis of 186. 
 Trimethylolethane underwent a threefold tosylation to give tritosylate 182 in good yield. 
182 was then to undergo a threefold SN2 with benzylamine, but unfortunately, no conversion of 
182 occurred. Instead, threefold SN2 was performed with sodium azide to give 184, which was 
hydrogenated to the corresponding triamine in reasonable yield over two steps. Next, triamine 
185 was to form the tris(isocyanate) by reaction with triphosgene, but unfortunately, after 
formation of the first isocyanate, the other two amines cyclised to form the corresponding 
triazabicyclo[2.2.2]octanol. It was suspected that the same would occur if aryl carbamates were 
used instead of isocyanates, so a different strategy was sought. 
To prevent cyclisation of the other amines, a tris(isocyanate) scaffold used by Davis and 
co-workers was prepared (Scheme 55).31  
 
Scheme 55 – Synthesis of 190. 
 Threefold SN2 of 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene with trifluoroacetamide 
and NaH gave tris(trifluoroacetamide) 187 in good yield. The trifluoroacetamides were then 
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hydrolysed and the tris(isocyanate) was formed using triphosgene in excellent yield over two 
steps. TACN was added slowly to triisocyanate 189 at high dilution in an attempt to make triurea 
190, but unfortunately an insoluble precipitate formed which could not be characterised by mass 
spectrometry.* 
 A preliminary attempt was made to synthesise a tris(guanidine) analogue of 175 (Scheme 
56), where it was hoped that modification of the amphoteric functional group would result in a 
new family of cyclochiral TACN derivatives. Additionally, it was foreseen that protonation of 
one of the guanidines could be stabilised by proton transfer to the other two guanidines, 
effectively stabilising positive charge over nine nitrogen atoms. This could potentially render the 
tris(guanidine) a very powerful organic superbase, which could have chiral influence through 
appropriate substitution. 
 
Scheme 56 – Synthesis of 193. 
 Phenyl isothiocyanate was treated with methylammonium chloride and base to make N-
methyl-N’-phenyl thiourea quantitatively. Thiourea 191 was then reacted with methyl iodide to 
attain the methyl isothiourea, 192 in poor yield. 192 was then to act as an electrophilic source of 
guanidine by displacement of methanethiol. Unfortunately, heating an excess of 192 with TACN 
converted none of the isothiourea. Heating to 150 °C in a sealed tube under microwave irradiation 
saw decomposition of the isothiourea. Future work on the synthesis of tris(guanidines) will 
involve seeking alternate conditions or electrophilic sources of guanidine to effect the desired 
trisubstitution. 
 Next, cyclochirality was researched in the analogous tetramine, 1,4,7,10-
tetraazacyclododecane (cyclen). Cyclen was reacted with 4-methoxyphenyl isocyanate to give the 
                                                   
* Work performed by Giulia Marsico. 
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desired tetraurea, 194 in good yield. Unfortunately, no diastereotopicity was observed in 194 in 
CDCl3 or d6-benzene. The same feature was observed in analogous alkyl tetraureas.
* It was 
suspected that the cyclododecane was unable to adopt a conformation where the ureas hydrogen 
bond to each other in a cyclochiral fashion. It has been reported that alcohols can be used to form 
intermolecular bridging hydrogen bonds between the ureas in cyclen-derived tetraureas in the 
solid state.112 It was hoped that this could be used to induce cyclochirality, so CD3OH was titrated 
into a sample of tetraurea 194 in CDCl3. Unfortunately, this gave no change in 194, so a new 
scheme was envisaged where alcohols could be used to make bridging hydrogen bonds in an 
intramolecular manner (Scheme 57). 
 
Scheme 57 – Synthesis of 196. 
 Cyclen was reacted with methyl 2-isocyanatobenzoate to give the corresponding tetraurea 
195 in poor yield. The ethyl esters of 195 were then reduced to alcohols using LiBH4, yielding 
tetrol, 196 in good yield. Unfortunately, 196 was insoluble in CDCl3, d6-benzene and 
CDCl3/CD3OH mixtures. It was soluble in d6-DMSO but this displayed no chiral conformation. 
 Mechanical locking of the cyclen-derived tetraureas was then attempted by making a 
calix[4]arene, where the arenes were linked together by bridging methylenes (Scheme 58).  
                                                   




Scheme 58 – Synthesis of 198. 
 Calixarene synthesis is normally achieved by iterative electrophilic aromatic substitutions 
on aldehydes followed by condensation of water.116 Therefore, it was proposed that calix[4]arene, 
198 could be made from the corresponding tetrol, 197. Attempts at fourfold demethylation of 194 
using BBr3 saw decomposition of 194, presumably by reaction at the ureas. Instead, 194 was 
demethylated using HBr in AcOH, resulting in precipitation of several products which 
unfortunately could not be separated due to their lack of solubility. However, phenolic resonances 
were observed by 1H NMR, so the crude material was heated in toluene/H2O in an attempt to 
make the calix[4]arene. Unfortunately, this gave only insoluble products which could not be 
characterised by 1H NMR or mass spectrometry. It was assumed that polymerisation had occurred 
instead. 
 Finally, cyclochirality was preliminarily investigated in the hexamine, 1,4,7,10,13,16-
hexaazacyclooctadecane (hexacyclen) by reacting it with an excess of 4-methoxyphenyl 




Scheme 59 – Synthesis of 199. 




Figure 90 – 1H NMR of 199 (CD2Cl2, 400 MHz). 
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 Hexaurea 199 showed signals at 3.53 (alkyl methines, 12 H), 3.66 (alkyl methines, 12 H) 
and 8.72 ppm (ureido protons, 6 H). This spectrum showed that diastereotopicity had been 
revealed in the ethylene bridges, giving rise to two equal signals. It also indicated that each of the 
six ureas were in the same chemical environment, and that the ureido protons were in hydrogen 
bonding. The diastereotopicity gave rise to two signals as opposed to the four in triurea 175. 
Interestingly, hexaurea 199 could exist as one continuous cyclic hydrogen-bonding network (C6-
symmetry), or as two separate three-urea cyclic hydrogen-bonding networks (Figure 91). The 13C 
NMR and HSQC data indicates one environment for all of the methylenes, as opposed to two in 
triurea 175. 
 
Figure 91 – Possible conformations of 199. 
 Interestingly, in the proposed conformations (Figure 91, b and c), there are two sources 
of chirality, meaning that diastereomeric conformers could form of parallel and antiparallel 
hydrogen-bonding network alignments. In the parallel form, 199 is S6-symmetrical (rotational 
axis is the y axis), and in the antiparallel form, 199 is C2-symmetrical (rotational axis is the x 
axis). For all of the methylene carbons to be the same, directionality reversal must be fast on the 
NMR timescale, revealing bowl-inversion to be the mechanism of methine interconversion in 
these structures. Alkyl hexaureas did not exhibit this conformational phenomenon at 25 °C.* 
To summarise, a novel class of cyclochiral compounds derived from TACN have been 
discovered. These compounds are chiral due to the directionality of the hydrogen bonds in the 
cyclic hydrogen-bonding network and could be exploited as such. In order to access chiral 
function, the TACN-derived triureas were modified to raise the racemisation barrier and make it 
feasible to isolate enantioenriched triureas. Unfortunately, differing substitution on the arene saw 
                                                   
* Work performed by BSc student Elliot Seward.   
(a) (b) (c) 
176 
 
no appreciable change in barrier, and efforts to mechanically lock the ureas together were 
unfruitful. This conformational phenomenon was not observed in the analogous tetraurea but was 
alluded to in the hexaurea. Future work in this area will involve mechanistic elucidation of the 
racemisation of the TACN-derived triureas, and the result of this will be considered when making 
future analogues with greater barriers. When this informs new targets, the racemisation barriers 
will be ascertained and, if they are great enough, the triureas will be enantioenriched and applied 
in enantiospecific host-guest chemistry and asymmetric catalysis. The conformation of the 
hexaurea will be investigated further, and it is hoped that the same desirable functions can be 






















4.2 Cyclochirality in 2,2,5,5-Tetracarboxamidopyrrolidinyl Amino Acids 
 
Chirality in cyclic systems was first alluded to by Frisch and Wasserman, where they 
discuss the ‘enantiomorphism’ in Möbius strips and asymmetric catenanes.117 This was refined 
by Vögtle and co-workers through their work on the topological chirality of asymmetric 
rotaxanes.118,119 Since then, the term ‘cyclochiral’ has been used extensively to describe the 
unidirectional orientation of hydrogen bonds in resorcinarenes.120–123 Here, the unidirectionality 
of the hydrogen bonds derives from the helical chirality of the resorcinarene.  
Kawabata and co-workers have published seminal work on hydrogen-bonding catalysts 
that allow site-specific functionalisation of prochiral molecules.124 The 4-pyrrolidinopyridine 
(PPY) synthesised by the group was made to serve the same function, but it was discovered that 
it was in fact the first example of a compound that was chiral solely due to its cyclic hydrogen-
bonding array (Figure 92).125 
 
Figure 92 – Kawabata’s cyclochiral 4-pyrrolidinopyridines. 
 In this structure, the four amides on the pyrrolidine ring laid approximately coplanar to 
form a series of alternating 6- and 8-membered hydrogen-bonding rings in a cyclic hydrogen-
bonding array. The hydrogen bonds formed between the amides were so strong that two different 
sets of 1H NMR signals corresponding to the amido protons were observed at room temperature. 
Thus, the compound was chiral by virtue of the strength and orientation of its hydrogen-bonding 
array. Heating the compound caused the signals corresponding to the amide protons to coalesce 
into one signal. Subsequent line shape and Eyring plot analysis indicated that the racemisation 
barrier, ΔG
‡
298 K of the compound was 84 kJ mol
-1 where R = Ph. This high ΔG
‡
298 K corresponded 
to a half-life of over a week in hexane solution. Additionally, the enantiomers of the PPY could 
be separated by preparative chiral HPLC at 0 °C.  
 PPYs with a wide variety of amide substituents were synthesised, all showing similarly 
large ΔG‡298 K, with a maximum of 100 kJ mol
-1 when R = dicyclohexylmethyl. The amides were 
then synthesised with chiral substituents so that the conformers with opposite hydrogen-bond 
directionalities would be diastereomeric. The chiral group introduced was an (R)-1-(1-
naphthyl)ethyl group and in this case, the compound was present as a 73:27 mixture of 
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diastereomers. The pyridine of the PPY was then protonated using HCl, which interestingly 
resulted in an inversion of the equilibrium to 32:68. This cyclochiral PPY found use as a chiral 
nucleophilic catalyst found use in an acylative kinetic resolution of a chiral secondary alcohol. 
With a 10 mol% loading of the PPY, enantioselective acylation occurred with 59% e.e. and no 
racemisation of the catalyst.  
The following research was undertaken as part of a 3-month Young Researcher 
International Internship at the Institute for Chemical Research, Kyoto, Japan from September – 
December 2017. 
It was interesting to know whether this specific cyclochiral scaffold could lend itself to 
types of organocatalysis other than acylative kinetic resolution. The Iwasa group have previously 
shown that BINAP-derived catalysts with primary amine functions can be used in the asymmetric 
fluorination of aldehydes, furnishing trisubstituted aldehydes in high yield and enantioselectivity 
(Scheme 60).126 Asymmetric fluorination to give quaternary stereocentres is a highly desirable 
transformation due to the prevalence of quaternary fluorides in pharmaceuticals and due to their 
capacity for further synthetic elaboration.  
 
Scheme 60 – Asymmetric fluorination of aldehydes to give quaternary fluorides. 
 It was speculated that the cyclochiral pyrrolidine derivative of phenylalanine could be 




Scheme 61 – Retrosynthetic analysis of 200. 
 Target primary amine catalyst 200 was to be made by a method similar to what is typically 
used for the synthesis of PPYs in the Kawabata group.124 The tetramide was to be formed by 
tetraamidation of the corresponding tetraester, 210 which could be made by peptide coupling 
between phenylalanine and the secondary pyrrolidine, 204. 204 would be revealed by 
deprotection of N-benzylpyrrolidine, 203, which was to be made by dicarboxylation of 202. SN2 
and cyclisation of benzylamine would afford 202 from bis(bromo)diester, 201, which would be 
made by dibromination and methanolysis of adipoyl chloride. 
Firstly, adipoyl chloride underwent dibromination and subsequent methanolysis to yield 
the corresponding bis(bromo)diester 201, as a mixture of cis and trans diastereomers in good 
yield (Scheme 62). Benzylamine was then used in a twofold SN2 reaction to yield cis- and trans- 
N-benzylpyrrolidines in a 1:1.2 ratio. The diastereomers were then separated, and dicarboxylation 
of 202 to give the tetraester was attempted.  
 
Scheme 62 – Attempted synthesis of 204. 
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Initially, dicarboxylation of the pyrrolidine was attempted with potassium 
bis(trimethylsilyl)amide (KHMDS) and methyl cyanoformate. Unfortunately, this yielded only 
the triester, and so it was speculated that KHMDS was basic enough to deprotonate the pyrrolidine 
once, but not twice. The reaction was attempted again using lithium diisopropylamide (LDA) as 
the base, which gave the desired tetraester in 20% yield. The reaction was repeated using methyl 
chloroformate as the source of methyl ester and the yield was improved to 43%. Initial attempts 
to hydrogenolyse the benzyl group of the resultant N-benzyltetracarboxypyrrolidine, 203 using 
hydrogen with Pd/C gave no conversion of the starting material. More forcing reductions were 
attempted, such as using Pd(OH)2 in AcOH and Pd/C in MeOH at 5 bar pressure of hydrogen but 
these also proved unsuccessful. It was speculated that the bond to undergo cleavage may be too 
sterically encumbered by the proximate esters to be reduced. In order to circumvent this problem, 
an alternative route was proposed (Scheme 63).  
 
Scheme 63 – Synthesis of 204. 
 N-benzylpyrrolidine 202 was hydrogenated to give the corresponding secondary amine, 
and dicarboxylation was attempted, but unfortunately only carbamate formation at the 
pyrrolidinyl nitrogen was observed. From this, it was deduced that the pyrrolidinyl nitrogen 
needed to be protected with something other than a benzyl group. A Cbz group was used instead, 
so that the bond to be cleaved would be more remote from the steric bulk, allowing reduction to 
proceed.  
Pyrrolidine 205 was protected with CbzCl to give carbamate, 206. 206 then underwent 
dicarboxylation to give the corresponding tetraester in good yield,. Gratifyingly, the Cbz group 




Initial attempts to couple pyrrolidine 204 were performed in DCM using phenylalanine, 
HOBt/EDC and N-methylmorpholine (NMM) as base. Unfortunately, this gave no conversion, 
presumably due to poor solubility of the phenylalanine. The reaction was attempted again with 
the more soluble N-Boc-phenylalanine, but no reaction occurred, even under more forcing 
coupling conditions using HATU. It was speculated that this lack of reactivity could be attributed 
to steric bulk about the pyrrolidinyl nitrogen. It was hypothesised that steric encumbrance about 
the pyrrolidinyl nitrogen could be mitigated by preforming the cyclic hydrogen-bonding network 
as the amides should lie approximately coplanar in order to hydrogen bond, instead of protruding 
towards the pyrrolidinyl nitrogen (Scheme 64). Additionally, this route would avoid the use of 
strong base after coupling to the amino acid, thereby lowering epimerisation risk. 
 
Scheme 64 – Synthesis of 200. 
Tetraamidation of tetraester 204 was achieved in poor yield by treatment with sodium 
hydride and aniline. Use of N-Boc-phenylalanine, HOBt, EDC and NMM gave no conversion of 
208 to the desired peptide, but fortunately, treatment with HATU and TEA afforded the desired 
product, 209 in 17% yield. The Boc group was cleaved with HCl in EtOAc to give the target 







Figure 93 – 1H NMR of 200 in (CDCl3, 300 MHz). 
 Tetramide 200 showed signals at 8.28 (amido proton, 0.5 H), 8.30 (amido proton, 0.5 H), 
8.44 (amido proton, 1 H), 9.15 (amido proton, 1 H) and 9.34 ppm (amido proton, 1 H). The 
spectrum showed eight different signals corresponding to the amido protons. Three pairs of these 
amido proton signals came at the same chemical shift, but one pair (8.28 and 8.30 ppm) displayed 
observable anisochronicity. This phenomenon can be explained through consideration of the 
different exchange processes active in the molecule (Figure 94).  
 
Figure 94 – Dynamic processes in 200 (viewing the top of the pyrrolidine). 
The cyclic hydrogen-bonding network is exchanging between its two directionalities 
slowly on the NMR timescale at 20 °C. This means that the amido protons in adjacent amides are 
chemically different as one pair of them are in 6-membered hydrogen-bonding rings, and the other 
in 8-membered hydrogen-bonding rings. Also, the peptide bond is rotameric, meaning that at 20 
°C, one of the amido protons in a 6-membered ring is proximate to an amido carbonyl, and the 
other is proximate to the amino acid residue. Finally, due to the chiral centre in the amino acid, 
one of the amido protons in an 8-membered hydrogen-bonding ring is adjacent to an amine, and 
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the other adjacent to a methine, making them also chemically inequivalent. Each of the four amido 
protons in 200 are chemically distinct from each other due to the chiral centre in the amino acid 
and the rotameric peptide bond. Each of these four different amido protons corresponded to two 
different signals in the 1H NMR spectrum because the cyclic hydrogen-bonding network gives 
rise to two diastereomeric conformers that are in slow exchange on the NMR timescale. The 
diastereomeric conformers appeared to be present in a 50:50 ratio. Finally, 200 was studied by 
VTNMR (Figure 95). 
 
 
Figure 95 – VTNMR of 200 (600 MHz in d6-DMSO, 14 mM). 
 At 25 °C, signals were observed at 10.04 (amido proton, 1 H), 10.08 (amido proton, 1 H), 
10.25 (amido proton, 1 H) and 10.27 ppm (amido proton, 1 H). Upon heating, each of the signals 
moved significantly upfield and broadened. At 100 °C, the signals at 9.74 ppm coalesced, and 









tetramide 200 exists as two diastereomeric conformations that are in slow exchange at 25 °C in 
d6-DMSO, and enter fast exchange between 125 and 150 °C. Interestingly, each of the amido 
proton signals occurred much more downfield than they did in CDCl3, indicating that the d6-
DMSO can hydrogen bond to the amido protons when they are phenyl amides. This experiment 
also showed that the incorporation of an amino acid was not detrimental to the robustness of the 
cyclic hydrogen-bonding network, implying its potential utility in asymmetric catalysis. 200 was 
then trialled in the organocatalytic asymmetric fluorination of 2-phenylpropionaldehyde using N-
fluorobenzenesulfonimide (NFSI) (Table 3). 
Table 3 – Attempted asymmetric fluorination of 2-phenylpropionaldehyde. 
 
Entry Solvent Additive Yield 
1 THF None NR 
2 Toluene None NR 
3 Toluene 3,5-dinitrobenzoic acid Trace conversion 
 
 For entries 1 and 2, where no additive was employed, only non-fluorinated, reduced 
substrate was isolated. However, when 3,5-dinitrobenzoic acid was added, a trace amount of an 
alternative compound was isolated in trace amounts, but its structure could not be elucidated. In 
other examples of asymmetric fluorination, much longer reaction times were required, which 
could explain the initial lack of conversion.126 
 To conclude, the desired cyclochiral amino acid was successfully synthesised and its 
dynamics investigated in different solvents and by VTNMR. These studies showed that the cyclic 
hydrogen-bonding network can be appended with peptide bonds and primary amine functions and 
still exhibit cyclochirality. Preliminary investigations into the use of the amino acid derivative in 
asymmetric catalysis were performed, but this proved unfruitful. However, it is hoped that further 
investigation may show the utility of cyclochiral amino acids in organocatalysis. Once this has 
been demonstrated, the ability of the cyclic hydrogen-bonding network alone to effect asymmetric 






 In conclusion, ethylene-bridged oligoureas, a novel class of foldamers with the exotic 
property of reversible hydrogen-bond directionality, have been extensively investigated. These 
foldamers are conformationally mobile, yet each of the ureas in the foldamer adopts the same 
orientation to form hydrogen bonds, resulting in conformational homogeneity. This directional 
ubiquity was found to be thermodynamically insensitive to the presence of hydrogen-bonding 
cosolvents and additives and is highly tolerant of intramolecular hydrogen-bonding functions. 
Strong HBDs and HBAs were used to induce directionality in the urea adjacent to it, which was 
then propagated throughout the foldamer up to six ureas, without any evidence of communication 
decay. 
 Basic and acidic functions were appended to the foldamers, bestowing directional 
switchability to the foldamers (Figure 96). These foldamers responded to external stimuli, such 
as pH change and the presence of anions or hydrogen-bond-accepting additives by 
communicating these stimuli as binary information through the oligourea scaffold. The 
information was reliably reported by use of a fluorescent spectroscopic reporter, which was 
sensitive to intramolecular hydrogen bonding at millimolar concentrations. Preliminary 
investigations have also shown that directional switching may be possible in a temporally 
selective manner using light.  
 
Figure 96 – Ethylene-bridged oligoureas in informational communication. 
 This novel family of foldamers represents a significant simplification of how biological 
systems store, communicate and process information. Nature uses hydrogen-bond directionality 
as a conduit to reliably communicate information in different states, which results in a plethora 
of specific functions. If ethylene-bridged oligoureas can be used to replicate this phenomenon 
reliably and without erosion of efficacy, they could be used to perform biomimetic and novel 
functions. Then, if appended with the appropriate functionality for highly specific binding, they 
would be able to be delivered where required and undertake those functions in a nanomechanical 




  Ethylene-bridged oligoureas can also be made cyclic. These cyclic triureas adopt a chiral 
conformation due to hydrogen-bonding interactions, bestowing the property of cyclochirality to 
them (Figure 97). Several derivatives of the cyclochiral scaffold were synthesised and were 
revealed to have racemisation barriers of 62-65 kJ mol-1. Whilst this renders the scaffold amenable 
to dynamic enantioenrichment, it was desirable to raise this barrier so enantioenriched oligoureas 
could be used for asymmetric organocatalysis or enantiospecific host-guest chemistry. 








Figure 97 – Cyclochirality in tris(ureido)triazacyclononanes. 
 The mechanism of racemisation is to inform the appropriate functionalisation that would 
augment the racemisation barrier. Preliminary investigations have been made and compounds that 
could elucidate the mechanism have been proposed. Finally, this conformational phenomenon 





X-ray crystal structure 
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6.0 Future Work 
 
Research in this project has shown the robustness of ethylene-bridged oligoureas through 
the efficacy of its communication and the ease of its informational input. However, there has not 
yet been investigation into functions that could be attained. In principle, there is a vast space to 
be explored from the selective introduction of a strong HBD or HBA remote from its 
informational source. Preliminary investigations into this will involve the activation/deactivation 
of a catalyst or reactive substrate, and selective ion binding (Figure 98). 
 
Figure 98 – Chemical functions to be explored in ethylene-bridged oligoureas. 
 Liberation of a thiourea HBD could reveal a N,N’-disubstituted thiourea organocatalyst, 
which are known to catalyse a wide range of synthetically useful reactions in an enantioselective 
manner. Reporting N,N’-disubstituted thioureas have not been investigated at this point, so initial 
work here would involve making directionality-controlled molecules that could switch between 
both directionalities of the reporting thiourea. N,N’-disubstituted thioureas and alkyl thioureas are 
much stronger HBAs than aryl trisubstituted thioureas, so it is hoped that the directionality where 
the thiourea acts as an HBA could be selected and then used for hydrogen-bonding catalysis by 
judicious use of the directional controller.  
 Fluorimetry studies using DTM reporters and fault induction studies using succinimides 
have already shown that imides can be used to terminate the foldamers, without disrupting the 
hydrogen-bonding fidelity. This could be exploited by selecting a urea HBD to hydrogen bond to 
an imide, activating it to reactions such as Diels-Alder cycloadditions or Michael additions. This 
could also be performed stereoselectively by appendage of chiral groups on the neighbouring 
188 
 
ethylene bridge. Finally, selection of a urea HBD could fill the binding site of a pendent cryptand, 
where subsequent switching to a urea HBA could open the cryptand and allow cation binding to 
occur. More exotic function could involve the design of a nanometre-range cargo transporter 
(Figure 99). 
 
Figure 99 – Proposed nanometre-range cargo transporter. 
 In one imposed directionality, the hydroxypropyl ureas are too far away from the thioester 
to be acylated by it. Upon directional switching, the hydroxypropyl group is brought closer to the 
thioester, allowing acyl transfer to occur. The acyl group is then transferred stepwise between the 
different alcohols in a random fashion until eventually it is irreversibly captured by the 
aminopropyl urea. This forms an amide bond, which acts as a thermodynamic sink, and is also 
kinetically stable to the alcohol, making it the end destination for the acyl group. 
 Upon furnishing the foldamers with desirable function, analogous molecules that can 
communicate and perform function over greater distances can be made using the established 
methodology. This methodology could be extended to larger fragments to access foldamers that 
can communicate information over even greater distances. Other switching stimuli could be 
investigated, such as redox/electrochemical manipulations of a quinone HBA / hydroquinone 
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HBD. Finally, future work will involve derivatisation of the ureido arenes to confer water- and 
membrane-solubility to the oligoureas. This will bestow greater applicability to the scaffold as 
appropriate physiological conditions could be simulated, ultimately resulting in transmembrane 
communication and cellular function. 
It would be desirable to synthesise and study oligoureas analogous to bis(pyridine) 174 
with more ureas in the centre, where the 2-pyridyl ureas will compete to hydrogen bond to the 
central ureas (Figure 100). 
 
Figure 100 – Dynamics of bis(2-pyridyl urea) oligoureas, 211 and 212. 
 It is suspected that much like tetraurea 161 and bis(pyridine) 162, the 2-pyridyl ureas in 
bis(pyridine) 171 will induce some degree of hydrogen-bonding fault in the centre of the 
oligourea. 2D VTNMR will reveal the ratio of the conformers in this case. It is envisaged that 
isotopic labelling and analysis by 2D NMR are necessary due to the congestion of signals in the 
relevant region. As the directionality-controlling groups are the same in triurea 211 and tetraurea 
212, the ratio of conformers should be the same, unless introduction of another urea to the 
foldamer results in a change of hydrogen-bond strength. This experiment would serve to 
determine the presence and degree of hydrogen-bond cooperativity in ethylene-bridged 
oligoureas. Finally, hexaurea 213 would be of sufficient length to permit the presence of three 
different faults (Figure 101). Analysis of this would reveal the preference or lack thereof for 
hydrogen-bonding faults to be closer or farther from the source of directional control. It is 
suspected that identification of the two unsymmetrical conformers by would be very challenging, 
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but determination of the conformer ratio would be pertinent to the investigation into multiple 
possible faults and hydrogen-bond cooperativity. 
 
Figure 101 – Dynamics of 213. 
 Cockroft and co-workers investigated the use of rotameric formamides for the 
quantification of hydrogen-bond cooperativity.29 Whilst experiments in this project have indicated 
a lack of hydrogen-bond cooperativity in ethylene-bridged oligoureas from a kinetic standpoint, 
these formamides could be used to give evidence for hydrogen-bond cooperativity using 




Figure 102 – Hydrogen-bond cooperativity balances for ethylene-bridged oligoureas. 
 The formamide can hydrogen bond to two different ureas. These two ureas are identical, 
except one of them is hydrogen bonding to another urea, isolating the thermodynamic 
connotations of hydrogen-bond cooperativity in these structures. K can be easily deduced by 
NMR and converted to a value for ΔG‡  , which will correspond to the energy gain from hydrogen-
bond cooperativity. An analogous compound can be made with one urea on one side and three 
ureas on the other, and this could also be used to quantify the effects of upon further urea 
extension. This is also not limited to investigating hydrogen-bond cooperativity – this tool could 
be used to pit different HBDs with different ring sizes against each other, and the observed K can 




 In the area of cyclochirality, the racemisation mechanism of TACN-derived triureas could 
be elucidated by appropriate substitution on the TACN (Figure 103).  
 
Figure 103 – Substrates for mechanistic elucidation of TACN-derived triurea racemisation. 
 Spirocycle 214 has a spirocyclic cyclohexane on one of the ethylene bridges of the 
TACN. This allows isolation of two of the vicinal methines, where they will equilibrate as normal 
if the bowl inversion is the rate-determining mechanism. Similarly, bicycle 215 bears a cis-fused 
cyclohexane on one of the ethylene bridges, isolating two of the vicinal methines and allowing 
equilibration as normal if directionality reversal is the operating mechanism. It is assumed that 
cyclohexane ring-flipping will occur quickly relative to racemisation, allowing facile analysis. 
Bicycle 216 has a trans-fused cyclohexane, where only the operation of both mechanisms would 
allow interconversion of the methines, meaning that the barrier to racemisation would match that 
of spirocycle 214 or bicycle 215 depending on which mechanism was rate-determining. It is 
noteworthy that (a) bowl inversion is associated with a cyclohexane ring flip into a 1,2-diaxial 
relationship of the ureas, which may be rate-limiting and (b) the chirality of the trans-fused 
cyclohexane may give rise to diastereomeric cyclic hydrogen-bonding networks. Finally, bicycle 
217 has a cis-fused piperidine (Figure 103, diequatorial conformation depicted), where linking 
across one of the ureas will block bowl inversion of that urea and therefore force directionality 
reversal to operate. If ΔG‡ significantly decreases in this case, bowl inversion is the rate-






Mechanistic elucidation will inform methods to raise the barrier and allow isolation of 
enantioenriched cyclochiral compounds. Those compounds will then be trialled in asymmetric 
organocatalysis and enantiospecific host-guest chemistry. The same will apply to the hexacyclen-
derived hexaureas, which will have different properties as the size of the cavitand will be different. 
 At this point, the only cyclochiral compounds isolated racemise quickly. This renders 
them a chiral cavitand that can potentially undergo dynamic enantioenrichment (Figure 104).  
 
Figure 104 – Dynamic enantioenrichment of TACN-derived triureas. 
 For example, if the cavitand was appended with basic pyridines, a chiral acid, such as L-
tartaric acid, could bind to it and permit a dynamic enantioenrichment of the cyclic hydrogen-
bonding network. This makes the cavitand chiral with a fixed directionality, where one 
enantiomer of a desired guest could be captured, while the other would be enantioenriched and 
uncomplexed in the solution. This allows dynamic enantioenrichment of a racemic guest which 
doesn’t interact with the original chiral input (the acid) but is of the correct size and geometry to 






7.1 General Information 
 
Where specified, procedures were performed using dried solvents and reagents under an 
atmosphere of nitrogen with glassware dried by flame-drying. Air and moisture-sensitive 
liquids/solutions were transferred to reaction vessels by syringe under an atmosphere of nitrogen. 
Anhydrous DCM, THF, MeCN, Et2O and toluene were dried using an anhydrous Engineering 
Grubbs-type solvent system. All other solvents and reagents were purchased from commercial 
suppliers and were used without further purification unless otherwise specified. Agitation was 
achieved using Teflon coated stirrer bars by magnetic induction. All thin layer chromatography 
(TLC) experiments were conducted on pre-coated plastic plates (Macherey-Nagel polygram SIL 
G/UV254) and visualised using ultraviolet light (254 nm) or staining. TLC eluents are reported in 
solvent:solvent v/v ratios. Irradiation was achieved using Thorlabs mounted high-power LEDs of 
the appropriate wavelength, mounted onto a Thorlabs LED driver DC4100. Flash 
chromatography was performed manually using Sigma Aldrich silica gel 60 (40-63 mM) or on an 
automated Biotage IsoleraTM Spektra Four using gradient elution on pre-packed silica gel 
Biotage® SNAP Ultra or ZIP Sphere columns. All melting point experiments were performed 
using a Stuart SMP10 Melting Point Apparatus upon recrystallisation from the specified 
solvent(s). All low-temperature VTNMR experiments were conducted using a JEOL ECS 300 
spectrometer (300 MHz) or a Bruker AVANCE III HD 500 MHz NMR Spectrometer with 5 mm 
DCH 13C–1H/D Cryo Probe (500 MHz). All high-temperature VTNMR experiments were 
conducted using a Varian VNMRS 500 MHz Direct Drive Spectrometer with Agilent OneNMR probe 
(500 MHz). All room temperature NMR experiments were conducted using a Bruker Nano 400 
Spectrometer (400 MHz) or a Bruker AVANCE III HD 500 MHz NMR Spectrometer with 5 mm 
DCH 13C–1H/D Cryo Probe (500 MHz), with chemical shifts reported (δ in ppm) relative to the 
specified deuterated solvent. All 19F NMR spectra are referenced relative to an internal standard 
(α,α,α-trifluorotoluene). All NMR characterisation experiments were performed at 25 °C and 1 
atm unless otherwise specified. Multiplicity is reported as follows – s = singlet, d = doublet, t = 
triplet, q = quartet. All spin-spin coupling constants (J) are reported in hertz (Hz) to the nearest 
0.1 Hz. When signal congestion precludes analysis of multiplicity, they are reported as m = 
multiplets. Signals of rotameric species are denoted as ‘rot.’. All reported signals in 13C NMR 
spectra are singlets unless otherwise specified. High resolution mass spectrometry experiments 
(HR-MS) were performed on a Bruker micrOTOF Spectrometer using electrospray ionisation, 
positive ion mode or a Bruker Ultraflex using MALDI with only molecular ion ([M+H]+ or 
[M+Na]+) peaks being reported. Fourier transform infrared spectroscopy (FTIR) experiments 
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were performed using a PerkinElmer Spectrum Two FTIR Spectrometer. All absorbances are 
reported in cm-1. Fluorescence spectra were recorded using a PerkinElmer LS45 fluorimeter in a 
Marco Fluorescence Quartz Cuvette. Recrystallisation for X-ray crystallography was achieved by 
slow evaporation of a precipitant into a solution containing the desired compound. Analysis was 





7.2 General Procedures 
 
General procedure A – Palladium-catalysed hydrogenative reductive amination 
Under a dry, inert atmosphere, a round-bottomed flask was charged with a solution of amine (1.00 
equiv., 0.10 M) in anhydrous MeOH. To this solution was added aldehyde (1.08 equiv.) and 
palladium on carbon (10% wt., 10 mol%). The flask was equipped with a three-way tap with a 
hydrogen-filled balloon attached. The flask was evacuated and refilled with nitrogen three times, 
then evacuated and refilled with hydrogen. The black suspension was left to stir for 16 h. The 
black suspension was filtered through celite and washed with MeOH. The filtrate was then 
concentrated in vacuo to give the crude secondary amine. 
 
General procedure B1 – (Thio)urea formation by (thio)carboxamidation of amines using 
iso(thio)cyanates. 
Under a dry, inert atmosphere, a solution of secondary amine (1.00 equiv., 0.10 M) in anhydrous 
DCM was cooled to 0 °C. To this solution was added iso(thio)cyanate (1.50 equiv. per amine) 
dropwise/over three portions. The resulting solution was stirred for 16 h and concentrated in vacuo 
to give the crude (thio)urea. 
 
General procedure B2 – Urea formation by carboxamidation of amines using carbamoyl 
chlorides or phenyl carbamates. 
Under a dry, inert atmosphere, a solution of secondary amine (1.00 equiv., 0.10 M) in anhydrous 
DCM was cooled to 0 °C. To this solution was added carbamoyl chloride or phenyl carbamate 
(1.50 equiv. per amine) dropwise/over three portions. Triethylamine (1.50 equiv. per amine) was 
added and the resulting solution warmed to room temperature and stirred for 16 h. The solution 
was concentrated in vacuo to give the crude urea. 
 
General procedure C – Boc-deprotection of amines using TFA 
Under a dry, inert atmosphere, TFA (20% v/v) was added dropwise to a solution of Boc-protected 
amine (1.00 equiv., 0.10 M) in anhydrous DCM (80% v/v). The solution was stirred for 16 h and 
concentrated in vacuo. The crude product was diluted with saturated aqueous NaHCO3 and the 
aqueous phase was extracted with DCM three times. The combined organic extracts were washed 
with brine, dried (MgSO4), filtered and concentrated in vacuo to give the crude amine. 
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General procedure D – Michael addition of amines with acrylonitrile 
Under a dry, inert atmosphere, a solution of amine (1.00 equiv., 0.10 M) in anhydrous MeOH was 
prepared. To this solution was added acrylonitrile (1.50 equiv.) in one portion. The solution was 
stirred for 16 h and concentrated in vacuo to give the title nitrile. 
 
General procedure E – Reductive amination by one-pot condensation/NaBH4 reduction 
Under a dry, inert atmosphere, aldehyde (1.50 equiv. per amine) was added to a solution of 
primary amine (1.00 equiv., 0.10 M) in anhydrous MeOH. The resulting solution was stirred for 
16 h. The solution was cooled to 0 °C and sodium borohydride (3.00 equiv. per amine) was added 
in one portion. The resulting white suspension was warmed to room temperature, stirred for 3 h 
and concentrated in vacuo. The residue was then diluted with MeOH and concentrated in vacuo. 
The crude product was diluted with deionised water and the aqueous solution was extracted with 
DCM three times. The combined organic extracts were washed with brine, dried (MgSO4), filtered 
and concentrated in vacuo to give the crude secondary amine. 
 
General procedure F – Chemoselective Boc-protection of secondary amines by 
trifluoroacetylation, carboxylation and hydrolysis. 
Under a dry, inert atmosphere, a solution of amine (1.00 equiv, 1.60 M) in anhydrous DCM was 
cooled to 0 °C. To the solution was added ethyl trifluoroacetate (1.10 equiv.) dropwise over 30 
minutes and the resultant solution was stirred for 30 minutes. The solution was warmed to room 
temperature and stirred for a further hour. The solution was then diluted with anhydrous DCM 
(10 mL mmol-1) and cooled to 0 °C. A solution of di-tert-butyl dicarbonate (1.20 equiv. per amine, 
2.00 M) in anhydrous DCM was added over three portions followed by anhydrous TEA (1.00 
equiv. per amine) in one portion. The resulting solution was stirred for 16 h and diluted with 
saturated aqueous NaHCO3. The organic phase was washed with deionised water, dried (MgSO4), 
filtered and concentrated in vacuo. The crude yellow oil (0.20 M) was dissolved in methanol and 
a solution of aqueous NaOH (7.30 equiv., 4.20 M) was added. The resulting colourless solution 
was stirred for 5 h and concentrated in vacuo. The crude product was dissolved in deionised water 
and the aqueous phase was extracted with DCM four times. The combined organic extracts were 






General procedure G – Oxidation of primary alcohols using DMP 
To a solution of alcohol (1.00 equiv, 0.10 M) in DCM was added DMP (1.20 equiv.) at 0 °C. The 
resulting white suspension was stirred for 16 h at room temperature. Saturated aqueous NaHCO3 
and saturated aqueous Na2S2O3 were added and the mixture was stirred for 30 minutes. The 
organic phase was washed with saturated aqueous NaHCO3, dried (MgSO4), filtered and 
concentrated in vacuo to yield the title aldehyde. 
 
General procedure H – Hydrolysis of trifluoroacetamides 
To a solution of trifluoroacetamide (1.00 equiv., 0.10 M) was added a solution of aqueous NaOH 
(7.30 equiv., 4.20 M). The resulting colourless solution was stirred for 5 h and concentrated in 
vacuo. The crude product was dissolved in deionised water and the aqueous phase was extracted 
with DCM three times. The combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo to give the crude primary amine. 
 
General procedure I – Succinimidation of amines by in situ activation with acetyl chloride 
Under a dry inert, atmosphere, succinic anhydride (1.00 equiv. per amine) was added in one 
portion to a solution of amine (1.00 equiv., 0.10 M) in anhydrous DCM. TEA (1.00 equiv. per 
amine) was added and the solution was heated to reflux for 16 h. The solution was cooled to 0 °C 
and acetyl chloride (2.00 equiv. per amine) was added dropwise and the solution was stirred at 
room temperature for a further 3 h. The resulting solution was concentrated in vacuo and the crude 
product was diluted in saturated aqueous NaHCO3. The aqueous solution was extracted with 
DCM three times and the combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo to give the crude succinimide.  
 
General procedure J – One-pot trifluoroacetylation/carboxamidation of 
oligoethylenediamines  
Under a dry, inert atmosphere, a solution of amine (1.00 equiv, 1.60 M) in anhydrous DCM was 
cooled to 0 °C. Ethyl trifluoroacetate (1.10 equiv. per primary amine) was added dropwise over 
30 minutes and the resulting solution was stirred for 30 minutes at 0 °C. The resulting solution 
was warmed to room temperature and stirred for a further hour. The solution was diluted with 
DCM (10 mL mmol-1) cooled to 0 °C. To this solution was added isocyanate (1.50 equiv. per 
secondary amine) and the resulting solution was stirred for 16 h to give the crude urea.  
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General procedure K – Boc-protection of amines 
To a solution of amine (1.00 equiv. 0.25 M) in DCM was added a solution of aqueous NaOH (1.00 
M, 4 mL mmol-1). The mixture was cooled to 0 °C and a solution of di-tert-butyl dicarbonate (1.00 
equiv., 0.25 M) in DCM was added over three portions. The resulting mixture was stirred for 16 
h and the aqueous phase was extracted with DCM three times. The combined organic extracts 
were washed with deionised water twice, dried (MgSO4), filtered and concentrated in vacuo to 
give the crude carbamate.  
 
General procedure L – Swern oxidation of primary alcohols 
Under a dry, inert atmosphere, a solution of anhydrous DMSO (3.00 equiv, 0.40 M) in anhydrous 
DCM was cooled to −78 °C. To this solution was added a solution of oxalyl chloride (1.50 equiv., 
2.00 M) in anhydrous DCM dropwise. The resulting solution was stirred for 20 minutes, and a 
solution of alcohol (1.00 equiv., 0.80 M) in anhydrous DCM was added dropwise. The resulting 
solution was stirred for 2 h at −78 °C and anhydrous TEA (9.00 equiv.) was added dropwise to 
give a white suspension. The suspension was warmed to 0 °C and stirred for 30 minutes. The 
reaction was quenched with aqueous citric acid (10% w/w., 10 mL mmol-1). The mixture was 
stirred for 15 minutes at 0 °C and warmed to room temperature. The aqueous phase was then 
extracted with DCM three times, and the combined organic extracts washed with aqueous citric 
acid (10% w/w), deionised water, saturated aqueous Na2CO3 and brine. The combined organic 
extracts were then dried (MgSO4), filtered and concentrated in vacuo to give the crude aldehyde. 
 
General Procedure M – Pyridylation of amines by nucleophilic aromatic substitution 
Under a dry, inert atmosphere, 2-fluoropyridine (1.00 equiv.) was added to amine (10.00 equiv.) 
and the resulting solution was heated to 120 °C and stirred for 16 h. The solution was cooled to 
room temperature, diluted with EtOAc and washed with deionised water three times. The organic 









General procedure N – Johnson-Lemieux oxidation of N-allyl carbamates/maleimides 
Under an inert atmosphere, a solution of allyl carbamate/maleimide (1.00 equiv., 0.10 M) in 
dioxane:water (3:1) was prepared. To this solution was added sodium periodate (4.00 equiv.), 2,6-
lutidine (2.00 equiv.) and osmium tetroxide (4% wt. in water, 10 mol%). The solution was stirred 
for 4 h and quenched with saturated aqueous Na2S2O3. After stirring for 30 minutes, the solution 
was diluted with EtOAc and the organic phase was washed with saturated aqueous Na2S2O3 and 
brine. The organic phase was dried (MgSO4), filtered and concentrated in vacuo to give the crude 
aldehyde. 
 
General procedure O – Fischer indole reaction to make 3H-indoles 
Under a dry, inert atmosphere, a solution of arylhydrazine hydrochloride (1.00 equiv, 1.00 M) in 
AcOH was prepared. To this solution was added ketone (1.20 equiv.) and the solution was heated 
to 100 °C and stirred for 3 h. The solution was cooled to room temperature and filtered. The 
filtrate was then diluted in DCM and poured onto deionised water. The organic phase was then 
washed with brine, dried (MgSO4), filtered and concentrated in vacuo to give the title 3H-indole. 
 
General procedure P – 3-Sulfonylpropylation of 3H-indoles by SN2 reaction with 1,3-
propanesultone 
Under a dry, inert atmosphere, a solution of 3H-indole (1.00 equiv., 0.50 M) in anhydrous 1,2-
DCB was prepared. To this solution was added 1,3-propanesultone (1.10 equiv.) and the solution 
was heated to 120 °C and stirred for 16 h. The solution was cooled to room temperature and 
recrystallised from cold Et2O. The brown suspension was filtered and the residue was washed 
with Et2O and air-dried to give the title indolium sulfonate. 
 
General procedure Q – Pseudo-aldol condensation of 3H-indoles with salicylaldehydes 
Under a dry, inert atmosphere, a solution of indolium sulfonate (1.00 equiv., 0.10 M) in anhydrous 
EtOH was prepared. To this solution was added salicylaldehyde (1.10 equiv.) and the solution 
was heated to reflux and stirred for 16 h. The solution was cooled to room temperature and 





General procedure R – Reductive amination with 2-maleimidoacetaldehydes and 
subsequent carboxamidation with isocyanates 
Under a dry, inert atmosphere, a solution of primary amine (1.00 equiv., 0.10 M) in anhydrous 
DCM was prepared. To this solution was added aldehyde (1.10 equiv.) and NaB(OAc)3H (1.50 
equiv.) in one portion. The resulting solution was stirred at room temperature for 16 h. The 
solution was quenched with saturated aqueous NaHCO3 and the aqueous phase was extracted with 
DCM three times. The combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated in vacuo to give the crude secondary amine. Under a dry, inert atmosphere, the 
crude product (1.00 equiv. 0.10 M) was then dissolved in anhydrous DCM and cooled to 0 °C. To 
this solution was added isocyanate (2.00 equiv.) and the resulting solution was stirred for 16 h. 
The solution was concentrated in vacuo to give the crude urea. 
 
General procedure S – Hydrogenative cleavage of benzyl groups 
Under a dry, inert atmosphere, a round-bottomed flask was charged with a solution of benzyl-
protected compound (1.00 equiv., 0.10 M) in anhydrous MeOH. To this solution was added 
palladium on carbon (10% wt., 10 mol%). The flask was equipped with a three-way tap with a 
hydrogen-filled balloon attached. The flask was evacuated and refilled with nitrogen three times, 
then evacuated and refilled with hydrogen. The black suspension was left to stir for 16 h. The 
black suspension was filtered through celite and washed with MeOH.  The filtrate was the 




7.3 Experimental Procedures 
 
1-Phenyl-7-(tert-butoxycarbonyl)-1,4,7-triazaheptane, 28  
Synthesised according to literature procedure A using N-
phenylethylenediamine (0.50 mL, 3.80 mmol) and N-Boc-2-
aminoacetaldehyde (653 mg, 4.10 mmol). The title carbamate was isolated as a colourless oil (727 
mg, 2.62 mmol, 69%). TLC – Rf = 0.31 (SiO2, 90:10:1 EtOAc:MeOH:TEA). ). 
1
H NMR (400 
MHz, CDCl3) δH 1.45 (s, 9H, C(CH3)3), 2.75 (t, J = 5.9, NCH2), 2.89 (t, J = 6.0, 2H, NCH2), 3.22 
(q, J = 5.4, 2H, NCH2), 6.64 (d, J = 8.5, 2H, 2 x ArH), 6.71 (tt, J = 1.0, 7.3, ArH), 7.18 (dd, J = 




Synthesised according to general procedure B1 using 28 (626 
mg, 2.24 mmol) and 4-methoxyphenyl isocyanate (0.87 mL, 
6.72 mmol). The crude product was purified by column 
chromatography (12-100% EtOAc:PE) to yield the title diurea 
as a foamy white solid (686 mg, 1.19 mmol, 53%). M.P. 80-
81 °C (CHCl3). TLC – Rf = 0.19 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.40 
(s, 9H, C(CH3)3), 3.26 (q, J = 5.7, NCH2), 3.44 (t, J = 6.1, 2H, NCH2), 3.65 (t, J = 5.7, 2H, NCH2), 
3.77 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.82 (t, J = 6.1, 2H, NCH2), 5.14 (t, J = 5.7, 1H, NH), 
6.15 (s, 1H, NH), 6.81 (d, J = 8.9, 2H, 2 x ArH), 6.83 (d, J = 8.9, 2H, 2 x ArH), 7.19 (d, J = 8.9, 
2H, 2 x ArH), 7.31 (d, J = 7.6, 2H, 2 x ArH), 7.41 (t, J = 7.6, 1H, ArH), 7.50 (t, J = 7.6, 2H, ArH), 
7.55 (d, J = 8.9, 2H, ArH), 8.67 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 28.6 (C(CH3)3), 
40.2 (NCH2), 46.5 (NCH2), 47.3 (NCH2), 49.6 (NCH2), 55.6 (2 x OCH3), 79.5 (C(CH3)3), 114.0-
114.2 (4 x ArC), 121.5-121.8 (4 x ArC), 128.1 (2 x ArC), 128.7 (ArC), 130.9 (2 x ArC), 131.4 
(ArC), 133.5 (ArC), 141.8 (ArC), 155.3-155.5 (2 x ArC), 156.0 (CO), 156.6 (2 x CO). HR-MS 
(ESI, positive ion mode) – m/z for [C31H39N5O6+H]
+ = 578.2979. Found 578.2954. FTIR (neat) 







1-Phenyl-1,4-bis(4-methoxyanilinylcarbonyl)-1,4,7-triazaheptane, 30  
Synthesised according to general procedure C using 29 (200 mg, 
0.34 mmol). The title amine was isolated as a foamy white solid (141 
mg, 0.30 mmol, 87%). M.P. 123-124 °C (DCM). TLC – Rf = 0.10 
(SiO2, 90:10 EtOAc:PE). 
1
H NMR (500 MHz, CDCl3) δH 2.91 (t, J 
= 5.6, 2H, NCH2), 3.41 (t, J = 5.6, 2H, NCH2), 3.63 (t, J = 7.2, 2H, 
NCH2), 3.76 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.86 (t, J = 7.2, 2H, NCH2), 6.28 (s, 1H, NH), 
6.79 (d, J = 9.0, 2H, 2 x ArH), 6.81 (d, J = 9.0, 2H, 2 x ArH), 7.20 (d, J = 9.0, 2H, 2 x ArH), 7.33 
(t, J = 8.2, 2H, 2 x ArH), 7.38 (tt, J = 7.4, 1.2, 1H, ArH), 7.42 (d, J = 9.0, 2H, 2 x ArH), 7.48 (t, J 
= 8.2, 2H, 2 x ArH), 9.23 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 41.5 (NCH2), 46.6 (NCH2), 
49.0 (NCH2), 51.5 (NCH2), 55.5 (2 x OCH3), 113.9-114.0 (4 x ArC), 121.1-121.8 (4 x ArC), 
128.0-128.2 (3 x ArC), 130.5 (2 x ArC), 131.4 (ArC), 133.5 (ArC), 141.8 (ArC), 155.1-155.4 (2 
x ArC), 157.0 (2 x CO). HR-MS (ESI, positive ion mode) – m/z for [C26H31N5O4+H]
+ = 478.2454. 
Found 478.2446. FTIR (neat) – 3677, 3432, 2985, 2902, 1654. 
 
1-Phenyl-1,4-bis(4-methoxyanilinylcarbonyl)-7-cyanoethyl-1,4,7-triazaheptane, 31  
Synthesised according to general procedure D using 30 
(141 mg, 0.30 mmol). The title nitrile was isolated as a 
foamy white solid (157 mg, 0.28 mmol, 94%). M.P. 197-
198 °C (CHCl3). TLC – Rf = 0.11 (SiO2, 1:99 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 2.45 (t, J = 
6.6, 2H, NCH2), 2.84 (t, J = 6.0, 2H, NCH2), 2.93 (t, J = 6.6, 
2H, NCH2), 3.44 (t, J = 6.0, 2H, NCH2), 3.65 (t, J = 7.2, 2H, NCH2), 3.77 (s, 3H, OCH3), 3.77 (s, 
3H, OCH3) 3.86 (t, J = 7.2, 2H, NCH2), 6.16 (s, 1H, NH), 6.80 (d, J = 9.0, 2H, 2 x ArH), 6.82 (d, 
J = 9.0, 2H, 2 x ArH), 7.18 (d, J = 9.0, 2H, NCH2), 7.34 (d, J = 7.4, 2H, 2 x ArH), 7.41 (tt, J = 
7.4, 1.2, 1H, ArH), 7.47 (d, J = 9.0, 2H, 2 x ArH), 7.50 (t, J = 7.4, 2H, 2 x ArH), 8.75 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 18.9 (NCH2), 45.3 (NCH2), 46.9 (NCH2), 48.6 (NCH2), 48.9 
(NCH2), 49.6 (NCH2) , 55.6 (2 x OCH3), 114.1 (2 x ArC), 114.2 (2 x ArC) 118.7 (C≡N), 121.4 (2 
x ArC), 122.0 (2 x ArC), 128.2 (2 x ArC), 128.6 (2 x ArC), 130.8 (ArC) 131.4 (2 x ArC), 133.5 
(ArC), 141.8 (ArC), 155.3-155.5 (2 x ArC), 156.1 (CO), 156.7 (CO). HR-MS (ESI, positive ion 
mode) – m/z for [C29H34N6O4+Na]
+ = 553.2539. Found 553.2546. FTIR (neat) – 3433, 3316, 




1-Phenyl-1,4,7-tris(4-methoxyanilinylcarbonyl)-7-cyanoethyl-1,4,7-triazaheptane, 32  
Synthesised according to general procedure B1 using 31 
(78 mg, 0.14 mmol) and 4-methoxyphenyl isocyanate (0.03 
mL, 0.22 mmol). The crude product was purified by column 
chromatography (12-100% EtOAc:PE) to yield the title 
diurea as a foamy white solid (54 mg, 0.08 mmol, 60%). 
M.P. 190-191 °C (CHCl3). TLC – Rf = 0.18 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (500 MHz, 
CDCl3) δH 2.67 (t, J = 6.1, 2H, NCH2), 3.52 (t, J = 5.4, 2H, NCH2), 3.58 (t, J = 6.1, 2H, NCH2), 
3.61 (t, J = 6.4, 2H, NCH2), 3.71 (t, J = 6.4, 2H, NCH2), 3.74 (s, OCH3), 3.78 (s, OCH3), 3.78 (s, 
OCH3), 3.84 (t, J = 5.4, NCH2), 6.11 (s, 1H, NH), 6.74 (d, J = 9.1, 2H, 2 x ArH), 6.81 (d, J = 9.1, 
2H, 2 x ArH), 6.84 (d, J = 9.1, 2H, 2 x ArH), 7.15 (d, J = 9.1, 2H, 2 x ArH), 7.18 (d, J = 9.1, 2H, 
2 x ArH), 7.31 (d, J = 7.1, 2H, 2 x ArH), 7.46 (tt, J = 7.8, 1.2, 1H, ArH), 7.47 (d, J = 9.1, 2H, 2 x 
ArH), 7.54 (t, J = 7.1, 2H, 2 x ArH), 8.15 (s, 1H, NH), 8.68 (s, 1H, NH). 
13
C NMR (126 MHz, 
CDCl3) δC 17.8 (NCH2), 46.0 (NCH2), 47.3 (NCH2), 47.7 (NCH2), 48.4 (NCH2), 50.1 (NCH2), 
55.6 (3 x OCH3), 114.0-114.1 (6 x ArC), 119.3 (C≡N), 121.1 (2 x ArC), 121.8 (2 x ArC), 123.2 
(2 x ArC), 127.8 (2 x ArC), 128.1 (ArC), 128.8 (2 x ArC), 130.9 (3 x ArC), 141.6 (ArC), 155.0-
155.3 (3 x ArC), 156.1-156.5 (3 x CO). HR-MS (ESI, positive ion mode) – m/z for 
[C37H41N7O6+Na]
+ = 702.3016. Found 702.3040. FTIR (neat) – 3345, 2974, 2964, 2234, 1652. 
 
1-Ethyl-7-(tert-butoxycarbonyl)-1,4,7-triazaheptane, 33  
Synthesised according to general procedure A using N-
ethylethylenediamine (0.60 mL, 5.67 mmol) and N-Boc-2-
aminoacetaldehyde (910 mg, 6.12 mmol). The title carbamate was isolated as a colourless oil (879 
mg, 3.80 mmol, 67%). TLC – Rf = 0.23 (SiO2, 10:90:1 MeOH:DCM:NH4OH). 
1
H NMR (400 
MHz, CDCl3) δH 1.23 (t, J = 6.5, 3H, CH3), 1.44 (s, 9H, C(CH3)3), 2.76 (t, J = 5.4, 2H, NCH2), 
2.91 (t, J = 6.3, 2H, NCH2), 3.00 (t, J = 6.3, 2H, NCH2), 3.23 (C
2H2, 2H, m), 3.71 (q, J = 5.4, 2H, 
NCH2), 5.45 (t, J = 5.4, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 18.4 (CH3), 28.5 (C(CH3), 40.1 
(NCH2), 46.0 (NCH2), 47.1 (NCH2), 49.1 (NCH2), 58.4 (NCH2), 81.4 (C(CH3)3), 156.9 (CO). 
HR-MS (ESI, positive ion mode) – m/z for [C11H25N3O2+H]
+ = 232.2025 . Found 232.2019. 




1-Ethyl-1,4-bis(anilinylcarbonyl)-7-(tert-butoxycarbonyl)-1,4,7-triazaheptane, 34  
Synthesised according to general procedure B1 using 33 (100 
mg, 0.43 mmol) and phenyl isocyanate (0.14 mL, 1.30 mmol). 
The crude product was purified by column chromatography 
(18-100% EtOAc:PE) to yield the title diurea as a foamy white 
solid (137 mg, 0.29 mmol, 68%). M.P. 130-131 °C (CHCl3). TLC – Rf = 0.19 (SiO2, 75:25 
EtOAc:PE). 
1
H NMR (500 MHz, CDCl3) δH 1.22 (t, J = 7.1, 3H, CH3), 1.48 (s, 9H, C(CH3)3), 
3.25 (q, J = 7.0, 2H, NCH2), 3.42 (q, J = 7.1, 2H, NCH2), 3.43-3.50 (m, 6H, 3 x NCH2), 5.28 (t, J 
= 7.0), 7.02 (t, J = 7.3, 1H, ArH), 7.04 (t, J = 7.3, 1H, ArH), 7.29 (t, J = 7.9, 2H, 2 x ArH), 7.31 
(t, J = 7.9, 2H, 2 x ArH), 7.62 (d, J = 7.9, 2H, 2 x ArH), 7.70 (d, J = 7.9, 2H, 2 x ArH), 8.68 (s, 
1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 14.2 (CH3), 28.4 (C(CH3)3), 40.2 (NCH2), 43.0 
(NCH2), 46.0 (NCH2), 47.8 (NCH2), 47.8 (NCH2), 80.3 (C(CH3)3), 119.6 (2 x ArC), 119.8 (2 x 
ArC), 122.5 (ArC), 122.6 (ArC), 128.7 (4 x ArC), 139.9 (2 x ArC), 155.6 (CO), 156.2 (CO), 157.1 
(CO). HR-MS (ESI, positive ion mode) – m/z for [C25H35N5O4+Na]
+ = 492.2587. Found 
492.2588. FTIR (neat) – 3311, 3137, 2983, 1710, 1664. 
 
1-Ethyl-1,4-bis(anilinylcarbonyl)-1,4,7-triazaheptane, 35  
Synthesised according to general procedure C using 34 (500 mg, 
1.06 mmol). The title amine was isolated as a foamy white solid 
(388 mg, 1.05 mmol, 99%). M.P. 137-138 °C (CHCl3). TLC – Rf 
= 0.07 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (500 MHz, CDCl3) δH 1.20 (t, J = 7.1, 3H, CH3), 1.70 
(s, 2H, NH2), 3.00 (t, J = 4.6, 2H, NCH2), 3.40-3.48 (m, 6H, 3 x NCH2), 3.52 (t, J = 7.3, 2H, 
NCH2), 6.94 (tt, J = 7.3, 1.2, 1H, ArH), 7.02 (tt, J = 7.3, 1.2, 1H, ArH), 7.24 (t, J =7.8, 2H, 2 x 
ArH), 7.27 (t, J =7.8, 2H, 2 x ArH), 7.42 (d, J = 8.1, 2H, 2 x ArH), 7.64 (d, J = 8.1, 2H, 2 x ArH), 
8.34 (s, 1H, NH), 10.22 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 14.1 (CH3), 41.7 (NCH2), 
42.6 (NCH2), 45.1 (NCH2), 48.1 (NCH2), 52.9 (NCH2), 118.9 (2 x ArC), 119.6 (2 x ArC), 122.2 
(ArC), 122.3 (ArC), 128.6 (2 x ArC), 128.8 (2 x ArC), 140.0 (2 x ArC), 155.5 (CO), 158.3 (CO). 
HR-MS (ESI, positive ion mode) – m/z for [C20H27N5O2+Na]
+ = 392.2062. Found 392.2081. 
FTIR (neat) – 3306, 2999, 2971, 1641. 
 
1-Ethyl-1,4-bis(anilinylcarbonyl)-7-cyanoethyl-1,4,7-triazaheptane, 36  
Synthesised according to general procedure D using 35 
(300 mg, 0.81 mmol). The title nitrile was isolated as a 
foamy white solid (317 mg, 0.75 mmol, 93%). M.P. 152-
206 
 
153 °C (CHCl3). TLC – Rf = 0.26 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 
1.15 (t, J = 7.2, 3H, CH3), 2.04 (s, 1H, NH), 2.38 (t, J = 6.6, 2H, NCH2), 2.75 (t, J = 6.6, 2H, 
NCH2), 2.84 (t, J = 6.6, 2H, NCH2), 3.32-3.48 (m, 8H, 4 x NCH2), 6.98 (t, J = 7.5, ArH), 7.01 (t, 
J = 7.5, ArH), 7.24 (t, J = 7.6, 2H, 2 x ArH), 7.28 (t, J = 7.6, 2H, 2 x ArH), 7.44 (d, J = 8.0, 2 x 
ArH), 7.58 (d, J = 8.0, 2 x ArH), 8.23 (s, 1H, NH), 9.33 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) 
δC 14.1 (CH3), 18.4 (NCH2), 42.7 (NCH2), 45.3 (2 x NCH2), 47.9 (NCH2), 48.9 (NCH2), 50.4 
(NCH2), 118.5 (C≡N), 119.3 (2 x ArC), 119.8 (2 x ArC), 122.5 (ArC), 122.6 (ArC), 128.7 (2 x 
ArC), 128.8 (2 xArC), 139.7 (ArC), 140.0 (ArC), 157.0 (CO), 157.5 (CO). HR-MS (ESI, positive 
ion mode) – m/z for [C23H30N6O2+Na]
+ = 445.2328. Found 445.2294. FTIR (neat) – 3341, 2975, 
2944, 2230, 1662. 
1-Ethyl-1,4,7-tris(anilinylcarbonyl)-7-cyanoethyl-1,4,7-triazaheptane, 37  
Synthesised according to general procedure B1 using 36 (130 
mg, 0.31 mmol) and phenyl isocyanate (0.05 mL, 0.46 
mmol). The crude product was purified by column 
chromatography (1-2% MeOH:DCM) to yield the title triurea as a white solid (135 mg, 0.25 
mmol, 80%). M.P. 118-119 °C (CHCl3). TLC – Rf = 0.26 (SiO2, 5:95 MeOH:DCM). 
1
H NMR 
(400 MHz, CDCl3) δH 1.32 (t, J = 7.1, 3H, CH3), 2.74 (t, J = 5.9, 2H, NCH2), 3.41 (q, J = 7.1, 2H, 
NCH2), 3.50 (t, J = 6.1, 2H, NCH2), 3.55-3.64 (m, 6H, 3 x NCH2), 3.68 (t, J = 5.9, 2H, NCH2), 
6.41 (s, 1H, NH), 7.02 (tt, J = 7.5, 1.2, 1H, ArH), 7.03 (tt, J = 7.4, 1.2, 1H, ArH), 7.11 (tt, J = 7.4, 
1.2, 1H, ArH), 7.29 (t, J = 7.8, 4H, 4 x ArH), 7.34 (t, J = 8.1, 2H, 2 x ArH), 7.44 (d, J = 7.8, 2H, 
2 x ArH), 7.73 (d, J = 8.1, 4H, 4 x ArH), 9.07 (s, 1H, NH), 9.14 (s, 1H, NH). 
13
C NMR (101 
MHz, CDCl3) δC 14.4 (CH3), 18.2 (NCH2), 44.4 (NCH2), 46.2 (NCH2), 47.5 (2 x NCH2), 48.0 
(NCH2), 49.0 (NCH2), 119.4 (C≡N), 119.4 (2 x ArC), 119.7 (2 x ArC), 120.0 (2 x ArC), 122.6 
(ArC), 122.7 (ArC), 123.7 (ArC), 128.7 (2 x ArC), 128.7 (2 x ArC), 129.0 (2 x ArC), 138.2 (ArC), 
139.8 (ArC), 139.9 (ArC), 155.4 (CO), 155.6 (CO), 156.4 (CO). HR-MS (ESI, positive ion mode) 
– m/z for [C30H35N7O5+Na]
+ = 564.2699. Found 564.2705. FTIR (neat) – 3310, 2957, 2254, 1652. 
 
1-Ethyl-1,4-bis(4-methoxyanilinylcarbonyl)-7-(tert-butoxycarbonyl)-1,4,7-triazanonane, 38  
Synthesised according to general procedure B1 using 33 (100 
mg, 0.43 mmol) and 4-methoxyphenyl isocyanate (0.17 mL, 
1.30 mmol). The crude product was purified by column 
chromatography (25-100% EtOAc:PE) to yield the title diurea 
as a foamy white solid (122 mg, 0.25 mmol, 57%). M.P. 158-
159 °C (CHCl3). TLC – Rf = 0.31 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.15 
(t, J = 7.1, 3H, CH3), 1.43 (s, 9H, C(CH3)3), 3.15 (t, J = 6.5, 2H, NCH2), 3.36-3.45 (m, 8H, 4 x 
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NCH2), 3.78 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 5.35 (s, 1H, NH), 6.82 (d, J = 9.1, 2H, 2 x ArH), 
6.84 (d, J = 9.1, 2H, 2 x ArH), 7.4 (d, J = 9.1, 2H, 2 x ArH), 7.54 (d, J = 9.1, 2H, 2 x ArH), 8.51 
(s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 14.1 (CH3), 28.2 (C(CH3)3), 40.1 (NCH2), 43.0 
(NCH2), 45.9 (NCH2), 47.8 (NCH2), 47.9 (NCH2), 55.5 (2 x OCH3), 80.1 (C(CH3)3), 114.0 (4 x 
ArC), 121.3 (2 x ArC), 121.8 (2 x ArC), 133.0 (ArC), 133.1 (ArC), 155.3 (ArC), 155.3 (ArC), 
155.9 (CO) 156.4 (CO), 157.1 (CO). HR-MS (ESI, positive ion mode) – m/z for 
[C27H39N5O6+Na]
+ = 552.2798. Found 552.2777. FTIR (neat) – 3311, 2917, 1645, 1628. 
 
1-Ethyl-1,4-bis(4-methoxyanilinylcarbonyl)-1,4,7-triazanonane, 39 
Synthesised according to general procedure C using 38 (100 mg, 0.22 
mmol). The title amine was isolated as a foamy white solid (76 mg, 
0.21 mmol, 96%). M.P. 162-163 °C (CHCl3). TLC – Rf = 0.03 (SiO2, 
90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.14 (t, J = 7.2, 
3H, CH3), 1.78 (s, 2H, NH2), 2.89 (t, J = 4.2, 2H, NCH2), 3.34-3.44 (m, 8H, 4 x NCH2), 3.74 (s, 
3H, OCH3), 3.75 (s, 3H, OCH3), 6.75 (d, J = 9.0, 2H, x ArH), 6.77 (d, J = 9.0, 2H, x ArH), 7.31 
(d, J = 9.0, 2H, ArH), 7.50 (d, J = 9.0, 2H, ArH), 8.29 (s, 1H, NH), 10.0 (s, 1H, NH). 
13
C NMR 
(101 MHz, CDCl3) δC 14.2 (CH3), 41.7 (NCH2), 42.7 (NCH2), 44.8 (NCH2), 48.1 (NCH2), 52.8 
(NCH2), 55.5 (OCH3), 55.6 (OCH3), 113.9 (2 x ArC), 114.0 (2 x ArC), 120.8 (2 x ArC), 121.5 (2 
x ArC), 133.3 (ArC), 133.5 (ArC), 155.1 (2 x ArC), 155.9 (CO), 158.4 (CO). HR-MS (ESI, 
positive ion mode) – m/z for [C22H31N5O4+H]
+ = 430.2454. Found 430.2451. FTIR (neat) – 3444, 
3354, 2966, 2902, 1671. 
 
1-Ethyl-1,4-bis(4-methoxyanilinylcarbonyl)-7-benzyl-1,4,7-triazanonane, 40  
Synthesised according to general procedure E using 39 (396 
mg, 0.94 mmol) and benzaldehyde (0.15 mL, 1.41 mmol). 
The crude product was purified by column chromatography 
(2-10% MeOH:DCM) to yield the title amine as a white solid 
(249 mg, 0.48 mmol, 51%). M.P – 132-133 °C (CHCl3). 
TLC – Rf = 0.30 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.14 (t, J = 7.0, 3H, 
CH3), 2.07 (s, 1H, NH), 2.85 (t, J = 4.3, NCH2), 3.33-3.45 (m, 8H, 4 x NCH2), 3.75 (s, 3H, OCH3), 
3.76 (s, 3H, OCH3), 3.81 (s, 2H, CH2Ar), 6.76 (d, J = 8.5, 2H, 2 x ArH), 6.79 (d, J = 8.5, 2H, 2 x 
ArH), 7.18 (d, J = 8.5, 2H, 2 x ArH), 7.23-7.33 (m, 5H, 5 x ArH), 7.51 (d, J = 8.5, 2H, 2 x ArH), 
8.27 (s, 1H, NH), 9.91 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 14.1 (CH3), 42.6 (NCH2), 
45.1 (NCH2), 48.2 (NCH2), 49.4 (NCH2), 50.7 (NCH2), 54.2 (CH2Ar), 55.5 (OCH3), 55.5 (OCH3), 
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113.9 (2 x ArC), 113.9 (2 x ArC), 120.9 (2 x ArC), 121.3 (2 x ArC), 127.5 (2 x ArC), 128.3 (2 x 
ArC), 128.7 (ArC), 133.1 (ArC), 133.5 (ArC), 138.9 (ArC), 155.0 (2 x ArC), 155.7 (CO), 158.2 
(CO). HR-MS (ESI, positive ion mode) – m/z for [C29H37N5O4+H]
+ = 520.2924. Found 520.2893. 
FTIR (neat) – 3337, 3322, 2993, 2912, 1654. 
 
1-Ethyl-1,4,7-tris(4-methoxyanilinylcarbonyl)-7-benzyl-1,4,7-triazanonane, 41  
Synthesised according to general procedure B1 using 40 
(120 mg, 0.23 mmol) and 4-methoxyphenyl isocyanate (0.04 
mL, 0.35 mmol). The crude product was purified by column 
chromatography (1-2% MeOH:DCM) to yield the title 
triurea as a foamy white solid (112 mg, 0.17 mmol, 73%). 
M.P. 110-111 °C (CHCl3). TLC – Rf = 0.15 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (500 MHz, 
CDCl3) δH 1.16 (t, J = 7.1, 3H, CH3), 3.30 (q, J = 7.1, 2H, NCH2), 3.29-3.41 (m, 6H, 3 x NCH2), 
3.49 (t, J = 7.4, 2H, NCH2), 3.76 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 4.58 (s, 
2H, CH2Ar), 6.79-6.83 (m, 6H, 6 x ArH), 7.27-7.33 (m, 4H, 4 x ArH), 7.34-7.39 (m, 5H, 5 x 
ArH), 7.57 (d, J = 9.0, 2H, 2 x ArH), 8.89 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 14.3 
(CH3), 43.7 (NCH2), 46.7 (NCH2), 47.9 (3 x NCH2), 51.9 (CH2Ar), 55.6 (3 x OCH3), 113.9 (2 x 
ArC), 113.9 (2 x ArC), 114.0 (2 x ArC), 121.2 (2 x ArC), 121.8 (2 x ArC), 122.0 (2 x ArC), 127.2 
(2 x ArC), 127.9 (ArC), 129.0 (2 x ArC), 133.3 (3 x ArC), 137.8 (ArC), 155.3 (CO), 155.6 (3 x 
ArC), 156.0 (CO), 156.5 (CO). HR-MS (ESI, positive ion mode) – m/z for [C37H44N6O6+H]
+ = 
669.3401. Found 669.3424. FTIR (neat) – 3312, 2978, 2923, 1650. 
 
1,1-Dibenzyl-3-(4-methoxyphenyl)urea, 42 
Synthesised according to general procedure B1 using N,N-
dibenzylamine (198 mg, 1.00 mmol) and 4-methoxyphenyl isocyanate 
(0.10 mL, 0.75 mmol). The crude product was diluted with aqueous HCl 
(1.00 M) and extracted with DCM (3 x 10 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated in vacuo to yield 
the title amine as a white solid (296 mg, 1.00 mmol, >99%). M.P. 179-180 °C (CHCl3). TLC – 
Rf = 0.23 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.66 (s, 3H, OCH3), 4.50 (s, 
4H, 2 x CH2Ar), 6.17 (s, 1H, NH), 6.69 (d, J = 9.0, 2H, 2 x ArH), 7.03 (d, J = 9.0, 2H, 2 x ArH), 
7.19-7.31 (m, 10H, 10 x ArH). 
13
C NMR (101 MHz, CDCl3) δC 50.8 (2 x CH2Ar), 55.6 (OCH3), 
114.2 (2 x ArC), 122.3 (2 x ArC), 127.5 (4 x ArC), 127.8 (2 x ArC), 129.0 (4 x ArC), 132.1 (2 x 
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ArC), 137.4 (ArC), 156.0 (ArC), 156.5 (CO). HR-MS (ESI, positive ion mode) – m/z for 
[C22H22N2O2+H]
+ = 347.1760. Found 347.1727. FTIR (neat) – 3431, 2988, 2901, 1653. 
 
1,4-Dibenzyl-1,4-bis(4-methoxyanilinylcarbonyl)-1,4-diazabutane, 43 
Synthesised according to general procedure B1 using N,N’-
dibenzylethylenediamine (100 mg, 0.42 mmol) and 4-
methoxyphenyl isocyanate (0.16 mL, 1.25 mmol). The crude 
product was purified by column chromatography (25-100% 
EtOAc:PE) to yield the title diurea as a foamy white solid (152 
mg, 0.28 mmol, 67%). M.P. 136-137 °C (CHCl3). TLC – Rf = 0.23 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.36 (s, 4H, 2 x NCH2), 3.76 (s, 6H, 2 x OCH3), 4.45 (s, 4H, 2 x 
CH2Ar), 6.80 (d, J = 9.0, 4H, 4 x ArH), 7.19 (d, J = 9.0, 4H, 4 x ArH, 7.29-7.39 (m, 10H, 10 x 
ArH), 7.61 (s, 2H, 2 x NH). 
13
C NMR (101 MHz, CDCl3) δC 46.7 (2 x CH2), 51.9 (2 x CH2Ar), 
55.5 (2 x OCH3), 114.0 (4 x ArC), 121.9 (4 x ArC), 127.3 (4 x ArC), 127.8 (4 x ArC), 129.0 (2 x 
ArC), 132.2 (2 x ArC), 137.5 (2 x ArC), 155.5 (2 x ArC), 156.4 (2 x CO). HR-MS (ESI, positive 
ion mode) – m/z for [C32H34N4O4+Na]




Synthesised according to general procedure E using 
diethylenetriamine (0.21 mL, 1.94 mmol) and benzaldehyde (0.39 
mL, 3.88 mmol). The title triamine was isolated as a white solid (330 mg, 1.18 mmol, 61%). TLC 
– Rf = 0.09 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 2.72-2.74 (m, 8H, 4 x 




Synthesised according to general procedure B1 using 
44 (300 mg, 1.06 mmol) and 4-methoxyphenyl 
isocyanate (0.41 mL, 3.18 mmol). The crude product 
was purified by column chromatography (25-100% 
EtOAc:PE) to yield the title triurea as a white solid 




H NMR (500 MHz, CDCl3) δH 3.34 (t, J = 7.4, 4H, 2 x NCH2), 3.48 (t, J = 7.4, 4H, 2 x NCH2), 
3.79 (s, 6H, 2 x OCH3), 3.81 (s, 3H, OCH3), 4.57 (s, 4H, 2 x CH2Ar), 6.83 (d, J = 9.0, 4H, 4 x 
ArH), 6.85 (d, J = 9.0, 2H, 2 x ArH), 7.29 (d, J = 9.0, 4H, 4 x ArH), 7.32-7.44 (m, 10H, 10 x 
ArH), 7.59 (d, J = 9.0, 2H, 2 x ArH), 8.84 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 47.8 (2 
x NCH2), 47.8 (2 x NCH2), 52.4 (2 x CH2Ar), 55.6 (2 x OCH3), 55.6 (OCH3), 114.0 (2 x ArC), 
114.1 (4 x ArC), 121.2 (2 x ArC), 121.8 (4 x ArC), 127.1 (4 x ArC), 127.2 (2 x ArC), 129.2 (4 x 
ArC), 133.1 (2 x ArC), 133.1 (ArC), 155.4 (2 x ArC), 155.4 (ArC), 156.5 (2 x CO), 156.5 (CO). 
HR-MS (ESI, positive ion mode) – m/z for [C42H46N6O6+Na]
+ = 753.3377. Found 753.3362. 
FTIR (neat) – 3334, 2992, 2948, 1650, 1624. 
 
1,10-Dibenzyl-1,4,7,10-tetrakis(4-methoxyanilinylcarbonyl)-1,4,7,10-tetraazadecane, 46 
Under a dry, inert atmosphere, a solution of 
triethylenetetramine (0.31 mL, 2.05 mmol, 
1.00 equiv., 0.10 M) in anhydrous MeOH (20 
mL) was prepared. To this solution was added 
benzaldehyde (0.42 mL, 4.10 mmol, 2.00 
equiv.) and the resulting colourless solution was stirred for 16 h. The solution was cooled to 0 °C 
and NaBH4 (388 mg, 10.26 mmol, 6.00 equiv.) was added in one portion. The resulting white 
suspension was warmed to room temperature, stirred for 3 h and concentrated in vacuo. The 
residue was diluted with MeOH and concentrated in vacuo. The crude product was diluted with 
deionised water (20 mL) and the aqueous solution extracted with DCM (3 x 20 mL). The 
combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated in 
vacuo to give the crude secondary amine. Under a dry, inert atmosphere, the crude brown oil (1.00 
equiv., 0.10 M) was dissolved in anhydrous DCM (20 mL) and cooled to 0 °C. To the solution 
was added 4-methoxyphenyl isocyanate (1.30 mL, 12.30 mmol, 3.00 equiv.) dropwise. The 
resulting solution was stirred for 16 h and concentrated in vacuo. The crude product was purified 
by column chromatography (1-2% MeOH:DCM) to yield the title tetraurea as a white solid (312 
mg, 0.34 mmol, 16%). M.P. 158-159 °C (DCM). TLC – Rf = 0.21 (SiO2, 1:99 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 3.32 (s, 4H, 2 x NCH2), 3.39-3.43 (m, 4H, 2 x NCH2), 3.48 (t, J = 
7.5, 4H, 2 x NCH2), 3.76 (s, 6H, 2 x OCH3), 3.78 (s, 6H, 2 x OCH3), 6.80 (d, J = 9.1, 4H, 4 x 
ArH), 6.82 (d, J = 9.1, 4H, 4 x ArH), 7.27 (d, J = 9.1, 4H, 4 X ArH), 7.29-7.40 (m, 10H, 10 x 
ArH), 7.59 (d, J = 9.1, 4H, 4 x ArH), 8.33 (s, 2H, 2 x NH), 8.93 (s, 2H, 2 x NH). 
13
C NMR (101 
MHz, CDCl3) δC 47.7 (6 x NCH2), 52.2 (2 x CH2Ar), 55.5 (2 x OCH3), 55.5 (2 x OCH3), 113.9 (4 
x ArC), 114.0 (4 x ArC), 121.1 (4 x ArC), 121.9 (4 x ArC), 126.8 (4 x ArC), 127.9 (2 x ArC), 
129.1 (4 x ArC), 133.1 (4 x ArC), 155.2 (4 x ArC), 156.4 (4 x CO). HR-MS (ESI, positive ion 
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mode) – m/z for [C52H58N8O8+Na]
+ = 945.4275. Found 945.4233. FTIR (neat) – 3330, 2992, 
2948, 1643, 1604. 
 
1,4-Diethyl-1,4-bis(4-methoxyanilinylcarbonyl)-1,4-diazabutane, 47  
Synthesised according to general procedure B1 using N,N’-
diethylethylenediamine (100 mg, 0.86 mmol) and 4-methoxyphenyl 
isocyanate (0.33 mL, 2.58 mmol). The crude product was purified by 
column chromatography (25-100% EtOAc:PE) to yield the title diurea as 
a foamy white solid (294 mg, 0.71 mmol, 82%). M.P. 219-220 °C (CHCl3). TLC – Rf = 0.40 
(SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.23 (t, J = 7.1, 6H, 2 x CH3), 3.40 (q, 
J = 7.1, 4H, 2 x CH2), 3.47 (s, 4H, 2 x CH2), 3.78 (s, 6H, 2 x OCH3), 6.82 (d, J = 9.0, 4H, 4 x 
ArH), 7.31 (s, 2H, 2 x NH), 7.41 (d, J = 9.0, 4H, 4 x ArH). 
13
C NMR (101 MHz, CDCl3) δC 14.4 
(2 x CH3), 43.5 (2 x NCH2CH3), 46.7 (2 x CH2), 55.7 (2 x OCH3), 114.1 (4 x ArC), 121.9 (4 x 
ArC), 132.7 (2 x ArC), 155.7 (2 x ArC), 155.9 (2 x CO). HR-MS (ESI, positive ion mode) – m/z 
for [C22H30N4O4+Na]
+ = 437.2165. Found 437.2143. FTIR (neat) – 3280, 2984, 2919, 1629. 
 
1,7-Diethyl-1,4-bis(4-methoxyanilinylcarbonyl)-1,4,7-triazanonane, 48 
Synthesised according to general procedure E using 39 (216 mg, 
0.50 mmol) and acetaldehyde (0.04 mL, 0.75 mmol). The crude 
product was purified by column chromatography (2-10% 
MeOH:DCM) to yield the title amine as a white solid (114 mg, 
0.25 mmol, 50%). M.P. 115-116 °C (DCM). TLC – Rf = 0.26 (SiO2, 5:95 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 1.15 (t, J = 7.3, 3H, CH3), 1.24 (t, J = 7.1, 3H, CH3), 2.67 (q, J = 7.1, 
2H, NCH2), 2.81 (t, J = 7.0, 2H, NCH2), 3.35 (q, J = 7.3, 2H, NCH2), 3.41 (t, J = 7.5, 2H, NCH2), 
3.46 (t, J = 7.5, 2H, NCH2), 3.52 (t, J = 7.0, 2H, NCH2), 3.77 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 
6.80 (d, J = 8.9, 2H, 2 x ArH), 6.81 (d, J = 8.9, 2H, 2 x ArH), 7.20 (d, J = 8.9, 2H, 2 x ArH), 7.46 
(d, J = 8.9, 2H, 2 x ArH), 8.13 (s, 1H, NH), 9.24 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 
14.9 (CH3), 15.7 (CH3), 44.0 (NCH2), 45.2 (NCH2), 46.0 (NCH2), 46.1 (NCH2), 47.5 (NCH2), 
48.0 (NCH2), 55.5 (OCH3), 55.5 (OCH3), 114.0 (2 x ArC), 114.1 (2 x ArC), 121.4 (2 x ArC), 
121.6 (2 x ArC), 132.4 (2 x ArC), 155.4 (2 x ArC), 156.0 (2 x CO). HR-MS (ESI, positive ion 
mode) – m/z for [C24H35N5O4+Na]
+
 =








Synthesised according to general procedure B1 using 48 (100 
mg, 0.22 mmol) and 4-nitrophenyl isothiocyanate (59 mg, 0.33 
mmol). The crude product was purified by column 
chromatography (1-10% MeOH:DCM) to yield the title thiourea 
as a yellow solid (145 mg, 0.22 mmol, >99%). M.P. 164-165 °C 
(DCM). TLC – Rf = 0.48 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.31 (t, J = 
7.5, 3H, CH3), 1.33 (t, J = 7.2, 3H, CH3), 3.39 (q, J = 7.2, 2H, NCH2), 3.47-3.49 (m, 2H, NCH2), 
3.50-3.57 (m, 4H, 2 x NCH2), 3.74-3.77 (m, 2H, NCH2), 3.79, (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 
3.97 (q, J = 7.5, 2H, NCH2), 6.34 (s, 1H, NH), 6.81 (d, J = 9.0, 2H, 2 x ArH), 6.86 (d, J = 8.9, 2H, 
2 x ArH), 7.30 (d, J = 8.9, 2H, 2 x ArH), 7.50 (d, J = 9.0, 2H, 2 x ArH), 7.94 (d, J = 9.1, 2H, 2 x 
ArH), 8.15 (d, J = 9.1, 2H, 2 x ArH), 9.04 (s, 1H, NH), 10.16 (s, 1H, NH). 
13
C NMR (101 MHz, 
CDCl3) δC 12.8 (CH3), 14.5 (CH3), 44.4 (NCH2), 47.9 (5 x NCH2), 55.7 (2 x OCH3), 114.1 (2 x 
ArC), 114.3 (2 x ArC), 121.3 (2 x ArC), 122.5 (2 x ArC), 122.8 (2 x ArC), 122.9 (2 x ArC), 131.0 
(ArC), 132.5 (ArC), 143.0 (ArC), 147.1 (ArC), 155.7 (2 x ArC), 156.0 (CO), 156.2 (CO), 182.1 
(CS). HR-MS (ESI, positive ion mode) – m/z for [C31H39N7O6S+Na]
+ = 660.2580. Found 
660.2559. FTIR (neat) – 3676, 3278, 2934, 1646, 1512. 
 
tert-Butyl-(2-aminoethyl)(2-hydroxyethyl)carbamate, 52 
Synthesised according to general procedure F using N-(2-hydroxyethyl)-
ethylenediamine (2.43 mL, 24.00 mmol). The title carbamate was isolated as a 
colourless oil (4.66 g, 22.80 mmol, 95%). TLC – Rf = 0.54 (SiO2, 10:90:1 
MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, CDCl3) δH 1.41 (s, 9H, C(CH3)3), 2.89-2.98 (m, 2H, 
NCH2), 3.07-3.14 (m, 2H, NCH2), 3.24-3.40 (m, 4H, 2 x NCH2), 3.67-3.71 (m, 2H, OCH2). 
Spectroscopic data matched that previously reported.89 
 
tert-Butyl (2-(phthalimidyl)ethyl)(2-hydroxyethyl)carbamate, 53 
Under a dry, inert atmosphere, phthalic anhydride (218 mg, 1.47 
mmol, 1.00 equiv.) was added to a solution of 52 (300 mg, 1.47 mmol, 
1.00 equiv., 0.10 M) in anhydrous toluene (15 mL). The solution was 
heated to reflux for 16 h and concentrated in vacuo. The crude brown oil was purified by column 
chromatography (1-2% MeOH:DCM) to yield the title phthalimide as a white solid (447 mg, 1.34 
mmol, 91%). M.P. 95-96 °C (CHCl3). TLC – Rf = 0.61 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 
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MHz, CDCl3) δH 1.16 (s, 9H, C(CH3)3), 3.36-3.39 (m, 2H, NCH2), 3.52-3.57 (m, 2H, NCH2), 
3.73-3.77 (m, 2H, NCH2), 3.85-3.90 (m, 2H, NCH2), 7.69 (d, J = 7.4, 2H, 2 x ArH), 7.79 (d, J = 
7.4, 2H, 2 x ArH). 
13
C NMR (101 MHz, CDCl3) δC 28.0 (C(CH3)3), 36.6 (NCH2, rot.), 37.4 
(NCH2, rot.), 47.3 (NCH2, rot.), 47.5 (NCH2, rot.), 51.5 (NCH2, rot.), 52.7 (NCH2, rot.), 61.1 
(OCH2, rot.), 61.6 (OCH2, rot.), 79.9 (C(CH3)3, rot.), 80.4 (C(CH3)3, rot.), 123.2 (2 x ArC, rot.), 
123.3 (2 x ArC, rot.), 132.0 (2 x ArC, rot.), 132.2 (2 x ArC, rot.), 133.7 (2 x ArC, rot.), 134.1 (2 
x ArC, rot.), 156.0 (CO, rot.), 156.5 (CO, rot.), 168.3 (CO, rot.) 168.9 (CO, rot.). HR-MS (ESI, 
positive ion mode) – m/z for [C17H22N2O5+Na]
+ = 357.1426. Found 357.1424. FTIR (neat) – 
3473, 2970, 1710, 1676.  
 
tert-Butyl (2-(phthalimidyl)ethyl)(2-oxoethyl)carbamate, 54 
Synthesised according to general procedure G using 53 (160 mg, 0.48 
mmol). The crude product was purified by column chromatography (1-
2% MeOH:DCM) to yield the title aldehyde as a colourless oil (111 
mg, 0.34 mmol, 70%). TLC – Rf = 0.18 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) 
δH 1.20 (s, 9H, C(CH3), rot.), 1.23 (s, 9H, C(CH3), rot.), 3.56 (t, J = 5.8, NCH2, rot.), 3.60 (t, J = 
5.8, NCH2, rot.), 3.79-3.85 (m, 2H, NCH2), 3.87 (s, 2H, NCH2, rot.), 4.00 (s, 2H, NCH2, rot.), 
7.70-7.76 (m, 2H, 2 x ArH), 7.80-7.85 (m, 2H, 2 x ArH), 9.56 (s, 1H, CHO). 
13
C NMR (101 
MHz, CDCl3) δC 27.9 (C(CH3)3, rot.), 28.0 (C(CH3)3, rot.), 35.8 (NCH2, rot.), 36.1 (NCH2, rot.)), 
46.6 (NCH2, rot.), 46.7 (NCH2, rot.), 57.0 (OCH2, rot.), 57.7 (OCH2, rot.), 81.0 (C(CH3)3, rot.), 
81.1 (C(CH3)3, rot.), 123.2 (2 x ArC, rot.), 123.3 (2 x ArC, rot.), 132.0 (2 x ArC, rot.), 132.1 (2 x 
ArC, rot.), 133.9 (2 x ArC, rot.), 134.1 (2 x ArC, rot.), 155.1 (CO, rot.), 155.4 (CO, rot.), 168.0 
(CO, rot.), 168.3 (CO, rot.), 198.4 (CHO, rot.), 199.0 (CHO, rot.). HR-MS (ESI, positive ion 
mode) – m/z for [C17H26N2O5+Na]
+ = 355.1270. Found 355.1261. FTIR (neat) – 2988, 1773, 
1706, 1616. 
 
tert-Butyl (N-2-aminoethyl- N-benzyl)carbamate, 56 
Synthesised according to general procedure F using N-benzylethylenediamine 
(1.00 mL, 6.66 mmol). The title carbamate was isolated as a colourless oil 
(1.64 g, 6.54 mmol, 98%). TLC – Rf = 0.10 (SiO2, 5:95:1 MeOH:DCM:TEA). 
1
H NMR (400 MHz, CDCl3) δH 1.42 (s, 9H, C(CH3)3), 2.92-2.96 (m, 2H, NCH2), 3.18-3.25 (m, 





tert-Butyl (2-(benzylamino)ethyl)(2-hydroxyethyl)carbamate, 57 
Synthesised according to general procedure E using 52 (2.40 g, 11.80 
mmol) and benzaldehyde (1.80 mL, 17.70 mmol). The crude product was 
purified by column chromatography (1-2% MeOH:DCM) to yield the title 
amine as a colourless oil (3.04 g, 10.42 mmol, 88%). TLC – Rf = 0.43 
(SiO2, 1:99 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.47 (s, 9H, C(CH3)3), 2.90 (t, J = 5.0, 
2H, NCH2, rot.), 2.94 (t, J = 5.0, 2H, NCH2, rot.), 3.41-3.43 (m, 4H, 2 x NCH2), 3.75-3.79 (m, 
2H, NCH2), 3.79-3.84 (m, 2H, OCH2), 7.26-7.38 (m, 5H, 5 x ArH). 
13
C NMR (101 MHz, CDCl3) 
δC 28.5 (C(CH3)3), 47.8 (NCH2, rot.), 48.2 (NCH2, rot.), 49.1 (NCH2, rot.), 49.7 (NCH2, rot.), 53.2 
(NCH2, rot.), 53.8 (NCH2, rot.), 62.1 (OCH2, rot.), 62.2 (OCH2, rot.), 80.0 (C(CH3)3), 127.4 (2 x 
ArC), 128.4 (ArC), 128.7 (2 x ArC), 139.0 (ArC), 156.0 (CO). HR-MS (ESI, positive ion mode) 
– m/z for [C16H26N2O3+H]
+ = 295.2022. Found 295.2009. FTIR (neat) – 3461, 3305, 2990, 1678. 
 
tert-Butyl (2-(1-benzyl-3-(4-nitrophenyl)thioureido)ethyl)(2-hydroxyethyl)carbamate, 58 
Synthesised according to general procedure B using 57 (1.23 g, 4.19 
mmol) and 4-nitrophenyl isothiocyanate (1.13 g, 6.29 mmol). The crude 
product was purified by column chromatography (2-20% EtOAc:PE) to 
yield the title diurea as a yellow oil (1.63 g, 3.43 mmol, 82%). TLC – Rf 
= 0.59 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.44 (s, 
9H, C(CH3)3), 3.24-3.30 (m, 4H, 2 x NCH2), 3.61-3.64 (m, 2H, OCH2), 
3.71-3.76 (m, 2H, NCH2), 5.27 (s, 2H, CH2Ar), 7.29-7.37 (m, 5H, 5 x 
ArH), 8.00 (d, J = 8.7, 2H, 2 x ArH), 8.18 (d, J = 8.7, 2H, 2 x ArH), 10.04 (s, 1H, NH). 
13
C NMR 
(101 MHz, CDCl3) δC 28.5 (C(CH3)3), 46.9 (NCH2), 47.4 (NCH2), 51.4 (NCH2), 56.2 (CH2Ar), 
61.7 (OCH2), 81.9 (C(CH3)3), 123.6 (2 x ArC), 123.9 (2 x ArC), 127.9 (ArC), 127.9 (2 x ArC), 
128.8 (2 x ArC), 136.6 (ArC), 136.9 (ArC), 147.1 (ArC), 156.7 (CO), 181.1 (CS). HR-MS (ESI, 
positive ion mode) – m/z for [C23H30N4O5S+Na]
+ = 497.1835. Found 497.1825. FTIR (neat) – 
3267, 3088, 2940, 1660, 1595, 1510. 
 
4,7-Bis(tert-butoxycarbonyl)-1,4,7,10-tetraazadecane, 60 
Synthesised according to general procedure F using 
triethylenetetramine (2.6 mL, 17.10 mmol). The title 
carbamate as a colourless oil (4.1 g, 11.89 mmol, 67%). TLC 
– Rf = 0.04 (SiO2, 5:95:1 MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, CDCl3) δH 1.41 (s, 18H, 2 
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x C(CH3)3), 2.78 (t, J = 6.2, 4H, 2 x NCH2), 3.18-3.32 (m, 8H, 4 x NCH2). Spectroscopic data 
matched that previously reported.129 
 
1-(Naphthalen-1-ylmethyl)-4,7-bis(tert-butoxycarbonyl)-1,4,7,10-tetraazadecane, 61 
Synthesised according to general procedure E using 60 
(4.20 g, 12.10 mmol) and 1-naphthaldehyde (1.68 mL, 
12.10 mmol, 1.00 equiv.). The crude product was 
purified by column chromatography (1-10% MeOH:DCM, 1% NH4OH) to yield the title amine 
as a foamy white solid (2.90 g, 6.0 mmol, 50%). M.P. 42-43 °C (CHCl3). TLC – Rf = 0.09 (SiO2, 
5:95:1 MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, CDCl3) δH 1.43 (s, 9H, C(CH3)3), 1.45 (s, 
9H, C(CH3)3), 2.78 (t, J = 6.2, 2H, NCH2), 2.88 (t, J = 6.2, 2H, NCH2), 3.17-3.46 (m, 8H, 4 x 
NCH2), 4.24 (s, 2H, CH2Ar), 7.37-7.53 (m, 4H, 4 x ArH), 7.75 (d, J = 8.1, 1H, ArH), 7.84 (d, J = 
7.5, 1H, ArH), 8.11-8.14 (m, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 28.5 (2 x C(CH3)3), 40.6 
(NCH2, rot.), 40.9 (NCH2, rot.), 45.7 (NCH2), 46.0 (NCH2), 47.7 (NCH2), 48.4 (NCH2), 51.2 
(CH2Ar), 51.6 (NCH2), 79.5 (C(CH3)3), 79.9 (C(CH3)3), 123.8 (ArC), 125.3 (ArC), 125.6 (ArC), 
126.0 (2 x ArC), 127.7 (ArC), 128.6 (ArC), 131.8 (ArC), 133.9 (ArC), 135.9 (ArC), 155.4 (CO), 
155.7 (CO). HR-MS (ESI, positive ion mode) – m/z for [C27H43N4O4+H]
+ = 487.3284. Found 
487.3279. FTIR (neat) – 3401, 2946, 1687. 
 
1-(Naphthalen-1-ylmethyl)-1,4,7-tris(tert-butoxycarbonyl)-1,4,7,10-tetraazadecane, 62 
Synthesised according to general procedure F using 61 
(2.3 g, 4.70 mmol). The title carbamate was isolated as 
a foamy white solid (2.3 g, 3.90 mmol, 82%). M.P. 56-
57 °C (CHCl3). TLC – Rf = 0.30 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.28-
1.50 (m, 27H, 3 x C(CH3)3), 3.05-3.39 (m, 12H, 6 x NCH2), 4.90 (s, 2H, CH2Ar), 7.21-7.47 (m, 
4H, 4 x ArH), 7.69-7.74 (m, 1H, ArH), 7.78-7.83 (m, 1H, ArH), 8.00-8.02 (m, 1H, ArH). 
13
C 
NMR (101 MHz, CDCl3) δC 28.4 (3 x C(CH3)3), 39.5 (NCH2), 43.5 (NCH2), 44.7 (NCH2), 45.2 
(NCH2), 45.4 (NCH2), 47.8 (NCH2), 53.1 (CH2Ar), 79.7 (C(CH3)3), 79.9 (C(CH3)3), 80.1 
(C(CH3)3), 125.3 (ArC), 125.8 (ArC), 126.8 (ArC), 128.1 (ArC), 128.9 (ArC), 131.2 (ArC), 132.0 
(ArC), 133.2 (ArC), 133.4 (ArC), 133.8 (ArC), 155.2 (CO), 155.4 (CO), 156.0 (CO). HR-MS 
(ESI, positive ion mode) – m/z for [C32H50N4O6+H]
+ = 587.3809. Found 587.3795. FTIR (neat) 






Under a dry, inert atmosphere, a solution of 61 (1.5 
g, 5.4 mmol, 1.00 equiv, 1.00 M) in anhydrous 
DCM (5.4 mL) was cooled to 0 °C. Ethyl 
trifluoroacetate (0.70 mL, 5.9 mmol, 1.10 equiv.) 
was added dropwise over 30 minutes and the 
resulting solution was stirred for 30 minutes. The solution was warmed to room temperature and 
stirred for a further hour. The solution was then diluted with saturated aqueous NaHCO3 (50 mL) 
and DCM (50 mL). The organic phase was washed with deionised water, dried (MgSO4), filtered 
and concentrated in vacuo to give the crude trifluoroacetamide. Under a dry, inert atmosphere, 
the crude product was dissolved in anhydrous DCM (43 mL) and TFA (11 mL) was added 
dropwise. The resulting solution was stirred for 16 h and concentrated in vacuo. The crude product 
was diluted with saturated aqueous NaHCO3 (100 mL) and extracted with DCM (3 x 50 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo to give the 
crude triamine. Under a dry, inert atmosphere, the residue was dissolved in anhydrous DCM (55 
mL) and cooled to 0 °C. Anhydrous TEA (6.7 mL, 48.6 mmol, 9.00 equiv.) was added in one 
portion and 4-methoxyphenyl isocyanate (3.2 mL, 24.3 mmol, 4.50 equiv.) was added dropwise 
to give a colourless solution. The solution was stirred for 16 h then concentrated in vacuo and 
purified by column chromatography (1-10% MeOH:DCM) to yield the title triurea as a foamy 
white solid (403 mg, 0.5 mmol, 9%). M.P. 140-141 °C (CHCl3). TLC – Rf = 0.19 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 2.89-3.57 (m, 12H, 6 x NCH2), 3.70 (s, 3H, 
OCH3), 3.71 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 5.04 (s, 2H, CH2Ar), 5.75 (s, 1H, NH), 6.66-
6.86 (m, 6H, 6 x ArH), 7.03 (d, J = 9.0, 2H, 2 x ArH), 7.35-7.60 (m, 8H, 8 x ArH), 7.76 (d, J = 
7.7, 1H, ArH), 7.81 (d, J = 7.7, 1H, ArH), 8.00 (d, J = 7.7, 1H, ArH), 8.57 (s, 1H, NH), 8.88 (s, 
1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 39.7 (NCH2), 45.8 (NCH2), 46.3 (NCH2), 47.5 (NCH2), 
47.8 (NCH2), 48.4 (NCH2), 49.7 (CH2Ar), 55.5 (3 x OCH3), 114.1 (2 x ArC), 114.2 (2 x ArC), 
114.4 (2 x ArC), 117.6 (q, J = 287.2, CF3), 121.3 (2 x ArC), 121.7 (2 x ArC), 122.3 (2 x ArC), 
125.4 (ArC), 126.3 (ArC), 126.8 (ArC), 128.3 (ArC), 128.6 (ArC), 128.9 (ArC), 129.3 (ArC), 
131.3 (ArC), 132.7 (ArC), 132.9 (ArC), 133.1 (ArC), 133.2 (ArC), 133.9 (ArC), 155.3 (ArC), 
155.4 (ArC), 155.6 (ArC), 156.2 (q, J = 36.2, CO), 156.7 (CO), 157.0 (CO). 
19
F NMR (377 MHz, 
CDCl3) δF −72.3 (CF3). HR-MS (MALDI) – m/z for [C43H46F3N7O7+Na]
+ = 852.3309. Found 







Synthesised according to general procedure H using 65 
(400 mg, 0.49 mmol). The title amine was isolated as a 
foamy white solid (342 mg, 0.47 mmol, 95%). M.P. 
133-134 °C (CHCl3). TLC – Rf = 0.30 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.88 (s, 
2H, NH2), 2.80 (t, J = 7.0, 2H, NCH2), 3.01-3.26 (m, 8H, 4 x NCH2), 3.45 (t, J = 6.3, 2H, NCH2), 
3.70 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 5.05 (s, 2H, CH2Ar), 5.97 (s, 1H, 
NH), 6.75 (d, J = 8.9, 2H, 2 x ArH), 6.77 (d, J = 8.9, 2H, 2 x ArH), 6.80 (d, J = 8.9, 2H, 2 x ArH), 
7.03 (d, J = 8.9, 2H, 2 x ArH), 7.34-7.47 (m, 4H, 4 x ArH), 7.50 (d, J = 8.9, 2H, 2 x ArH), 7.59 
(d, J = 8.9, 2H, 2 x ArH), 7.75 (d, J = 7.6, 1H, ArH), 7.80 (d, J = 7.6, 1H, ArH), 8.00 (d, J = 7.6, 
1H, ArH), 8.67 (s, 1H, NH), 9.01 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 39.3 (NCH2), 
46.9 (NCH2), 47.3 (NCH2), 47.0 (NCH2), 48.1 (NCH2), 49.2 (NCH2), 49.3 (CH2Ar), 55.4 (OCH3), 
55.5 (OCH3), 55.5 (OCH3), 113.9 (2 x ArC), 113.9 (2 x ArC), 114.0 (2 x ArC), 121.1 (2 x ArC), 
121.5 (2 x ArC), 121.6 (2 x ArC), 125.4 (ArC), 125.5 (ArC), 126.2 (ArC), 126.7 (ArC), 128.3 
(ArC), 128.4 (ArC), 128.8 (ArC), 131.2 (ArC), 131.6 (ArC), 131.8 (ArC), 132.9 (ArC), 133.1 
(ArC), 133.8 (ArC), 155.2 (ArC), 155.3 (ArC), 155.6 (ArC), 156.6 (CO), 156.6 (CO), 157.4 (CO). 
HR-MS (ESI, positive ion mode) – m/z for [C41H47N7O6+H]
+ = 734.3666. Found 734.3659. FTIR 




Synthesised according to general procedure E 
using 66 (175 mg, 0.24 mmol) and 1-
naphthaldehyde (0.05 mL, 0.36 mmol). The 
crude product was purified by column 
chromatography (2-10% MeOH:DCM) to give the title amine as a foamy white solid (132 mg, 
0.15 mmol, 63%). M.P. 149-150 °C (CHCl3). TLC – Rf = 0.44 (SiO2, 5:95 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 2.90 (t, J = 4.6, 2H, NCH2), 2.94-2.98 (m, 2H, NCH2), 3.08-3.17 (m, 
4H, 2 x NCH2), 3.26-3.29 (m, 2H, NCH2), 3.45 (t, J = 7.6, 2H, NCH2), 3.74 (s, 3H, OCH3), 3.76 
(s, 3H, OCH3), 3.77 (s, 3H, OCH3), 4.28 (s, 2H, CH2Ar), 5.10 (s, 2H, CH2Ar), 6.64 (d, J = 9.0, 
2H, 2 x ArH), 6.77 (d, J = 9.0, 2H, 2 x ArH), 6.83 (d, J = 9.0, 2H, 2 x ArH), 6.91 (d, J = 8.0, 2H, 
2 x ArH), 7.36-7.60 (m, 8H, 8 x ArH), 7.77-7.83 (m, 2H, 2 x ArH), 7.86-7.89 (m, 2H, 2 x ArH), 
8.00 (d, J = 8.0, 1H, ArH), 8.13 (d, J = 8.0, 1H, ArH), 8.48 (s, 1H, NH), 8.71 (s, 1H, NH), 9.59 
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(s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 45.4 (NCH2), 46.8 (NCH2), 46.9 (NCH2), 47.8 
(NCH2), 49.7 (NCH2), 51.1 (NCH2), 51.8 (CH2Ar), 53.3 (CH2Ar), 55.5 (3 x OCH3), 113.8 (2 x 
ArC), 113.9 (2 x ArC), 114.0 (2 x ArC), 120.9 (2 x ArC), 121.0 (2 x ArC), 121.5 (2 x ArC), 123.1 
(ArC), 123.7 (ArC), 125.3 (ArC), 125.4 (ArC), 126.0 (ArC), 126.2 (ArC), 126.6 (ArC), 126.7 
(ArC), 128.4 (ArC), 128.5 (ArC), 128.6 (ArC), 129.0 (ArC), 131.5 (ArC), 131.7 (ArC), 132.6 
(ArC), 132.8 (ArC), 133.1 (ArC), 133.8 (ArC), 134.0 (ArC), 134.3 (ArC), 155.1 (ArC), 155.3 
(ArC), 156.0 (ArC), 156.1 (CO), 156.4 (CO), 158.2 (CO). HR-MS (ESI, positive ion mode) – 
m/z for [C52H55N7O6+Na]




Synthesised according to general procedure B1 
using 67 (100 mg, 0.11 mmol) and 4-
nitrophenyl isothiocyanate (31 mg, 0.17 
mmol). The crude product was purified by 
column chromatography (1-2% MeOH:DCM) 
to yield the title thiourea as a yellow solid (116 mg, 0.11 mmol, >99%). M.P. 174-175 °C (DCM). 
TLC – Rf = 0.32 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 2.89-3.71 (m, 12H, 
2 x NCH2), 3.79 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 5.04 (s, 2H, CH2Ar), 
5.67 (s, 2H, CH2Ar), 6.38 (s, 1H, NH), 6.83 (d, J = 9.0, 2H, 2 x ArH), 6.83 (d, J = 9.0, 2H, 2 x 
ArH), 6.86 (d, J = 9.0, 2H, 2 x ArH), 7.17-7.48 (m, 8H, 8 x ArH), 7.51 (d, J = 9.0, 2H, 2 x ArH), 
7.60 (d, J = 9.0, 2H, 2 x ArH), 7.64-8.18 (m, 12H, 12 x ArH), 8.96 (s, 2H, 2 x NH), 10.44 (s, 1H, 
NH). 
13
C NMR (126 MHz, CDCl3) δC 47.0-47.9 (4 x NCH2), 48.6 (NCH2), 48.9 (NCH2), 51.1 
(CH2Ar), 54.1 (CH2Ar), 55.5 (3 x OCH3), 113.9 (2 x ArC), 113.9 (2 x ArC), 114.0 (2 x ArC), 
121.0 (6 x ArC), 122.4 (ArC), 123.2 (ArC), 123.4 (ArC), 123.8 (ArC), 124.0 (ArC), 125.3 (ArC), 
125.6 (ArC), 126.4 (ArC), 126.7 (ArC), 127.0 (2 x ArC), 127.2 (2 x ArC), 128.5 (ArC), 128.6 
(ArC), 128.8 (ArC), 129.1 (ArC), 129.3 (ArC), 130.6 (ArC), 131.0 (ArC), 131.5 (ArC), 132.6 
(ArC), 132.8 (ArC), 133.7 (ArC), 134.0 (ArC), 143.7 (ArC), 147.0 (ArC), 155.4 (ArC), 155.5 
(ArC), 155.5 (ArC), 156.4 (CO), 156.5 (CO), 156.9 (CO), 180.1 (CS). HR-MS (ESI, positive ion 
mode) – m/z for [C59H59N9O8S+Na]
+ = 1076.4105. Found 1076.4112. FTIR (neat) – 3698, 3304, 








Synthesised according to general procedure I using 66 
(75 mg, 0.10 mmol). The crude product was purified 
by column chromatography (1-10% MeOH:DCM) to 
give the title succinimide as a foamy white solid (67 
mg, 0.08 mmol, 80%). M.P. 152-153 °C (CHCl3). 
TLC – Rf = 0.50 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 2.74 (s, 4H, 2 x 
C(O)CH2), 3.14-3.19 (m, 2H, NCH2), 3.24-3.29 (m, 4H, 2 x NCH2), 3.39 (t, J = 6.4, 2H, NCH2), 
3.53 (t, J = 7.3, 2H, NCH2), 3.68 (t, J = 7.0, 2H, NCH2), 3.80-3.81 (m, 9H, 3 x OCH3), 5.13 (s, 
2H, CH2Ar), 6.82-6.86 (m, 6H, 6 x ArH), 7.47-7.63 (m, 10H, 10 x ArH), 7.90 (d, J = 8.3, 1H, 
ArH), 7.95 (d, J = 8.0, 1H, ArH), 8.11-8.13 (m, 1H, ArH), 8.69 (s, 1H, NH). 
13
C NMR (126 MHz, 
CDCl3) δC 28.2 (2 x C(O)CH2), 37.0 (NCH2), 45.2 (NCH2), 47.1 (NCH2), 47.3 (NCH2), 47.7 
(NCH2), 47.8 (NCH2), 49.4 (CH2Ar), 55.5 (OCH3), 55.5 (OCH3), 55.5 (OCH3), 113.9 (2 x ArC), 
113.9 (2 x ArC), 114.0 (2 x ArC), 121.0 (2 x ArC), 121.1 (2 x ArC), 121.7 (2 x ArC), 125.4 (2 x 
ArC), 126.3 (2 x ArC), 126.9 (3 x ArC), 128.6 (ArC), 128.8 (ArC), 128.9 (ArC), 133.0 (ArC), 
133.1 (ArC), 133.9 (ArC), 155.2 (ArC), 155.5 (ArC), 155.5 (ArC), 155.8 (CO), 156.2 (CO), 156.3 
(CO), 177.6 (2 x CO). HR-MS (ESI, positive ion mode) – m/z for [C45H49N7O8+Na]
+ = 838.3540. 
Found 838.3533. FTIR (neat) – 3322, 2997, 2908, 1699, 1651. 
 
N-(4-Methoxyphenyl)-N-methylcarbamoyl chloride, 70 
Under a dry, inert atmosphere, a solution of triphosgene (500 mg, 1.68 mmol, 
0.46 equiv.) in anhydrous DCM (5 mL) was cooled to 0 °C. To this solution 
was added anhydrous pyridine (0.30 mL, 3.66 mmol, 1.00 equiv.) dropwise and 
the solution was stirred for 5 minutes. 4-methoxy-N-methylaniline (502 mg, 3.66 mmol, 1.00 
equiv., 0.70 M) was added, the solution was warmed to room temperature and stirred for 1 h. 
Aqueous HCl (1 M, 10 mL) was added and the aqueous phase extracted with DCM (3 x 5 mL). 
The combined organic extracts were washed with saturated aqueous NaHCO3, dried (MgSO4), 
filtered and concentrated in vacuo. The crude mixture was purified by column chromatography 
(50% EtOAc:PE) to give the title carbamoyl chloride as a yellow oil (731 mg, 3.66 mmol, >99%). 
TLC – Rf = 0.63 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 3.33 (s, 3H, NCH3), 
3.81 (s, 3H, OCH3), 6.91 (d, J = 8.8, 2 x ArH), 7.14 (d, J = 8.8, 2 x ArH). Spectroscopic data 






Synthesised according to general procedure B2 
using 67 (30 mg, 0.03 mmol) and 70 (10 mg, 
0.05 mmol). The crude product was purified by 
column chromatography (1-2% MeOH:DCM) 
to yield the title tetraurea as a white solid (27 
mg, 0.03 mmol, 88%). M.P. 153-154 °C (CHCl3). TLC – Rf = 0.14 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (500 MHz, CD2Cl2) δH 2.86-2.96 (m, 4H, 2 x NCH2), 3.05 (NCH2), 3.27-3.30 (m, 4H, 
2 x NCH2), 3.36 (t, J = 7.0, 2H, NCH2), 3.66 (s, 3H, NCH3), 3.76 (s, 3H, OCH3), 3.78 (s, 3H, 
OCH3), 3.78 (s, 3H, OCH3), 4.50 (s, 2H, CH2Ar), 5.08 (s, 2H, CH2Ar), 6.71 (d, J = 8.9, 2H, 2 x 
ArH), 6.79 (d, J = 9.0, 2H, 2 x ArH), 6.85 (d, J = 9.0, 2H, 2 x ArH), 6.86 (d, J = 9.0, 2H, 2 x ArH), 
7.05 (d, J = 8.9, 2H, 2 x ArH), 7.12 (d, J = 6.7, 1H, ArH), 7.27 (t, J = 7.5, 1H, ArH), 7.36-7.73 
(m, 13H, 13 x ArH), 7.79 (d, J = 8.0, 1H, ArH), 7.83 (d, J = 8.0, 1H, ArH), 8.15 (d, J = 8.0, 1H, 
ArH), 8.73 (s, 1H, NH), 8.85 (s, 1H, NH). 9.09 (s, 1H, NH). 
13
C NMR (126 MHz, CD2Cl2) δC 
40.9 (NCH3), 44.9 (NCH2), 47.0 (NCH2), 47.1 (NCH2), 47.4 (NCH2), 47.8 (NCH2), 48.5 (NCH2), 
48.7 (CH2Ar), 51.9 (CH2Ar), 55.4 (4 x OCH3), 113.7 (2 x ArC), 113.7 (2 x ArC), 113.8 (2 x ArC), 
114.8 (2 x ArC), 121.0 (2 x ArC), 121.1 (2 x ArC), 122.5 (2 x ArC), 123.5 (2 x ArC), 125.0 (ArC), 
125.2 (ArC), 125.3 (ArC), 125.8 (ArC), 126.0 (ArC), 126.1 (ArC), 126.4 (ArC), 126.5 (ArC), 
126.7 (ArC), 128.0 (ArC), 128.4 (ArC), 128.3 (ArC), 128.5 (ArC), 128.6 (ArC), 128.9 (ArC), 
131.1 (ArC), 131.6 (ArC), 132.3 (ArC), 133.2 (ArC), 133.3 (ArC), 133.6 (ArC), 133.8 (ArC), 
138.9 (ArC), 155.0 (ArC), 155.1 (ArC), 155.3 (ArC), 156.4 (CO), 156.5 (CO), 157.4 (CO), 162.8 
(CO). HR-MS (ESI, positive ion mode) – m/z for [C61H64N8O8+Na]
+ = 1059.4745. Found 
1059.4725. FTIR (neat) – 3315, 2990, 2905, 1652, 1609. 
 
4,7,10,13-Tetrakis(tert-butoxycarbonyl)-1,4,7,10,13,16-hexaazahexadecane, 72 
Synthesised according to general procedure F 
using pentaethylenehexamine (3.16 mL, 
12.91 mmol). The title tetracarbamate was 
isolated as a pale yellow oil (6.53 g, 10.33 mmol, 80%). TLC – Rf = 0.10 (SiO2, 5:95:1 
MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, CDCl3) δH 1.39-1.44 (m, 36H, 4 x C(CH3)3), 2.39 
(s, 4H, 2 x NH2), 2.71-2.82 (m, 4H, 2 x NCH2), 3.15-3.40 (m, 16, 8 x NCH2). 
13
C NMR (101 
MHz, CDCl3) δC 28.4-28.6 (2 x C(CH3)3), 40.9 (2 x NCH2), 45.5-50.5 (8 x NCH2), 79.5-80.0 (4 
x C(CH3)3), 155.1-155.9 (4 x CO). HR-MS (ESI, positive ion mode) – m/z for [C30H60N6O8+H]
+ 





Synthesised according to general 
procedure E using 72 (3.00 g, 4.74 
mmol) and 1-naphthaldehyde (0.66 
mL, 4.74 mmol). The crude product was purified by column chromatography (1-10% 
MeOH:DCM, 1% NH4OH) to yield the title amine as a foamy white solid (1.83 g, 2.37 mmol, 
50%). M.P. 80-81 °C (CHCl3). TLC – Rf = 0.20 (SiO2, 5:95:1 MeOH:DCM:NH4OH). 
1
H NMR 
(400 MHz, CDCl3) δH 1.40-1.48 (m, 36H, 4 x C(CH3)3), 2.76-2.94 (m, 4H, 2 x NCH2), 3.17-3.45 
(m, 16H, 8 x NCH2), 4.25 (s, 2H, CH2Ar), 7.37-7.54 (m, 4H, 4 x ArH), 7.76 (d, J = 7.8, 1H, ArH), 
7.85 (d, J = 7.8, 1H, ArH), 8.11 (d, J = 7.8, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 28.5-28.7 
(4 x C(CH3)3), 40.8-41.0 (2 x NCH2), 45.6-48.3 (8 x NCH2), 51.7 (CH2Ar), 79.6-80.0 (4 x 
C(CH3)3), 123.8 (ArC), 125.5 (ArC), 125.8 (ArC), 126.5 (ArC), 126.6 (ArC), 127.8 (ArC), 128.8 
(ArC), 131.4 (ArC), 131.9 (ArC), 136.0 (ArC), 155.0 (CO), 155.5 (CO), 155.7 (CO), 156.2 (CO). 
HR-MS (ESI, positive ion mode) – m/z for [C41H68N6O8+H]
+ = 773.5177. Found 773.5145. FTIR 
(neat) – 3398, 2973, 2931, 1683. 
 
1-(Naphthalen-1-ylmethyl)-16-trifluoroacetyl-1,4,7,10,13,16-hexaazahexadecane, 74 
Under a dry, inert atmosphere, a 
solution of 73 (1.00 g, 1.29 
mmol, 1.00 equiv. 1.60 M) in 
anhydrous DCM (0.8 mL) was cooled to 0 °C. Ethyl trifluoroacetate (0.17 mL, 1.42 mmol, 1.10 
equiv.) was added dropwise over 30 minutes and the resulting solution was stirred for 30 minutes 
at 0 °C. The solution was then warmed to room temperature and stirred for a further hour. The 
solution was then diluted with anhydrous DCM (10 mL) and TFA (2 mL) was added dropwise. 
The solution was stirred for 16 h and concentrated in vacuo. The crude product was diluted with 
saturated aqueous NaHCO3 and then extracted with DCM (3 x 25 mL). The combined organic 
extracts were washed with brine, dried (MgSO4), filtered and concentrated in vacuo to give the 
title pentamine as a colourless oil (369 mg, 0.77 mmol, 61%). TLC – Rf = 0.04 (SiO2, 10:90:1 
MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, CDCl3) δH 2.86-3.01 (m, 18H, 9 x NCH2), 3.42 
(NCH2), 7.29-7.46 (m, 4H, 4 x ArH), 7.70 (d, J = 8.0, 1H, ArH), 7.86 (d, J = 8.0, 1H, ArH), 8.14 
(d, J = 8.0, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 43.2 (NCH2), 44.6-46.8 (9 x NCH2), 52.3 
(CH2Ar), 115.9 (q, J = 288.1, CF3), 123.8 (ArC), 125.5 (ArC), 125.8 (ArC), 126.5 (ArC), 126.6 




F NMR (377 MHz, CDCl3) δF −74.3 (CF3). HR-MS (ESI, positive ion mode) – m/z for 
[C24H35F3N6O+Na]
+ = 491.2722. Found 491.2701. FTIR (neat) – 3410, 2991, 2950, 1650. 
 
1,16-Bis(trifluoroacetyl)-4,7,10,13-tetrakis(4-methoxyanilinylcarbonyl)-1,4,7,10,13,16-
hexaazahexadecane, 76  
Synthesised according to general 
procedure J using 
pentaethylenehexamine (2.11 mL, 8.61 
mmol) and 4-methoxyphenyl 
isocyanate (6.70 mL, 51.70 mmol). 
After 16 h, a white precipitate formed and was filtered. The residue was washed with DCM (3 x 
10 mL) and air-dried to afford the title tetraurea as a white solid (1.76 g, 1.72 mmol, 20%). M.P. 
228-229 °C (DCM). TLC – Rf = 0.31 (5:95 MeOH:DCM). 
1
H NMR (400 MHz, (CD3)2SO) δH 
3.33 (s, 4H, 2 x NCH2), 3.35-3.53 (m, 16H, 8 x NCH2), 3.70 (s, 6H, 2 x OCH3), 3.72 (s, 6H, 2 x 
OCH3), 6.82 (d, J = 9.1, 4H, 4 x ArH), 6.83 (d, J = 9.1, 4H, 4 x ArH), 7.37 (d, J = 9.1, 4H, 4 x 
ArH), 7.43 (d, J = 9.1, 4H, 4 x ArH), 8.37 (s, 2H, 2 x NH), 8.77 (s, 2H, 2 x NH), 9.49 (t, J = 5.7, 
2H, 2 x NH). 
13
C NMR (101 MHz, (CD3)2SO) δC 38.3 (2 x NCH2), 45.9 (2 x NCH2), 46.1 (2 x 
NCH2), 46.5 (2 x NCH2), 46.6 (2 x NCH2), 55.1 (2 x OCH3), 55.1 (2 x OCH3), 113.4 (4 x ArC), 
113.5 (4 x ArC), 115.8 (q, J = 288.6, 2 x CF3), 121.6 (4 x ArC), 121.8 (4 x ArC), 132.9 (2 x ArC), 
133.1 (2 x ArC), 154.3 (2 x ArC), 154.7 (2 x ArC), 155.6 (CO), 155.9 (CO), 156.9 (q, J = 35.9, 2 
x CO),. 
19
F NMR (377 MHz, (CD3)2SO) δF −74.5 (2 x CF3). HR-MS (MALDI) – m/z for 
[C46H54F6N10O10+Na]
+ = 1043.3826. Found 1043.3795. FTIR (neat) – 3444, 3240, 2947, 1661, 
1640, 1622.  
 
4,7,10,13-Tetrakis(4-methoxyanilinylcarbonyl)-1,4,7,10,13,16-hexaazahexadecane, 77 
Synthesised according to general procedure H 
using 76 (3.00 g, 2.94 mmol). After 5 h, a white 
precipitate formed and was filtered. The 
residue was washed with MeOH (3 x 10 mL) 
and air-dried to afford the title diamine as a white solid (2.32 g, 2.79 mmol, 95%). M.P. 144-145 
°C (DCM). TLC – Rf = 0.05 (5:95:1 MeOH:DCM:TEA). 
1
H NMR (400 MHz, (CD3)2SO) δH 
2.71 (t, J = 5.6, 4H, 2 x NCH2), 3.29-3.50 (m, 16H, 8 x NCH2), 3.69 (s, 6H, 2 x OCH3), 3.71 (s, 
6H, 2 x OCH3), 6.82 (d, J = 9.0, 4H, 4 x ArH), 6.83 (d, J = 9.0, 4H, 4 x ArH), 7.35 (d, J = 9.0, 4H, 





(101 MHz, (CD3)2SO) δC 41.5 (2 x NCH2), 46.7 (2 x NCH2), 46.9 (2 x NCH2), 47.1 (2 x NCH2), 
48.4 (2 x NCH2), 55.5 (2 x OCH3), 55.6 (2 x OCH3), 114.0 (4 x ArC), 114.2 (4 x ArC), 120.0 (8 
x ArC), 134.0 (2 x ArC), 134.1 (2 x ArC), 154.0 (2 x ArC), 154.3 (2 x ArC), 154.8 (2 x CO), 
155.0 (2 x CO). HR-MS (MALDI) – m/z for [C42H56N10O8+Na]
+ = 851.4180. Found 851.5194. 




Synthesised according to general procedure J 
using tetraethylenepentamine (2.51 mL, 13.20 
mmol) and 4-methoxyphenyl isocyanate (6.84 
mL, 52.80 mmol). After 16 h, a white precipitate 
formed and was filtered. The residue was washed 
with DCM (3 x 10 mL) and air-dried to afford the title triurea as a white solid (2.74 g, 3.32 mmol, 
25%). M.P. 177-178 °C (DCM). TLC – Rf = 0.26 (5:95 MeOH:DCM). 
1
H NMR (400 MHz, 
(CD3)2SO) δH 3.36-3.54 (m, 16H, 8 x NCH2), 3.71 (s, 6H, 2 x OCH3), 3.72 (3H, s, OCH3), 6.83 
(d, J = 9.0, 4H, 4 x ArH), 6.85 (d, J = 9.0, 2H, 2 x ArH), 7.38 (d, J = 9.0, 4H, 4 x ArH), 7.44 (d, J 
= 9.0, 2H, 2 x ArH), 8.47 (s, 2H, 2 x NH), 8.81 (s, 1H, NH), 9.50 (t, J = 5.7, 2H, 2 x NH). 
13
C 
NMR (101 MHz, (CD3)2SO) δC 38.3 (2 x NCH2), 46.5 (2 x NCH2), 46.7 (2 x NCH2), 47.0 (2 x 
NCH2), 55.1 (2 x OCH3), 55.2 (OCH3), 113.5 (4 x ArC), 113.6 (2 x ArC), 116.3 (q, J = 290.7, 2 
x CF3), 121.4 (2 x ArC), 121.8 (4 x ArC), 133.2 (2 x ArC), 133.3 (ArC), 154.7 (2 x CO), 155.6 
(ArC), 155.9 (q, J = 35.6, 2 x CO). 
19
F NMR (377 MHz, (CD3)2SO) δF −74.5 (2 x CF3). HR-MS 
(MALDI) – m/z for [C36H42F6N8O8+Na]
+ = 851.2927. Found 851.2888. FTIR (neat) – 3296, 2976, 
2945, 1719, 1645. 
 
4,7,10-Tris(4-methoxyanilinylcarbonyl)-1,4,7,10,13-pentaazatridecane, 80 
Synthesised according to general procedure H using 79 
(4.30 g, 5.19 mmol). After 5 h, a white precipitate 
formed and was filtered. The residue was washed with 
MeOH (3 x 10 mL) and air-dried to afford the title 
diamine as a white solid (3.11 g, 4.88 mmol, 94%). M.P. 163-164 °C (DCM). TLC – Rf = 0.05 
(5:95:1 MeOH:DCM:TEA). 
1
H NMR (400 MHz, (CD3)2SO) δH 2.78 (t, J = 5.7, 4H, 2 x NCH2), 
3.37 (t, J = 6.0, 4H, 2 x NCH2), 3.42 (t, J = 6.6, 4H, 2 x NCH2), 3.48 (t, J = 6.6, 4H, 2 x NCH2), 
3.70 (s, 6H, 2 x OCH3), 3.71 (s, 3H, OCH3), 6.83 (d, J = 9.0, 4H, 4 x ArH), 6.85 (d, J = 9.0, 2H, 
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2 x ArH), 7.37 (d, J = 9.0, 4H, 4 x ArH), 7.49 (d, J = 9.0, 2H, 2 x ArH), 8.98 (s, 1H, NH), 9.51 (s, 
2H, 2 x NH). 
13
C NMR (101 MHz, (CD3)2SO) δC 40.8 (2 x NCH2), 46.3 (2 x NCH2), 46.8 (2 x 
NCH2), 47.0 (2 x NCH2), 55.6 (2 x OCH3), 55.7 (OCH3), 114.1 (4 x ArC), 114.1 (2 x ArC), 121.1 
(2 x ArC), 121.2 (4 x ArC), 134.0 (ArC), 134.1 (2 x ArC), 154.8 (2 x CO), 154.9 (2 x ArC), 156.1 
(ArC), 157.0 (CO). HR-MS (MALDI) – m/z for [C32H44N8O6+Na]
+ = 659.3282. Found 659.3329. 
FTIR (neat) – 3237, 2987, 2930, 1647. 
 
tert-Butyl benzyl(2-hydroxyethyl)carbamate, 81 
Synthesised according to general procedure K using N-benzylethanolamine 
(3.55 mL, 25.00 mmol). The crude product was purified by column 
chromatography (10-30% EtOAc:PE) to give the title carbamate as a colourless 
oil (5.72 g, 22.80 mmol, 91%). 
1
H NMR (400 MHz, CDCl3) δH 1.41 (s, 9H, C(CH3)3), 3.13-3.16 
(m, 2H, NCH2), 3.60-3.65 (m, 2H, OCH2), 4.40-4.45 (m, 2H, CH2Ar), 7.28-7.35 (m, 5H, 5 x ArH). 
TLC – Rf = 0.05 (10:90 EtOAc:PE). Spectroscopic data matched that previously reported.
131 
 
tert-Butyl benzyl(2-oxoethyl)carbamate, 82 
Synthesised according to general procedure L using 81 (1.0 g, 3.98 mmol). The 
crude product was purified by column chromatography (10-20% EtOAc:PE) to 
give the title aldehyde as a colourless oil (982 mg, 3.94 mmol, 99%). 
1
H NMR 
(400 MHz, CDCl3) δH 1.42 (s, 9H, C(CH3)3),  4.12-4.16 (m, 2H, NCH2), 4.60 (s, 2H, CH2Ar), 
7.28-7.35 (m, 5H, 5 x ArH), 9.69-9.73 (m, 1H, CHO). TLC – Rf = 0.13 (10:90 EtOAc:PE). 




Synthesised according to general 
procedure E using 80 (200 mg, 0.31 
mmol) and 82 (86 mg, 0.35 mmol). 
The crude product was purified by 
column chromatography (1-10% 
MeOH:DCM, 1% TEA) to give the title amine as a foamy white solid (122 mg, 0.14 mmol, 45%). 
M.P. 150-151 °C (CHCl3). TLC – Rf = 0.38 (10:90:1 MeOH:DCM:TEA). 
1
H NMR (400 MHz, 
CDCl3) δH 1.45 (s, 9H, C(CH3)3), 2.70-2.83 (m, 4H, 2 x NCH2), 2.96 (t, J = 4.9, NCH2), 3.26-3.57 
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(m, 14H, 7 x NCH2), 3.76 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 4.41 (s, 2H, 
CH2Ar), 6.79 (d, J = 9.1, 2H, 2 x ArH), 6.80 (d, J = 9.1, 2H, 2 x ArH), 6.82 (d, J = 9.1, 2H, 2 x 
ArH), 7.18 (d, J = 9.1, 2H, 2 x ArH), 7.27-7.37 (m, 7H, 7 x ArH), 7.57 (d, J = 9.1, 2H, 2 x ArH), 
8.96 (s, 1H, NH), 9.73 (s, 1H, NH), 9.83 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 28.5 
(C(CH3)3), 46.1 (7 x NCH2), 46.4 (NCH2), 47.2 (NCH2), 48.1 (CH2Ar), 49.6 (NCH2), 55.6 (3 x 
OCH3), 80.4 (C(CH3)3), 113.8-114.3 (6 x ArC), 120.0-121.4 (6 x ArC), 127.3 (2 x ArC), 127.5 
(ArC), 128.6 (2 x ArC), 133.3-133.7 (3 x ArC), 138.3 (ArC), 155.1 (3 x ArC), 156.0 (3 x CO), 
156.4 (CO). HR-MS (ESI, positive ion mode) – m/z for [C46H63N9O8+H]
+ = 870.4878. Found 
870.4899. FTIR (neat) – 3290, 2994, 2934, 1649. 
 
1-Benzyl-7,10,13-tris(4-methoxyanilinylcarbonyl)-16-trifluoroacetyl-1,4,7,10,13,16-
hexaazahexadecane, 84  
Under a dry, inert atmosphere, a 
solution of 83 (700 mg, 0.80 
mmol, 1.00 equiv., 1.0 M) in 
anhydrous DCM (0.8 mL) was 
cooled to 0 °C. Ethyl 
trifluoroacetate (0.11 mL, 0.88 mmol, 1.10 equiv.) was added dropwise over 30 minutes and the 
resulting solution was stirred for 30 minutes at 0 °C. The solution was then warmed to room 
temperature and stirred for a further hour. The solution was then diluted with anhydrous DCM (6 
mL) and TFA (2 mL) was added dropwise. The solution was stirred for 16 h and concentrated in 
vacuo. The crude product was diluted with saturated aqueous NaHCO3 and then extracted with 
DCM (3 x 25 mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
in vacuo to give the title amine as a foamy white solid (540 mg, 0.62 mmol, 78%). M.P. 156-157 
°C (CHCl3). TLC – Rf = 0.21 (5:95:1 MeOH:DCM:TEA). 
1
H NMR (400 MHz, CDCl3) δH 2.69-
2.85 (m, 8H, 4 x NCH2), 3.32-3.55 (m, 14H, CH2Ar, 6 x NCH2), 3.74 (s, 3H, OCH3), 3.76 (s, 6H, 
2 x OCH3), 6.74-6.84 (m, 6H, 6 x ArH), 7.21-7.32 (m, 5H, 5 x ArH), 7.52 (d, J = 8.9, 2H, 2 x 
ArH), 7.59 (d, J = 8.9, 2H, 2 x ArH), 7.60 (d, J = 8.9, 2H, 2 x ArH), 8.82 (s, 1H, NH), 9.00 (s, 
1H, NH), 9.13 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 46.4 (NCH2), 47.1 (NCH2), 48.3 
(NCH2), 48.4 (NCH2), 48.4 (NCH2), 48.5 (NCH2), 49.2 (CH2Ar), 49.6 (NCH2), 49.7 (NCH2), 50.0 
(NCH2), 50.1 (NCH2), 55.5 (3 x OCH3), 113.9 (2 x ArC), 114.0 (2 x ArC), 114.0 (2 x ArC), 115.9 
(q, J = 287.8, CF3), 120.9 (2 x ArC), 121.1 (2 x ArC), 121.5 (2 x ArC), 127.1 (ArC), 128.0 (2 x 
ArC), 128.5 (2 x ArC), 132.9-133.6 (3 x ArC), 140.1 (ArC), 155.0 (ArC), 155.2 (ArC), 155.3 
(ArC), 155.3 (CO), 155.5 (CO), 156.4 (q, J = 36.4, CO), 156.6 (CO). 
19
F NMR (377 MHz, CDCl3) 
δF −74.3 (CF3). HR-MS (ESI, positive ion mode) – m/z for [C43H54F3N9O7+Na]
+ = 888.3996. 





Synthesised according to general 
procedure B1 using 84 (1.0 g, 1.15 
mmol) and 4-methoxyphenyl 
isocyanate (0.45 mL, 3.46 mmol). 
The crude product was purified by 
column chromatography (2-10% MeOH:DCM) to give the title pentaurea as a foamy white solid 
(503 mg, 0.43 mmol, 38%). M.P. 186-187 °C (DCM/Et2O). TLC – Rf = 0.25 (5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.32-3.64 (m, 20H, 10 x NCH2), 3.71-3.81 (m, 15H, 5 x OCH3), 
4.49 (s, 2H, CH2Ar), 5.88 (s, 1H, NH), 6.78-6.85 (m, 10H, 10 x ArH), 7.07 (d, J = 9.0, 2H, 2 x 
ArH), 7.20 (d, J = 9.0, 2H, 2 x ArH), 7.26-7.36 (m, 5H, 5 x ArH), 7.49 (d, J = 9.0, 2H, 2 x ArH), 
7.56 (d, J = 9.0, 2H, 2 x ArH), 7.57 (d, J = 9.0, 2H, 2 x ArH), 8.34 (s, 1H, NH), 8.87-9.18 (m, 5H, 
5 x NH). 
13
C NMR (101 MHz, CDCl3) δC 47.0-48.0 (10 x NCH2), 48.2 (CH2Ar), 55.5-55.6 (5 x 
OCH3), 114.0 (6 x ArC), 114.1 (2 x ArC), 114.2 (2 x ArC), 116.5 (q, J = 284.9, CF3), 121.1-121.3 
(10 x ArC), 126.6 (2 x ArC), 127.9 (ArC), 129.1 (2 x ArC), 132.8 (ArC), 132.9 (ArC), 133.0 (3 x 
ArC), 140.6 (ArC), 155.3 (4 x ArC), 155.9 (ArC), 156.6 (4 x CO), 156.7 (q, J = 36.1, CO), 157.3 
(CO). 
19
F NMR (377 MHz, CDCl3) δF −74.9 (CF3). HR-MS (MALDI) – m/z for 
[C59H68F3N11O11+Na]




Synthesised according to general 
procedure H using 85 (450 mg, 0.39 
mmol). The title amine was isolated as 
a foamy white solid (340 mg, 0.32 
mmol, 82%). M.P. 150-151 °C 
(DCM/Et2O). TLC – Rf = 0.18 (8:92 MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 2.97 (t, J = 
4.0, 2H, NCH2), 3.35-3.63 (m, 18H, 9 x NCH2), 3.79-3.82 (m, 15H, 5 x OCH3), 4.63 (s, 2H, 
CH2Ar), 6.80-6.88 (m, 10H, 10 x ArH), 7.26-7.36 (m, 9H, 9 x ArH), 7.60 (d, J = 8.8, 2H, 2 x 
ArH), 7.63 (d, J = 8.8, 4H, 4 x ArH), 8.97 (s, 1H, NH), 9.08-9.13 (m, 3H, 3 x NH), 10.1 (s, 1H, 
NH). 
13
C NMR (126 MHz, CDCl3) δC 42.1 (NCH2), 46.8-48.6 (9 x NCH2), 51.0 (CH2Ar), 55.5-
55.6 (5 x OCH3), 113.9 (6 x ArC), 114.0 (2 x ArC), 114.1 (2 x ArC), 120.6 (2 x ArC), 121.1 (6 x 
ArC), 121.7 (2 x ArC), 126.9 (2 x ArC), 127.7 (ArC), 129.0 (2 x ArC), 133.2-133.5 (5 x ArC), 
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140.0 (ArC), 155.2 (5 x ArC), 156.7 (5 x CO). HR-MS (ESI, positive ion mode) – m/z for 
[C57H69N11O10+Na]
+ = 1090.5127. Found 1090.5095. FTIR (neat) – 3315, 3031, 2950, 1640. 
 
1,19-Dibenzyl-1,4,7,10,13-pentakis(4-methoxyanilinylcarbonyl)-19-(tert-butoxycarbonyl)-
1,4,7,10,13,16,19-heptaazanonadecane, 87  
Synthesised 
according to general 
procedure E using 86 
(340 mg, 0.32 mmol) 
and 82 (159 mg, 0.64 
mmol). The crude product was purified by column chromatography (2-10% MeOH:DCM) to give 
the title amine as a foamy white solid (233 mg, 0.18 mmol, 56%). M.P. 155-156 °C (DCM/Et2O). 
TLC – Rf = 0.33 (8:92 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.46 (s, 9H, C(CH3)3), 
1.91 (s, 1H, NH), 2.71-2.79 (m, 4H, 2 x NCH2), 3.24-3.58 (m, 20H, 10 x NCH2), 3.74-3.79 (m, 
15H, 5 x OCH3), 4.40 (s, 2H, CH2Ar), 4.58 (s, 2H, CH2Ar), 6.77-6.87 (m, 10H, 10 x ArH), 7.15 
(d, J = 9.0, 2H, 2 x ArH), 7.25-7.39 (m, 14H, 14 x ArH), 7.53-7.68 (m, 6H, 6 x ArH), 8.98-9.15 
(m, 4H, 4 x NH), 9.91 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 28.5 (C(CH3)3), 42.4 (NCH2), 
43.2 (NCH2), 46.4-49.0 (10 x NCH2), 50.2 (CH2Ar), 51.3 (CH2Ar), 55.4-55.6 (5 x OCH3), 80.1 
(C(CH3)3), 113.8-114.1 (10 x ArC), 121.0-121.3 (10 x ArC), 126.9-128.8 (10 x ArC), 132.8-133.9 
(5 x ArC), 140.2 (ArC), 140.8 (ArC), 155.1-155.4 (5 x ArC) 156.0-156.5 (6 x CO). HR-MS (ESI, 
positive ion mode) – m/z for [C71H88N12O12+H]
+ = 1301.6723. Found 1301.6700. FTIR (neat) – 





according to general 
procedure B1 using 
87 (135 mg, 0.10 
mmol) and 4-
methoxphenyl isocyanate (0.02 mL, 0.16 mmol). The crude product was purified by column 
chromatography (2-10% MeOH:DCM) to give the title hexaurea as a foamy white solid (130 mg, 
0.09 mmol, 90%). M.P. 190-191 °C (DCM/Et2O). TLC – Rf = 0.23 (3:97 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 1.50 (s, 9H, C(CH3)3), 3.28-3.60 (m, 24H, 12 x NCH2), 3.74-3.81 
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(m, 18H, 6 x OCH3), 4.41 (s, 2H, CH2Ar), 4.57 (s, 2H, CH2Ar), 6.76-6.87 (m, 12H, 12 x ArH), 
7.19 (d, J = 9.0, 2H, 2 x ArH), 7.28-7.41 (m, 10H, 10 x ArH), 7.57-7.65 (m, 10H, 10 x ArH), 8.83 
(s, 1H, NH), 8.97 (s, 1H, NH), 9.02 (s, 1H, NH), 9.13 (s, 1H, NH), 9.17 (s, 1H, NH). 
13
C NMR 
(101 MHz, CDCl3) δC 28.5 (C(CH3)3), 45.8-49.0 (12 x NCH2), 50.2-51.5 (2 x CH2Ar), 55.5-55.6 
(6 x OCH3), 80.0 (C(CH3)3), 113.7-114.1 (12 x ArC), 120.7-121.7 (12 x ArC), 127.4-128.8 (10 x 
ArC), 132.8-133.6 (6 x ArC), 139.9-140.6 (2 x ArC), 155.0-155.4 (6 x ArC), 156.7-157.1 (7 x 
CO). HR-MS (MALDI) – m/z for [C79H95N13O14+Na]
+ = 1472.7019. Found 1472.6984. FTIR 





according to general 
procedure C using 88 
(130 mg, 0.09 
mmol). The title 
amine was isolated as a foamy white solid (101 mg, 0.07 mmol, 83%). M.P. 204-205 °C 
(DCM/Et2O). TLC – Rf = 0.13 (3:97 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 2.87 (s, 2H, 
NCH2), 3.30-3.62 (m, 22H, 11 x NCH2), 3.75-3.78 (m, 18H, 6 x OCH3), 3.82 (s, 2H, CH2Ar), 
4.57 (CH2Ar), 6.74-6.86 (m, 12H, 12 x ArH), 7.22 (d, J = 9.0, 2H, 2 x ArH), 7.28-7.41 (m, 12H, 
12 x ArH), 7.55-7.64 (m, 8H, 8 x ArH), 8.95 (s, 1H, NH), 9.06 (s, 1H, NH), 9.08 (s, 1H, NH), 
9.15 (s, 1H, NH), 10.04 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 47.0-49.2 (12 x NCH2), 
51.0-52.2 (2 x CH2Ar), 55.6-55.7 (6 x OCH3), 113.8-114.3 (12 x ArC), 121.1-122.6 (12 x ArC), 
127.6-129.0 (10 x ArC), 133.0-133.8 (6 x ArC), 140.3-140.6 (2 x ArC), 155.2-156.8 (6 x CO, 6 
x ArC). HR-MS (ESI, positive ion mode) – m/z for [C74H87N13O12+Na]
+ = 1372.6495. Found 









according to general 
procedure B1 using 
89 (40 mg, 0.03 
mmol) and 4-
nitrophenyl isothiocyanate (8 mg, 0.04 mmol). The crude product was purified by column 
chromatography (2-10% MeOH:DCM) to give the title thiourea as a yellow solid (46 mg, 0.03 
mmol, >99%). M.P. 159-160 °C (DCM/Et2O). TLC – Rf = 0.28 (3:97 MeOH:DCM). 
1
H NMR 
(500 MHz, CD2Cl2) δH 3.38-3.68 (m, 24H, 12 x NCH2), 3.76-3.85 (m, 18H, 6 x OCH3), 4.61 (s, 
2H, CH2Ar), 5.32 (s, 2H, CH2Ar), 6.31 (s, 1H, NH), 6.84-6.93 (m, 12H, 12 x ArH), 7.17-7.67 (m, 
22H, 22 x ArH), 8.06 (d, J = 9.0, 2H, 2 x ArH), 8.19 (d, J = 8.8, 2H, 2 x ArH), 9.03 (s, 1H, NH), 
9.17 (s, 1H, NH), 9.19 (s, 1H, NH), 9.23 (s, 1H, NH), 9.29 (s, 1H, NH), 10.48 (s, 1H, NH). 
13
C 
NMR (126 MHz, CD2Cl2) δC 47.3-49.0 (12 x NCH2), 53.3 (CH2Ar), 55.9-56.2 (6 x OCH3), 56.8 
(CH2Ar), 114.3-114.7 (12 x ArC), 121.6-121.9 (12 x ArC), 123.0 (2 x ArC), 124.4 (2 x ArC), 
126.6-130.2 (10 x ArC), 133.4-134.0 (6 x ArC), 138.9-139.3 (2 x ArC), 143.7 (ArC), 147.4 (ArC), 
155.4-155.8 (6 x ArC), 156.7-157.2 (6 x CO), 182.3 (CS). HR-MS (MALDI) – m/z for 
[C81H91N15O14S+Na]
+ = 1552.6488. Found 1552.6491. FTIR (neat) – 3675, 3345, 2971, 2914, 





according to general 
procedure B2 using 
89 (40 mg, 0.03 
mmol) and 70 (9 mg, 
0.04 mmol). The crude product was purified by column chromatography (2-10% MeOH:DCM) 
to give the title heptaurea as a foamy white solid (37 mg, 0.02 mmol, 80%). M.P. 170-171 °C 
(DCM/Et2O). TLC – Rf = 0.15 (3:97 MeOH:DCM). 
1
H NMR (500 MHz, CD2Cl2) δH 3.30-3.60 
(m, 12H, 6 x NCH2), 3.76 (s, 3H, NCH3), 3.80-3.84 (m, 18H, 6 x OCH3), 4.07 (s, 2H, CH2Ar), 
4.59 (s, 2H, CH2Ar), 6.77-6.89 (m, 14H, 14 x ArH), 6.95 (d, J = 7.0, 2H, 2 x ArH), 7.02 (d, J = 
8.8, 2H, 2 x ArH), 7.17-7.40 (m, 10H, 10 x ArH), 7.56-7.67 (m, 10H, 10 x ArH), 8.99-9.23 (m, 
6H, 6 x NH). 
13
C NMR (126 MHz, CD2Cl2) δC 40.4 (NCH3), 46.3-49.1 (12 x NCH2), 53.0 
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(CH2Ar), 53.8 (CH2Ar), 55.3-55.5 (7 x OCH3), 113.7-114.1 (14 x ArC), 121.0-121.5 (14 x ArC), 
126.2-128.7 (10 x ArC), 133.2-133.6 (6 x ArC), 137.7 (ArC), 138.6-139.2 (2 x ArC), 155.2-155.7 
(7 x ArC), 156.5-157.0 (6 x CO), 163.1 (CO). HR-MS (MALDI) – m/z for [C83H96N14O14+Na]
+ 
= 1535.7128. Found 1535.7096. FTIR (neat) – 3349, 2968, 2931, 1649. 
 
N-(2-Pyridyl)ethylenediamine, 92 
Synthesised according to general procedure M using freshly distilled 
ethylenediamine (23.40 mL, 350.00 mmol) and 2-fluoropyridine (3.00 mL, 
35.00 mmol). The title N-(2-pyridyl)-amine was isolated as a colourless oil (2.70 g, 19.40 mmol, 
83%). TLC – Rf = 0.05 (SiO2, 10:90:1 MeOH:DCM:TEA). 
1
H NMR (400 MHz, CDCl3) δH 2.80 
(t, J = 6.0, 2H, NCH2), 3.18 (q, J = 6.0, 2H, NCH2), 6.40 (d, J = 8.3, 1H, ArH), 6.58 (t, J = 6.0, 




Synthesised according to general procedure A using 92 (490 
mg, 3.57 mmol) and N-Boc-2-aminoacetaldehyde (614 mg, 
3.86 mmol). The title carbamate was isolated as a white solid (370 mg, 1.32 mmol, 37%). M.P. 
72-73 °C (CHCl3). TLC – Rf = 0.09 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 
1.44 (s, 9H, C(CH3)3), 2.76 (t, J = 5.8, 2H, NCH2), 2.88 (t, J = 5.8, 2H, NCH2), 3.22 (q, J = 5.8, 
2H, NCH2), 3.34 (q, J = 5.8, 2H, NCH2), 4.85 (s, 1H, NH), 4.92 (s, 1H, NH), 6.41 (d, J = 8.5, 1H, 
ArH), 6.56 (t, J = 6.0, 1H, ArH), 7.40 (t, J = 7.6, 1H, ArH), 8.08 (d, J = 4.9, 1H, ArH). 
13
C NMR 
(101 MHz, CDCl3) δC 28.6 (C(CH3)3), 40.5 (NCH2), 41.9 (NCH2), 48.7 (NCH2), 49.1 (NCH2), 
79.2 (C(CH3)3), 107.4 (ArC), 113.0 (ArC), 137.5 (ArC), 148.3 (ArC), 156.5 (CO), 158.5 (ArC). 
HR-MS (ESI, positive ion mode) – m/z for [C14H26N4O+Na]
+ = 303.1797. Found 303.1807. FTIR 










Synthesised according to general procedure B1 using 93 (163 
mg, 0.58 mmol) and 4-methoxyphenyl isocyanate (0.23 mL, 
1.74 mmol). The crude product was purified by column 
chromatography (12-100% EtOAc:PE) to yield the title 
diurea as a foamy white solid (114 mg, 0.20 mmol, 34%). 
M.P. 119-120 °C (CHCl3). TLC – Rf = 0.48 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (500 MHz, 
CD2Cl2) δH 1.44 (s, 9H, C(CH3)3), 3.32 (q, J = 6.3, 2H, NCH2), 3.54 (t, J = 6.6, 2H, NCH2), 3.64 
(t, J = 6.6, 2H, NCH2), 3.78-3.79 (m, 6H, 2 x OCH3), 4.10 (t, J = 6.3, 2H, NCH2), 5.31 (t, J = 5.3, 
1H, NH), 6.86 (d, J = 9.0, 2H, 2 x ArH), 6.89 (d, J = 9.0, 2H, 2 x ArH), 7.04 (dd, J = 5.1, 7.2, 1H, 
ArH), 7.42 (s, 1H, ArH), 7.50 (d, J = 9.0, 2H, 2 x ArH), 7.56 (d, J = 9.0, 2H, 2 x ArH), 7.82 (ddd, 
J = 8.0, 7.5, 1.9, 1H, ArH), 8.34 (dd, J = 4.9, 1.5, 1H, ArH), 8.68 (s, 1H, NH), 12.48 (s, 1H, NH). 
13
C NMR (126 MHz, CD2Cl2) δC 28.7 (C(CH3)3), 41.0 (NCH2), 45.2 (NCH2), 46.7 (NCH2), 48.3 
(NCH2), 56.0 (2 x OCH3), 80.0 (C(CH3)3), 113.0 (ArC), 114.3-114.5 (4 x ArC), 118.4 (ArC), 
121.8 (2 x ArC), 122.6 (2 x ArC), 132.5 (ArC), 134.1 (ArC), 140.0 (ArC), 146.4 (ArC), 154.9 
(ArC), 155.8 (ArC), 155.9 (CO), 156.5 (CO), 156.8 (CO). HR-MS (ESI, positive ion mode) – 
m/z for [C30H38N6O6+H]




Synthesised according to general procedure C using 94 (200 mg, 
0.34 mmol). The title amine was isolated as a foamy white solid 
(163 mg, 0.34 mmol, >99%). M.P. 139-140 °C (CHCl3). TLC – Rf 
= 0.09 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 
3.00 (t, J = 4.9, 2H, NCH2), 3.51 (t, J = 4.9, 2H, NCH2), 3.61 (t, J = 
7.2, 2H, NCH2), 3.77 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 4.17 (t, J = 7.2, 2H, NCH2), 6.84 (d, J 
= 8.9, 2H, 2 x ArH), 6.88 (d, J = 8.9, 2H, 2 x ArH), 6.98 (dd, J = 5.0, 6.8, 1H, ArH), 7.35 (d, J = 
8.9, 2H, NCH2), 7.45 (d, J = 8.9, 2H, NCH2), 7.67 (d, J = 7.7, 1H, ArH), 7.78 (ddd, J = 1.8, 5.8, 
7.7, 1H, ArH), 8.28 (d, J = 5.0, 1H, ArH), 9.75 (s, 1H, NH), 12.61 (s, 1H, NH). 
13
C NMR (101 
MHz, CDCl3) δC 41.8 (NCH2), 43.6 (NCH2), 46.1 (NCH2), 52.1 (NCH2), 55.5 (2 x OCH3), 112.7 
(ArC), 114.1 (4 x ArC), 117.5 (ArC), 121.3 (2 x ArC), 122.5 (2 x ArC), 131.9 (ArC), 133.4 (ArC), 
139.6 (ArC), 145.3 (ArC), 154.4 (CO), 155.1 (ArC), 155.4 (ArC), 158.0 (ArC). HR-MS (ESI, 
positive ion mode) – m/z for [C25H30N6O4+H]
+ = 479.2407. Found 479.2380. FTIR (neat) – 3329, 
3130, 2992, 2947, 1659. 
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1-(2-Pyridyl)-1,4-bis(4-methoxyanilinylcarbonyl)-7-benzyl-1,4,7-triazaheptane, 96  
Synthesised according to general procedure E using 95 
(140 mg, 0.29 mmol) and benzaldehyde (0.05 mL, 0.44 
mmol). The crude product was purified by column 
chromatography (3-10% MeOH:DCM) to yield the title 
triamine as a foamy white solid (87 mg, 0.15 mmol, 53%). 
M.P. 142-143 °C (CHCl3). TLC – Rf = 0.48 (SiO2, 10:90 MeOH:DCM). 
1
H NMR (500 MHz, 
CDCl3) δH 2.03 (s, 1H, NH), 2.95 (t, J = 4.9, 2H, NCH2), 3.56 (t, J = 4.9, 2H, NCH2), 3.60 (t, J = 
8.2, 2H, NCH2), 3.78 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.84 (s, 2H, CH2Ar), 4.15 (t, J = 8.2, 
2H, NCH2), 6.80 (d, J = 9.0, 2H, 2 x ArH), 6.88 (d, J = 9.0, 2H, 2 x ArH), 6.98 (dd, J = 5.0, 7.2, 
1H, ArH), 7.22 (d, J = 9.0 2H, 2 x ArH), 7.25-7.34 (m, 5H, 5 x ArH), 7.46 (d, J = 9.0, 2H, 2 x 
ArH), 7.66-7.70 (m, 1H, ArH), 7.74 (ddd, J = 1.8, 7.4, 8.6, 1H, ArH), 8.27 (d, J = 5.0, 1H, ArH), 
9.70 (s, 1H, NH), 12.61 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 43.5 (NCH2), 46.2 (NCH2), 
49.6 (NCH2), 50.0 (NCH2), 54.3 (CH2Ar), 55.5 (2 x OCH3), 112.8 (ArC), 114.0 (2 x ArC), 114.1 
(2 x ArC) 117.4 (ArC), 121.5 (2 x ArC), 122.4 (2 x ArC), 127.5 (ArC), 128.3 (2 x ArC), 128.7 (2 
x ArC), 132.0 (ArC), 133.3 (ArC), 138.9 (ArC), 139.6 (ArC), 145.3 (ArC), 154.3 (ArC), 155.1 
(ArC), 155.4 (CO), 155.9 (ArC), 158.0 (CO). HR-MS (ESI, positive ion mode) – m/z for 
[C32H36N6O4+H]
+ = 569.2876. Found 569.2875. FTIR (neat) – 3326, 2993, 2950, 1652. 
 
1-(2-Pyridyl)-1,4,7-tris(4-methoxyanilinylcarbonyl)-7-benzyl-1,4,7-triazaheptane, 97 
Synthesised according to general procedure B using 96 (62 
mg, 0.11 mmol) and 4-methoxyphenyl isocyanate (0.02 
mL, 0.17 mmol) dropwise. The crude product was purified 
by column chromatography (1-2% MeOH:DCM) to yield 
the title triurea as a foamy white solid (47 mg, 0.07 mmol, 
60%). M.P. 200-201 °C (DCM). TLC – Rf = 0.26 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (500 
MHz, CDCl3) δH 3.32-3.37 (m, 2H, NCH2), 3.51 (t, J = 8.0, 2H, NCH2), 3.54 (t, J = 8.2, 2H, 
NCH2), 3.76 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.98 (t, J = 8.0, 2H, NCH2), 
4.63 (s, 2H, CH2Ar), 6.82 (d, J = 9.0, 2H, 2 x ArH), 6.86 (d, J = 9.0, 2H, 2 x ArH), 6.88 (d, J = 
9.0, 2H, 2 x ArH), 7.08 (dd, J = 5.0, 7.2, 1H, ArH), 7.30-7.40 (m, 6H, 6 x ArH), 7.48 (d, J = 9.0, 
2H, 2 x ArH), 7.51-7.53 (m, 2H, 2 x ArH), 7.61 (d, J = 9.0, 2H, 2 x ArH), 7.82 (ddd, J = 1.9, 7.4, 
8.7, 1H, ArH), 8.36 (dd, J = 1.6, 5.0, 1H, ArH), 8.95 (s, 1H, NH), 12.34 (s, 1H, NH). 
13
C NMR 
(126 MHz, CDCl3) δC 45.2 (NCH2), 47.0 (2 x NCH2), 48.5 (NCH2), 51.2 (CH2Ar), 55.4 (3 x 
OCH3), 112.0 (ArC), 113.7 (2 x ArC), 113.8 (2 x ArC), 114.0 (2 x ArC), 118.1 (ArC), 121.1 (2 x 
ArC), 121.3 (2 x ArC), 122.0 (2 x ArC), 127.3 (ArC), 127.6 (2 x ArC), 128.7 (2 x ArC), 131.7 
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(ArC), 133.4 (2 x ArC), 139.5 (2 x ArC), 146.1 (ArC), 154.4 (CO), 155.1 (ArC), 155.2 (ArC), 
155.3 (ArC), 156.0 (CO), 156.3 (CO). HR-MS (ESI, positive ion mode) – m/z for 
[C40H43N7O6+H]




Synthesised according to general procedure E using 30 (300 
mg, 0.63 mmol) and benzaldehyde (0.13 mL, 1.26 mmol). 
The crude product was purified using column 
chromatography (1-5% MeOH:DCM, 1% TEA) to yield the 
title amine as a foamy white solid (285 mg, 0.50 mmol, 
80%). M.P. 187-188 °C (CHCl3). TLC – Rf = 0.08 (SiO2, 1:99 MeOH:DCM). 
1
H NMR (400 
MHz, CDCl3) δH 2.88 (t, J = 5.5, 2H, NCH2), 3.48 (t, J = 5.5, 2H, NCH2), 3.62 (t, J = 6.9, 2H, 
NCH2), 3.76 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.81 (s, 2H, CH2Ar), 3.85 (t, J = 6.9, 2H, NCH2), 
6.30 (s, 1H, NH), 6.78 (d, J = 9.0, 2H, 2 x ArH), 6.79 (d, J = 9.0, 2H, 2 x ArH), 7.20 (d, J = 9.0, 
2H, 2 x ArH), 7.26-7.39 (m, 10H, 10 x ArH), 7.46 (d, J = 9.0, 2H, 2 x ArH), 9.26 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 46.8 (NCH2), 48.9-49.3 (3 x NCH2), 54.1 (CH2Ar), 55.5 (2 x 
OCH3), 113.9 (2 x ArC), 114.1 (2 x ArC), 121.2 (2 x ArC), 121.8 (2 x ArC), 127.0 (ArC), 127.2 
(2 x ArC), 128.0 (2 x ArC), 128.2 (ArC), 128.3 (2 x ArC), 128.5 (2 x ArC), 131.5 (ArC), 133.5 
(ArC), 141.9 (ArC), 150.3 (ArC), 155.0 (ArC), 155.2 (ArC), 155.9 (CO), 156.4 (CO). HR-MS 
(ESI, positive ion mode) – m/z for [C33H37N5O4+H]
+ = 568.2924. Found 569.2897. FTIR (neat) 
– 3410, 2933, 2833, 1651. 
 
1-Phenyl-1,4,7-tris(4-methoxyanilinylcarbonyl)-7-benzyl-1,4,7-triazaheptane, 99 
Synthesised according to general procedure D using 98 (100 
mg, 0.18 mmol) and 4-methoxyphenyl isocyanate (0.03 mL, 
0.26 mmol). The crude product was purified using column 
chromatography (2-10% MeOH:DCM) to give the title 
triurea as a foamy white solid (65 mg, 0.09 mmol, 50%). 
M.P. 146-147 °C (CHCl3). TLC – Rf = 0.43 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, 
CDCl3) δH 3.15 (t, J = 7.0, 2H, NCH2), 3.35 (t, J = 7.0, 2H, NCH2), 3.48 (t, J = 7.0, 2H, NCH2), 
3.64 (t, J = 7.0, 2H, NCH2), 3.78 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 4.60 (s, 
2H, CH2Ar), 6.14 (s, 1H, NH), 6.73 (d, J = 9.1, 2H, 2 x ArH), 6.74 (d, J = 9.1, 2H, 2 x ArH), 6.75 
(d, J = 9.1, 2H, 2 x ArH), 7.10 (d, J = 9.1, 2H, 2 x ArH), 7.20-7.36 (m, 10H, 10 x ArH), 7.43 (d, 
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J = 9.1, 2H, 2 x ArH), 7.48 (d, J = 9.1, 2H, 2 x ArH), 8.33 (s, 1H, NH), 8.72 (s, 1H, NH). 
13
C 
NMR (101 MHz, CDCl3) δC 45.5 (NCH2), 47.3 (NCH2), 47.8 (NCH2), 49.9 (NCH2), 51.0 
(CH2Ar), 55.5 (3 x OCH3), 113.9 (2 x ArC), 113.9 (2 x ArC), 114.1 (2 x ArC), 121.2 (2 x ArC), 
121.4 (2 x ArC), 121.9 (2 x ArC), 127.4-128.7 (10 x ArC), 130.7 (ArC), 131.0 (ArC), 133.0 
(ArC), 138.7 (ArC), 141.7 (ArC), 155.2 (ArC), 155.3 (ArC), 155.5 (ArC), 156.1 (CO), 156.2 
(CO), 156.4 (CO). HR-MS (ESI, positive ion mode) – m/z for [C41H44N6O6+H]
+ = 717.3401. 
Found 717.3391. FTIR (neat) – 3398, 2952, 1651. 
 
2-(Pyridin-2-ylamino)ethan-1-ol, 100 
Synthesised according to general procedure M using ethanolamine (29.8 mL, 
0.49 mol) and 2-fluoropyridine (4.20 mL, 49.10 mmol). The title N-(2-pyridyl)-
amine was isolated as a white solid (5.23 g, 37.30 mmol, 76%). TLC – Rf = 0.12 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.44 (q, J = 5.5, 2H, NCH2), 3.74 (t, J = 4.6, 2H, 
OCH2), 4.79 (s, 1H, OH), 6.38 (dt, J = 0.9, 8.4, 1H, ArH), 6.51 (ddd, J = 0.9, 5.2, 7.1, 1H, ArH), 
7.33 (ddd, J = 1.1, 7.1, 8.9, 1H, ArH), 7.96 (ddd, J = 0.9, 1.7, 5.2, 1H, ArH). Spectroscopic data 
matched that previously reported.133 
 
tert-Butyl (2-hydroxyethyl)(pyridin-2-yl)carbamate, 101 
Synthesised according to general procedure K using 100 (2.40 g, 17.37 mmol). 
The crude product was then purified by column chromatography (2-10% 
MeOH:DCM) to yield the title carbamate as a colourless oil (3.02 g, 12.68 mmol, 
73%). TLC – Rf = 0.34 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) 
δH 1.48 (s, 9H, C(CH3)3), 3.64 (q, J = 5.5, 2H, NCH2), 4.26 (t, J = 5.1, 2H, OCH2), 4.73 (s, 1H, 
OH), 6.40 (d, J = 8.3, 1H, ArH), 6.57 (t, J = 5.6, 1H, ArH), 7.39 (t, J = 7.9, 1H, ArH), 8.08 (d, J 
= 4.5, 1H, ArH). Spectroscopic data matched that previously reported.133 
 
1-(2-Pyridyl)-4-(tert-butoxycarbonyl)-4-hydroxyethyl-1,4-diazabutane, 103 
Under a dry, inert atmosphere, 2-fluoropyridine (0.42 mL, 4.90 mmol, 1.00 
equiv.) was added to a solution of 52 (1.0 g, 4.90 mmol, 1.00 equiv., 0.10 
M) in anhydrous toluene (49 mL). DIPEA (1.71 mL, 9.80 mmol, 2.00 
equiv.) was added and the solution was refluxed for 16 h. Upon cooling to room temperature, the 
solution was concentrated in vacuo. The crude product was diluted with deionised water (50 mL) 
and extracted with DCM three times. The combined organic extracts were dried (MgSO4), filtered 
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and concentrated in vacuo. The crude product was purified by column chromatography (5% 
MeOH:DCM) to give the title amine as a colourless oil (875 mg, 3.09 mmol, 63%). TLC – Rf = 
0.32 (5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.24 (s, 9H, C(CH3)3), 3.38-3.54 (m, 
6H, 3 x NCH2), 3.92-4.04 (m, 2H, NCH2), 4.75 (s, 1H, OH), 6.40 (dd, J = 4.5, 8.2, 1H, ArH), 6.48 
(dd, J = 0.9, 7.3, 1H, ArH), 7.27 (t, J = 7.0, 1H, ArH), 8.02 (d, J = 4.5, 1H, ArH). 
13
C NMR (101 
MHz, CDCl3) δC 28.6 (C(CH3)3), 46.7 (NCH2), 48.0 (NCH2), 51.3 (NCH2), 64.4 (OCH2), 80.5 
(C(CH3)3), 110.3 (ArC), 115.5 (ArC), 138.1 (ArC), 148.1 (ArC), 151.0 (ArC), 155.6 (CO). HR-
MS (ESI, positive ion mode) – m/z for [C14H23N3O3+Na]
+ = 304.1637. Found 304.1592. FTIR 
(neat) – 3360, 2955, 1691.  
 
1-(2-Pyridyl)-1,4-bis(tert-butoxycarbonyl)-4-hydroxyethyl-1,4-diazabutane, 104 
Synthesised according to general procedure K using 43 (1.54 g, 5.47 
mmol). The crude product was purified by column chromatography (20-
40% EtOAc:PE) to give the title carbamate as a colourless oil (1.65 g, 4.32 
mmol, 79%). TLC – Rf = 0.10 (20:80 EtOAc:PE). 
1
H NMR (400 MHz, 
CDCl3) δH 1.34-1.42 (m, 18H, 2 x C(CH3)3), 3.35-3.46 (m, 6H, 3 x NCH2), 
4.06-4.16 (m, 2H, OCH2), 4.64 (s, 1H, OH, rot.), 4.96 (s, 1H, OH, rot.), 6.34 (d, J = 8.3, 1H, ArH), 
6.46-6.48 (m, 1H, ArH), 7.30 (t, J = 7.3, 1H, ArH), 8.00 (d, J = 4.5, 1H, ArH). 
13
C NMR (101 
MHz, CDCl3) δC 27.8 (C(CH3)3), 28.4 (C(CH3)3), 46.9 (NCH2), 47.6 (NCH2), 60.3 (NCH2), 64.9 
(OCH2), 80.3 (C(CH3)3), 82.2 (C(CH3)3), 112.8 (ArC), 120.9 (ArC), 137.1 (ArC), 148.1 (ArC), 
153.3 (ArC), 154.4 (CO), 154.6 (CO). HR-MS (ESI, positive ion mode) – m/z for [C-
19H31N3O5+H]
+ = 382.2342. Found 382.2354. FTIR (neat) – 3385, 2949, 1741, 1689.  
 
1-(2-Pyridyl)-1,4-bis(tert-butoxycarbonyl)-4-oxoethyl-1,4-diazabutane, 105 
Synthesised according to general procedure L using 104 (500 mg, 1.31 
mmol). The crude product was purified by column chromatography (25% 
EtOAc:PE) to give the title aldehyde as a colourless oil (383 mg, 1.00 mmol, 
77%). TLC – Rf = 0.30 (25:75 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 
1.38 (s, 9H, C(CH3)3), 1.39 (s, 9H, C(CH3)3), 3.34-3.59 (m, 4H, 2 x NCH2), 
4.07-4.15 (m, 2H, NCH2), 6.27 (d, J = 8.8, 1H, ArH), 6.47-6.49 (m, 1H, ArH), 7.13 (dd, J = 1.6, 
7.2, 1H, ArH, rot.), 7.23 (d, J = 7.2, 1H, ArH, rot.), 7.90-7.93 (m, 1H, ArH, rot.), 7.96-7.98 (m, 
1H, ArH, rot.), 9.48 (s, 1H, CHO, rot.), 9.48 (s, 1H, CHO, rot.). 
13
C NMR (101 MHz, CDCl3) δC 
27.7 (C(CH3)3), 28.3 (C(CH3)3), 47.0 (NCH2, rot.), 47.2 (NCH2, rot.), 47.6 (NCH2, rot.), 47.7 
(NCH2, rot.), 58.3 (NCH2, rot.), 58.8 (NCH2, rot.), 79.6 (C(CH3)3, rot.), 80.1 (C(CH3)3, rot.), 81.0 
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(C(CH3)3, rot.), 82.1 (C(CH3)3, rot.), 111.7 (ArC, rot.), 112.4 (ArC, rot.), 115.3 (ArC, rot.), 115.8 
(ArC, rot.), 136.7 (ArC, rot.), 137.6 (ArC, rot.), 146.0 (ArC, rot.), 146.9 (ArC, rot.), 153.3 (ArC), 
156.3 (CO), 156.6 (CO), 198.5 (CHO, rot.), 198.6 (CHO, rot.). HR-MS (ESI, positive ion mode) 
– m/z for [C19H29N3O5+Na]
+ = 402.2005. Found 402.1984. FTIR (neat) – 2963, 2922, 1719, 1678. 
 
1-Benzyl-1-(4-methoxyanilinylcarbonyl)-4-trifluoroacetyl-1,4-diazabutane, 106 
 Synthesised according to general procedure K using N-
benzylethylenediamine (1.00 g, 6.66 mmol) and 4-methoxyphenyl 
isocyanate (1.29 mL, 9.99 mmol). The crude product was purified by 
column chromatography (1-10% MeOH:DCM, 1% NH4OH) to yield 
the title amine as a colourless oil (2.63 g, 6.66 mmol, >99%). TLC – 
Rf = 0.56 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.45 (q, J = 5.5, 2H, NCH2), 
3.65 (t, J = 5.5, 2H, NCH2), 3.74 (s, 3H, OCH3), 4.54 (s, 2H, CH2Ar), 6.47 (t, J = 5.5, 1H, NH), 
6.78 (d, J = 8.8, 2H, 2 x ArH), 7.09 (d, J = 8.8, 2H, 2 x ArH), 7.26 (d, J = 8.5, 2H, 2 x ArH), 7.34 
(t, J = 7.5, 1H, ArH), 7.40 (t, J = 8.0, 2H, 2 x ArH), 8.39 (s, 1H, NH). 
13
C NMR (101 MHz, 
CDCl3) δC 40.3 (NCH2), 46.4 (NCH2), 51.6 (CH2Ar), 55.6 (OCH3), 114.2 (2 x ArC), 115.7 (q, J 
= 286.4, CF3), 122.7 (2 x ArC), 126.5 (2 x ArC), 128.4 (ArC), 129.6 (2 x ArC), 131.3 (ArC), 
136.1 (ArC), 156.3 (ArC), 157.7 (CO), 158.1 (q, J = 37.3, CO). 
19
F NMR (377 MHz, CDCl3) δF 
−76.4 (CF3). HR-MS (ESI, positive ion mode) – m/z for [C19H20F3N3O3+Na]
+ = 418.1354. Found 
418.1380. FTIR (neat) – 3243, 2980, 1661, 1640. 
 
1-Benzyl-1-(4-methoxyanilinylcarbonyl)-1,4-diazabutane, 107 
Synthesised according to general procedure H using 106 (1.00 g, 4.74 
mmol). The title amine was isolated as a colourless oil (1.13 g, 3.79 
mmol, 80%). TLC – Rf = 0.23 (SiO2, 5:95:1 MeOH:DCM:NH4OH). 
1
H 
NMR (400 MHz, CDCl3) δH 2.76 (t, J = 4.9, 2H, NCH2), 3.31 (t, J = 4.9, 
2H, NCH2), 3.71 (OCH3), 4.50 (s, 2H, CH2Ar), 6.76 (d, J = 8.9, 2H, 2 x 
ArH), 7.21-7.28 (m, 7H, 7 x ArH), 9.39 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 40.9 
(NCH2), 50.6 (NCH2), 51.0 (CH2Ar), 55.6 (OCH3), 114.1 (2 x ArC), 121.1 (2 x ArC), 127.3 (ArC), 
127.8 (2 x ArC), 128.6 (2 x ArC), 133.4 (ArC), 138.4 (ArC), 155.1 (ArC), 158.0 (CO). HR-MS 
(ESI, positive ion mode) – m/z for [C17H21N3O3+Na]
+ = 322.1531. Found 322.1547. FTIR (neat) 





 Synthesised according to general procedure M using N-(2-
hydroxyethyl)ethylenediamine (37.6 mL, 0.37 mol) and 2-
fluoropyridine (3.2 mL, 37.2 mmol). The title N-(2-pyridyl)-amine was isolated as a colourless 
oil (6.7 g, 0.26 mmol, 70%). TLC – Rf = 0.10 (SiO2, 10:90:1 MeOH:DCM:NH4OH). 
1
H NMR 
(400 MHz, CDCl3) δH 2.71 (t, J = 6.1, 2H, NCH2), 2.90 (t, J = 5.5, 2H, NCH2), 3.20 (t, J = 6.1, 
2H, NCH2), 3.48 (t, J = 5.5, 2H, OCH2), 4.98 (s, 1H, OH), 6.38 (dd, J = 4.8, 8.0, 1H, ArH), 6.50 
(dd, J = 1.2, 7.2, 1H, ArH), 7.21 (t, J = 7.2, 1H, ArH), 7.98 (d, J = 4.8, 1H, ArH). 
13
C NMR (101 
MHz, CDCl3) δC 47.5 (NCH2), 48.6 (NCH2), 50.1 (NCH2), 60.9 (OCH2), 111.0 (ArC), 115.2 
(ArC), 139.6 (ArC), 149.1 (ArC), 150.3 (ArC), 156.1 (CO). HR-MS (ESI, positive ion mode) – 
m/z for [C9H16N3O+Na]
+ = 182.1293. Found 182.1304. FTIR (neat) – 3412, 3230, 2973, 2920. 
 
1-(2-Pyridyl)-1,4-bis(4-methoxyanilinylcarbonyl)-4-hydroxyethyl-1,4-diazabutane, 110 
 Synthesised according to general procedure B using 109 (518 mg, 
1.08 mmol) and 4-methoxyphenyl isocyanate (0.42 mL, 3.24 mmol). 
The title diurea was isolated as a white solid (259 mg, 0.54 mmol, 
45%). TLC – Rf = 0.27 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 
MHz, CDCl3) δH 3.51-3.62 (m, 4H, 2 x NCH2), 3.69 (t, J = 6.1, 2H, 
NCH2), 3.77 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 4.32 (t, J = 6.0, 2H, OCH2), 4.98 (s, 1H, OH), 
6.82 (d, J = 8.9, 2H, 2 x ArH), 6.85 (d, J = 8.9, 2H, 2 x ArH), 6.98 (dd, J = 5.1, 7.0, 1H, ArH), 
7.34 (d, J = 8.9, 2H, NCH2), 7.39 (d, J = 8.9, 2H, NCH2), 7.67 (d, J = 7.5, 1H, ArH), 7.78 (ddd, J 
= 1.8, 5.1, 7.5, 1H, ArH), 8.28 (d, J = 5.1, 1H, ArH), 9.14 (s, 1H, NH), 12.54 (s, 1H, NH). 
13
C 
NMR (101 MHz, CDCl3) δC 40.7 (NCH2), 46.6 (NCH2), 47.7 (NCH2), 55.5 (2 x OCH3), 63.2 
(OCH2), 109.6 (ArC), 113.9 (2 x ArC), 114.2 (2 x ArC), 120.8 (2 x ArC), 122.2 (2 x ArC), 123.8 
(ArC), 131.0 (ArC), 132.8 (ArC), 137.6 (ArC), 147.4 (ArC), 154.1 (CO), 156.0 (ArC), 156.8 
(ArC), 158.0 (CO). HR-MS (ESI, positive ion mode) – m/z for [C25H29N5O5+Na]
+ = 502.2066. 
Found 502.2093. FTIR (neat) – 3487, 3309, 2933, 1641. 
 
N-(2-Pyridyl)-2-chloroethylamine, 112  
Under a dry, inert atmosphere, a solution of 100 (138 mg, 1.00 mmol, 1.00 equiv., 
0.10 M) in anhydrous DCM (10 mL) was prepared and cooled to 0 °C. To this 
solution was added thionyl chloride (0.09 mL, 1.20 mmol, 1.20 equiv.) and the solution was 
warmed to room temperature. The solution was stirred for 30 minutes, heated to reflux and stirred 
for a further 3 h. Upon cooling, the solution was concentrated in vacuo. The residue was diluted 
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with DCM (5 mL) and the resulting solution was concentrated in vacuo. The residue was diluted 
with aqueous NaOH (10 mL, 2.00 M) and extracted with DCM (3 x 10 mL). The combined organic 
extracts were washed with brine, dried (MgSO4), filtered and concentrated in vacuo to yield the 
desired chloride as a pale-green solid (96 mg, 0.61 mmol, 61%). M.P. decomp. >110 °C (EtOAc). 
TLC – Rf = 0.12 (SiO2, EtOAc). 
1
H NMR (400 MHz, CDCl3) δH 4.09 (t, J = 9.7, 2H, NCH2), 
4.84 (t, J = 9.7, 2H, NCH2), 6.75 (t, J = 6.8, 1H, ArH), 7.37 (d, J = 8.8, 1H, ArH), 7.71 (ddd, J = 
1.2, 7.0, 8.6, 1H, ArH), 8.09 (d, J = 8.8, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 43.2 (NCH2), 
50.9 (NCH2), 110.1 (ArC), 112.9 (ArC), 135.6 (ArC), 143.4 (ArC), 151.1 (ArC). HR-MS (ESI, 
positive ion mode) – m/z for [C7H9N2Cl+H]




Under a dry, inert atmosphere, a solution of 2-aminopyridine (1.0 g, 10.60 mmol, 
1.00 equiv., 0.17 M) in THF (35 mL) was prepared. To this solution was added a 
solution of potassium tert-butoxide in THF (15.9 mL, 1.00 M, 15.90 mmol, 1.50 equiv.). The 
solution was stirred for 1 h at room temperature and a solution of allyl bromide (1.10 mL, 12.70 
mmol, 1.20 equiv.) in THF (10 mL) was added in one portion to give a brown solution. The 
solution was stirred for 2 h at room temperature and then diluted with deionised water (100 mL). 
The THF was removed in vacuo and the aqueous phase was extracted with EtOAc (2 x 25 mL). 
The combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated 
in vacuo. The crude product was purified by column chromatography (20-100% EtOAc:PE) to 
give the title amine as a white solid (711 mg, 5.30 mmol, 50%). TLC – Rf = 0.15 (SiO2, 20:80 
EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 4.10 (d, J = 5.5, 2H, NCH2), 5.05 (dd, J = 1.5, 10.8, 
1H, C=CH), 5.18 (dd, J = 1.5, 16.0, 1H, C=CH), 5.98 (ddd, J = 5.5, 10.8, 16.1, 1H, C=CH),  6.78 
(t, J = 6.6, 1H, ArH), 7.41 (d, J = 8.6, 1H, ArH), 7.75 (ddd, J = 1.3, 7.1, 8.6, 1H, ArH), 8.13 (d, J 
= 8.6, 1H, ArH). Spectroscopic data matched that previously reported.133 
 
N-(2-Pyridyl)(tert-butoxycarbonyl)allylamine, 115 
Under a dry, inert atmosphere, to a solution of 114 (536 mg, 4.00 mmol, 1.00 
equiv. 0.10 M) in DCM (20 mL) was added 4-(dimethylamino)pyridine (49 mg, 
0.40 mmol, 0.10 equiv.). The solution was cooled to 0 °C and a solution of Boc2O 
(959 mg, 4.40 mmol, 1.10 equiv.) in DCM (20 mL) was added in one portion. The 
solution was stirred for 16 h and then diluted with saturated NaHCO3 (100 mL). The aqueous 
phase was extracted with DCM (3 x 50 mL) and the combined organic extracts were dried 
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(MgSO4), filtered ad concentrated in vacuo. The crude product was purified by column 
chromatography (25-100% DCM:PE) to give the title carbamate as a colourless oil (703 mg, 3.00 
mmol, 75%). TLC – Rf = 0.20 (SiO2, 25:75 DCM:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.49 (s, 
9H, C(CH3)3), 4.54 (d, J = 5.4, 2H, NCH2), 5.07 (dd, J = 1.5, 10.2, 1H, C=CH), 5.13 (dd, J = 1.5, 
17.2, 1H, C=CH), 5.94 (ddd, J = 5.6, 10.2, 16.4, 1H, C=CH), 6.98 (t, J = 5.1, 1H, ArH), 7.57-7.65 




Synthesised according to general procedure N using 115 (250 mg, 1.07 mmol). 
The crude product was then purified by column chromatography (20-100% 
EtOAc) to give the title aldehyde as a colourless oil (253 mg, 1.07 mmol, >99%). 
TLC – Rf = 0.36 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.51 
(s, 9H, C(CH3)3), 4.64 (NCH2), 6.99 (dd, J = 4.0, 7.3, 1H, ArH), 7.64 (t, J = 7.7, 1H, ArH), 7.86 
(d, J = 8.5, 1H, ArH), 8.27 (d, J = 4.0, 1H, ArH), 9.65 (s, 1H, CHO). 
13
C NMR (101 MHz, CDCl3) 
δC 28.3 (C(CH3)3), 55.8 (NCH2), 82.6 (C(CH3)3), 118.1 (ArC), 119.6 (ArC), 137.4 (ArC), 147.2 
(ArC), 153.6 (CO), 197.9 (CHO). HR-MS (ESI, positive ion mode) – m/z for [C12H16N2O3+H]
+ 




Synthesised according to 
general procedure E using 
86 (250 mg, 0.23 mmol) 
and 102 (111 mg, 0.47 
mmol, 2.00 equiv.). The 
crude product was purified by column chromatography (2-10% MeOH:DCM) to give the title 
amine as a foamy white solid (150 mg, 0.12 mmol, 51%). M.P. 201-202 °C (DCM/Et2O). TLC 
– Rf = 0.18 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 1.49 (s, 9H, C(CH3)3), 
2.87-2.90 (m, 2H, NCH2), 3.01 (t, J = 5.6, 2H, NCH2), 3.33-3.59 (m, 20H, 10 x NCH2), 3.75-3.79 
(m, 15H, 5 x OCH3), 4.01 (t, J = 5.8, 2H, NCH2), 4.60 (s, 2H, CH2Ar), 6.77-6.85 (m, 10H, 10 x 
ArH), 6.99 (ddd, J = 1.3, 4.9, 7.2, 1H, ArH), 7.27-7.41 (m, 9H, 9 x ArH), 7.54 (d, J = 8.2, 1H, 
ArH), 7.59-7.64 (m, 8H, 8 x ArH), 8.29 (dd, J = 1.3, 4.9, 1H, ArH), 8.97 (s, 1H, NH), 9.14 (s, 1H, 
NH). 9.18 (s, 1H, NH), 10.35 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 28.4 (C(CH3)3), 46.6-
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50.0 (12 x NCH2), 51.2 (CH2Ar), 55.5 (5 x OCH3), 81.8 (C(CH3)3), 113.9-114.3 (10 x ArC), 119.8 
(ArC), 120.2 (ArC), 120.9-122.0 (10 x ArC), 127.0-129.3 (5 x ArC), 133.1-133.6 (5 x ArC), 137.4 
(ArC), 147.7 (ArC), 153.9 (ArC), 154.6 (ArC), 155.2 (3 x ArC), 156.6 (5 x CO), 158.6 (CO). 
HR-MS (ESI, positive ion mode) – m/z for [C69H85N13O12+H]
+ = 1288.6519. Found 1288.6500. 




Synthesised according to 
general procedure C using 
116 (150 mg, 0.12 mmol). 
The title diamine was 
isolated as a foamy white 
solid (120 mg, 0.10 mmol, 84%). M.P. 222-223 °C (DCM/Et2O). TLC – Rf = 0.15 (SiO2, 
MeOH:DCM 10:90). 
1
H NMR (500 MHz, CDCl3) δH 2.82-2.85 (m, 2H, NCH2), 2.87 (t, J = 5.4, 
2H, NCH2), 3.31-3.59 (m, 18H, 9 x NCH2), 3.75-3.81 (m, 15H, 5 x OCH3), 4.60 (s, 2H, CH2Ar), 
4.76 (s, 1H, NH), 6.28 (d, J = 8.0, 1H, ArH), 6.56 (t, J = 5.8, 1H, ArH), 6.79-6.88 (m, 10H, 10 x 
ArH), 7.29-7.39 (m, 9H, 9 x ArH), 7.60-7.70 (m, 7H, 7 x ArH), 8.02-8.05 (m, 1H, ArH), 8.99-
9.13 (m, 4H, 4 x NH), 10.10 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 41.2 (NCH2), 41.3 
(NCH2), 46.9-48.6 (10 x NCH2), 50.0 (CH2Ar), 55.4-55.6 (5 x OCH3), 113.3-114.3 (10 x ArC), 
120.9-122.0 (10 x ArC), 126.6-129.3 (5 x ArC), 133.0-133.5 (5 x ArC), 137.4 (ArC), 147.7 (ArC), 
155.1-155.3 (5 x ArC), 156.5 (4 x CO), 158.5 (CO). HR-MS (MALDI, positive ion mode) – m/z 
for [C64H78N13O10+H]




 Synthesised according to general procedure B using 114 (1.00 g, 7.45 mmol) 
and 4-methoxyphenyl isocyanate (1.49 mL, 11.18 mmol). The crude product 
was purified by column chromatography (1-10% MeOH:DCM) to yield the title 
urea as a colourless oil (1.31 g, 4.62 mmol, 62%). TLC – Rf = 0.18 (SiO2, 20:80 
EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 3.80 (s, 3H, OCH3), 4.65 (dt, J = 
1.8, 4.7, 2H, NCH2), 5.21-5.23 (m, 1H, C=CH), 5.24 (dd, J = 1.2, 10.6, 1H, C=CH), 5.99 (ddt, J 
= 4.7, 10.6, 17.2, 1H, C=CH), 6.87 (d, J = 9.0, 2H, 2 x ArH), 6.98 (ddd, J = 0.6, 5.0, 7.3, 1H, 
ArH), 7.05 (d, J = 8.7, 1H, ArH), 7.49 (d, J = 9.0, 2H, 2 x ArH), 7.69 (ddd, J = 2.0, 7.3, 8.7, 1H, 
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ArH), 8.32 (dd, J = 2.0, 5.0, 1H, ArH), 12.64 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 47.8 
(NCH2), 55.6 (OCH3), 112.7 (ArC), 114.2 (2 x ArC), 116.2 (ArC), 117.4 (C=CH), 122.1 (2 x 
ArC), 132.5 (ArC), 133.4 (C=CH), 138.9 (ArC), 145.7 (ArC), 153.8 (ArC), 155.6 (ArC), 155.8 
(CO). HR-MS (ESI, positive ion mode) – m/z for [C16H17N3O2+Na]
+ = 306.1218. Found 
306.1203. FTIR (neat) – 3464, 2983, 2941, 1663, 1629. 
 
3,3-Dibutyl-5-hexyl-2-methyl-3H-indole, 125 
Synthesised according to general procedure O using (4-
hexylphenyl)hydrazine hydrochloride (500 mg, 2.18 mmol) and 3-butyl-
heptan-2-one (447 mg, 2.62 mmol). The crude product was purified by 
column chromatography (10% EtOAc:PE) to give the title 3H-indole as a brown oil (490 mg, 
1.50 mmol, 69%). TLC – Rf = 0.23 (10:90 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 0.73 (t, 
J = 7.4, 6H, 2 x CH3), 0.87 (t, J = 7.1, 3H, CH3), 1.12-1.15 (m, 4H, 2 x CH2), 1.27-1.33 (m, 6H, 
3 x CH2), 1.59-1.64 (m, 2H, CH2), 1.66-1.74 (m, 4H, 2 x CH2), 1.80-1.89 (m, 4H, 2 x CH2), 2.18 
(s, 3H, CH3), 2.64 (t, J = 7.8, 2H, CH2Ar), 6.97 (d, J = 1.2, 1H, ArH), 7.09 (dd, J = 1.2, 7.8, 1H, 
ArH), 7.39 (d, J = 7.8, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 13.9 (2 x CH3), 14.2 (CH3), 
16.2 (CH3), 22.8 (CH2), 23.0 (2 x CH2), 25.9 (2 x CH2), 29.0 (CH2), 31.9 (CH2), 31.9 (CH2), 36.1 
(2 x CH2), 36.9 (CH2Ar), 62.5 (Cquat.), 119.2 (ArC), 121.9 (ArC), 127.5 (ArC), 139.8 (ArC), 142.5 
(ArC), 153.5 (ArC), 185.6 (C=N). HR-MS (ESI, positive ion mode) – m/z for [C23H37N+Na]
+ = 
350.2824. Found 350.2799. FTIR (neat) – 2993, 2970, 2941, 1679.  
 
3-(3,3-Dibutyl-5-hexyl-2-methyl-3H-indolium)propane-1-sulfonate, 126 
Synthesised according to general procedure P using 125 (490 mg, 1.43 
mmol) and 1,3-propanesultone (0.14 mL, 1.58 mmol). The crude 
product was purified by column chromatography (25% EtOAc:PE) to 
give the title indolium sulfonate as a brown oil (213 mg, 0.45 mmol, 
29%). TLC – Rf = 0.15 (25:75 EtOAc:PE). 
1
H NMR (400 MHz, 
CDCl3) δH 0.74 (t, J = 7.2, 6H, 2 x CH3), 0.86 (t, J = 7.0, 3H, CH3), 1.15-1.18 (m, 4H, 2 x CH2), 
1.22-1.32 (m, 10H, 5 x CH2), 1.60-1.64 (m, 2H, CH2), 1.97-2.10 (m, 4H, 2 x CH2), 2.33-2.37 (m, 
2H, CH2), 2.72 (t, J = 7.3, 2H, CH2Ar), 2.96 (s, 3H, CH3), 3.11-3.15 (m, 2H, SCH2), 5.07-5.10 
(m, 2H, NCH2), 7.20 (s, 1H, ArH), 7.41 (d, J = 7.6, 1H, ArH), 7.94 (d, J = 7.6, 1H, ArH). 
13
C 
NMR (101 MHz, CDCl3) δC 13.6 (2 x CH3), 14.1 (CH3), 14.8 (CH3), 22.6 (2 x CH2), 22.7 (CH2), 
25.2 (CH2), 25.9 (2 x CH2), 28.8 (CH2), 31.0 (SCH2), 31.4 (CH2), 31.7 (CH2), 36.0 (CH2Ar), 37.4 
(2 x CH2), 47.6 (Cquat.), 63.3 (NCH2), 116.0 (ArC), 123.1 (ArC), 130.3 (ArC), 138.7 (ArC), 140.5 
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(ArC), 145.9 (ArC), 194.3 (C=N). HR-MS (ESI, positive ion mode) – m/z for [C26H43NO3S+Na]
+ 
= 472.2861. Found 472.2899. FTIR (neat) – 2981, 2967, 1613. 
 
(E)-3-(3,3-Dibutyl-5-hexyl-2-(2-hydroxystyryl)-3H-indolium)propane-1-sulfonate, 127 
Synthesised according to general procedure Q using 126 (150 
mg, 0.33 mmol) and salicylaldehyde (0.04 mL, 0.36 mmol). The 
crude product was purified by column chromatography (1-5% 
MeOH:DCM) to give a brown solid, which was recrystallised 
from CHCl3/Et2O to give the title merocyanine as a brown solid 
(129 mg, 0.22 mmol, 62%). M.P. 184-185 °C (CHCl3/Et2O). TLC – Rf = 0.20 (5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 0.68 (t, J = 7.3, 6H, 2 x CH3), 0.88 (t, J = 6.8, 3H, 
CH3), 1.09-1.13 (m, 4H, 2 x CH2), 1.23-1.34 (m, 5 x CH2), 1.62-1.66 (m, 2H, CH2), 2.26-2.33 (m, 
4H, 2 x CH2), 2.44-2.47 (m, 2H, CH2), 2.73 (t, J = 7.5, 2H, CH2Ar), 3.20 (t, J = 5.8, 2H, SCH2), 
4.89 (t, J = 7.7, 2H, NCH2), 6.85 (t, J = 7.5, 1H, ArH), 7.20 (s, 1H, ArH), 7.29 (t, J = 7.6, 1H, 
ArH), 7.36 (d, J = 8.2, 1H, ArH), 7.43 (d, J = 8.4, 1H, ArH), 7.63 (d, J = 7.6, 1H, ArH), 7.81 (d, 
J = 8.2, 1H, ArH), 8.22 (d, J = 15.9, 1H, C=CH), 8.30 (d, J = 15.9, C=CH), 11.32 (s, 1H, OH). 
13
C NMR (101 MHz, CDCl3) δC 13.6 (2 x CH3), 14.2 (CH3), 22.4-22.8 (3 x CH2), 24.8 (CH2), 
25.9 (2 x CH2), 28.8 (CH2), 31.5 (CH2), 31.8 (CH2), 36.1 (CH2Ar), 42.0 (2 x CH2), 46.2 (NCH2), 
47.8 (SCH2), 61.6 (Cquat.), 112.9 (C=CH), 114.8 (ArC), 118.7 (ArC), 120.2 (ArC), 121.3 (ArC), 
122.2 (ArC), 130.3 (ArC), 133.1 (ArC), 136.4 (ArC), 140.2 (ArC), 140.5 (ArC), 145.3 (ArC), 
152.0 (C=CH), 161.8 (ArC), 180.1 (C=N). HR-MS (ESI, positive ion mode) – m/z for 
[C33H47NO4S+Na]
+ = 576.3123. Found 576.3092. FTIR (neat) – 3060, 2958, 1587, 1525. 
 
3,3-Dimethyl-5-hexyl-2-methyl-3H-indole, 128 
Synthesised according to general procedure O using (4-
hexylphenyl)hydrazine hydrochloride (500 mg, 2.18 mmol) and methyl 
isopropyl ketone (0.28 mL 2.62 mmol). The title 3H-indole was isolated as a brown oil (302 mg, 
1.24 mmol, 57%). TLC – Rf = 0.23 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 
0.85 (t, J = 5.9, 3H, CH3), 1.25-1.33 (m, 6H, 3 x CH2), 1.59 (tt, J = 7.0, 7.5, 2H, CH2), 2.06 (s, 
3H, CH3), 2.24 (s, 6H, 2 x CH3), 2.60 (t, J = 7.6, 2H, CH2Ar), 7.05 (s, 1H, ArH), 7.07 (d, J = 7.8, 
1H, ArH), 7.41 (d, J = 7.8, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 14.1 (2 x CH3), 15.1 (CH3), 
22.5 (CH3), 23.1 (CH2), 29.0 (CH2), 31.7 (CH2), 31.9 (CH2), 36.0 (CH2Ar), 53.3 (Cquat.), 119.3 
(ArC), 121.5 (ArC), 127.5 (ArC), 140.3 (ArC), 145.5 (ArC), 151.1 (ArC), 174.9 (ArC), 187.4 
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(C=N). HR-MS (ESI, positive ion mode) – m/z for [C17H25N+Na]
+ = 266.1885. Found 266.1904. 
FTIR (neat) – 2987, 2947, 1666. 
 
3-(3,3-Dimethyl-5-hexyl-2-methyl-3H-indolium)propane-1-sulfonate, 129 
Synthesised according to general procedure P using 128 (304 mg, 1.24 
mmol) and 1,3-propanesultone (0.12 mL, 1.37 mmol). The title 
indolium sulfonate was isolated as a brown gum (340 mg, 0.93 mmol, 
75%). TLC – Rf = 0.30 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, 
CDCl3) δH 0.85 (t, J = 6.9, 3H, CH3), 1.26-1.31 (m, 6H, 3 x CH2), 1.52 (s, 6H, 2 x CH3), 2.34 (tt, 
J = 5.9, 6.9, 2H, CH2), 2.64 (t, J = 7.7, 2H, CH2), 2.95 (s, 3H, CH3), 2.97 (t, J = 6.3, SCH2), 4.89 
(t, J = 7.9, 2H, NCH2), 7.22 (d, J = 1.3, 1H, ArH), 7.29 (dd, J = 1.3, 8.3, 1H, ArH), 7.79 (d, J = 
8.3, 1H, ArH). 
13
C NMR (101 MHz, CDCl3) δC 14.6 (CH3), 15.8 (CH3), 22.9 (CH2), 24.6 (CH2), 
28.4 (CH2), 32.0 (CH2), 33.7 (CH2), 35.4 (SCH2), 38.2 (CH2Ar), 40.6 (2 x CH3), 62.1 (NCH2), 
116.5 (ArC), 123.7 (ArC), 131.0 (ArC), 139.3 (ArC), 141.0 (ArC), 146.7 (ArC), 190.5 (C=N). 
HR-MS (ESI, positive ion mode) – m/z for [C20H31NO3S+Na]
+ = 388.1922. Found 388.1946. 
FTIR (neat) – 2983, 2914. 
 
(E)-3-(3,3-Dimethyl-5-hexyl-2-(2-hydroxystyryl)-3H-indolium)propane-1-sulfonate, 130 
 Synthesised according to general procedure Q using 129 (100 
mg, 0.36 mmol) and salicylaldehyde (0.04 mL, 0.39 mmol). The 
crude product was purified by column chromatography (1-5% 
MeOH:DCM) to give a brown solid, which was recrystallised 
from CHCl3/Et2O to give the title merocyanine as a brown gum (68 mg, 0.14 mmol, 40%). TLC 
– Rf = 0.41 (SiO2, 25:75 acetone:DCM). 
1
H NMR (400 MHz, CDCl3) δH 0.88 (t, J = 6.7, 3H, 
CH3), 1.25-1.35 (m, 8H, 4 x CH2), 1.57-1.61 (m, 2H, CH2), 1.68 (s, 6H, 2 x CH3), 2.67 (t, J = 7.6, 
2H, CH2Ar), 3.14-3.16 (m, 2H, SCH2), 4.84-4.89 (m, 2H, NCH2), 6.70 (t, J = 7.5, 1H, ArH), 7.12 
(t, J = 7.5, 1H, ArH), 7.24 (s, 1H, ArH), 7.28 (d, J = 8.0, 1H, ArH), 7.51 (d, J = 5.7, 1H, ArH), 
7.53 (d, J = 5.7, 1H, ArH), 7.81 (d, J = 8.0, 1H, ArH), 7.89 (d, J = 15.8, 1H, C=CH), 8.34 (d, J = 
15.8, C=CH), 10.96 (s, 1H, OH). 
13
C NMR (101 MHz, CDCl3) δC 11.2 (CH3), 14.0 (2 x CH3), 
22.5 (CH2), 27.5 (CH2), 28.9 (CH2), 30.4 (CH2), 31.5 (CH2), 36.0 (CH2Ar), 38.7 (SCH2), 51.7 
(NCH2), 68.2 (Cquat.), 110.8 (C=CH), 114.6 (ArC), 117.9 (ArC), 120.1 (ArC), 121.3 (ArC), 122.2 
(ArC), 129.8 (ArC), 132.4 (ArC), 138.7 (ArC), 141.6 (ArC), 143.0 (ArC), 145.1 (ArC), 160.1 
(C=CH), 167.8 (ArC), 181.0 (C=N). HR-MS (ESI, positive ion mode) – m/z for 
[C27H35NO4S+Na]




Under a dry, inert atmosphere, a solution of 2,3,3-trimethylindolenine (2.00 g, 12.56 
mmol, 1.00 equiv., 0.50 M) in anhydrous MeCN (25 mL) was prepared. To this 
solution was added methyl iodide (1.95 mL, 31.40 mmol, 2.50 equiv.) and the 
solution was heated to reflux and stirred for 16 h. The resulting brown solution was cooled to 
room temperature and concentrated in vacuo. The residue was triturated with Et2O and filtered. 
The residue was then washed with Et2O (2 x 25 mL) and dried in vacuo. The residue was added 
to aqueous KOH (25 mL, 1.00 M) and stirred for 30 minutes. The aqueous phase was extracted 
with Et2O (3 x 25 mL) and the combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo to give the title indoline as a brown oil (2.11 g, 12.12 mmol, 
97%). TLC – Rf = 0.23 (SiO2, 50:50 DCM:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.15 (s, 6H, 2 x 
CH3), 3.02 (s, 3H, NCH3), 3.78 (s, 2H, C=CH2), 6.36 (d, J = 7.1, 1H, ArH), 6.74 (t, J = 7.8, 1H, 




Synthesised according to general procedure Q using 131 (2.00 g, 11.54 mmol) 
and salicylaldehyde (1.57 mL, 14.73 mmol). The crude product was purified 
by column chromatography (10% DCM:PE) to yield the title spiropyran as a 
red solid (2.88 g, 10.39 mmol, 90%). TLC – Rf = 0.12 (SiO2, 50:50 DCM:PE). 
1
H NMR (400 
MHz, CDCl3) δH 1.13 (s, 3H, CH3), 1.26 (s, 3H, CH3), 2.70 (s, 3H, NCH3), 5.75 (d, J = 10.2, 1H, 
C=CH), 6.55 (d, J = 8.1, 1H, ArH), 6.59 (d, J = 8.1, 1H, ArH), 6.81 (dt, J = 0.9, 7.4, 1H, ArH), 
6.84 (dt, J = 1.1, 7.4, 1H, ArH), 6.94 (d, J = 10.2, 1H, C=CH), 7.07-7.13 (m, 3H, 3 x ArH), 7.16 
(dt, J = 1.3, 7.7, 1H, ArH). Spectroscopic data matched that previously reported.96  
 
1’,3’,3’-Trimethyl-6-nitro-spiro[chromene-2,2’-indoline], 133 
Synthesised according to general procedure Q using 131 (250 mg, 1.44 
mmol) and 5-nitrosalicylaldehyde (301 mg, 1.80 mmol). The crude 
product was purified by column chromatography (10-20% EtOAc:PE) to 
yield the title spiropyran as a red solid (292 mg, 0.91 mmol, 63%). TLC – Rf = 0.47 (SiO2, 20:80 
EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.12 (s, 3H, CH3), 1.23 (s, 3H, CH3), 2.67 (s, 3H, 
NCH3), 5.79 (d, J = 10.3, 1H, C=CH), 6.49 (d, J = 7.8, 1H, ArH), 6.70 (dt, J = 0.6, 8.4, 1H, ArH), 
6.82 (td, J = 0.9, 7.5, 1H, ArH), 6.85 (d, J = 10.3, 1H C=CH), 7.02 (dd, J = 1.2, 7.3, 1H, ArH), 
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7.14 (td, J = 1.3, 7.8, 1H, ArH), 7.92-7.96 (m, 2H, 2 x ArH). Spectroscopic data matched that 
previously reported.96  
 
N-Phenylmaleamic acid, 134 
To a solution of maleic anhydride (1.00 g, 10.20 mmol, 1.00 equiv., 0.20 M) in 
toluene (50 mL) was added aniline (0.93 mL, 10.20 mmol, 1.00 equiv.) 
dropwise. The solution was stirred for 5 minutes and a white solid precipitated 
out of solution. The suspension was filtered and the residue was washed with toluene (2 x 25 mL) 
and dried in vacuo to yield the title amic acid as a white solid (1.95 g, 10.20 mmol, >99%). TLC 
– Rf = 0.28 (SiO2, 10:90 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 6.61 (d, J = 11.0, 1H, 
C=CH), 6.93 (d, J = 11.0, 1H, C=CH), 7.10 (t, J = 8.0, 1H, ArH), 7.29 (t, J = 6.9, 2H, 2 x ArH), 
7.40 (d, J = 7.5, 2H, 2 x ArH), 9.57 (s, 1H, NH), 10.31 (s, 1H, OH). Spectroscopic data matched 
that previously reported.135 
 
N-2-(Benzylamino)(4-methoxyanilinylcarbonyl)ethyl-N’-phenylmaleamide, 135 
Under a dry, inert atmosphere, a solution of 107 (300 mg, 1.00 
mmol, 1.00 equiv., 0.10 M) in anhydrous DMF (10 mL) was 
prepared. To this solution was added 134 (191 mg, 1.00 mmol, 
1.00 equiv.), HBTU (531 mg, 1.40 mmol, 1.40 equiv.) and 
DIPEA (0.24 mL, 1.40 mmol, 1.40 equiv.) and the resulting 
solution was stirred for 1 h. The solution was diluted with EtOAc 
(25 mL) and washed with aqueous LiCl (5% w/w, 3 x 25 mL), saturated aqueous KHSO4 (25 mL) 
and brine (25 mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo to 
yield the title maleamide as a white solid (246 mg, 0.52 mmol, 52%). TLC – Rf = 0.41 (SiO2, 
5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.29 (q, J = 6.2, 2H, NCH2), 3.42 (t, J = 6.2, 
2H, NCH2), 3.72 (s, 3H, OCH3), 4.54 (s, 2H, CH2Ar), 6.02 (d, J = 13.3, 1H, C=CH), 6.14 (d, J = 
13.3, 1H, C=CH), 6.75 (d, J = 8.9, 2H, 2 x ArH), 7.08 (t, J = 7.1, 1H, ArH), 7.21-7.34 (m, 9H, 9 
x ArH), 7.51 (d, J = 8.9, 2H, 2 x ArH), 7.89 (s, 1H, NH), 9.16 (t, J = 6.2, 1H, NH), 11.40 (s, 1H, 
NH). 
13
C NMR (101 MHz, CDCl3) δC 39.4 (NCH2), 45.7 (NCH2), 51.3 (CH2Ar), 55.6 (CH2Ar), 
114.2 (2 x ArC), 120.6 (2 x ArC), 123.3 (2 x ArC), 127.3 (2 x ArC), 127.9 (ArC), 128.1 (ArC), 
129.0 (2 x ArC), 129.0 (2 x ArC), 131.1 (ArC), 132.0 (ArC), 134.3 (C=CH), 135.4 (C=CH), 137.8 
(ArC), 156.2 (ArC), 157.0 (CO), 162.9 (CO), 166.7 (CO). HR-MS (ESI, positive ion mode) – 
m/z for [C27H28N4O4+Na]
+ = 495.2008. Found 495.2034. FTIR (neat) – 3321, 3256, 3193, 2998, 





 Synthesised according to general procedure E using 95 
(350 mg, 0.73 mmol) and 1-pyrenecarboxaldehyde (253 
mg, 1.10 mmol) in an anhydrous MeOH:anhydrous 
DCM mixture (7 mL, 1 :1). The crude product was 
purified by column chromatography (1-10% 
MeOH:DCM) to yield the title amine as a pale-yellow solid (278 mg, 0.40 mmol, 55%). M.P. 
167-168 °C (DCM/Et2O). TLC – Rf = 0.15 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, 
CDCl3) δH 3.05 (t, J = 4.8, 2H, NCH2), 3.48-3.56 (m, 4H, 2 x NCH2), 3.58 (s, 3H, OCH3), 3.72 (s, 
3H, OCH3), 4.04 (t, J = 7.7, 2H, NCH2), 4.47 (s, 2H, CH2Ar), 6.80 (d, J = 9.0, 2H, 2 x ArH), 6.81 
(d, J = 9.0, 2H, 2 x ArH), 6.88-6.89 (m, 1H, ArH), 7.00-7.03 (m, 1H, ArH), 7.38 (d, J = 9.0, 2H, 
2 x ArH), 7.44 (d, J = 9.0, 2H, 2 x ArH), 7.84-8.14 (m, 11H, 11 x ArH), 8.22 (d, J = 9.2, 1H, 
ArH), 9.35 (s, 1H, NH), 12.50 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 46.3 (NCH2), 50.2 
(2 x NCH2), 52.3 (NCH2), 55.4 (CH2Ar), 55.6 (OCH3), 113.7 (2 x ArC), 114.1 (2 x ArC), 117.3 
(ArC), 121.4 (2 x ArC), 122.4 (2 x ArC), 122.8 (ArC), 124.8 (2 x ArC), 124.8 (ArC), 125.2 (2 x 
ArC), 125.3 (ArC), 126.0 (ArC), 127.4 (4 x ArC), 128.2 (ArC), 129.1 (ArC), 130.8 (ArC), 131.0 
(ArC), 131.3 (ArC), 132.0 (ArC), 133.1 (ArC), 139.4 (ArC), 145.2 (ArC), 154.3 (ArC), 155.0 
(ArC), 155.3 (CO), 155.9 (CO). HR-MS (ESI, positive ion mode) – m/z for [C42H40N6O4+Na]
+ = 




 Synthesised according to general procedure B1 using 
136 (75 mg, 0.10 mmol) and 4-methoxyphenyl 
isocyanate (0.02 mL, 0.16 mmol). The crude product was 
purified by column chromatography (1-10% 
MeOH:DCM) to yield the title triurea as a white solid (36 
mg, 0.04 mmol, 43%). M.P. 220-221 °C (DCM). TLC – Rf = 0.38 (SiO2, 5:95 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 3.46-3.68 (m, 6H, 3 x NCH2), 3.78 (s, 3H, OCH3), 3.79 (s, 3H, 
OCH3), 3.79 (s, 3H, OCH3), 4.02 (t, J = 6.7, 2H, NCH2), 6.85 (d, J = 8.8, 2H, 2 x ArH), 6.85 (d, J 
= 8.8, 2H, 2 x ArH), 6.85 (d, J = 8.8, 2H, 2 x ArH), 7.00 (dd, J = 5.1, 7.3, 1H, ArH), 7.40 (d, J = 
8.8, 2H, 2 x ArH), 7.51 (t, J = 7.7, 1H, ArH), 7.58 (d, J = 8.8, 2H, 2 x ArH), 7.62 (d, J = 8.8, 2H, 
2 x ArH), 7.94-8.20 (m, 9H, 9 x ArH), 8.26 (dd, J = 1.9, 5.1, 1H, ArH), 8.34 (d, J = 9.2, 1H, ArH), 
8.76 (s, 1H, NH), 12.31 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 44.9 (NCH2), 46.8 (NCH2), 
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48.5 (NCH2), 49.3 (NCH2), 55.5 (CH2Ar), 55.6 (3 x OCH3), 114.0 (2 x ArC), 114.0 (2 x ArC), 
114.1 (2 x ArC), 117.9 (ArC), 121.1 (2 x ArC), 121.5 (2 x ArC), 122.1 (2 x ArC), 123.0 (ArC), 
124.4 (ArC), 124.7 (ArC), 125.0 (ArC), 125.5 (ArC), 125.6 (2 x ArC), 126.3 (ArC), 127.2 (ArC), 
127.7 (ArC), 128.5 (ArC), 129.0 (ArC), 129.4 (ArC), 130.8 (ArC), 131.1 (ArC), 131.2 (ArC), 
131.4 (ArC), 131.5 (ArC), 133.1 (ArC), 133.4 (ArC), 139.4 (ArC), 145.9 (ArC), 154.2 (ArC), 
154.8 (ArC), 155.3 (ArC), 155.3 (ArC), 156.0 (CO), 156.1 (CO), 156.1 (CO). HR-MS (ESI, 
positive ion mode) – m/z for [C50H47N7O6+Na]
+ = 864.3486. Found 864.3495. FTIR (neat) – 
3336, 2948, 2922, 1652. 
 
Pyren-1-ylmethyl isocyanate, 138 
Under a dry, inert atmosphere, 1-pyrenylmethylammonium chloride (250 mg, 0.94 
mmol, 1.00 equiv., 0.50 M) was suspended in anhydrous DCM (2 mL). Pyridine (0.08 
mL, 0.94 mmol, 1.00 equiv.) was added and the resulting solution was stirred for 10 
minutes. The solution was cooled to 0 °C and a solution of triphosgene (128 mg, 0.43 
mmol, 0.46 equiv., 1.00 M) in anhydrous DCM (0.5 mL) was added. The solution was warmed to 
room temperature and stirred for 1 h, after which time the solution was diluted with Et2O (10 mL). 
A white precipitate formed, and the suspension was filtered. The filtrate was then concentrated in 
vacuo to give the title isocyanate as a white solid (202 mg, 0.78 mmol, 83%). TLC – Rf = 0.70 
(SiO2, 50:50 Et2O:PE). 
1
H NMR (400 MHz, CDCl3) δH 5.24 (s, 2H, CH2Ar), 8.21-8.43 (m, 9H, 




Synthesised according to general procedure B1 using 
136 (75 mg, 0.10 mmol) and 138 (39 mg, 0.15 mmol). 
The crude product was purified by column 
chromatography (1-10% MeOH:DCM) to yield the title 
amine as a yellow solid (74 mg, 0.08 mmol, 78%). M.P. 
decomp. >250 °C (DCM). TLC – Rf = 0.51 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.15-3.65 (m, 6H, 3 x NCH2), 3.75 (s, 3H, OCH3), 
3.77 (s, 3H, OCH3), 5.12 (s, 2H, CH2Ar), 5.17 (s, 2H, CH2Ar), 6.74 (d, J = 8.9, 2H, 2 x ArH), 
6.81 (d, J = 9.0, 2H, 2 x ArH), 6.93 (dd, J = 5.1, 7.4, 1H, ArH), 7.28 (d, J = 9.0, 2H, 2 x ArH), 
7.38 (d, J = 8.9, 2H, 2 x ArH), 7.63-8.18 (m, 19H, 19 x ArH), 8.21 (dd, J = 1.9, 5.0, 1H, ArH), 
8.61 (d, J = 4.2, 1H, ArH), 8.68 (s, 1H, NH), 12.35 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 
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43.3 (NCH2), 46.6 (NCH2), 48.0 (NCH2), 49.6 (NCH2), 53.1 (CH2Ar), 55.4 (CH2Ar), 55.5 (2 x 
OCH3), 113.9 (2 x ArC), 114.0 (2 x ArC), 117.7 (ArC), 121.1 (2 x ArC), 123.8 (2 x ArC), 124.4-
131.3 (32 x ArC), 131.6 (ArC), 133.2 (ArC), 136.1 (ArC), 139.3 (ArC), 145.6 (ArC), 149.7 (ArC), 
154.1 (ArC), 155.9 (ArC), 156.0 (CO), 156.1 (CO), 158.3 (CO). HR-MS (ESI, positive ion mode) 
– m/z for [C60H53N7O5+Na]
+ = 974.4006. Found 974.4039. FTIR (neat) – 3299, 2950, 1638. 
 
Dibromomaleic anhydride, 140 
 Under a dry, inert atmosphere, bromine (1.57 mL, 30.6 mmol, 2.00 equiv.) was added 
to maleic anhydride (1.5 g, 15.3 mmol, 1.00 equiv.) in a 20 mL microwave vial. To this 
solution was added aluminium trichloride (300 mg, 2.3 mmol, 0.15 equiv.). The vial 
was sealed and heated to 160 °C for 20 h behind a blast shield. The suspension was cooled to 
room temperature and carefully opened to air. The suspension was diluted with EtOAc (25 mL) 
and filtered. The residue was washed with EtOAc (10 mL) and the filtrate was concentrated in 
vacuo to give the desired anhydride as a white solid (2.7 g, 10.7 mmol, 70%). TLC – Rf = 0.75 
(SiO2, 1:99 MeOH:DCM). 
13
C NMR (101 MHz, CDCl3) δC 128.1 (2 x C=CBr), 161.0 (2 x CO). 
Spectroscopic data matched that previously reported.137 
 
Allyl dibromomaleimide, 141 
Under a dry, inert atmosphere, allylamine (0.72 mL, 9.58 mmol, 1.00 equiv., 0.10 
M) was added to a solution of 140 (2.45 g, 9.58 mmol, 1.00 equiv.) in AcOH (96 
mL). The solution was heated to reflux and stirred for 5 h, after which time the 
AcOH was removed by distillation. The crude product was purified by column chromatography 
(5-20% EtOAc:PE) to give the title maleimide as a white solid (2.51 g, 8.51 mmol, 89%). M.P. 
96-97 °C (DCM). TLC – Rf = 0.65 (SiO2, 20:80 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 
4.20 (dt, J = 1.4, 5.9, 2H, NCH2), 5.20-5.28 (m, 2H, C=CH2), 5.79 (ddt, J = 5.9, 10.2, 17.0, 1H, 
C=CH). 
13
C NMR (101 MHz, CDCl3) δC 41.8 (CH2), 119.1 (C=CH2), 129.5 (2 x C=CBr), 130.6 
(C=CH), 163.6 (2 x CO). HR-MS (ESI, positive ion mode) – m/z for [C7H6Br2NO2+H]
+ = 
293.8765. Found 293.8760. FTIR (neat) – 2932, 1783, 1713. 
 
Allyl di(n-butylmercapto)maleimide, 142 
Under a dry, inert atmosphere, triethylamine (0.99 mL, 7.12 mmol, 2.10 
equiv.) was added dropwise to a solution of 141 (1.0 g, 3.39 mmol, 1.00 
equiv., 0.10 M) in anhydrous Et2O (34 mL). To this solution was added 1-
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butanethiol (0.76 mL, 7.12 mmol, 2.10 equiv.) dropwise and a yellow precipitate formed. The 
suspension was stirred at room temperature for 16 h. The suspension was then concentrated in 
vacuo and the crude product was purified by column chromatography (5-20% Et2O:PE) to give 
the title bis(sulfide) as a yellow oil (814 mg, 2.60 mmol, 77%). TLC – Rf = 0.60 (SiO2, 20:80 
Et2O:PE). 
1
H NMR (400 MHz, CDCl3) δH 0.92 (t, J = 7.3, 6H, 2 x CH3), 1.43-1.45 (m, 4H, 2 x 
CH2), 1.60-1.63 (m, 4H, 2 x CH2), 3.29 (t, J = 7.5, 4H, 2 x SCH2), 4.10 (dd, J = 1.3, 5.7, 2H, 
NCH2), 5.14-5.22 (m, 2H, C=CH2), 5.79 (ddt, J = 5.9, 10.2, 15.9, 1H, C=CH). 
13
C NMR (101 
MHz, CDCl3) δC 13.7 (2 x CH3), 21.7 (2 x CH2), 31.6 (2 x SCH2), 32.6 (2 x CH2), 40.7 (NCH2), 
117.8 (C=CH2), 131.7 (C=CH), 135.8 (2 x C=CS), 166.3 (2 x CO). HR-MS (ESI, positive ion 
mode) – m/z for [C15H23NO2S2+H]
+ = 314.1248. Found 314.1231. FTIR (neat) – 2958, 2930, 
2872, 1764, 1701. 
 
2-Oxoethyl-di(n-butylmercapto)maleimide, 143 
Synthesised according to general procedure N using 142 (250 mg, 0.70 
mmol). The crude product was purified by column chromatography (20-
100% Et2O:PE) to give the title aldehyde as a yellow oil (123 mg, 0.39 
mmol, 56%). TLC – Rf = 0.08 (SiO2, 20:80 Et2O:PE). 
1
H NMR (500 MHz, CDCl3) δH 0.92 (t, J 
= 7.3, 6H, 2 x CH3), 1.41-1.44 (m, 4H, 2 x CH2), 1.62-1.64 (m, 4H, 2 x CH2), 3.28 (t, J = 7.4, 2 x 
SCH2), 4.36 (s, 2H, NCH2), 9.56 (s, 1H, CHO). 
13
C NMR (126 MHz, CDCl3) δC 13.5 (2 x CH3), 
21.6 (2 x CH2), 31.6 (2 x SCH2), 32.5 (2 x CH2), 47.7 (NCH2), 136.1 (C=CS), 165.8 (2 x CO), 
193.6 (CHO). HR-MS (ESI, positive ion mode) – m/z for [C14H22NO3S2+H]
+ = 316.1041. Found 




Synthesised according to general procedure R using 92 
(43 mg, 0.31 mmol), 143 (72 mg, 0.31 mmol) and 4-
methoxyphenyl isocyanate (0.08 mL, 0.62 mmol). The 
crude product was purified by column chromatography 
(1-5% MeOH:DCM) to give the title diurea as a yellow 
solid (30 mg, 0.04 mmol, 13%). M.P. 167-168 °C (CHCl3/PE). TLC – Rf = 0.13 (SiO2, 1:99 
MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 0.89 (t, J = 7.4, 6H, 2 x CH3), 1.40-1.42 (m, 4H, 
2 x CH2), 1.58-1.61 (m, 4H, 2 x CH2), 3.24 (t, J = 7.5, 4H, 2 x SCH2), 3.62-3.67 (m, 4H, 2 x 
NCH2), 3.78 (t, J = 6.4, 2H, NCH2), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 4.11 (t, J = 7.8, 2H, 
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NCH2), 6.84 (d, J = 8.8, 2H, 2 x ArH), 6.89 (d, J = 8.8, 2H, 2 x ArH), 7.04 (dd, J = 5.0, 7.3, 1H, 
ArH), 7.33 (d, J = 8.4, 1H, ArH), 7.48 (d, J = 8.8, 2H, 2 x ArH), 7.53 (d, J = 8.8, 2H, 2 x ArH), 
7.81 (ddd, J = 1.7, 7.3, 8.4, 1H, ArH), 8.28 (s, 1H, NH), 8.33 (d, J = 5.0, 1H, ArH), 12.43 (s, 1H, 
NH). 
13
C NMR (126 MHz, CDCl3) δC 13.7 (2 x CH3), 21.8 (2 x CH2), 31.8 (2 x SCH2), 32.5 (2 x 
CH2), 37.2 (NCH2), 44.7 (NCH2), 46.0 (NCH2), 46.3 (NCH2), 55.7 (2 x OCH3), 112.3 (ArC), 
114.1 (2 x ArC), 114.3 (2 x ArC), 118.0 (ArC), 121.6 (2 x ArC), 122.4 (2 x ArC), 131.9 (ArC), 
133.2 (ArC), 136.3 (2 x C=CS), 139.7 (ArC), 146.0 (ArC), 154.4 (CO), 155.4 (CO), 155.5 (ArC), 
155.8 (ArC), 156.1 (ArC), 166.9 (2 x CO). HR-MS (ESI, positive ion mode) – m/z for 
[C37H46N6O6S2+H]
+ = 735.2998. Found 735.2994. FTIR (neat) – 3281, 2991, 1739, 1671. 
 
1,7-Dibenzyl-1,4,7-tris(butylaminocarbonyl)-1,4,7-triazaheptane, 146 
Synthesised according to general procedure B1 using 
44 (30 mg, 0.10 mmol) and n-butyl isocyanate (0.06 
mL, 0.45 mmol). The crude product was purified by 
column chromatography (1-5% MeOH:DCM) to yield 
the title triurea as a white solid (31 mg, 0.05 mmol, 54%). M.P. 111-112 °C (CHCl3). TLC – Rf 
= 0.68 (SiO2, 90:10 DCM:MeOH). 
1
H NMR (400 MHz, CDCl3) δH 0.80 (t, J = 7.4, 6H, 2 x CH3), 
0.85 (t, J = 7.3, 3H, CH3), 1.12-1.50 (m, 12H, 6 x CH2), 3.04-3.26 (m, 14H, 7 x NCH2), 4.34 (s, 
4H, 2 x CH2Ar), 5.06 (s, 2H, 2 x NH), 6.38 (t, J = 5.0, 1H, NH), 7.13 (d, J = 7.5, 4H, 4 x ArH), 
7.20 (t, J = 7.2, 2H, 2 x ArH), 7.26 (t, J = 7.5, 4H, 4 x ArH). 
13
C NMR (101 MHz, CDCl3) δC 13.9 
(2 x CH3), 14.0 (CH3), 20.1 (2 x CH2), 20.3 (CH2), 32.2 (CH2), 32.3 (2 x CH2), 47.3 (3 x NCH2), 
52.0 (2 x CH2Ar), 127.0 (4 x ArC), 127.7 (2 x ArC), 129.0 (4 x ArC), 138.0 (2 x ArC), 158.7 (2 
x CO), 158.8 (CO). HR-MS (ESI, positive ion mode) – m/z for [C33H52N6O3+Na]
+ = 603.3999. 
Found 603.4012. FTIR (neat) – 3326, 2963, 2910, 1640.  
 
1,7-Bis(trifluoroacetyl)-4-(4-methoxyanilinylcarbonyl)-1,4,7-triazaheptane, 147 
Synthesised according to general procedure J using 
diethylenetriamine (2.10 mL, 19.4 mmol) and 4-methoxyphenyl 
isocyanate (3.77 mL, 29.1 mmol). The resulting solution was 
concentrated in vacuo and the residue was recrystallised from 
DCM:Et2O. The residue was then washed with Et2O and air-dried 
to yield the title urea as a white solid (8.20 g, 18.5 mmol, 95%). M.P. 134-135 °C (CHCl3). TLC 
– Rf = 0.25 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (500 MHz, (CD)3SO) δH 3.38 (q, J = 5.9, 4H, 2 
x NCH2), 3.46 (t, J = 5.9, 4H, 2 x NCH2), 6.84 (d, J = 8.9, 2H, 2 x ArH), 7.32 (d, J = 8.9, 2H, 2 x 
ArH), 8.08 (s, 1H, NH), 9.50 (t, J = 5.9, 2H, 2 x NH). 
13
C NMR (126 MHz, (CD)3SO) δC 38.1 (2 
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x NCH2), 45.7 (2 x NCH2), 55.1 (OCH3), 113.5 (2 x ArC), 115.9 (q, J = 287.5, 2 x CF3), 122.2 (2 
x ArC), 133.1 (ArC), 154.7 (OCH3), 155.3 (CO), 156.5 (q, J = 37.3, 2 x CO). 
19
F NMR (377 
MHz, CDCl3) δF −76.8 (2 x CF3). HR-MS (ESI, positive ion mode) – m/z for [C16H18F6N4O4+H]
+ 
= 445.1310. Found 445.1292. FTIR (neat) – 2960, 1731, 1706. 
 
4-(4-Methoxyanilinylcarbonyl)-1,4,7-triazaheptane, 148 
Synthesised according to general procedure H using 147 (2.5 g, 5.63 
mmol). The resulting solution was concentrated in vacuo and the residue 
was diluted with deionised water. The aqueous solution was extracted 
with DCM (3 x 50 mL). The combined organic extracts were washed with 
brine, dried (MgSO4), filtered and concentrated in vacuo to give the title diamine as a colourless 
oil (450 mg, 1.78 mmol, 32%). TLC – Rf = 0.04 (SiO2, 10:90:1 DCM:MeOH:TEA).
1
H NMR 
(400 MHz, CDCl3) δH 1.49 (s, 4H, 2 x NH2), 2.84 (t, J = 5.7, 4H, 2 x NCH2), 3.29 (t, J = 5.7, 4H, 
2 x NCH2), 3.68 (s, 3H, OCH3), 6.72 (d, J = 9.0, 2H, 2 x ArH), 7.20 (d, J = 9.0, 2H, 2 x ArH), 
9.86 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 41.2 (2 x NCH2), 51.3 (2 x NCH2), 55.5 
(OCH3), 114.0 (2 x ArC), 120.8 (2 x ArC), 133.8 (ArC), 154.8 (ArC), 158.3 (CO). HR-MS (ESI, 
positive ion mode) – m/z for [C12H20N4O2+H]
+ = 253.1665. Found 253.1653. FTIR (neat) – 2938, 
2838, 1643, 1604. 
 
1,7-Dibenzyl-4-(4-methoxyanilinylcarbonyl)-1,4,7-triazaheptane, 149 
Synthesised according to general procedure E using 148 
(380 mg, 1.51 mmol) and benzaldehyde (0.46 mL, 4.52 
mmol). The crude product was purified using column 
chromatography (2-10% MeOH:DCM) to yield the title 
diamine as a colourless oil (315 mg, 0.73 mmol, 48%). 
TLC – Rf = 0.26 (SiO2, 10:90 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.85 (s, 2H, 2 x 
NH), 2.86 (t, J = 5.6, 4H, 2 x NCH2), 3.44 (t, J = 5.6, 4H, 2 x NCH2), 3.76 (s, 3H, OCH3), 3.81 (s, 
4H, 2 x CH2Ar), 6.76 (d, J = 9.0, 2H, 2 x ArH), 7.14 (d, J = 9.0, 2H, 2 x ArH), 7.26-7.34 (m, 10H, 
10 x ArH), 9.70 (s, 1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 48.7 (2 x NCH2), 49.2 (2 x NCH2), 
54.2 (2 x CH2Ar), 55.7 (OCH3), 114.1 (2 x ArC), 121.1 (2 x ArC), 127.2 (2 x ArC), 128.4 (4 x 
ArC), 128.7 (4 x ArC), 133.7 (ArC), 139.7 (2 x ArC), 155.0 (ArC), 158.2 (CO). HR-MS (ESI, 
positive ion mode) – m/z for [C26H32N4O2+H]
+ = 433.2604. Found 4332.2586. FTIR (neat) – 





Synthesised according to general procedure B1 using 
149 (271 mg, 0.63 mmol) and 4-methoxyphenyl 
isocyanate (0.08 mL, 0.63 mmol). The crude product 
was purified using column chromatography (2-10% 
MeOH:DCM) to yield the title diamine as a foamy white 
solid (238 mg, 0.41 mmol, 65%). M.P. 140-141 °C (CHCl3/PE). TLC – Rf = 0.26 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 2.82 (t, J = 4.5, 2H, NCH2), 3.25 (t, J = 7.8, 2H, 
NCH2), 3.29 (t, J = 4.5, 2H, NCH2), 3.47 (d, J = 7.8, 2H, NCH2), 3.77 (s, 3H, OCH3), 3.77 (s, 3H, 
OCH3), 3.82 (s, 2H, CH2Ar), 4.62 (s, 2H, CH2Ar), 6.76 (d, J = 8.8, 2H, 2 x ArH), 6.80 (d, J = 9.0, 
2H, 2 x ArH), 7.15 (d, J = 9.0, 2H, 2 x ArH), 7.24-7.27 (m, 2H, 2 x ArH), 7.27-7.35 (m, 8H, 8 x 
ArH), 7.52 (d, J = 8.8, 2H, 2 x ArH), 8.36 (s, 1H, NH), 9.81 (s, 1H, NH). 
13
C NMR (126 MHz, 
CDCl3) δC 45.3 (NCH2), 48.0 (NCH2), 49.4 (NCH2), 51.0 (NCH2), 51.1 (CH2Ar), 54.4 (CH2Ar), 
55.7 (2 x OCH3), 114.0 (2 x ArC), 114.1 (2 x ArC), 121.0 (2 x ArC), 121.5 (2 x ArC), 127.6 
(ArC), 127.7 (ArC), 127.9 (2 x ArC), 128.5 (2 x ArC), 128.8 (2 x ArC), 128.9 (2 x ArC), 133.1 
(ArC), 133.5 (ArC), 138.6 (ArC), 138.9 (ArC), 155.3 (2 x ArC), 156.3 (CO), 158.3 (CO). HR-
MS (ESI, positive ion mode) – m/z for [C34H39N5O4+H]
+ = 582.3080. Found 582.3101. FTIR 




Synthesised according to general procedure B1 using 
150 (60 mg, 0.10 mmol) and n-butyl isocyanate (0.02 
mL, 0.15 mmol). The crude product was purified using 
column chromatography (2-5% MeOH:DCM) to yield 
the title triurea as a foamy white solid (38 mg, 0.06 
mmol, 56%). M.P. 171-172 °C (Et2O/PE). TLC – Rf = 0.45 (SiO2, EtOAc). 
1
H NMR (400 MHz, 
CDCl3) δH 0.85 (t, J = 7.8, 3H, CH3), 1.20-1.22 (m, 2H, CH2), 1.37-1.40 (m, 2H, CH2), 3.16-3.47 
(m, 10H, 5 x NCH2), 3.76 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 4.38 (s, 2H, CH2Ar), 4.57 (s, 2H, 
CH2Ar), 6.81 (d, J = 9.0, 2H, 2 x ArH), 6.84 (d, J = 9.0, 2H, 2 x ArH), 7.12 (d, J = 7.5, 2H, 2 x 
ArH), 7.18-7.33 (m, 10H, 10 x ArH), 7.38 (s, 1H, NH), 7.53 (d, J = 8.9, 2H, 2 x ArH), 8.84 (s, 
1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 13.9 (CH3), 20.0 (CH2), 32.2 (CH2), 40.7 (NCH2), 46.7 
(NCH2), 47.6 (NCH2), 48.4 (NCH2), 49.9 (NCH2), 51.9 (CH2Ar), 52.7 (CH2Ar), 55.7 (2 x OCH3), 
114.0 (4 x ArC), 121.1 (2 x ArC), 121.6 (2 x ArC), 126.6 (2 x ArC), 127.6 (2 x ArC), 128.0 (2 x 
ArC), 128.9 (2 x ArC), 129.2 (2 x ArC), 133.0 (ArC), 133.4 (ArC), 137.7 (ArC), 138.2 (ArC), 
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155.3 (ArC), 155.4 (ArC), 156.4 (CO), 156.6 (CO), 158.9 (CO). HR-MS (ESI, positive ion mode) 
– m/z for [C39H48N6O5+Na]




Synthesised according to general procedure R using 
152 (160 mg, 0.35 mmol), 143 (89 mg, 0.39 mmol) 
and n-hexyl isocyanate (0.02 mL, 0.08 mmol). The 
crude product was purified by column 
chromatography (2-10% MeOH:DCM) to give the 
title urea as a yellow oil (25 mg, 0.03 mmol, 55%). TLC – Rf = 0.50 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 0.82 (t, J = 7.2, 3H, CH3), 0.87 (t, J = 6.9, 3H, CH3), 0.94 (t, J = 
7.2, 6H, 2 x CH3), 1.15-1.34 (m, 12H, 6 x CH2), 1.41-1.56 (m, 8H, 4 x CH2), 1.60-1.66 (m, 4H, 2 
x CH2), 3.14-3.22 (m, 4H, 2 x NCH2), 3.27 (t, J = 7.6, 4H, 2 x SCH2), 3.31-3.45 (m, 10H, 5 x 
NCH2), 3.65 (t, J = 7.0, 2H, NCH2), 5.67 (s, 1H, NH), 6.31 (s, 1H, NH), 6.84 (s, 1H, NH), 7.43 
(s, 1H, ArH), 7.98 (s, 2H, 2 x ArH) 8.73 (s, 1H, NH). 
13
C NMR (126 MHz, CDCl3) δC 13.5 (2 x 
CH3), 13.9 (CH3), 14.0 (CH3), 21.6 (2 x CH2), 22.5 (CH2), 22.6 (CH2). 26.6 (CH2), 26.6 (CH2), 
29.7 (CH2), 29.8 (CH2), 31.4 (CH2), 31.5 (CH2), 31.6 (2 x SCH2), 32.4 (2 x CH2), 36.4 (NCH2), 
39.1 (NCH2), 41.3 (2 x NCH2), 45.6 (NCH2), 46.5 (NCH2), 46.9 (NCH2), 48.1 (NCH2), 114.8 
(ArC), 117.9 (2 x ArC), 123.4 (q, J = 273.4, 2 x CF3), 131.9 (q, J = 33.0, 2 x ArC), 135.9 (2 x 
C=CS), 141.6 (ArC), 156.1 (CO), 158.3 (CO), 159.1 (CO), 166.8 (2 x CO). 
19
F NMR (377 MHz, 
CDCl3) δF −64.3 (2 x CF3). HR-MS (ESI, positive ion mode) – m/z for [C41H68F6N7O5S2+Na]
+ = 




Synthesised according to general 
procedure R using 155 (45 mg, 
0.06 mmol), 143 (15 mg, 0.07 
mmol) and n-butyl isocyanate 
(0.06 mL, 0.05 mmol). The crude product was purified by column chromatography (2-10% 
MeOH:DCM) to give the title urea as a yellow solid (33 mg, 0.03 mmol, 48%). M.P. 165-166 °C 
(CHCl3/PE). TLC – Rf = 0.36 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (500 MHz, CDCl3) δH 0.93-
0.98 (m, 18H, 6 x CH3), 1.42-1.67 (m, 24H, 12 x CH2), 3.18-3.43 (m, 30H, 13 x NCH2, 2 x SCH2), 
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3.65 (t, J = 7.1, 2H, NCH2), 6.10 (s, 1H, NH), 6.65-6.91 (m, 3H, 3 x NH), 7.45 (s, 1H, ArH), 7.99 
(s, 2H, 2 x ArH). 
13
C NMR (126 MHz, CDCl3) δC 13.5-14.3 (6 x CH3), 18.8 (CH2), 19.4 (CH2), 
20.2 (CH2), 20.4 (CH2), 21.7 (CH2), 22.3 (2 x CH2), 22.6 (2 x CH3), 27.7 (CH2), 28.9 (CH2), 29.1 
(CH2), 31.6 (2 x SCH2), 32.1 (NCH2), 32.4 (NCH2), 33.7 (NCH2), 34.1 (NCH2), 36.1 (NCH2), 
36.4 (NCH2), 36.5 (NCH2), 40.8 (NCH2), 40.8 (NCH2), 41.4 (NCH2), 46.0 (NCH2), 47.3 (NCH2), 
47.9 (NCH2), 49.0 (NCH2), 114.8 (ArC), 117.8 (2 x ArC), 123.4 (q, J = 272.2, 2 x CF3), 131.9 (q, 
J = 33.2, 2 x ArC), 136.0 (2 x C=CS), 141.5 (ArC), 156.0 (CO), 158.1-159.1 (4 x CO), 166.9 (2 
x CO). 
19
F NMR (377 MHz, CDCl3) δF −64.6 (2 x CF3). HR-MS (ESI, positive ion mode) – m/z 
for [C51H83F6N11O7S2+Na]




Synthesised according to general procedure J using 
triethylenetetramine (2.0 mL, 13.7 mmol) and 4-
methoxyphenyl isocyanate (4.2 mL, 32.8 mmol). After 
16 h, a white precipitate formed and was filtered. The 
residue was washed with DCM (3 x 10 mL) and air-
dried to afford the title diurea as a white solid (4.60 g, 7.23 mmol, 53%). M.P. 191-192 °C 
(CHCl3). TLC – Rf = 0.23 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, (CD3)2SO) δH 3.39 (t, 
J = 6.1, 4H, 2 x NCH2), 3.42 (s, 4H, 2 x NCH2), 3.50 (t, J = 6.1, 4H, 2 x NCH2), 3.72 (s, 6H, 2 x 
OCH3), 6.84 (d, J = 9.2, 4H, 4 x ArH), 7.38 (d, J = 9.2, 4H, 4 x ArH), 8.57 (s, 2H, 2 x NH), 9.50 
(s, 2H, 2 x NH). 
13
C NMR (101 MHz, (CD3)2SO) δC 39.0 (2 x NCH2), 46.5 (2 x NCH2), 46.7 (2 
x NCH2), 55.6 (2 x OCH3), 114.0 (4 x ArC), 116.3 (q, J = 287.1, 2 x CF3), 122.1 (4 x ArC), 133.7 
(2 x ArC), 155.1 (2 x ArC), 156.2 (2 x CO), 157.2 (q, J = 36.1, 2 x CO). 
19
F NMR (377 MHz, 
(CD3)2SO) δF −74.4 (2 x CF3). HR-MS (ESI, positive ion mode) – m/z for [C26H30F6N6O6+H]
+ = 
637.2209. Found 637.2193. FTIR (neat) – 3442, 3261, 2969, 1652, 1638. 
 
4,7-Bis(4-methoxyanilinylcarbonyl)-1,4,7,10-tetraazadecane, 159 
Synthesised according to general procedure H using 158 (4.60 
g, 7.23 mmol). After 5 h, a white precipitate formed and was 
filtered. The residue was washed with MeOH (3 x 10 mL) and 
air-dried to afford the title diamine as a white solid (3.05 g, 6.87 
mmol, 95%). M.P. 163-164 °C (DCM). TLC – Rf = 0.04 (SiO2, 5:95 MeOH:DCM). 
1
H NMR 
(400 MHz, CDCl3) δH 2.96 (t, J = 5.1, 4H, 2 x NCH2), 3.43 (t, J = 5.1, 4H, 2 x NCH2), 3.50 (s, 
255 
 
4H, 2 x NCH2), 3.77 (s, 6H, 2 x OCH3), 6.81 (d, J = 9.0, 4H, 4 x ArH), 7.36 (d, J = 9.0, 4H, 4 x 
ArH), 9.62 (s, 2H, 2 x NH). 
13
C NMR (101 MHz, CDCl3) δC 41.7 (2 x NCH2), 46.8 (2 x NCH2), 
52.2 (2 x NCH2), 55.5 (2 x OCH3), 114.0 (4 x ArC), 120.9 (4 x ArC), 133.5 (2 x ArC), 155.0 (2 
x ArC), 157.7 (2 x CO). HR-MS (ESI, positive ion mode) – m/z for [C22H32N6O4+Na]
+ = 
467.2383. Found 467.2401. FTIR (neat) – 3242, 2980, 1650. 
 
1,4-Bis(succinimidylethyl)-1,4-bis(4-methoxyanilinylcarbonyl)-1,4-diazabutane, 160 
Synthesised according to general procedure I using 159 (200 
mg, 0.45 mmol). The crude product was purified by column 
chromatography (2-10% MeOH:DCM) to give the title 
disuccinimide as a white solid (112 mg, 0.18 mmol, 41%). 
M.P. 181-182 °C (CHCl3). TLC – Rf = 0.10 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 2.64 (s, 8H, 4 x C(O)CH2), 3.41 (s, 4H, 2 x NCH2), 
3.44 (t, J = 6.4, 4H, 2 x NCH2), 3.66 (t, J = 6.4, 4H, 2 x NCH2), 3.74 (s, 6H, 2 x OCH3), 6.79 (d, 
J = 9.0, 4H, 4 x ArH), 7.46 (d, J = 9.0, 4H, 4 x ArH), 8.04 (s, 2H, 2 x NH). 
13
C NMR (101 MHz, 
CDCl3) δC 28.3 (4 x C(O)CH2), 37.1 (2 x NCH2), 45.0 (2 x NCH2), 46.5 (2 x NCH2), 55.5 (2 x 
OCH3), 114.0 (4 x ArC), 121.0 (4 x ArC), 132.9 (2 x ArC), 155.3 (2 x ArC), 155.9 (2 x CO), 
177.7 (4 x CO). HR-MS (ESI, positive ion mode) – m/z for [C30H36N6O8+Na]
+ = 631.2492. Found 
631.2481. FTIR (neat) – 3332, 2988, 2902, 1698, 1644.  
 
1,10-Dibenzyl-4,7-bis(4-methoxyanilinylcarbonyl)-1,4,7,10-tetraazadecane, 163 
Synthesised according to general procedure E 
using 159 (500 mg, 1.12 mmol) and 
benzaldehyde (0.23 mL, 2.25 mmol). The crude 
product was purified by column 
chromatography (3-10% MeOH:DCM) to give 
the title diamine as a white solid (87 mg, 0.15 mmol, 53%). M.P. 192-193 °C (CHCl3). TLC – Rf 
= 0.26 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.92 (s, 2H, 2 x NH), 2.85 (t, 
J = 5.0, 4H, 2 x NCH2), 3.39 (s, 4H, 2 x NCH2), 3.45 (t, J = 5.0, 4H, 2 x NCH2), 3.76 (s, 6H, 2 x 
OCH3), 3.81 (s, 4H, 2 x CH2Ar), 6.77 (d, J = 9.0, 4H, 4 x ArH), 7.23-7.35 (m, 14H, 14 x ArH), 
9.62 (s, 2H, 2 x NH). 
13
C NMR (101 MHz, CDCl3) δC 47.0 (2 x NCH2), 49.2 (2 x NCH2), 49.8 (2 
x NCH2), 54.2 (2 x CH2Ar), 55.5 (2 x OCH3), 113.9 (4 x ArC), 121.0 (4 x ArC), 127.3 (2 x ArC), 
128.3 (4 x ArC), 128.6 (4 x ArC), 133.5 (2 x ArC), 139.3 (2 x ArC), 155.0 (2 x ArC), 157.6 (2 x 
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CO). HR-MS (ESI, positive ion mode) – m/z for [C36H44N6O4+H]
+ = 625.3502. Found 625.3500. 
FTIR (neat) – 3306, 2954, 1653. 
 
1,10-Dibenzyl-4,7-bis(tert-butoxycarbonyl)-1,4,7,10-tetraazadecane, 166 
Synthesised according to general procedure E 
using 60 (2.00 g, 5.8 mmol) and benzaldehyde 
(1.76 mL, 17.3 mmol). The crude product was 
purified by column chromatography (3-10% MeOH:DCM) to yield the title diamine as a foamy 
white solid (2.20 g, 4.15 mmol, 72%). M.P. 77-78 °C (CHCl3). TLC – Rf = 0.13 (SiO2, 5:95 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.38-1.44 (s, 18H, 2 x C(CH3)3), 2.34-2.45 (t, J = 
4.8, 2H, 2 x NH), 2.71-2.78 (q, J = 4.8, 4H, 2 x NCH2), 3.22-3.38 (m, 8H, 4 x NCH2), 3.75-3.76 
(s, 4H, 2 x CH2Ar), 7.17-7.29 (m, 10H, 10 x ArH). 
13
C NMR (101 MHz, CDCl3) δC 28.4 (2 x 
(C(CH3)3), 45.5 (2 x NCH2), 47.2 (2 x NCH2), 48.0 (2 x NCH2), 53.4 (2 x CH2Ar), 79.6 (2 x 
C(CH3)3), 126.8 (2 x ArC), 128.0 (4 x ArC), 128.3 (4 x ArC), 140.3 (2 x ArC), 155.6 (2 x CO). 
HR-MS (ESI, positive ion mode) – m/z for [C30H46N4O4+H]
+ = 527.3597. Found 527.3575. FTIR 




Synthesised according to general procedure B2 
using 166 (1.0 g, 1.9 mmol) and N-methyl-N-
phenylcarbamoyl chloride (967 mg, 5.7 mmol). 
The crude product was purified by column 
chromatography (2-10% MeOH:DCM) to yield the title diurea as a foamy white solid (678 mg, 
0.86 mmol, 45%). M.P. 111-112 °C (CHCl3). TLC – Rf = 0.26 (SiO2, 5:95 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 1.28-1.38 (m, 18H, 2 x C(CH3)3), 2.99-3.14 (m, 18H, 2 x NCH3, 6 x 
NCH2), 4.16-4.28 (m, 4H, 2 x CH2Ar), 6.96-7.26 (m, 20H, 20 x ArH). 
13
C NMR (101 MHz, 
CDCl3) δC 28.5 (2 x C(CH3)3), 40.1 (2 x NCH3), 44.9-45.6 (6 x NCH2), 52.9 (2 x CH2Ar), 79.8 (2 
x C(CH3)3), 124.0-129.6 (20 x ArC), 137.3 (2 x ArC), 146.7 (2 x ArC), 155.0 (2 x CO), 162.1 (2 
x CO). HR-MS (MALDI) – m/z for [C46H60N6O6+Na]
+ = 815.4472. Found 815.4499. FTIR (neat) 






Synthesised according to general procedure C 
using 167 (400 mg, 0.50 mmol). The title 
diamine was isolated as a foamy white solid (296 
mg, 0.50 mmol, >99%). M.P. 99-100 °C 
(CHCl3). TLC – Rf = 0.10 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 2.02 (s, 2H, 
2 x NH), 2.46 (s, 4H, 2 x NCH2), 2.49 (t, J = 6.6, 4H, 2 x NCH2), 3.09 (s, 6H, 2 x NCH3), 3.09 (t, 
J = 6.6, 4H, 2 x NCH2), 4.14 (s, 4H, 2 x CH2Ar), 7.00-7.05 (m, 10H, 10 x ArH), 7.13-7.25 (m, 
10H, 10 x ArH). 
13
C NMR (101 MHz, CDCl3) δC 39.9 (2 x NCH3), 47.2 (2 x NCH2), 47.5 (2 x 
NCH2), 48.9 (2 x NCH2), 52.3 (2 x CH2Ar), 123.9 (4 x ArC), 124.8 (2 x ArC), 127.4 (2 x ArC), 
127.7 (4 x ArC), 128.5 (4 x ArC), 129.5 (4 x ArC), 137.9 (2 x ArC), 146.8 (2 x ArC), 162.4 (2 x 
CO). HR-MS (ESI, positive ion mode) – m/z for [C36H44N6O2+H]
+ = 593.3604. Found 593.3570. 




Synthesised according to general procedure B1 
using 168 (100 mg, 0.17 mmol) and 4-
methoxyphenyl isocyanate (0.07 mL, 0.51 
mmol). The crude product was purified by 
column chromatography (25-100% EtOAc:PE) 
to give the title tetraurea as a foamy white solid (79 mg, 0.09 mmol, 52%). M.P. 138-139 °C 
(CHCl3). TLC – Rf = 0.39 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 3.25 (s, 6H, 
2 x NCH3), 3.27-3.36 (m, 12H, 6 x NCH2), 3.79 (s, 6H, 2 x OCH3), 4.09 (s, 4H, 2 x CH2Ar), 6.85 
(d, J = 9.0, 4H, 4 x ArH), 7.01-7.14 (m, 10H, 10 x ArH), 7.20-7.33 (m, 10H, 10 x ArH), 7.62 (d, 
J = 9.0, 4H, 4 x ArH), 8.83 (s, 2H, 2 x NH). 
13
C NMR (101 MHz, CDCl3) δC 40.1 (2 x NCH3), 
46.2 (2 x NCH2), 47.3 (2 x NCH2), 47.7 (2 x NCH2), 53.7 (2 x CH2Ar), 55.6 (2 x OCH3), 114.1 
(4 x ArC), 121.1 (4 x ArC), 124.2 (4 x ArC), 125.4 (2 x ArC), 127.6 (4 x ArC), 127.6 (2 x ArC), 
128.8 (4 x ArC), 129.8 (4 x ArC), 133.7 (2 x ArC), 137.4 (2 x ArC), 146.3 (2 x ArC), 155.2 (2 x 
ArC), 156.1 (2 x CO), 162.5 (2 x CO). HR-MS (MALDI) – m/z for [C52H58N8O6+Na]
+ = 







Under a dry, inert atmosphere, benzyl bromide (2.4 mL, 19.9 mmol, 1.10 equiv.) 
was added to a solution of 100 (2.5 g, 18.1 mmol, 1.00 equiv., 0.50 M) in 
anhydrous THF (36 mL). The solution was heated to reflux and stirred for 16 h. 
After cooling to room temperature, the solution was concentrated in vacuo and purified by column 
chromatography (2-10% MeOH:DCM) to yield the title amine as a white solid (4.0 g, 17.5 mmol, 
88%). TLC – Rf = 0.29 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.74 (t, J = 
4.7, 2H, NCH2), 3.79 (t, J = 4.7, 2H, NCH2), 4.59 (s, 2H, CH2Ar), 5.67 (s, 1H, OH), 6.40 (d, J = 
8.4, 1H, ArH), 6.52 (ddd, J = 0.6, 5.1, 7.1, 1H, ArH), 7.13-7.16 (m, 2H, 2 x ArH), 7.18-7.21 (m, 
1H, ArH), 7.24-7.28 (m, 2H, 2 x ArH), 7.31 (ddd, J = 2.0, 7.1, 8.8, 1H, ArH), 8.01 (dd, J = 1.9, 
5.1, 1H, ArH). Spectroscopic data matched that previously reported.138 
 
N-(2-Pyridyl)(benzyl)aminoacetaldehyde, 170 
Synthesised according to general procedure G using 169 (650 mg, 2.9 mmol). The 
crude product was purified by column chromatography (1-2% MeOH:DCM) to 
yield the title aldehyde as a yellow oil (262 mg, 1.2 mmol, 40%). TLC – Rf = 0.60 
(SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 4.10 (d, J = 1.5, 2H, NCH2), 4.61 (s, 
2H, CH2Ar), 6.47 (d, J = 8.7, 1H, ArH), 6.53 (ddd, J = 7.1, 5.1, 0.7, 1H, ArH), 7.13-7.26 (m, 5H, 
5 x ArH), 7.34 (ddd, J = 8.9, 7.1, 1.9, 1H, ArH), 8.07 (d, J = 5.1, 1H, ArH), 9.40 (s, 1H, CHO). 
13
C NMR (101 MHz, CDCl3) δC 53.6 (NCH2), 58.6 (CH2Ar), 106.2 (ArC), 113.4 (ArC), 126.9 (2 
x ArC), 127.6 (ArC), 128.9 (2 x ArC), 137.3 (ArC), 138.1 (ArC), 147.2 (ArC), 157.6 (ArC), 193.3 
(CHO). HR-MS (ESI, positive ion mode) – m/z for [C14H14N2O+H]
+ = 227.1184. Found 




Under a dry, inert atmosphere, to a solution of 
ethylenediamine (0.03 mL, 0.75 mmol, 1.00 
equiv., 0.10 M) in anhydrous MeOH (8 mL) 
was added 170 (170 mg, 0.75 mmol, 2.00 
equiv.). The resulting solution was stirred for 
16 h. The solution was then cooled to 0 °C and sodium borohydride (71 mg, 1.88 mmol, 6.00 
equiv.) was added in one portion. The resulting white suspension was warmed to room 
temperature, stirred for 3 h and concentrated in vacuo. The residue was diluted in MeOH (10 mL) 
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and concentrated in vacuo. The crude product was diluted with deionised water and the aqueous 
solution extracted with DCM (3 x 5 mL). The combined organic extracts were washed with brine, 
dried (MgSO4), filtered and concentrated in vacuo. Under a dry, inert atmosphere, the crude 
product (1.00 equiv. 0.10 M) was dissolved in anhydrous DCM (8 mL), cooled to 0 °C and 4-
methoxyphenyl isocyanate (0.29 mL, 2.25 mmol, 3.00 equiv.) was added dropwise. The solution 
was stirred for 16 h and concentrated in vacuo. The crude product was purified by column 
chromatography (18-100% EtOAc:PE) to yield the title diurea as a white solid (117 mg, 0.15 
mmol, 20%). M.P. 121-122 °C (CHCl3). TLC – Rf = 0.33 (SiO2, 70:30 EtOAc:PE). 
1
H NMR 
(500 MHz, CDCl3) δH 3.51 (s, 4H, 2 x NCH2), 3.58 (t, J = 7.5, 4H, 2 x NCH2), 3.80 (s, 6H, 2 x 
OCH3), 3.81-3.84 (m, 4H, 2 x NCH2), 6.45 (d, J = 8.7, 2H, 2 x ArH), 6.54 (t, J = 6.1, 2H, 2 x 
ArH), 6.86 (d, J = 9.0, 4H, 4 x ArH), 7.17 (d, J = 9.0, 4H, 4 x ArH), 7.24 (t, J = 7.7, 4H, 4 x ArH), 
7.25 (d, J = 7.7, 2H, 2 x ArH), 7.30 (t, J = 7.6, 4H, 4 x ArH), 7.36-7.37 (m, 2H, 2 x ArH), 8.04 
(d, J = 5.2, 2H, 2 x ArH), 9.39 (s, 2H, 2 x NH). 
13
C NMR (126 MHz, CDCl3) δC 45.4 (2 x NCH2), 
47.7 (2 x NCH2), 48.9 (2 x NCH2), 54.0 (2 x CH2Ar), 55.7 (2 x OCH3), 107.2 (2 x ArC), 112.6 (2 
x ArC), 114.1 (4 x ArC), 124.1 (4 x ArC), 126.4 (4 x ArC), 127.4 (2 x ArC), 129.0 (4 x ArC), 
133.2 (2 x ArC), 137.6 (2 x ArC), 138.0 (2 x ArC), 147.8 (2 x ArC), 156.1 (2 x ArC), 157.0 (2 x 
CO), 158.1 (2 x ArC). HR-MS (ESI, positive ion mode) – m/z for [C46H50N8O4+H]
+ = 779.4033. 
Found 779.4023. FTIR (neat) – 3299, 2988, 2915, 1655. 
 
1,4-Bis(2-pyridyl)-1,4-diazabutane, 172 
Synthesised according to general procedure M using freshly distilled 
ethylenediamine (1.56 mL, 23.41 mmol) and 2-fluoropyridine (1.00 mL, 
11.73 mmol). The title diamine was isolated as a yellow solid (2.62 g, 
19.42 mmol, 83%). TLC – Rf = 0.30 (SiO2, 10:90:1 MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, 
CDCl3) δH 2.94 (s, 4H, 2 x NCH2), 6.38 (d, J = 8.2, 2H, 2 x ArH), 6.59 (t, J = 6.0, 2H, 2 x ArH), 




Synthesised according to general procedure B using 172 (50 mg, 0.23 
mmol) and 4-methoxyphenyl isocyanate (0.09 mL, 0.70 mmol). The 
crude product was purified by column chromatography (2-10% 
MeOH:DCM) to yield the title diurea as a foamy white solid (152 mg, 





H NMR (500 MHz, CDCl3) δH 3.81 (2 x OCH3), 4.27 (2 x NCH2), 6.91 (d, 
J = 9.0, 4H, 4 x ArH), 7.05 (ddd, J = 7.2, 5.0, 0.8, 2H, 2 x ArH), 7.52 (d, J = 9.0, 4H, 4 x ArH), 
7.89 (ddd, J = 7.2, 5.0, 0.8, 2H, 2 x ArH), 8.02 (dt, J = 8.6, 0.8, 2H, 2 x ArH), 8.34 (ddd, J = 5.0, 
2.0, 0.8, 2H, 2 x ArH), 12.59 (s, 2H, 2 x NH). 
13
C NMR (126 MHz, CD2Cl2) δC 43.9 (2 x NCH2), 
56.0 (2 x OCH3), 113.5 (2 x ArC), 114.5 (4 x ArC), 118.0 (2 x ArC), 123.0 (4 x ArC), 132.8 (2 x 
ArC), 140.1 (2 x ArC), 146.0 (2 x ArC), 155.0 (2 x ArC), 156.2 (2 x CO), 156.5 (2 x ArC). HR-
MS (ESI, positive ion mode) – m/z for [C28H28N6O4+H]
+ = 513.2250. Found 513.2237. FTIR 
(neat) – 3031, 2992, 2955, 1672. 
 
1,7-Bis(2-pyridyl)-1,4,7-tris(4-methoxyanilinylcarbonyl)-1,4,7-triazaheptane, 174 
Under a dry, inert atmosphere, a solution of diethylenetriamine 
(0.28 mL, 2.57 mmol, 1.00 equiv.) and 2-fluoropyridine (4.4 mL, 
51.5 mmol, 20.00 equiv.) was prepared. The solution was heated 
to 120 °C and stirred for 3 h. The solution was cooled to 0 °C 
and 4-methoxyphenyl isocyanate (2.0 mL, 15.45 mmol, 6.00 
equiv.) was added. The solution was warmed to room temperature and stirred for a further 16 h, 
generating a white solid. The solid was dried in vacuo and purified by column chromatography 
(1-10% MeOH:DCM) to yield the title triurea as a white solid (308 mg, 0.44 mmol, 17%). M.P. 
266-267 °C (DCM). TLC – Rf = 0.55 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 
3.79 (t, J = 8.1, 4H, 2 x NCH2), 3.81 (s, 9H, 3 x OCH3), 4.17 (t, J = 8.1, 4H, 2 x NCH2), 6.89 (d, 
J = 9.0, 6H, 6 x ArH), 7.00 (dd, J = 5.4, 6.9, 2H, 2 x ArH), 7.51 (d, J = 9.0, 4H, 4 x ArH), 7.64 (d, 
J = 9.0, 2H, 2 x ArH), 7.76 (dt, J = 1.6, 7.9, 2H, 2 x ArH), 8.29 (d, J = 4.8, 2H, 2 x ArH), 8.95 (s, 
1H, NH), 12.68 (s, 2H, 2 x NH). 
13
C NMR (101 MHz, CDCl3) δC 45.1 (2 x NCH2), 47.1 (2 x 
NCH2), 55.6 (2 x OCH3), 55.6 (OCH3), 112.6 (2 x ArC), 114.1 (2 x ArC), 114.2 (4 x ArC), 117.8 
(2 x ArC), 121.7 (2 x ArC), 122.2 (4 x ArC), 132.1 (ArC), 133.5 (2 x ArC), 139.8 (2 x ArC), 
145.6 (2 x ArC), 154.4 (2 x ArC), 155.4 (ArC), 156.0 (2 x CO), 156.3 (CO). HR-MS (ESI, 
positive ion mode) – m/z for [C38H40N8O6+Na]
+ = 727.2969. Found 727.2990. FTIR (neat) – 









 Synthesised according to general procedure B1 using TACN (20 
mg, 0.15 mmol) and 4-methoxyphenyl isocyanate (0.03 mL, 0.70 
mmol). The crude product was purified by column 
chromatography (1-10% MeOH:DCM) to yield the title triurea as 
a foamy white solid (78 mg, 0.14 mmol, 90%). M.P. 207-208 °C 
(CHCl3). TLC – Rf = 0.17 (SiO2, 5:95 MeOH:DCM). 
1
H NMR 
(400 MHz, CDCl3) δH 3.04-3.06 (m, 6H, 6 x CH
AHB), 3.74 (s, 9H, 
3 x OCH3), 3.94-3.96 (m, 3H, 3 x CH
AHB), 4.40-4.42 (m, 3H, 3 x CHAHB), 6.49 (d, J = 9.0, 6H, 
6 x ArH), 6.63 (d, J = 9.0, 6H, 6 x ArH), 7.84 (s, 3H, 3 x NH). 
13
C NMR (101 MHz, CDCl3) δC 
45.0 (3 x NCH2), 47.0 (3 x NCH2), 55.6 (3 x OCH3), 113.6 (6 x ArC), 122.7 (6 x ArC), 132.3 (3 
x ArC), 155.4 (3 x ArC), 159.0 (3 x CO). HR-MS (ESI, positive ion mode) – m/z for 
[C30H30N6O6+Na]
+ = 599.2594. Found 599.2565. FTIR (neat) – 3337, 2939, 1641. 
 
Phenyl N-(4-pyridyl)carbamate, 176 
Under a dry, inert atmosphere, a solution of 4-aminopyridine (1.00 g, 10.6 
mmol, 1.00 equiv., 0.10 M) in anhydrous DCM (60 mL) was cooled to 0 °C. 
To this solution was added phenyl chloroformate (1.47 mL, 11.7 mmol, 1.10 equiv.) dropwise 
followed by anhydrous TEA (2.07 mL, 14.9 mmol, 1.40 equiv.) in one portion. The resulting 
colourless solution was warmed to room temperature and stirred for 2 h, after which time saturated 
aqueous NaHCO3 (60 mL) was added slowly. The aqueous phase was extracted with DCM (3 x 
50 mL) and the combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo 
to yield the title carbamate as a white solid (1.30 g, 6.0 mmol, 57%). TLC – Rf = 0.25 (SiO2, 1:99 
MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 7.19 (d, J = 8.1, 2H, 2 x ArH), 7.26-7.29 (m, 1H, 
ArH), 7.39-7.44 (m, 4H, 4 x ArH), 7.99 (s, 1H, NH), 8.51 (d, J = 8.1, 2H, 2 x ArH). Spectroscopic 
data matched that previously reported.140  
 
1,4,7-Tris(4-pyridylaminocarbonyl)-1,4,7-triazacyclononane, 177 
Synthesised according to general procedure B2 using TACN (50 mg, 
0.39 mmol) and 176 (373 mg, 1.74 mmol). The title triurea was isolated 
as a white solid (132 mg, 0.27 mmol, 70%). M.P. decomp. >300 °C 
(MeCN). TLC – Rf = 0.08 (SiO2, 10:90:1 MeOH:DCM:NH4OH). 
1
H 
NMR (400 MHz, DMSO) δH 3.59 (s, 12H, 6 x NCH2), 7.38 (d, J = 5.8, 





NMR (101 MHz, DMSO) δC 45.7 (6 x NCH2), 114.0 (6 x ArC), 150.0 (6 x ArC), 156.2 (3 x CO). 
HR-MS (ESI, positive ion mode) – m/z for [C24H27N9O3+Na]
+ = 512.2135. Found 512.2129. 
FTIR (neat) – 3288, 2976, 2928, 1644. 
 
1,4,7-Tris(4-trifluoromethylanilinylcarbonyl)-1,4,7-triazacyclononane, 178 
Synthesised according to general procedure B1 using TACN (50 
mg, 0.39 mmol) and 4-(trifluoromethyl)-phenyl isocyanate (0.25 
mL, 1.74 mmol). The title triurea was isolated as a white solid 
(132 mg, 0.27 mmol, 56%). M.P. decomp. >300 °C 
(MeCN/DMF). TLC – Rf = 0.36 (SiO2, 10:90 MeOH:DCM). 
1
H 
NMR (500 MHz, 1:1 CD3OD:CD2Cl2) δH 3.42 (s, 12H, 6 x 
NCH2), 6.78 (d, J = 8.3, 6H, 6 x ArH), 7.05 (d, J = 8.3, 6H, 6 x 
ArH), 8.06 (s, 3H, 3 x NH). 
13
C NMR (126 MHz, 1:1 CD3OD:CD2Cl2) δC 48.0 (6 x NCH2), 118.8 
(6 x ArC), 122.4 (q, J = 293.5, 3 x CF3), 124.1 (6 x ArC), 134.1 (q, J = 45.8, 3 x ArC), 141.0 (3 x 




NMR (377 MHz, 1:1 CD3OD:CD2Cl2) δF −62.5 (3 x CF3). HR-MS 
(MALDI) – m/z for [C30H27F9N6O3+Na]
+ = 713.1899. Found 713.1893. FTIR (neat) – 3338, 2990, 
2907, 1648. 
 
1,4,7-Tris(4-cyanoanilinylcarbonyl)-1,4,7-triazacyclononane, 179  
Synthesised according to general procedure B1 using TACN (50 
mg, 0.39 mmol) and 4-cyanophenyl isocyanate (251 mg, 1.74 
mmol). The title triurea was isolated as a white solid (72 mg, 
0.13 mmol, 33%). M.P. decomp. >300 °C (MeCN/DMF). TLC 
– Rf = 0.54 (SiO2, 10:90 MeOH:DCM). 
1
H NMR (500 MHz, 
1:1 CD3OD:CD2Cl2) δH 3.42 (s, 12H, 6 x NCH2), 7.60 (d, J = 
7.5, 6H, 6 x ArH), 7.94 (d, J = 7.5, 6H, 6 x ArH), 8.10 (s, 3H, 3 
x NH). 
13
C NMR (126 MHz, 1:1 CD3OD:CD2Cl2) δC 47.1 (6 x 
NCH2), 110.5 (3 x ArC), 118.8 (3 x C≡N), 120.8 (6 x ArC), 133.5 (6 x ArC), 142.2 (3 x ArC), 
158.0 (3 x ArC). HR-MS (ESI, positive ion mode) – m/z for [C30H27F9N9O3+H]
+ = 562.2315. 






1,4,7-Tris(4-chloroanilinylcarbonyl)-1,4,7-triazacyclononane, 180  
Synthesised according to general procedure B1 using TACN (50 
mg, 0.39 mmol) and 4-chlorophenyl isocyanate (267 mg, 1.74 
mmol). The title triurea was isolated as a white solid (267 mg, 0.18 
mmol, 45%). M.P. decomp. >300 °C (MeCN). TLC – Rf = 0.36 
(SiO2, 10:90 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.02-
3.04 (m, 3H, 3 x CHAHB), 3.11-3.15 (m, 3H, 3 x CHAHB), 3.89-
3.91 (m, 3H, 3 x CHAHB), 4.34-4.37 (m, 3H, 3 x CHAHB), 6.58 (d, J = 8.9, 6H, 6 x ArH), 6.85 (d, 
J = 8.9, 6H, 6 x ArH), 7.90 (s, 3H, 3 x NH). 
13
C NMR (101 MHz, CDCl3) δC 44.9 (3 x NCH2), 
46.9 (3 x NCH2), 122.3 (6 x ArC), 128.3 (3 x ArC), 128.4 (6 x ArC), 137.4 (3 x ArC), 158.7 (3 x 
CO). HR-MS (MALDI) – m/z for [C27H27Cl3N6O3+Na]
+ = 611.1108. Found 611.1102. FTIR 
(neat) – 3257, 2966, 2934, 1641. 
 
1,4,7-Tris(4-(ethylcarboxy)anilinylcarbonyl)-1,4,7-triazacyclononane, 181  
Synthesised according to general procedure B1 using TACN 
(50 mg, 0.37 mmol) and ethyl 4-isocyanatobenzoate (333 mg, 
1.74 mmol). The residue was washed with cold acetonitrile 
and air-dried to give the title triurea as a white solid (272 mg, 
0.30 mmol, 80%). M.P. 189-190 °C (CHCl3). TLC – Rf = 
0.35 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) 
δH 1.37 (t, J = 7.1, 9H, 3 x CH3), 3.08-3.15 (m, 6H, 6 x 
CHAHB), 4.00-4.02 (m, 3H, 3 x CHAHB), 4.32 (q, J = 7.1, 6H, 
3 x OCH2), 4.44-4.47 (m, 3H, 3 x CH
AHB), 6.91 (d, J = 8.9, 6H, 6 x ArH), 7.61 (d, J = 8.9, 6H, 6 
x ArH), 8.19 (s, 3H, 3 x NH). 
13
C NMR (101 MHz, CDCl3) δC 14.4 (3 x CH3), 44.9 (3 x NCH2), 
46.9 (3 x NCH2), 60.8 (3 x OCH2), 119.5 (6 x ArC), 124.9 (3 x ArC), 130.2 (6 x ArC), 143.0 (3 
x ArC), 158.3 (3 x CO), 166.3 (3 x CO). HR-MS (ESI, positive ion mode) – m/z for 
[C36H42N6O9+Na]
+ = 725.2911. Found 725.2901. FTIR (neat) – 3326, 2995, 2958, 1714, 1649. 
 
1,3-Ditosyloxy-2-tosyloxymethyl-2-methylpropane, 182 
Under a dry, inert atmosphere, a solution of trimethylolethane (2.0 
g, 16.7 mmol, 1.00 equiv., 0.28 M) in anhydrous DCM (60 mL) 
was prepared. The solution was cooled to 0 °C and tosyl chloride 
(14.3 g, 74.9 mmol, 4.50 equiv.) was added over three portions. 
Triethylamine (13.9 mL, 100.0 mmol, 6.00 equiv.) was then added and the resulting solution was 
264 
 
warmed to room temperature and stirred for 2 h. The solution was diluted with saturated aqueous 
NaHCO3 and the aqueous phase was extracted with DCM (3 x 50 mL). The combined organic 
extracts were washed with brine, dried (MgSO4), filtered and concentrated in vacuo to give the 
title tritosylate as a white solid (6.9 g, 11.8 mmol, 71%). TLC – Rf = 0.10 (SiO2, 20:80 
EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 2.40 (s, 9H, 3 x CH3), 3.69 (s, 6H, 3 x OCH2), 7.29 




Under a dry, inert atmosphere, a solution of 182 (100 mg, 0.51 mmol, 1.00 equiv., 
0.10 M) in anhydrous DMF (5 mL) was prepared. To this solution was added sodium 
azide (166 mg, 2.55 mmol, 5.00 equiv.) over three portions and the resulting solution was stirred 
for 16 h behind a blast shield at room temperature. The solution was then poured onto cold water 
(25 mL) and the aqueous phase was extracted with Et2O (3 x 5 mL). The combined organic phases 
were dried (MgSO4), filtered and concentrated to half their volume in vacuo to give the crude 
triazide, which was used without further purification. 
 
1,3-Diamino-2-aminomethyl-2-methylpropane, 185 
Under a dry, inert atmosphere, a solution of 184 (25 mg, 0.13 mmol, 1.00 equiv., 
0.07 M) in anhydrous THF (2 mL) was prepared. The solution was cooled to 0 °C 
and LiAlH4 (50 mg, 1.30 mmol, 10.00 equiv.) was added in one portion. The suspension was 
warmed to room temperature and stirred for 16 h. The solution was cooled to 0 °C and aqueous 
NaOH (2 mL, 1.00 M) was added dropwise. The aqueous phase was then extracted with Et2O (3 
x 5 mL) and the combined organic extracts were washed with brine, dried (MgSO4), filtered and 
concentrated in vacuo to give the title triamine as a colourless oil (7 mg, 0.06 mmol, 50%). TLC 
– Rf = 0.07 (SiO2, 10:90:1 MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, D2O) δH 1.21 (s, 3H, 






Under a dry, inert atmosphere, a solution of sodium hydride (60% wt. in 
mineral oil, 1.36 g, 34.14 mmol, 6.00 equiv.) in anhydrous DMF (15 mL) 
was prepared. The suspension was cooled to 0 °C and a solution of 
trifluoroacetamide (5.77 g, 51.0 mmol, 9.00 equiv.) in anhydrous DMF 
(15 mL) was added dropwise. The resulting suspension was warmed to 
room temperature and stirred for 1 h. To the suspension was added 1,3,5-tris(bromomethyl)-2,4,6-
triethylbenzene (2.50 g, 5.69 mmol, 1.00 equiv., 0.19 M) and the suspension was stirred for 16 h. 
Aqueous HCl (50 mL, 0.50 M) was added and a white precipitate formed. The suspension was 
filtered and the residue was washed with deionised water (50 mL) and dried in vacuo to give the 
title tris(trifluoroacetamide) as a white solid (1.38 g, 2.56 mmol, 45%). TLC – Rf = 0.54 (SiO2, 
5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 1.20 (t, J = 5.4, 9H, 3 x CH3), 2.90 (q, J = 
5.4, 6H, 3 x CH2Ar), 4.47 (s, 6H, 3 x CH2Ar), 9.20 (s, 3H, 3 x NH). Spectroscopic data matched 
that previously reported.142 
 
1,3,5-Tris(aminomethyl)-2,4,6-triethylbenzene, 188  
Synthesised according to general procedure H using 187 (1.0 g, 1.86 mmol). The 
title triamine was isolated as a colourless oil (334 mg, 1.34 mmol, 72%). TLC 
– Rf = 0.16 (SiO2, 5:95:1 MeOH:DCM:NH4OH). 
1
H NMR (400 MHz, CDCl3) 
δH 1.21 (t, J = 5.1, 9H, 3 x CH3), 2.86 (q, J = 5.4, 6H, 3 x CH2Ar), 3.43 (s, 6H, 
3 x CH2Ar) . Spectroscopic data matched that previously reported.
142 
 
N-Methyl-N’-phenyl thiourea, 191 
Synthesised according to general procedure B1 using methylammonium chloride 
(570 mg, 8.45 mmol), triethylamine (1.18 mL, 8.45 equiv.) and phenyl 
isothiocyanate (1.0 g, 7.68 mmol). The crude product was diluted in Et2O and filtered. The filtrate 
was concentrated in vacuo to yield the title thiourea as a yellow solid (701 mg, 4.22 mmol, 55%). 
TLC – Rf = 0.23 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 3.06 (d, J = 4.6, 3H, 
NCH3), 6.00 (s, 1H, NH), 7.15 (d, J = 8.0, 2H, 2 x ArH), 7.23 (tt, J = 1.1, 7.5, 1H, ArH), 7.36 (t, 






N-Methyl-N’-phenyl-S-methyl isothiourea, 192 
Under a dry, inert atmosphere, a solution of 191 (700 mg, 4.21 mmol, 1.00 equiv., 
0.10 M) in anhydrous acetone (42 mL) was prepared. To this solution was added 
methyl iodide (0.39 mL, 6.32 mmol, 1.50 equiv.) and the resulting solution was heated to 60 °C 
and stirred for 4 h. The solution was concentrated in vacuo and suspended in Et2O (50 mL). The 
suspension was filtered and the residue was washed with Et2O (25 mL). The residue was then 
dissolved in H2O:THF mixture (1:1, 25 mL) and basified with aqueous K2CO3 (1.00 M) until the 
solution reached pH = 10. The solution was then extracted with DCM (3 x 25 mL) and the 
combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated in 
vacuo to give the title isothiourea as a yellow solid (319 mg, 1.77 mmol, 42%). TLC – Rf = 0.40 
(SiO2, 10:90 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 0.80 (s, 3H, NCH3), 2.40 (s, 3H, 
SCH3), 7.17 (d, J = 7.8, 2H, 2 x ArH), 7.26 (m, 1H, ArH), 7.33 (t, J = 7.8, 2H, 2 x ArH). 
Spectroscopic data matched that previously reported.143 
 
1,4,7,10-Tetrakis(4-methoxyanilinylcarbonyl)-1,4,7,10-tetraazacyclododecane, 194 
Synthesised according to general procedure B using cyclen (100 
mg, 0.58 mmol) and 4-methoxyphenyl isocyanate (0.45 mL, 
3.48 mmol). The white suspension was filtered and the residue 
washed with ice-cold DCM to give the title tetraurea as a white 
solid (758 mg, 0.99 mmol, 85%). M.P. 206-207 °C (DCM). 
TLC – Rf = 0.42 (SiO2, 10:90 MeOH:DCM). 
1
H NMR (400 
MHz, CDCl3) δH 3.65 (s, 16H, 8 x NCH2), 3.75 (s, 12H, 4 x 
OCH3), 6.71 (d, J = 9.1, 8H, 8 x ArH), 7.09 (d, J = 9.1, 8H, 8 x 
ArH), 7.49 (s, 4H, 4 x NH). 
13
C NMR (101 MHz, CDCl3) δC 49.7 (8 x NCH2), 55.6 (4 x OCH3), 
114.1 (8 x ArC), 122.8 (8 x ArC), 131.6 (4 x ArC), 156.2 (4 x ArC), 158.7 (4 x CO). HR-MS 
(ESI, positive ion mode) – m/z for [C40H48N8O8+Na]
+ = 791.3493. Found 791.3494. FTIR (neat) 











Synthesised according to general procedure B using cyclen (200 
mg, 1.16 mmol) and methyl 2-isocyanatobenzoate (1234 mg, 6.97 
mmol, 6.00 equiv.) The crude product was triturated with acetone 
and dried in vacuo to give the title tetraurea as a white solid (260 
mg, 0.30 mmol, 25%). M.P. = 236-237 °C (acetone/PE). TLC – Rf 
= 0.56 (SiO2, 90:10 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 
3.51 (s, 12H, 4 x OCH3), 3.78 (s, 16H, 8 x NCH2), 6.95 (dt, J = 1.1, 
7.7, 4H, 4 x ArH), 7.47 (ddd, J = 1.7, 7.2, 8.8, 4H, 4 x ArH), 7.92 (dd, J = 1.7, 8.0, 4H, 4 x ArH), 
8.52 (d, J = 8.4, 4H, 4 x ArH), 10.79 (s, 4H, 4 x NH). 
13
C NMR (101 MHz, CDCl3) δC 51.3 (8 x 
NCH2), 56.2 (4 x OCH3), 114.5 (4 x ArC), 120.3 (4 x ArC), 121.0 (4 x ArC), 130.6 (4 x ArC), 
134.4 (4 x ArC), 143.4 (4 x ArC), 156.6 (4 x CO), 169.0 (4 x CO). HR-MS (ESI, positive ion 
mode) – m/z for [C44H48N8O12+Na]
+ = 903.3289. Found 903.3255. FTIR (neat) – 3324, 2967, 




Under a dry, inert atmosphere, a solution of 195 (70 mg, 0.08 
mmol, 1.00 equiv., 0.10 M) in anhydrous THF (1 mL) was 
cooled to 0 °C. To this solution was added LiBH4 (14 mg, 0.63 
mmol, 8.00 equiv.) in one portion and the resulting solution was 
stirred for 16 h at room temperature. The reaction mixture was 
concentrated in vacuo and the crude product diluted with MeOH 
(1 mL) and saturated aqueous KHSO4 (1 mL). The aqueous 
phase was extracted with ethyl acetate (3 x 2 mL) and the combined organic extracts were washed 
with brine, dried (MgSO4), filtered and concentrated in vacuo to yield the title tetrol as a white 
solid (46 mg, 0.06 mmol, 76%). M.P. 225-226 °C (THF). TLC – Rf = 0.40 (SiO2, 90:10 
EtOAc:PE). 
1
H NMR (400 MHz, DMSO) δH 3.70 (s, 16H, 8 x NCH2), 4.54 (s, 8H, 4 x CH2Ar), 
5.59 (s, 4H, 4 x OH), 7.03 (t, J = 7.7, 4H, 4 x ArH), 7.19 (t, J = 7.7, 4H, 4 x ArH), 7.28 (d, J = 
7.4, 4H, 4 x ArH), 7.60 (d, J = 8.0, 4H, 4 x ArH), 8.62 (s, 4H, 4 x NH). 
13
C NMR (101 MHz, 
DMSO) δC 48.2 (8 x NCH2), 61.3 (4 x OCH2), 123.2 (4 x ArC), 123.2 (4 x ArC), 127.2 (4 x ArC), 
127.5 (4 x ArC), 133.3 (4 x ArC), 137.7 (4 x ArC), 155.8 (4 x CO). HR-MS (MALDI) – m/z for 
[C40H48N8O8+Na]






Synthesised according to general procedure B using 
hexacyclen (100 mg, 0.39 mmol) and 4-methoxyphenyl 
isocyanate (0.45 mL, 3.48 mmol) dropwise. The white 
suspension was filtered and the residue washed with ice-
cold DCM to give the title hexaurea as a white solid (398 
mg, 0.35 mmol, 88%). M.P. 238-239 °C (DCM). TLC – 
Rf = 0.51 (SiO2, 10:90 MeOH:DCM). 
1
H NMR (400 
MHz, CD2Cl2) δH 3.53 (s, 12H, 12 x CH
AHB), 3.66 (s, 
12H, 12 x CHAHB), 3.74 (s, 18H, 18 x OCH3), 6.73 (d, J 
= 9.1, 12H, 12 x ArH), 7.38 (d, J = 9.1, 12H, 12 x ArH), 8.73 (s, 6H, 6 x NH). 
13
C NMR (101 
MHz, (CD3)2SO) δC 46.1 (12 x NCH2), 55.1 (6 x OCH3), 113.6 (6 x ArC), 113.9 (6 x ArC), 119.8 
(6 x ArC), 121.4 (6 x ArC), 132.1 (3 x ArC), 133.2 (3 x ArC), 154.1 (3 x ArC), 154.7 (3 x ArC), 
154.7 (3 x CO), 155.6 (3 x CO). HR-MS (ESI, positive ion mode) – m/z for [C60H72N12O12+Na]
+ 
= 1175.5290. Found 1175.5286. FTIR (neat) – 3411, 2962, 1653. 
 
Dimethyl 2,5-dibromoadipoate, 201 
A three-necked round-bottomed flask was appended with a condenser 
attached to a conical flask charged with aqueous NaOH/Na2S2O3 (1.00 M 
NaOH/15% wt. Na2S2O3). Adipoyl chloride (5.0 mL, 34.4 mmol, 1.00 equiv.) was added to the 
flask and then heated to 75 °C. Bromine (3.5 mL, 68.8 mmol, 2.00 equiv.) was then added over 2 
h by use of a dropping funnel and the resulting solution was stirred for a further 4 h. The solution 
was cooled to 0 °C and anhydrous MeOH (14.0 mL, 344.0 mmol, 10.00 equiv.) was added 
dropwise. The resulting solution was stirred for 1 h and quenched with aqueous Na2S2O3 (250 
mL, 1.00 M). The aqueous phase was extracted with Et2O (3 x 100 mL) and the combined organic 
extracts were washed with aqueous Na2S2O3 (1.00 M), brine, dried (Na2SO4), filtered and 
concentrated in vacuo to give the title diester as a colourless oil, some of which crystallised on 
standing (9.4 g, 28.2 mmol, 82%). TLC – Rf = 0.58 (SiO2, 50:50 EtOAc:PE). 
1
H NMR (400 
MHz, CDCl3) δH 2.06-2.36 (m, 4H, 2 x CH2), 3.82 (s, 6H, 2 x OCH3), 4.24-4.30 (m, 2H, 2 x 




Dimethyl N-benzylpyrrolidine-2,5-dicarboxylate, 202 
In a round-bottomed flask, a solution of 201 (4.57 g, 13.72 mmol, 1.00 equiv., 
0.10 M) in toluene (69 mL) was prepared. To this solution was added deionised 
water (68 mL), K2CO3 (9.51 g, 68.83 mmol, 5.00 equiv.) and freshly distilled 
benzylamine (2.10 mL, 19.21 mmol, 1.40 equiv.). The mixture was heated to reflux and stirred 
for 16 h. The mixture was cooled to room temperature and the aqueous phase was extracted with 
EtOAc (3 x 50 mL). The combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated in vacuo. The crude products were then purified by column 
chromatography (20-40% EtOAc:PE) to give the desired pyrrolidines, cis-202 (1.33 g, 4.80 
mmol, 35%) and trans-202 (1.56 g, 5.63 mmol, 41%) as colourless oils. TLC – Rf (trans) = 0.16 
(SiO2, 20:80 EtOAc:PE). Rf (cis) = 0.25 (SiO2, 20:80 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) 
δH (trans) 1.88-1.95 (m, 2H, 2 x CH), 2.26-2.34 (m, 2H, 2 x CH), 3.63 (s, 6H, 2 x OCH3), 3.77 
(d, J = 13.4, 1H, CHAHBAr), 3.81-3.85 (m, 2H, 2 x C(O)CH), 3.95 (d, J = 13.4, 1H, CHAHBAr), 
7.21-7.32 (m, 5H, 5 x ArH). δH (cis) 2.04-2.07 (m, 4H, 2 x CH2), 3.40-3.44 (m, 2H, 2 x C(O)CH), 
3.57 (s, 6H, 2 x OCH3), 3.91 (s, 2H, CH2Ar), 7.25-7.33 (m, 5H, 5 x ArH). Spectroscopic data 
matched that previously reported.144  
 
Tetramethyl N-benzylpyrrolidine-2,2,5,5-tetracarboxylate, 203 
Under a dry, inert atmosphere, a solution of diisopropylamine (4.89 mL, 34.92 
mmol, 6.00 equiv.) in anhydrous THF (58 mL) was cooled to 0 °C. To this 
solution was added nBuLi (1.60 M in hexane, 17.5 mL, 17.46 mmol, 3.00 
equiv.) dropwise and the resulting solution was stirred for 30 minutes. The 
solution was cooled to −78 °C and 202 (1.61 g, 5.82 mmol, 1.00 equiv., 0.05 M) in anhydrous 
THF (58 mL) was added dropwise. The solution was stirred for 30 minutes at −78 °C and methyl 
chloroformate (2.70 mL, 34.92 mmol, 3.00 equiv.) was added dropwise. The solution was then 
stirred for a further 2 h and quenched with saturated aqueous NH4Cl (100 mL). The aqueous phase 
was then extracted with DCM (3 x 50 mL) and the combined organic extracts were washed with 
brine, dried (Na2SO4), filtered and concentrated in vacuo. The crude product was then purified by 
column chromatography (30-60% EtOAc:PE) to give the title tetraester as a white solid (984 mg, 
2.50 mmol, 43%). M.P. 145-146 °C (DCM). TLC – Rf = 0.25 (SiO2, 50:50 EtOAc:PE). 
1
H NMR 
(400 MHz, CDCl3) δH 2.48 (s, 4H, 2 x CH2), 3.51 (s, 12H, 4 x OCH3), 3.67 (s, 2H, CH2Ar), 7.11 
(t, J = 7.8, 1H, ArH), 7.22 (t, J = 7.8, 2H, 2 x ArH), 7.30 (d, J = 7.4, 2H, 2 x ArH). 
13
C NMR (101 
MHz, CDCl3) δC 33.3 (2 x CH2), 50.3 (CH2Ar), 52.4 (4 x OCH3), 75.0 (2 x NCquat.), 126.5 (ArC), 
127.8 (2 x ArC), 127.8 (2 x ArC), 139.9 (ArC), 170.5 (4 x CO). HR-MS (ESI, positive ion mode) 
– m/z for [C19H23NO8+H]
+ = 394.4000. Found 394.4001. FTIR (KBr) – 2973, 2891, 1748. 
270 
 
cis-Dimethyl pyrrolidine-2,5-dicarboxylate, cis-205 
Synthesised according to general procedure S using cis-202 (1.0 g, 3.61 mmol). 
The title secondary amine was isolated as a colourless oil (608 mg, 3.25 mmol, 
90%). TLC – Rf = 0.10 (SiO2, EtOAc). 
1
H NMR (400 MHz, CDCl3) δH 1.97-2.03 (m, 4H, 2 x 
CH2), 3.23-3.29 (m, 2H, 2 x C(O)CH), 3.49 (s, 6H, 2 x OCH3). Spectroscopic data matched that 
previously reported.145 
 
trans-Dimethyl pyrrolidine-2,5-dicarboxylate, trans-205 
 Synthesised according to general procedure S using trans-202 (1.0 g, 3.61 
mmol). The title secondary amine was isolated as a colourless oil (608 mg, 3.25 
mmol, 90%). TLC – Rf = 0.11 (SiO2, EtOAc). 
1
H NMR (400 MHz, CDCl3) δH 1.88-1.96 (m, 2H, 
2 x CH), 2.20-2.29 (m, 2H, 2 x CH), 3.60 (s, 6H, 2 x OCH3), 3.67-3.72 (m, 2H, 2 x C(O)CH). 
Spectroscopic data matched that previously reported.146 
 
cis-Dimethyl N-benzyloxycarbonylpyrrolidine-2,5-dicarboxylate, cis-206 
Under a dry, inert atmosphere, a solution of cis-205 (579 mg, 3.09 mmol, 1.00 
equiv., 0.10 M) in anhydrous THF (31 mL) was prepared. To this solution was 
added DIPEA (0.59 mL, 3.40 mmol, 1.10 equiv.) and the solution was cooled 
to 0 °C. Benzyl chloroformate (0.49 mL, 3.40 mmol, 1.10 equiv.) was added 
dropwise and the resulting solution was warmed to room temperature and stirred for 4 h. Saturated 
aqueous NaHCO3 (50 mL) was added and the aqueous phase was extracted with DCM (3 x 25 
mL). The combined organic extracts were then washed with brine, dried (Na2SO4), filtered and 
concentrated in vacuo. The crude product was then purified by column chromatography (20-40% 
EtOAc:PE) to give the desired carbamate as a white solid (636 mg, 1.98 mmol, 64%). TLC – Rf 
= 0.16 (SiO2, 20:80 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 2.10-2.15 (m, 4H, 2 x CH2), 
3.67-3.72 (m, 2H, 2 x C(O)CH), 3.70 (s, 6H, 2 x OCH3), 5.02 (s, 2H, CH2Ar), 7.24-7.33 (m, 5H, 
5 x ArH). Spectroscopic data matched that previously reported.147  
 
trans-Dimethyl N-benzyloxycarbonylpyrrolidine-2,5-dicarboxylate, trans-206 
Under a dry, inert atmosphere, a solution of trans-205 (600 mg, 3.21 mmol, 
1.00 equiv., 0.10 M) in anhydrous THF (32 mL) was prepared. To this solution 
was added DIPEA (0.61 mL, 3.53 mmol, 1.10 equiv.) and the solution was 
cooled to 0 °C. Benzyl chloroformate (0.50 mL, 3.53 mmol, 1.10 equiv.) was 
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added dropwise and the resulting solution was warmed to room temperature and stirred for 4 h. 
Saturated aqueous NaHCO3 (50 mL) was added and the aqueous phase was extracted with DCM 
(3 x 25 mL). The combined organic extracts were then washed with brine, dried (Na2SO4), filtered 
and concentrated in vacuo. The crude product was then purified by column chromatography (20-
40% EtOAc:PE) to give the desired carbamate as a white solid (712 mg, 2.22 mmol, 69%). TLC 
– Rf = 0.12 (SiO2, 20:80 EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 1.90-1.96 (m, 2H, 2 x CH), 
2.32-2.35 (m, 2H, 2 x CH), 3.81 (s, 6H, 2 x OCH3), 3.81-3.85 (m, 2H, 2 x C(O)CH), 5.01 (d, J = 
12.4, 1H, CHAHBAr), 5.25 (d, J = 12.4, 1H, CHAHBAr), 7.21-7.32 (m, 5H, 5 x ArH). Spectroscopic 
data matched that previously reported.147  
 
Tetramethyl N-benzyloxycarbonylpyrrolidine-2,2,5,5-tetracarboxylate, 207 
Under a dry, inert atmosphere, a solution of diisopropylamine (1.43 mL, 10.2 
mmol, 6.00 equiv.) in anhydrous THF (17 mL) was cooled to 0 °C. To this 
solution was added nBuLi (1.60 M in hexane, 3.2 mL, 5.1 mmol, 3.00 equiv.) 
dropwise and the resulting solution was stirred for 30 minutes. The solution 
was cooled to −78 °C and 206 (545 mg, 1.70 mmol, 1.00 equiv., 0.05 M) in 
anhydrous THF (17 mL) was added dropwise. The solution was stirred for 30 minutes at −78 °C 
and methyl chloroformate (0.79 mL, 10.2 mmol, 6.00 equiv.) was added dropwise. The solution 
was then stirred for a further 2 h and quenched with saturated aqueous NH4Cl (50 mL). The 
aqueous phase was then extracted with DCM (3 x 20 mL) and the combined organic extracts were 
washed with brine, dried (Na2SO4), filtered and concentrated in vacuo. The crude product was 
then purified by column chromatography (2-4% MeOH:DCM to give the title tetraester as a white 
solid (512 mg, 1.17 mmol, 69%). M.P. 180-181 °C (DCM). TLC – Rf = 0.17 (SiO2, 50:50 
EtOAc:PE). 
1
H NMR (400 MHz, CDCl3) δH 2.52 (s, 4H, 2 x CH2), 3.55 (s, 6H, 2 x OCH3), 3.83 
(s, 6H, 2 x OCH3), 5.13 (s, 2H, CH2Ar), 7.27-7.34 (m, 5H, 5 x ArH). 
13
C NMR (101 MHz, CDCl3) 
δC 34.4 (CH2), 35.7 (CH2), 53.2 (2 x OCH3), 53.5 (2 x OCH3), 68.4 (CH2Ar), 73.7 (NCquat.), 74.1 
(NCquat.), 128.4 (ArC), 128.5 (2 x ArC), 128.6 (2 x ArC), 135.7 (ArC), 153.7 (CO), 168.8 (2 x 
CO), 168.9 (2 x CO). HR-MS (ESI, positive ion mode) – m/z for [C20H23NO10+H]
+ = 438.4090. 
Found 438.4105. FTIR (KBr) – 2962, 2917, 1740, 1662. 
 
Tetramethyl pyrrolidine-2,2,5,5-tetracarboxylate, 204 
Synthesised according to general procedure S using 207 (354 mg, 0.81 mmol. 
The title secondary amine was isolated as a white solid (245 mg, 0.81 mmol, 




H NMR (400 MHz, CDCl3) δH 2.39 (s, 4H, 2 x CH2), 3.72 (s, 12H, 4 x OCH3). 
13
C NMR (101 
MHz, CDCl3) δC 33.8 (2 x CH2), 52.4 (4 x OCH3), 70.9 (2 x NCquat.), 168.1 (4 x CO). HR-MS 
(ESI, positive ion mode) – m/z for [C12H17NO8+H]
+ = 304.1032. Found 304.1039. FTIR (KBr) – 










-Tetraphenyl pyrrolidine-2,2,5,5-tetracarboxamide, 208 
Under a dry, inert atmosphere, NaH (323 mg, 60% in mineral oil, 8.09 mmol, 
10.00 equiv.) was washed with hexane (3 x 10 mL). The pure NaH was then 
suspended in anhydrous THF (20 mL) and cooled to 0 °C. To the suspension 
was added aniline (1.11 mL, 12.15 mmol, 15.00 equiv.) dropwise and the resulting suspension 
was stirred for 30 minutes at 0 °C. A solution of 204 (245 mg, 0.81 mmol, 1.00 equiv., 0.02 M) 
in anhydrous THF (20 mL) was added dropwise. The resulting suspension was warmed to room 
temperature and stirred for 4 h. The suspension was then quenched with saturated aqueous NH4Cl 
(25 mL) and stirred for 15 minutes. The aqueous phase was then extracted with DCM (3 x 25 mL) 
and the combined organic phases were washed with brine, dried (Na2SO4), filtered and 
concentrated in vacuo. The crude product was then purified by column chromatography (2-5% 
MeOH:DCM) to yield the title tetramide as a white solid (146 mg, 0.27 mmol, 33%). M.P. 166-
167 °C (DCM). TLC – Rf = 0.38 (SiO2, 5:95 MeOH:DCM). 
1
H NMR (400 MHz, CDCl3) δH 2.55 
(s, 4H, 2 x CH2), 7.06 (t, J = 8.1, 4H, 4 x ArH), 7.19 (t, J = 7.7, 8H, 8 x ArH), 7.29 (d, J = 7.7, 
8H, 8 x ArH), 11.51 (s, 4H, 4 x NH). 
13
C NMR (101 MHz, CDCl3) δC 38.1 (2 x CH2), 75.5 (2 x 
NCquat.), 123.5 (8 x ArC), 127.3 (4 x ArC), 128.5 (8 x ArC), 138.3 (4 x ArC), 165.6 (4 x CO). 
HR-MS (ESI, positive ion mode) – m/z for [C32H29N5O4+H]
+ = 548.2298. Found 548.2307. FTIR 














Under a dry, inert atmosphere, a solution of 208 (113 mg, 0.21 mmol, 1.00 
equiv., 0.10 M) in anhydrous DMF (2 mL) was prepared. To this solution was 
added HATU (15 mg, 0.29 mmol, 1.40 equiv.), TEA (0.04 mL, 0.29 mmol, 
1.40 equiv.) and Boc-L-phenylalanine (10 mg, 0.29 mmol, 1.40 equiv.). The 
resulting solution was stirred for 72 h at room temperature and then diluted 
with aqueous HKSO4 (5 mL, 1.00 M). The aqueous phase was extracted with 
DCM (3 x 5 mL) and the combined organic phases were washed with aqueous KHSO4 (2 x 5 mL) 
and brine, dried (Na2SO4), filtered and concentrated in vacuo. The crude product was then purified 
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by column chromatography (2-5% MeOH:DCM) to yield the title amide as a white solid (28 mg, 
0.04 mmol, 17%). M.P. 139-140 °C (DCM). TLC – Rf = 0.40 (SiO2, 5:95 MeOH:DCM). 
1
H 
NMR (400 MHz, CDCl3) δH 1.40 (s, 9H, C(CH3)3), 2.52 (s, 4H, 2 x CH2), 3.08-3.18 (m, 2H, 
CH2Ar), 4.80 (dd, J = 6.2, 9.8, 1H, NCH, rot.), 4.87 (dd, J = 6.2, 9.8, 1H, NCH, rot.), 6.91 (d, J = 
6.8, 2H, 2 x ArH), 6.96 (d, J = 6.1, 1H, ArH), 7.09 (t, J = 7.3, 1H, ArH), 7.15-7.58 (m, 21H, 21 x 
ArH), 7.92 (s, 1H, NH, rot.), 7.93 (s, 1H, NH, rot.), 8.18 (s, 1H, NH), 8.86 (s, 1H, NH), 8.96 (s, 
1H, NH). 
13
C NMR (101 MHz, CDCl3) δC 28.4 (C(CH3)3), 36.9 (CH2), 37.8 (CH2), 41.8 (CH2Ar), 
58.7 (NCH), 72.3 (NCquat.), 74.0 (NCquat.), 80.2 (C(CH3)3), 121.2 (2 x ArC), 121.3 (2 x ArC), 121.8 
(2 x ArC), 122.0 (2 x ArC), 125.2 (ArC), 127.6 (2 x ArC), 128.0 (ArC), 128.3 (ArC), 128.4 (ArC), 
128.4 (ArC), 128.6 (2 x ArC), 128.8 (2 x ArC), 129.0 (2 x ArC), 129.1 (2 x ArC), 129.1 (2 x 
ArC), 139.0 (ArC), 139.0 (ArC), 139.4 (ArC), 139.4 (ArC), 140.3 (ArC), 156.5 (CO), 168.2 (CO), 
168.4 (CO), 168.5 (CO), 168.8 (CO), 172.8 (CO). HR-MS (ESI, positive ion mode) – m/z for 
[C46H46N6O7+Na]













Under a dry, inert atmosphere, a solution of 212 (24 mg, 0.03 mmol, 0.03 M) 
in anhydrous EtOH (0.5 mL) was prepared. To this solution was added HCl 
(4.00 M in EtOAc, 0.5 mL) and the resulting solution was stirred for 16 h at 
room temperature. The solution was concentrated in vacuo and the residue was 
diluted with EtOAc (4 mL). The solution was diluted with saturated aqueous NaHCO3 (4 mL) 
and the organic phase was washed with saturated aqueous NaHCO3 (4 mL) and brine, dried 
(Na2SO4), filtered and concentrated in vacuo to yield the title amine as a white solid (20 mg, 0.03 
mmol, 97%). M.P. 193-194 °C (CHCl3). TLC – Rf = 0.20 (SiO2, 5:95 MeOH:DCM). 
1
H NMR 
(400 MHz, CDCl3) δH 2.56 (s, 4H, 2 x CH2), 3.00-3.10 (m, 2H, CH2Ar), 4.11 (dd, J = 7.3, 9.2, 
1H, NCH, rot.), 4.30 (dd, J = 7.3, 9.2, 1H, NCH, rot.), 7.01 (d, J = 7.1, 2H, 2 x ArH), 7.06 (d, J = 
6.1, 1H, ArH), 7.10 (t, J = 7.0, 1H, ArH), 7.13-7.60 (m, 21H, 21 x ArH), 8.28 (s, 1H, NH, rot.), 
8.30 (s, 1H, NH, rot.), 8.44 (s, 1H, NH), 9.15 (s, 1H, NH), 9.34 (s, 1H, NH). 
13
C NMR (101 MHz, 
CDCl3) δC 37.0 (CH2), 37.9 (CH2), 40.5 (CH2Ar), 50.3 (NCH), 74.6 (NCquat.), 75.3 (NCquat.), 121.4 
(2 x ArC), 121.5 (2 x ArC), 122.0 (2 x ArC), 122.0 (2 x ArC), 125.2 (ArC), 127.2 (2 x ArC), 
128.1 (ArC), 128.1 (ArC), 128.5 (ArC), 128.6 (ArC), 128.8 (2 x ArC), 129.1 (2 x ArC), 129.4 (2 
x ArC), 129.5 (2 x ArC), 129.8 (2 x ArC), 139.1 (ArC), 141.4 (ArC), 141.4 (ArC), 141.9 (ArC), 
141.9 (ArC), 166.3 (CO), 166.4 (CO), 167.2 (CO), 167.2 (CO), 174.9 (CO). HR-MS (ESI, 
positive ion mode) – m/z for [C41H38N6O5+H]
+ = 695.2982. Found 695.2997. FTIR (KBr) – 3354, 




































Figure A2 – VTNMR of 45 (CD2Cl2, 300 MHz, 14 mM). 
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Figure A3 – VTNMR of 45 (40% v/v CD3OH in CD2Cl2, 300 MHz, 14 mM). 
 
Figure A4 – VTNMR of 45 (10% v/v d6-DMSO in CD2Cl2, 300 MHz, 14 mM). 
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Figure A5 – VTNMR of 46 (CD2Cl2, 300 MHz, 11 mM). 
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Figure A6 – VTNMR of 46 (10% v/v d6-DMSO in CD2Cl2, 300 MHz, 11 mM). 
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8.3 Eyring Analyses 
 
All Eyring plots were constructed using rate constants that were attained by line shape 
fitting of experimental spectra at different temperatures. Spectra were simulated using SpinWorks 
4 NMR processing software (available at 
ftp://davinci.chem.umanitoba.ca/pub/marat/SpinWorks/) with appropriate exchange vectors. For 
each temperature, the corresponding rate of hydrogen-bond-directionality reversal was estimated 
using the dynamic NMR simulation module DNMR3. The Eyring-Polanyi equation was 
rearranged to give an equation of the form y = mx + c such that a plot of 1/T against ln(k/T) gave 
a straight line of gradient 
−Δ𝐻‡
𝑅






. These data were used with the Gibbs 
free energy equation to extrapolate ΔG
‡
298 K. Examples of the simulation of systems in mutual 





























Figure A8 – Experimental (left) and simulated (right) spectra for 41.  








) t½ (s) 
193 36 0.0052 -1.6792 40.4763 0.0096 
203 100 0.0049 -0.7080 41.2913 0.0035 
213 220 0.0047 0.0323 42.1064 0.0016 
223 530 0.0045 0.8657 42.9215 0.0007 
233 850 0.0043 1.2942 43.7365 0.0004 
243 1500 0.0041 1.8202 44.5516 0.0002 
253 2200 0.0040 2.1628 45.3667 0.0002 
263 2800 0.0038 2.3652 46.1817 0.0001 
 














k / s-1 
ΔG
‡
298 K = 48.9 kJ mol
-1 
(CD2Cl2) 

























) t½ (s) 
193 25 0.0052 -2.0438 41.5908 0.0139 
203 29 0.0049 -1.9459 43.3350 0.0120 
213 34 0.0047 -1.8349 45.0791 0.0102 
223 50 0.0045 -1.4951 46.8233 0.0069 
233 61 0.0043 -1.3402 48.5674 0.0057 
243 80 0.0041 -1.1110 50.3116 0.0043 
253 100 0.0040 -0.9282 52.0557 0.0035 
 

















298 K = 59.9 kJ mol-1 
(40% CD3OD in CD2Cl2) 


























) t½ (s) 
193 30 0.0052 -1.8615 40.9945 0.0116 
203 58 0.0049 -1.2528 42.2732 0.0060 
213 100 0.0047 -0.7561 43.5518 0.0035 
223 150 0.0045 -0.3965 44.8305 0.0023 
233 225 0.0043 -0.0349 46.1091 0.0015 
243 310 0.0041 0.2435 47.3878 0.0011 
 












298 K = 54.5 kJ mol-1 
(10% (CD3)2SO in CD2Cl2) 

























) t½ (s) 
248 17 0.0040 -2.6802 54.6897 0.0204 
258 27 0.0039 -2.2571 55.6309 0.0128 
268 51 0.0037 -1.6592 56.5721 0.0068 
278 90 0.0036 -1.1278 57.5133 0.0039 
288 150 0.0035 -0.6523 58.4544 0.0023 
298 250 0.0034 -0.1756 59.3956 0.0014 
 


















298 K = 59.4 kJ mol-1 
(CD2Cl2) 














































) t½ (s) 
203 20 0.0049 -2.3175 44.0026 0.0173 
213 35 0.0047 -1.8059 45.1939 0.0099 
223 60 0.0045 -1.3128 46.3852 0.0058 
243 180 0.0041 -0.3001 48.7678 0.0019 
253 290 0.0040 0.1365 49.9591 0.0012 
263 430 0.0038 0.4916 51.1504 0.0008 
273 490 0.0037 0.5849 52.3418 0.0007 
283 700 0.0035 0.9056 53.5331 0.0005 
 
















298 K = 55.3 kJ mol-1 












) t½ (s) 
213 18 0.0047 -2.4709 46.4921 0.0193 
223 35 0.0045 -1.8518 47.1746 0.0099 
233 80 0.0043 -1.0690 47.8572 0.0043 
243 200 0.0041 -0.1947 48.5397 0.0017 
253 450 0.0040 0.5759 49.2222 0.0008 
263 850 0.0038 1.1731 49.9048 0.0004 
273 1300 0.0037 1.5606 50.5873 0.0003 
283 1800 0.0035 1.8501 51.2698 0.0002 
 
















298 K = 52.3 kJ mol-1 
(10% (CD3)2SO in CD2Cl2) 




























) t½ (s) 
248 16 0.0040 -2.7408 54.8299 0.0217 
258 27 0.0039 -2.2571 55.6705 0.0128 
268 55 0.0037 -1.5837 56.5110 0.0063 
278 85 0.0036 -1.1850 57.3515 0.0041 
288 165 0.0035 -0.5570 58.1920 0.0021 
298 310 0.0034 0.0395 59.0325 0.0011 
      
Figure A15 – Eyring plot for 45.  
 








) t½ (s) 
213 50 0.0047 -1.4493 52.4842 0.0069 
223 60 0.0045 -1.3128 53.2037 0.0058 
233 100 0.0043 -0.8459 53.9233 0.0035 
253 220 0.0040 -0.1398 55.3623 0.0016 
298 700 0.0034 0.8540 58.6002 0.0005 
 
Figure A16 – Eyring plot for 45 (40% CD3OH in CD2Cl2). 
ΔG
‡
298 K = 59.0 kJ mol-1 
(CD2Cl2) 






























298 K = 58.6 kJ mol-1 













) t½ (s) 
238 22 0.0042 -2.3812 51.9623 0.0158 
248 45 0.0040 -1.7068 52.4464 0.0077 
258 83 0.0039 -1.1341 52.9305 0.0042 
268 230 0.0037 -0.1529 53.4145 0.0015 
278 450 0.0036 0.4816 53.8986 0.0008 
288 850 0.0035 1.0823 54.3827 0.0004 
298 1500 0.0034 1.6161 54.8667 0.0002 
      






























298 K = 54.9 kJ mol-1 














) t½ (s) 
213 17 0.0047 -2.5281 46.6874 0.0204 
223 21 0.0045 -2.3626 48.3624 0.0165 
233 27 0.0043 -2.1552 50.0374 0.0128 
243 35 0.0041 -1.9377 51.7124 0.0099 
253 60 0.0040 -1.4390 53.3874 0.0058 
283 95 0.0035 -1.0916 58.4124 0.0036 
298 130 0.0034 -0.8296 60.9249 0.0027 
 

































































) t½ (s) 
253 85 0.0040 -1.0907 52.4946 0.0041 
263 165 0.0038 -0.4662 52.7524 0.0021 
273 400 0.0037 0.3820 53.0102 0.0009 
283 850 0.0035 1.0998 53.2681 0.0004 
293 1600 0.0034 1.6976 53.5259 0.0002 
298 2800 0.0034 2.2403 53.6548 0.0001 
 


















298 K = 53.7 kJ mol-1 













) t½ (s) 
248 18 0.0040 -2.6231 54.6252 0.0193 
258 32 0.0039 -2.0748 55.3295 0.0107 
268 52 0.0037 -1.6245 56.0338 0.0066 
278 144 0.0036 -0.6578 56.7382 0.0024 
288 240 0.0035 -0.1823 57.4425 0.0014 
298 396 0.0034 0.2843 58.1468 0.0009 
      
Figure A20 – Eyring plot for 41 (minor conformer to major conformer). 
 








) t½ (s) 
248 12 0.0040 -3.0285 55.4624 0.0289 
258 22 0.0039 -2.4803 56.2005 0.0160 
268 35 0.0037 -2.0299 56.9385 0.0098 
278 96 0.0036 -1.0633 57.6766 0.0036 
288 160 0.0035 -0.5878 58.4147 0.0022 
298 264 0.0034 -0.1211 59.1527 0.0013 
      





298 K = 58.1 kJ mol-1 




298 K = 59.2 kJ mol-1 
(major conformer to minor 
conformer) 
(CD2Cl2) 
y = −4469.1x + 15.289




























) t½ (s) 
193 55 0.0052 -1.2554 45.5790 0.0063 
233 80 0.0043 -1.0690 47.8309 0.0043 
243 200 0.0041 -0.1947 48.3939 0.0017 
253 450 0.0040 0.5759 48.9569 0.0008 
263 900 0.0038 1.2302 49.5198 0.0004 
273 1600 0.0037 1.7683 50.0828 0.0002 
283 2700 0.0035 2.2556 50.6458 0.0001 
298 4000 0.0034 2.5970 51.4902 0.0001 
 


















298 K = 51.5 kJ mol-1 
(CD2Cl2) 




























) t½ (s) 
223 12 0.0045 -2.9223 49.3977 0.0289 
233 19 0.0043 -2.5066 50.5376 0.0182 
243 38 0.0041 -1.8555 51.6775 0.0091 
253 75 0.0040 -1.2159 52.8173 0.0046 
263 130 0.0038 -0.7046 53.9572 0.0027 
273 198 0.0037 -0.3212 55.0970 0.0018 
283 260 0.0035 -0.0848 56.2369 0.0013 
298 310 0.0034 0.0395 57.9467 0.0011 
 




















































) t½ (s) 
298 21 0.0034 -2.6526 65.3357 0.0165 
303 34 0.0033 -2.1874 65.5875 0.0102 
313 55 0.0032 -1.7389 66.0911 0.0063 
323 120 0.0031 -0.9902 66.5947 0.0029 
333 220 0.0030 -0.4145 67.0983 0.0016 
343 350 0.0029 0.0202 67.6019 0.0010 
353 600 0.0028 0.5305 68.1055 0.0006 
363 1050 0.0028 1.0621 68.6091 0.0003 
373 1600 0.0027 1.4562 69.1128 0.0002 
 









































) t½ (s) 
298 20 0.0034 -2.7014 63.1811 0.0173 
303 37 0.0033 -2.1028 63.3757 0.0094 
313 63 0.0032 -1.6031 63.7650 0.0055 
323 135 0.0031 -0.8724 64.1542 0.0026 
333 250 0.0030 -0.2867 64.5435 0.0014 
343 425 0.0029 0.2144 64.9328 0.0008 
353 650 0.0028 0.6105 65.3220 0.0005 
363 1250 0.0028 1.2365 65.7113 0.0003 
373 1750 0.0027 1.5458 66.1005 0.0002 
 














298 K = 63.2 kJ mol-1 
(CD2Cl2) 






























) t½ (s) 
323 180 0.0031 -0.5847 65.7157 0.0019 
333 330 0.0030 -0.0090 65.9564 0.0011 
343 500 0.0029 0.3769 66.1971 0.0007 
353 900 0.0028 0.9359 66.4378 0.0004 
363 1900 0.0028 1.6552 66.6785 0.0002 
373 4000 0.0027 2.3725 66.9192 0.0001 
 




298 K = 62.7 kJ mol-1 
(CD2Cl2) 



















8.4 NOE Analyses 
 
All 1D NOE studies were conducted on a Bruker AVANCE III HD 500 MHz NMR 









































Figure A31 – NOE studies of 91 (irradiation of blue).  
 




Figure A33 – NOE studies of 97.TFA (irradiation of blue).  
 
 










Fluorescence spectra were recorded using a PerkinElmer LS45 fluorimeter in a Marco 
Fluorescence Quartz Cuvette in anhydrous DCM. 
 
Figure A36 – Emission profile of 142 after addition of anionic ligands (irradiation at 405 nm, ~1 
mM). 
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Figure A38 – Emission profile of 157 after addition of TFA (irradiation at 405 nm, ~1 mM). 
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8.6 X-Ray Crystallographic Data 
 
Recrystallisation for X-ray crystallography was achieved by slow evaporation of a 
precipitant into a solution containing the desired compound. Analysis was performed using a 
Bruker Apex II Goniometer. 
 
X-ray data for 175 (recrystallised from CHCl3/PE) – 
Bond precision: C-C = 0.0038 A Wavelength=0.71073 
Cell: a=12.6236(4) b=14.4638(4) c=34.9564(9) 
 alpha=90 beta=92.5613(17) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 6376.2(3) 6376.1(3) 
Space group P 21/c P 1 21/c 1 
Hall group -P 2ybc -P 2ybc 
Moiety formula C30 H36 N6 O6 [+ solvent] C30 H36 N6 O6 
Sum formula C30 H36 N6 O6 [+ solvent] C30 H36 N6 O6 
Mr 576.65 576.65 
Dx,g cm-3 1.201 1.201 
Z 8 8 
Mu (mm-1) 0.085 0.085 
F000 2448.0 2448.0 
F000' 2449.10  
h,k,lmax 15,18,43 15,18,43 
Nref 13032 13032 
Tmin,Tmax 0.969,0.984 0.688,0.746 
Tmin' 0.961  
Correction method= # Reported T Limits: Tmin=0.688 Tmax=0.746 AbsCorr = 
MULTI-SCAN 
 
Data completeness= 1.000 Theta(max)= 26.372 
R(reflections)= 0.0564( 9664) wR2(reflections)= 0.1332( 13032) 
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